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Studying the effects of inbreeding in human populations could provide insights into the genetic
architecture ofmedically relevant quantitative traits and common complex diseases of late onset.
In a historic example of 2,761 examinees from isolated village populations of the islands of Brae,
Hvar and Korcula, Croatia, collected through field work undertaken in the 1970's and 1980's,
individual inbreeding coefficients were computed based on genealogical records. Inbreeding
showed a strong positive effect on blood pressure and negative on cortical index. The 14 villages
were revisited in 2000 to assess the prevalence of learning disability and of common complex
diseases of late onset. A cohort study and an ecological study, after appropriate standardization,
both showed that inbreeding increased the prevalence of coronary heart disease, stroke,
psychiatric disorders, cancer, gout, asthma, glaucoma and peptic ulcer, but not type II diabetes.
A strong effect on the prevalence of learning disability was also noted in 10 villages. In a follow-
up study on 1,001 examinees from 10 other villages sampled on neighbouring islands in 2002,
positive effects of outbreeding on fitness, height, blood pressure, cholesterol and triglyceride
values were detected. The possible explanations for the observed effects include: (i) The joint
effect of inbreeding depression on all polygenic quantitative phenotypes that confer risk for late-
onset diseases is predicted to be multiplicative rather than additive, (ii) The "genetic load" of
rare "Mendelian" variants with large deleterious effects in post-reproductive adults is unknown,
but could be much greater than expected as these variants were invisible to selection through
human history, (iii) Deleterious effects resulting from autozygosity in hundreds of affected rare
recessive variants of small effect under common disease/rare variant (CD/RV) hypothesis could
result in epistatic effects that could jointly impair the capacity to compensate against
environmental risks, (iv) Heterozygote advantage in loci under balancing selection could be
reduced by inbreeding. Consanguinity is common in many populations and the possible effects
of inbreeding depression on disease burden and reduced life expectancy should be further
investigated.
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FOREWORD
This thesis is a result ofmy involvement in a large research programme, which includes
several groups of researchers in both Scotland in Croatia. Although 1 acknowledged their
continuing help and support (see Acknowledgement on page 163), in this foreword I
explain in detail which elements of this PhD Thesis were entirely my own work, and
which resulted from the work of the entire group involved in the joint research
programme.
The idea for the thesis, to investigate the effects of inbreeding on late-onset quantitative
traits and complex common diseases in Croatian islands isolates, is my own. I began to
develop it in 1997 and I published the first concepts, objectives, strategies and results as
a single author in the years of 1999 and 2001, based on the datasets that I collected
myself, originating from the Croatian Cancer Registry and from the Island of Lastovo,
Croatia.
Since May 2000,1 closely collaborated with Professor Harry Campbell from the
University of Edinburgh, who is my supervisor on this thesis and who substantially
helped me to further develop those ideas over the course of time. In this thesis, we
agreed to test our hypotheses on the effects of inbreeding on late-onset traits and
diseases in two datasets:
(i) A historic, 20-year old sample from 25 villages of 3 different Croatian islands (Brae,
Hvar and Korcula) where inbreeding is prevalent; the data on blood pressure, cortical
index and socio-economic variables were collected by the team of the Institute of
Anthropological Research in Zagreb, Croatia, in late 1970s and early 1980s. That field
research was undertaken under the leadership of Professor Pavao Rudan, who is the
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Director of the Institute. The two variables of interest were measured by DrNina
Smolej-Narancic, who kindly provided them for our further analyses.
This historic dataset was appended with individual inbreeding coefficients computed
from the genealogical records, which I reconstructed myself between 1997 and 2000,
and with data on complex chronic diseases in the individuals from the historic sample
who were still alive in 2000, which I extracted myself in collaboration with the local
general practitioners.
(ii) A newly collected dataset derived from contemporary populations of 10 villages
from 4 different Croatian islands (Rab, Vis, Lastovo and Mljet), where inbreeding is also
prevalent; Professor Campbell and I jointly raised funding for the field work leading to
the development of this second database from the Wellcome Trust, the Croatian Ministry
of Science and Technology, the British Council, the Royal Society UK, the Medical
Research Council UK and the National Institutes of Health (USA). I led the field work
to collect the new dataset in 2002 and 2003.
The analysis of the collected data is my own work, supervised by my mentor Professor
Harry Campbell. The only exception is the statistical analyses of association between
individual inbreeding coefficients and blood pressure and its implications on genetic
architecture of the trait. That analysis was performed by Dr Andrew Carothers from the
Human Genetics Unit of the Medical Research Council in Edinburgh, to increase the
quality of the presentation of the results when a related paper was submitted for
publication, and I have repeated those analyses under his supervision when writing this
thesis.
Professor Alan Wright has substantially assisted me in interpreting the data and realizing
their significance in wider context, and I used the elements from our discussions to write
the two closing sections of the discussion of this thesis.
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The mixture of two or more genetically distinct populations
Homozygosity in which both alleles at a locus in an individual
are a copy of a single allele inherited from an ancestor who was
related to both parents of the individual
Linked region of the genome (see "Linkage analyses") that is
more likely to contain a causal genetic variant influencing a
studied phenotype of interest
A measured phenotype, such as disease status or a quantitative
trait, which is influenced by many environmental and genetic
factors, and potentially by interactions in and between them
Genetic relatedness between individuals due to joint sharing of
the gene(s) inherited from a common ancestor from the more
distant past
Probability of observing a presumed genotype given the
phenotype
The extent to which a factor influences the risk of the condition
under study, rather than simply an indication of whether the
factor is significantly related to the condition
At the level of individuals or a population, a measure describing
how likely it was that the ancestors of the individuals seen
presently to inhabit an area were also born and chose a spouse
from the same area

















A genetic variant is genotyped in a population for which
phenotypic information is available; if a correlation is observed
between genotype and phenotype, there is said to be an
association between the variant and the disease or trait
Changes in allele frequencies in a population from one
generation to another as the result of chance events in mating,
meiosis and number of offspring
A set of alleles that is present on a single chromosome
The proportion of variation in a given characteristic or state that
can be attributed to (additive) genetic factors
Also termed "founder populations"; populations that have been
derived from a limited pool of individuals within the last 100 or
fewer generations.
See "Autozygosity"
The probability that both copies of an allele are inherited from a
common ancestor (identical-by-descent)
The detrimental effects of inbreeding, typically causing a
reduction in the means of fitness-related traits as a result of
increased homozygosity
Mapping genes by typing genetic markers in families to identify
chromosome regions that are associated with disease or trait
values within pedigrees more often than expected by chance.
The non-random association of alleles of different linked
polymorphisms in a population
Diseases inherited in simple (Mendelian) fashion, as the entire
disease phenotype is due to a mutation in a single gene
xiv
Mutation Any change in genome sequence
Penetrance Probability of observing a presumed phenotype given the
genotype
Polymorphism A variant allele with a frequency greater than 0.01
Quantitative trait loci Genetic loci that contribute to variations in quantitative
(continuous) phenotypes
Statistical power The probability of correctly rejecting the null hypothesis when
it is truly false
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1. INTRODUCTION
1.1. CURRENT APPROACHES TO STUDYING THE
GENETIC BASIS OF HUMAN TRAITS AND DISEASES
1.1.1. Introduction
Human health is defined by the World Health Organisation as "...a state of
complete physical, mental and social well-being and not merely the absence of disease
or infirmity." (1). Critics of this definition argue that health is a process rather than a
state, and that well-being cannot ever be expected to be "complete" (2). This shows how
difficult it is to define either health or disease and to clearly separate them. Human
diseases represent a complex spectrum of health disturbance, ranging from those
presenting early in life to those with very late onset and from mainly genetically
determined to nearly entirely caused by environmental exposures (3).
It is certain, however, that the aetiology of some diseases is considerably simpler
than of the others. Some diseases, such as Mendelian diseases, often present early in life,
thus limiting the importance of environmental exposures in their aetiology in
comparison to diseases of later onset (although the role of intrauterine exposures to
different environmental stressors and its effects on health in later life are not yet well
understood). Such diseases are usually due to the structural or functional deficiency of a
single protein, resulting from random change in thegenetic code controlling the synthesis
of this protein (4). The partial or a complete structural deficit of a single enzyme, or a
building protein, eventually leads to cascade of events presenting as a disease
phenotype. In this case, in all affected patients the disease phenotype is a direct
consequence of a single change in genetic information. At the other end of the
complexity spectrum are diseases such as cardiovascular disease and cancer. They
develop for years as a result of the combination of inherited polygenic susceptibility and
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lifetime exposure to the environment (3). Their slow development can only be monitored
as a gradual breakdown of physiological mechanisms that became unable to compensate
for microscopic structural damage or functional changes at various levels of the human
organism. The result is a continuing deviation of monitored metabolic or biochemical
parameters from the expected value. Over the course of time, this results in the first
presenting symptoms and eventually leads to the development of the characteristic
disease phenotype (3).
The investigation of genetic and environmental factors that interact in causing a
disease has been a fundamental goal of the modern epidemiology of non-communicable
diseases. This science recognises that each human being has a different genetic build-up
(except monozygotic twins) and a personal history of lifetime environmental exposures,
and therefore represents an unique evolutionary experiment in time and space. However,
by designing appropriate prospective and retrospective studies, modern epidemiology
attempts to identify genetic characteristics and environmental exposures that are
significantly more frequent among the persons with the disease phenotype than in the
general population. Such characteristics, found among those who exhibit the disease
phenotype more frequently than it would be expected by chance, are then considered
"disease risk factors". Once the risk factors are identified, an evaluation of the relative
contribution of each of them to the development of disease and assessing whether the
associations found between diseases and risk factors are causal or coincidental represent
other important goals of modern epidemiology (5-8).
To produce results of any validity, epidemiological studies heavily rely on an
investigator's ability to measure suspected risk factors (genetic characteristics or
environmental exposures) precisely and to classify study subjects correctly according to
the presence or absence of the disease. The presence of disease is typically "measured"
by a set of diagnostic criteria. These criteria have a validity of nearly 100% for many
diseases (especially if based on pathohistological examinations or various biochemical
tests). Still, for some common diseases, misclassification is a serious concern even
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nowadays (9,10). Regarding the risk factors, researchers usually investigated those that
could be measured with a reasonable degree of precision. This included a multitude of
variables related to the individual's environmental exposures, physiological or metabolic
monitoring, or even psychological profiling. The most investigated risk factors in non-
communicable disease epidemiology during the 20th century therefore included a
person's age, marital status, occupational exposures, smoking, body mass index, blood
pressure, cholesterol levels, food intake frequency, psychological assessment of life
quality, etc. These all fostered the development of environmental, ecological,
occupational, nutritional and psychological epidemiology (5).
Genetic epidemiology, however, was unable to expand in a similar fashion. This
was because during most of the 20th century it was hardly possible to measure an
individual's genetic build-up in any direct way. The investigation of genetic risk factors
was limited to twin studies (11), heritability studies (12), inbreeding studies (13) and
studies of phenotypically expressed genetic variation (e.g. classic erythrocyte antigens,
HLA systems) (14,15). These studies had a variety of designs and could only provide
indirect insights into general patterns of association between factors related to
inheritance and the occurrence of diseases. This was very far from designs that
researchers ideally desired to apply. However, this situation dramatically changed during
the past two decades, when methods for the analysis of the variation in the DNA
molecule in each human individual were first introduced (16,17). This development
immediately attracted epidemiologists of non-communicable diseases, who realised the
opportunities provided by directly measuring genetic material as a disease risk factor (6).
The early excitement and optimism were justified, as today it is possible to measure an
individual's genetic build-up more precisely than we will ever be able to measure a
person's environmental exposures (such as diet). The progress in genomic research,
especially in understanding the patterns of variation in the human genome, is destined to
nurture a further rapid expansion of genetic (genomic) epidemiology, possibly to the
levels that eventually may surpass all historic successes of other approaches to
epidemiological research in non-communicable diseases (18-21).
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In this introduction, current strategies to find genes responsible for susceptibility
to human diseases will be discussed, especially those associated with the greatest burden
of disability and death, such as cardiovascular diseases, cancer, diabetes or psychiatric
disorders. The ongoing debates on the likely genetic architecture of most common
human diseases will be addressed. The suitability of the available tools to find
underlying genes to the existing knowledge gathered from both genetic and
epidemiological research of human disease aetiology will be analysed. Finally, based on
the results of various applied strategies to find common disease susceptibility genes,
current prospects for translating genomic advances into measurable public health
benefits will be discussed.
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1.1.2. Advances in Genome Research Enhanced the Development of
Genetic Epidemiology
The main goal of genetic epidemiology is to express the genetic build-up of an
individual as a (predictor) variable, so that it can be statistically correlated to other
variables of interest - disease phenotype and interacting environmental risk factors. The
criterion variable in this design can be qualitative (the presence or absence of disease
phenotype) or quantitative (such as levels of blood pressure, serum cholesterol or blood
glucose). The advances in the study of the human genome during 1990s through the
publicly funded Human Genome Project (HGP) and the privately funded project at
Celera Genomics made important steps towards achieving this goal (22,23). The
sequencing of the human genome showed that all humans are identical in about 99.9%
of their genome sequence. More importantly, however, the genes (which are, in broad
terms, the segments of the genome sequence that contain code for protein synthesis)
formed only about 3% of that sequence, while the function of the remaining 97% of the
genome remained largely unknown.
After those discoveries, it initially seemed logical to assume that the entire
variation in terms of susceptibility to acquiring or avoiding diseases during a life span
would have to be due entirely to the variation found within those 3% of the coding
genome sequence, i.e. the genes, as only more recently comparative genomics between
different mammals began to point to the presence of ultraconserved elements in the non-
coding genomic regions, implying that they too may be of relevance. Efforts by HGP
and Celera both initially estimated that there are about 40,000 genes scattered across the
human genome, a number later corrected to about 25,000 (22,23). The term "gene",
however, has a number of possible definitions. For the purpose of genetic
epidemiological studies, a "gene" can be considered a location in a human DNA
molecule, usually several thousand nucleotides (i.e. base pairs) long, in which there are
shorter segments of coding sequence ("exons") and longer segments of non-coding
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sequence ("introns"). During protein synthesis, the coding elements ("exons") are first
transcribed into "messenger RNA" (mRNA) molecules, while the non-coding elements
("introns") are cut out. Messenger RNA then travels from the cell nucleus to the
ribosomes where it is being read in "triplets" of nucleotides, each encoding the
subsequent amino-acid to be built into the structure of a resulting protein. It is important
to note that the location in the DNA that we refer to as a "gene" jointly assumes the
coding information inherited from the person's mother (one DNA strain) and father (the
complementary DNA strain). If those two sequences ("gene alleles") inherited from both
of the parents are identical, then a person will be "homozygous" for that gene, and if
they differ the individual is "heterozygous". If both differing sequences ("alleles") of a
gene in a heterozygous individual are eventually expressed in a phenotype, then they act
"codominantly". If only one of them is phenotypically fully expressed and the other is
not, then they are "dominant" and "recessive" alleles, respectively (6,22,23).
The defined terms "homozygosity" and "heterozygosity" refer to characteristic of
each gene in an individual. Genetic epidemiology is also interested in terms that relate to
characteristics of genes in the entire population. A gene is "monomorphic" if there is
only one ("fixed") allele for this gene present in the entire population. This means that
all the individuals in the population will have to be homozygous for that gene, as they
will always inherit the same allele, whoever their parents are. It is thought that about
65% of all human genes are monomorphic. Those probably include many genes with
regulatory signalling function that determine that we only should have two kidneys, one
liver, and five fingers on each hand. Other genes are "polymorphic", as two or more
sequence variants ("alleles"), each with population frequency of at least 1%, can be
found in the population at their precise genomic location. The differences between
humans at their birth are thought to be mainly due to genetic variants found at
polymorphic genomic loci (22,23).
I argued that one of the important goals of genetic epidemiology was to precisely
measure the genetic build-up of each individual and to quantitatively express it as a
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variable. This means that genetic epidemiologists are interested only in the varying part
of human genetic material. If one accepts that 97% of the non-coding human genome
sequence has no apparent function, then this part of the genome should not influence
disease susceptibility. In addition to that, some two thirds of the predicted 25,000 human
genes could be monomorphic ("human genetic invariance"), and their role in disease
susceptibility may therefore not influence the variation in disease risk among humans.
This intuitively suggests that only the differences in combinations of alleles that can be
found at remaining ~ 10,000 polymorphic human genes determine genetic variation in
susceptibility to human disease.
If this is true, it would reduce the aim of genetic epidemiology to identifying
different sequence variants ("alleles") in polymorphic genes that are significantly more
frequently present among the diseased than in healthy population. Subsequent goals
would then include understanding how the change in sequence ("mutation"), which
introduced this new allele, affects protein synthesis, and by what mechanisms does this
lead to disease phenotype. Therefore, finding alleles associated with increased disease
risk could, in the long term, allow genetic testing of individuals at a very early age and
permit the institution of preventive measures from childhood to decrease environmental
disease risks. Another apparent benefit of finding these alleles is that insights into
change in function of the protein they encode could enhance our understanding of
complex mechanisms that cause the disease and provide new targets for development of
related drugs.
In an ideal genetic epidemiological longitudinal study, all -10,000 polymorphic
human genes would be sequenced in the entire human population. All the existing
sequence variants ("alleles") would be catalogued and their population frequencies
determined. Then, all humans would be followed up for disease status during their entire
lifetime. After correcting for known environmental risks, gene-environment interactions
and gene-gene interactions, it would theoretically be possible to assign relative risks and
the population-attributable fraction of disease incidence in the population to each allelic
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variant that exists for each polymorphic gene. Such an undertaking would currently be
impossible, as large funds and years ofwork by many research groups would have to be
spent at the current state of technology to perform this study even in 10 individuals
(22,23). However, the costs of genotyping (i.e. determining existing alleles at different
genome locations in DNA from individual subjects) are rapidly decreasing and the speed
at which it can be performed is increasing. This led to recent calls to set the target at an
affordable price for whole genome sequencing, i.e. setting a long-term goal to reduce the
price of sequencing each individual's genome to about $1,000 (24). This is still far from
realistic, but hardly anyone in the field would argue that it might not become possible in
the future. Genetic screening and individually tailored drug treatment and prevention
strategies could therefore become available to everyone who could afford the sequencing
of his/her own genome.
Until then, we will have to design alternative approaches to locate genes
underlying human diseases and find allelic variants responsible for functional changes
that lead to disturbed health. The main problem is correctly associating disease
phenotype with the specific allelic variant of a gene located somewhere in a genome.
The advances in human genomics offered the first tools. These are based on two
fundamental properties of the human genome. The first is the existence of several
abundant classes of polymorphic sites scattered across the entire genome with precisely
determined locations ("polymorphisms", "genetic markers"), that can be genotyped
using the polymerase chain reaction (25-28). The second is a property of the genome
called "linkage disequilibrium", which reflects the observation that markers that are
physically close to each other will tend to be co-inherited, and so will the entire genomic
sequence between them (29-32).
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1.1.3. Polymorphic Markers and Linkage Disequilibrium Enabled
Search for Genes Responsible for Human Diseases
The sequencing of the human genome produced evidence of the general identity
of genomic sequence among humans in about 99.9% of base pairs when any two humans
are compared. However, this is not to say that all 6 billion people have nearly identical
sequences, and that the entire observed variation is due to the remaining 0.1% of the
genetic code. Virtually any of the 3 billion nucleotides in the haploid genome can be
randomly changed by mutation at any generation in any individual (33). However, since
every person has 2 alleles for every gene (apart from those on Y-chromosome), the
frequencies of such changes at the time of their first appearance will be 1 in 12 billion
alleles, i.e. negligible. We speak of "polymorphic sites" in the human genome only when
such newly introduced mutations gradually increase in population frequency over a
number of generations, and eventually the frequency of the second allele of a previously
monomorphic gene reaches frequency of at least 1% in the entire population (33). Loci
with two or several alleles present in the population, each in frequency greater than 1%,
have been found at about 0.1% of human with a genome sequence. These polymorphic
sites can be exactly located by applying specifically tailored restriction enzymes. There
are several classes of those "polymorphic sites" in the genome ("genetic markers",
"polymorphisms"), but only two will be addressed here as they have an important
potential to assist finding genes responsible for common human diseases.
The first class of polymorphisms is jointly termed "short sequence repeats"
(SSR). At some locations in the genome, short nucleotide sequences tend to repeat
several times (e.g. "TATATATA" represents a dinucleotide "TA" which is repeated four
times; "GTCGTCGTC" is a trinucleotide "GTC" repeated three times). For some reason,
when DNA is duplicated during the cell division, the number of repeating times of these
nucleotide sequences can be slightly mistaken (e.g. 6 or 8 repeats are transcribed into the
DNA of a separating cell instead of 7). The locations in the genome where variable
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number of short tandem repeats can be found are called "STR"-s (from "short tandem
repeats") or "microsatellites". The exact location of hundreds of those "markers" has
been defined in the human genome, which roughly translates into one per each 1 million
nucleotides (bp). They are very informative, as not only are they variable in a population
at each individual location, but their sequence along the chromosomes (termed
"haplotype") is becoming more unique for each person with introduction of each
following microsatellite into a haplotype. With each new polymorphic STR added, the
probability of any two persons sharing exactly the same haplotype rapidly diminishes,
until it is so small that it allows the unique identification of each person based on
variation found in the DNA (25,26,34).
Another large and promising class of polymorphisms are "single nucleotide
polymorphisms" (SNP). These have been one of the major discoveries of the Human
Genome Project. It is thought that there should be several million of these
polymorphisms scattered throughout the human genome (33). As each of 3 billion
nucleotides in the human genome can mutate (e.g. from "A" to "C", "T" or "G"), this
gives rise to a new "allele" of extremely low frequency in the population (which equals
exactly one over the doubled number of all humans). However, not many of these
mutations will increase in frequency over many generations to reach an allele frequency
of 1% needed for that precise location in the genome to be formally declared a "single
nucleotide polymorphism" (SNP). It should be noted that each individual SNP marker is
incapable of subdividing humans into as many categories as each individual STR
marker. This is because each SNP locus can theoretically only have four different
"alleles" ("A", "C", "T" or "G"), one of which is usually highly predominant. At the
same time, each STR marker can have numerous alleles (e.g. 10 alleles with 5 to 14
repeats), many of them with quite similar allele frequencies. This makes a haplotype of
any 5 consecutive STR markers far more informative, while any 5 consecutive SNP
markers may be shared by a large number of humans.
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However, there are also large advantages of SNPs over STRs. Firstly, they are
several orders ofmagnitude more numerous in the human genome, and one can be found
roughly in every 1 thousand nucleotides, while one STR can approximately be found per
1 million nucleotides. Thus, SNPs should allow for a very fine-scale search for genes on
sequence segments that have been suspected as candidate for harbouring disease genes.
This is often referred to as "fine-mapping" and it uses the property of the genome termed
"linkage disequilibrium", which we will attempt to explain in more detail (35,36). Also,
STR markers are very informative in families, where they are directly transmitted from
ancestors to the offspring, but their use is very limited at the level of population because
they mutate too frequently and therefore obscure the signal with the disease variants at
the level of population, which is highly unlikely to happen within the several generations
of extended pedigrees under study. Finally, a very practical advantage of the SNPs over
STRs is that SNPs can be tested in very large numbers due to the technological
development of DNA chips, while STR markers are much more difficult to work with
and genotype in the laboratory.
The human genome is diploid in nature, which means that the large majority of
its 3 billion nucleotide sequences exist in duplicate, with one copy inherited from each
parent. These two copies coexist and functionally represent a single human genome. The
only two exceptions to this rule are the sequence of the Y-chromosome (haploid in
nature and always inherited from the father) and mitochondrial DNA (always inherited
from the mother). The rest of the human genome is diploid, and it has the property of
recombination ("crossing over"): exchanging the corresponding complementary
segments of the genome sequence between parents' haploid genome sequences in each
person. This happens during meiosis, when the recombined 23 chromosome haploid
genome does not contain exclusively a single parent chromosomes, but rather a
relatively random mixture of maternal and paternal sequences within each chromosome.
This has the obvious consequence of breaking down the haplotypes of specific STR or
SNP markers that were originally found along the paternal chromosomes. However,
polymorphic alleles on a haplotype that are physically close to each other will have a
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smaller probability of separation through recombination from those that are located far
apart. Therefore, some alleles will have a probability of co-inheritance greater that the
expected 50%, as if they were on different chromosomes or recombination could occur
randomly between them. For such alleles that remain together on a paternal haplotype
("unrecombined"), we say that they are in "linkage disequilibrium" (29-32).
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1.1.4. Study Designs of Genetic Epidemiology: Extended Pedigree
Studies, Affected Sib-Pair Studies and Genetic Association
Studies
Based on this understanding and definition of polymorphic markers and their
positions, the first genetic epidemiological study designs aiming to find alleles
responsible for diseases could begin to emerge. There are presently three very broad
strategies to identify genetic variants associated with susceptibility to human diseases:
(i) extended pedigree studies; (ii) affected sib-pair studies, and (iii) genetic association
studies of population samples.
The pedigree approaches emerged from Mendelian understanding of the
inheritance, and reflect primarily the interest of biologists in finding clues to the
aetiology of diseases. The latter two strategies emerged from the concept of disease risk
factors at the interest from the perspective of public health. Affected sib-pair linkage
studies represent the extension of early genetic epidemiological studies trying to assess
disease risk in relatives of the affected individuals in comparison to the general
population. Genetic association studies reflect primarily the interest of epidemiologists
in population-attributable fraction associated with different disease risks, which in this
case are genetic variants present in different frequencies in a population.
All three approaches were made possible by the development of so-called
"linkage maps", i.e. sets of hundreds of STR polymorphic markers, or hundreds of
thousands of SNP polymorphic markers intended for "genome-wide scan". These
"genome-wide scans" aimed to identify at least one marker, but preferably the specific
haplotype, that would be found at excess frequency (with extremely high statistical
significance) among affected disease cases in comparison to unaffected controls. When a
marker was found in excess frequency among affected individuals in comparison to
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controls, it would then be presumed that it must be physically "linked" to the disease
gene. Then, the whole "candidate" region around the marker would be fine-mapped by a
more dense set ofmarkers to identify the precise position of the responsible gene (37).
The development of genetic maps of polymorphic markers made pedigree-based
linkage studies of Mendelian disorders a routine. This was followed by the development
of physical maps based on linkage disequilibrium, which further allowed fine-scale
mapping. Historically, pedigree-based linkage studies have proven to be a very
successful and powerful approach in finding genetic variants responsible for Mendelian
(monogenic) diseases if several realistic requirements were fulfilled. Firstly, it was
necessary to collect a number of nuclear (or extended) families with multiple disease
cases. Secondly, it was essential that the affected persons were correctly classified as
"diseased" and the unaffected as "healthy". Thirdly, all disease cases in each family
needed to be caused by mutations in only one gene, resulting in an apparent pattern of
disease inheritance ("Mendelian" diseases: autosomal or sex-linked, with dominant,
recessive or codominant modes of inheritance). Fourthly, there should be no genetic
heterogeneity in disease aetiology, meaning that all the disease cases in all collected
families from the population were caused by mutations in the very same gene with a
unique position in the human genome (6, 37). Fifthly, both "penetrance" and
"detectance" needed to be reasonably high. The penetrance indicates a probability of
developing the disease phenotype given the disease genotype (if less than 100% among
carriers of the mutation that can cause the disease phenotype, it leads to misclassification
of some study subjects and decreases the power of the study to detect underlying disease
genes). The "detectance" indicates a probability of the disease genotype given the
disease phenotype, as not all cases of disease phenotype in a population would have a
single, or sometimes even any, genetic cause to the development of their disease, again
leading to misclassification.
If the studied disease was recessive, especially if it was found in an inbred
pedigree (which was usually the case), linkage analysis would be even more powerful.
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The gene would have to be in the parts of the genome of the affected child that is
inherited identical-by-descent from both parents (38). In the children of second cousins,
only 1.56% of the genome is expected to be shared identical-by-descent, so if 800 STR
markers were used to locate the gene, only about 10 of them would remain possible
candidates after the analysis of a single case and his parents. Therefore, it was enough in
some instances to find only 3 cases from an inbred isolate human population to be able
to narrow down a "candidate region" to a single marker. Many genes for Mendelian
diseases were indeed firstly detected in isolate and inbred human communities, as it was
extremely likely that the rare genetic mutation had to be introduced on only one
occasion in history by a single founder (39). Thus, genetic heterogeneity of the studied
disease was not a concern, as was the case when the families were collected from the
general population.
After the candidate marker linked to a disease gene was identified, fine-mapping
of the surrounding region would be performed with a more dense set of markers,
involving both STRs and SNPs. The density of selected markers for both the genome-
wide scan and subsequent fine-mapping of a specific gene is always an important issue
in any linkage analysis. As base pairs (nucleotides) measure physical distance between
positions in the genome, Morgans measure the probability of recombination occurring
between them per meiosis (generation). This makes it a more appropriate measure of
distance between markers when they are used to locate the unknown gene, whereby 1
million base pairs roughly equals to 1 centimorgan (cM) (40). The use of a linkage set
with markers that are 5 cM apart meant that there was only a 5% chance that
recombination occurred between those two markers during meiosis. The initial genome-
wide scans are therefore usually performed with markers spanning 5 or 10 cM, as this
represents an acceptably low probability that recombination destroyed the connection
between the marker and disease gene, given the large number of recruited families that
would eventually point to the region of interest. Sometimes, however, the eventually
determined candidate region spans over the entire haplotype of several markers, i.e.
several megabases in distance, and harbours hundreds of genes. Therefore, it typically
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took years until the causal genetic variant was found by fine mapping and its function
understood. However, through this procedure a near-complete understanding of the
genetic aetiology of those diseases was obtained, which would be impossible by any
other available means.
Deciding which markers are significantly associated with disease phenotype is
based on agreement among the scientists in the field on a procedure targeted to reduce
the likelihood of false positive result. For linkage analysis, a sequential procedure is
used for sampling and analysing extended pedigrees until the evidence in favour of
linkage with a marker (usually expressed as logarithm base 10 of the likelihood ratio)
reaches the level of 3. The "LOD score" value of 3 corresponds to P-value of 10"4, when
2 • •the x approximation is used for "one-sided" likelihood ratio test. This concept achieved
wide acceptance because it was possible to assess the prior probability. For genetic
association studies (see later), estimates of prior probability are usually very subjective,
but essentially there is no prior evidence that could be used to assess and quantify prior
probability. This coupled with ever larger number of polymorphic markers tested in
genome-wide scans (up to 1 million SNPs or more), makes it very difficult to decide on
the appropriate cut-off points of the p-value needed to reduce the reporting of the false
positive associations. Another problem of genetic-association approaches are the
phenotypes: when genetic basis of the multiple phenotypes is studied in the same set of
samples, this gives rise to the statistical problem of multiple comparisons. Only the wide
replication of the results in different populations may eventually help to bypass the two
problems in the foreseeable future.
Extended pedigree studies are currently thought to be the most powerful
approach for identifying "intermediate phenotypes", i.e., loci influencing the variation in
quantitative traits that are confirmed risk factors for common complex diseases. These
studies are being conducted in several isolated populations with available genealogical
records, and the first results are awaited. The power of these studies to find genetic
variants underlying common complex diseases of late-onset is nevertheless thought to be
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limited, due to small number of disease cases in most of the isolated populations
presently studied. Despite their success in finding genes underlying Mendelian diseases,
extended pedigree studies of more common complex diseases yielded unrepeatable
results and a rough theoretical analysis showed that they are vastly underpowered to
detect the variants underlying more complex common diseases. Two alternative
strategies were proposed: affected sib-pair studies (usually hospital-based) and genetic
association studies (usually population-based).
Affected sib-pair studies are currently the predominant approach in genome-wide
mapping of common complex diseases. Most of the conducted studies to date were
underpowered to yield the promised results, but large international consortia are being
formed to overcome this problem. This approach does not require genealogical
reconstruction like the extended pedigree studies. It is robust to differences in genetic
structure of study populations, which is a problem of genetic association studies. It does
not require dense genome-wide scans and the related statistical analyses have been
theoretically well developed.
Genetic association studies are the most intriguing and the least exploited of the
three approaches to date. There is a hope that dense genome-wide scans using hundreds
of thousands (or even millions) of SNPs in sufficiently large cohorts of diseased
individuals and healthy controls will provide ultimate answers not only about genetic
variants involved in disease pathogenesis, but also in public health significance of those
variants at the level of the population. However, one of perhaps the main uncertainties
that may determine the future success of the genetic association studies is that they too
often rely on an assumption that diseases that are commonly found in population would
have common allelic variants causing them. Those common variants should, ideally, all
descend from a single mutational event occurring in one person in human history. In
theory, this may be possible if harsh selection was introduced. For example, in a time of
catastrophic historic epidemics, a person could have had a disease-causing mutation in
his genome located very close to (i.e., "in linkage disequilibrium with") an important
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and rare HLA variant that helped in surviving the epidemics. The selection
("epidemics") would then cause a massive reduction in the population size ("bottleneck
effect"), after which the frequency of the favourable HLA variant would be dramatically
increased in the surviving population, but along with it also the unfavourable disease-
causing mutation. The other mechanism through which susceptibility variants for
common diseases could have reached high frequencies is "antagonistic pleiotropy": a
variant that was positively selected, because it controlled a fitness-improving trait early
in life, may have negative health effects in the post-reproductive period (41). An
apparent example of this "thrifty genotype" hypothesis is type II diabetes (42). It is very
likely that humans were exposed to starvation throughout most of their evolution, thus
positively selecting genetic variants for slow and highly efficient food metabolism.
However, large environmental changes during the past century and the general
availability of food in developed countries led to epidemics of obesity later in life, which
seems to be the main determinant of type II diabetes.
In genetic association studies, all that is thought required to find the genes
underlying late-onset complex diseases would be genotyping many disease cases in the
population and many unaffected controls, until some differences in marker allele
frequencies begin to show significant differences. Therefore, genetic association studies
can be considered in some respects as linkage analyses where the entire population is
considered a giant pedigree (7,37). However, it is still a matter of great debate if this
approach is efficient, as it is based on a number of assumptions that in many cases may
prove quite unrealistic (8). This will be further discussed in the chapter on the leading
current approaches to find genes for complex diseases.
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1.1.5. Recent Understanding of Genetic Determinants of a Spectrum
of Human Diseases
1.1.5.1. MONOGENIC (MENDELIAN) DISEASES
The common feature of "Mendelian" diseases is that their entire phenotype is
caused by a rare mutation in a single gene in the genome. Therefore, the segregation of
affected individuals in families follows simple Mendelian predictions (4). The catalogue
of known Mendelian diseases is regularly published and currently there have been
16,373 phenotypes with suspected or proven Mendelian basis identified to date (OMIM
Statistics, Nov 13, 2005) (43). The last decade witnessed great successes in identifying
genetic variants underlying more than 10,000 of these diseases (11,43,44,45). The key
property of Mendelian diseases that made this success possible is that a causal genetic
mutation is both necessary and sufficient for the development of disease. This ensures
good correlation between disease phenotypes and underlying genotypes, given the
penetrance of the genetic effect is high, which is an important requirement for successful
linkage analyses or genetic association studies (44,45).
However, the initial successes in mapping variants underlying Mendelian
diseases were soon followed by unexpected insights into the complexity of those "most
simple" diseases. Two examples that were most extensively studied are retinitis
pigmentosa and the thalassaemias. Following the mapping of initial variants responsible
for the phenotype of retinitis pigmentosa in large pedigrees, it soon became apparent that
there are many different genes, perhaps dozens, scattered throughout the genome, that
may lead to the same disease phenotype when mutated. The aetiology of this condition
proved even more complex when it was recognised that numerous genetic variants that
underlie this condition follow very different modes of transmission: autosomal
dominant, autosomal recessive, sex-linked dominant and sex-linked recessive (37,46).
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Perhaps the most comprehensive insight into the complexity of phenotype-
genotype relationships in monogenic disease was given by Weatherall (45). His studies
on the thalassaemias across the world, arising through positive selection as a condition
protective against death from malaria, but based on extremely different genetic
mechanisms, showed how a remarkable diversity in phenotypes is encountered even in
this relatively "simple" disease (45). Thalassaemias are probably the commonest human
monogenic diseases, and approximately 7% of the world's population are carriers for
different inherited disorders of haemoglobin. The extreme phenotypic diversity of this
condition encountered throughout the world is determined by "...layer upon layer of
complexity" (45). Firstly, there is a variety of primary mutations at the beta-globin
genes, similar to the example of retinitis pigmentosa. Then, there is the action of two
known "secondary genetic modifiers": alpha and gamma-globin genes, which affect the
magnitude of the effect of excess of alpha chains. The result of the combined action of
primary and secondary modifiers is then affected by an unknown number of less well
defined "tertiary modifiers" (e.g. vitamin D receptor, oestrogen receptor, genes
implicated in collagen synthesis, the locus for hereditary haemochromatosis, UGT
glucuronyltransferase, HLA-DR locus, tumour-necrosis factor alpha, intracellular
adhesion molecule 1) (45). Finally, it is recognized that environmental, ethnological and
cultural factors also strongly affect the disease phenotype, although the underlying
mechanisms are less clear (45). This all shows the complexity underlying even the
"simplest" of genetically determined diseases and it should be taken into account when
studies searching for genetic determinants of more complex diseases are designed,
which is not usually the case.
1.1.5.2. "OLIGOGENIC" DISEASES
The initial successes in discovering genetic variants underlying monogenic
diseases encouraged further progress with the diseases that showed high heritability and
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were thought to be simpler in aetiology - "oligogenic diseases". An excellent example is
Hirschprung's disease, which is the most common hereditary cause of intestinal
obstruction. The pathogenesis of the disease was roughly understood, and the absence of
ganglion cells in the specific plexuses of the gastrointestinal tract (myenteric and
submucosal) was implicated as a cause (47). This understanding and the early onset of
the disease led the scientists to believe that Hirschprung disease (HD) is mainly
genetically determined and of relatively simple aetiology, although a clear Mendelian
pattern of inheritance could not be established. A linkage analysis in pedigrees with
multiple affected cases ("multiplex pedigrees") led to insights which categorised the
disease by genetic aetiology and explained both the familial and population risk of the
disease (48). There is the more common "short segment" form (S-HD), influenced by
three susceptibility loci at the chromosomes 3, 10 and 19, that explain the complete
population incidence of this form of HD. The gene at chromosome 3 is probably RET,
which seems to have the crucial role in all forms of HD (but not both necessary and
sufficient, as is the case with other genes that cause monogenic diseases). Other forms of
the disease ("long-segment" and "syndromic" HD) are more rare and genetically more
complex, with coding sequence mutations in RET, GDNF, EDNRB, EDN3 and SOXIO
genes being implicated in various studies (48).
Another disease that seems to show an "oligogenic" determination of
susceptibility is perhaps also an unexpected one - leprosy. Although this disease is
infectious, development of the phenotype seems to be strongly genetically determined. A
recent paper by Mira et al. (49) showed how the association of the disease with
chromosomal region 6q25 was first implicated in a sample of 86 Vietnamese multiplex
families using model-free linkage analysis. The association of the candidate region was
then repeated in 208 independent simplex Vietnamese families consisting of both
parents and one affected child (50). Fine mapping using single nucleotide
polymorphisms implied that a regulatory region shared by genes PARK2 and PACRG
was responsible for leprosy susceptibility (49). The authors replicated this association in
a sample of 975 unrelated cases and controls from Brazil, in whom the same variants
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also showed significant association with leprosy in a candidate gene study (49). Another
chromosomal region (1 Opl3), earlier implicated in an Indian sample of "paucibacillary"
disease cases (51), also showed strong association in a "paucibacillary" subset of
Vietnamese cases, but not in the "multibacillary" subset. The authors concluded that
variants in PARK2 and PACRG are common alleles that confer susceptibility to leprosy
"per se" globally, and that variants in 10pl3 region are also common alleles that
determine clinical presentation of disease as "paucibacillary" or "multibacillary" (49,50).
In recent years, more promising evidence is being gathered suggesting that some
other diseases may have a reasonably simpler architecture of genetic susceptibility than
common complex diseases of late onset. There is recently increased enthusiasm over the
identification of variants underlying the susceptibility of asthma (52-55), systemic lupus
erythematosus (56) and psoriasis (57,58).
1.1.5.3. COMPLEX POLYGENIC DISEASES OF LATE ONSET
The genetic basis of common complex diseases of late onset, responsible for
most of the public health burden in wealthy countries of the world, is currently perhaps
the greatest focus of interest of the entire biomedical scientific community. This is partly
because the identification of common genetic risk variants in human populations would
enable genetic screening and possibly provide new therapeutic targets for drugs that
could be administered in the same manner to a large number of persons at increased risk.
As both of those prospects would certainly be extremely lucrative and lead to an
unprecedented increase in revenues for those producing genetic tests and drugs, the
investments into research for genetic determinants of common late-onset diseases have
been enormous during recent years. Llowever, the output to date was hardly proportional
to the investments. It appears that apparent successes in mapping genes for monogenic
diseases and sequencing of the human genome prompted large number of research
groups, as well as both private and public investors, into the "gold rush" (search for the
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"Croesus Code") that may have been based on slightly over-optimistic assumptions (59).
Primarily, the common diseases of greatest interest, i.e. cardiovascular disease, cancer,
type II diabetes and psychiatric disorders, are frequently extremely complex phenotypes
that are, contrary to most monogenic diseases, difficult to measure uniformly and define.
Secondly, many of the approaches neglected the cumulative effects of the environment
on disease development, being interested only in the genetic component. This is in spite
of the knowledge that most of these diseases show rather low heritability and the
majority of cases in general population may be due to environmental exposures. Thirdly,
an appealing concept of "common disease/common variant" (CD/CV) gained popularity
among the mainstream researchers in the field, based on the assumption that frequent
diseases will be determined mainly by genetic variants common to all affected people
from different human populations (60).
The outcomes of the research based on previous assumptions were not
spectacular. This is not to say that there were no successes. Due to large investments,
many small successes have been made and the research field is rapidly expanding.
However, the massive undertaking of poorly designed genetic association studies based
on possibly false assumptions resulted in a great number of reported associations of
common diseases to numerous genes across the genome, but a substantial portion of
published reports is likely to be false-positive. Therefore, the issues of repeatability and
interpretation of such associations slowly became nearly as important as conducting the
studies themselves (61-63). Some general conclusions can be drawn at this point. The
t
variants that show repeatable associations with common diseases in more than one
population are usually of very small effect and not always common in the populations
under study. There were some isolated successes, such as the widely publicized
association between APO s4 variant in Alzheimer's disease, which indeed explained a
substantial fraction of disease cases in the population, but the majority of the variants
identified to date were unlikely to individually explain a substantial proportion of the
disease burden in the studied population. Other variants that were implicated but not
repeated may also be causal, but specific to the population under study (e.g., an unusual
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gene-environment interaction in the studied population). The genetic architecture of
common diseases is slowly beginning to reveal a large diversity of potential genetic
causes, all of them acting through a somewhat limited number of mechanisms, with an
increasingly appreciated contribution of environmental interactions (3,44).
Several individual efforts, however, increased our understanding of the genetic
basis of complex polygenic diseases to the extent worthy of specific mention. The
presented examples will be limited to cardiovascular diseases and cancer only, as those
two complex diseases are jointly responsible for up to 75% of deaths in western
countries and therefore represent the principal interest. The first example is the study by
Ozaki et al. (64), in which about 1,000 cases of myocardial infarction (MI) were
compared to roughly as many control individuals using 92,788 gene-based single-
nucleotide polymorphism markers (SNP). The authors used this impressive number of
markers in a nearly ideal high-tech genetic association study, conducted in a relatively
genetically homogenous Japanese population. Although they covered about half of the
entire human genome with their SNP markers, they could only find one statistically
significant association (coding region of LTA gene on chromosome 6) when a recessive
mode of inheritance was assumed, and no significant association (p< 10"6) under a
dominant model. The increase in risk of variant carriers was modest, i.e. about 1.7.
Although presented as a success, this study was actually rather discouraging for the
proponents of genetic association studies that are based on extremely large numbers of
SNP-markers, reasonably large samples of cases and controls from the outbred general
population, and linkage disequilibrium. Even if the reported association is truly causal, it
is certain that there must be far more genes underlying MI risk, but they were not
identified even in this exercise that was massive in scale. The confirmation of the
finding in a population other than Japanese is thus eagerly awaited.
Another interesting effort is the one performed by the deCODE Genomics
company in the Iceland population. This company was founded in 1996 with the aim of
identifying the genetic causes of common diseases and developing new drugs and
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diagnostics based upon its research. It used a different approach from the one presented
above, based on appreciating the large genetic heterogeneity and complexity underlying
common diseases. The Iceland population was chosen as it offered most of the potential
advantages needed to tackle this complexity - reduced genetic diversity, available
disease data and reliable genealogical information. deCODE invested hundreds of
millions of dollars into attempts to identify major genes involved in more than 20 of the
most common diseases, and has successfully isolated genes in seven of these to date,
which is possibly the greatest success rate by any group in the world. Two very recent
examples related to cardiovascular disease are identification of the gene encoding
phosphodiesterase 4D on chromosome 5 as a risk factor of ischaemic stroke (65), and
the gene encoding 5-lipoxigenase activating protein on chromosome 13 as a risk factor
for MI and stroke (66).
The investigations of genetic basis of cardiovascular diseases are still at a
reasonably early stage. However, the research into the genetic changes found in human
cancers has been conducted for decades (67). The extreme diversity and complexity of
the causes, mechanisms and consequences underlying malignant transformation of the
human cell is possibly a good predictor of what will be encountered in the future when
studying the genetic basis of other complex diseases (68). It is now known that familial
(monogenic) forms of cancer, such as breast cancer cases "exclusively" due to BRCA1
and BRCA2 mutations, account for only about 20% of the familial breast cancer cases,
while familial cases constitute only about 5-10% of all breast cancer cases in the general
population. Even among those "monogenic" breast cancers, only 25% can be explained
by changes in BRCA and other known "breast cancer" genes, while the remaining 75%
of familial cases are due to unknown familial predisposing genes. Non-familial cases,
which constitute 90-95% of cases in general population, can therefore be explained only
through the interaction of unknown polygenic predisposing genes and environmental
factors (69).
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Some of the changes in genetic material that are frequently postulated as
occurring in tumour cells, although neither necessary nor sufficient in all cases in a
population to lead to cancer, are mutations in coding or regulatory sequences, changes in
overall ploidy, high amplification, structural rearrangements and loss of heterozygosity
(67). The key feature of malignant cells is genomic instability, which can be due to
inherited mutations in genes that monitor genome integrity, or acquired in any somatic
cell during the development of cancer (70). However, the processes that follow are
mediated through an extreme diversity of mechanisms, where it is difficult to distinguish
the changes that led to cancer from the changes that arose as a consequence of cellular
transformation. The amount of published results in cancer research that is becoming
available on different molecular genetic aspects of the disease in recent years is so vast,
that possibly the leading current problem seems to be integrating and coordinating this
knowledge (68). It is hoped that many discovered signalling pathways act in parallel
through organized networks, but the only way to find those universal principles that are
somewhat more limited in number is to combine models and experiments. To achieve
this, developing a system of categorization of knowledge will be essential, and one such
effort is represented in the National Cancer Institute's Cancer Genome Anatomy project
(68). It is probable that the experience with cancer genetics and genomics will soon be
repeated through research into genetic causes of other complex chronic diseases of late
onset that were not mentioned here (e.g. psychiatric disorders, type II diabetes, and
others).
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1.1.6. Current Understanding of Genetic Architecture of Common
Complex Diseases
There is still a lot of uncertainty and a great deal of controversy over an
understanding of the genetic architecture underlying complex chronic diseases of late
onset. These diseases occur mainly in the post-reproductive period, and their genetic
determinants are therefore less subject to selective impacts from the environment than is
the case with more simple (monogenic and oligogenic) diseases of early onset. However,
cumulative negative impacts of the environment over time are also more important in the
aetiology of late-onset diseases than in early onset diseases. Late-onset diseases are
therefore not only genetically more complex, but also multifactorially determined. The
key questions that gave rise to recent debates are about the frequency of the responsible
susceptibility variants in a population (common / rare), the number of loci in the genome
that underlie these diseases (oligogenic / polygenic), and on the size of their effects
(large / small).
Some argue that, because diseases of late onset are quite common in a
population, their genetic determinants (variants responsible for increased susceptibility)
should, intuitively, also be common and therefore evolutionarily rather old. This is
known as the "common disease - common variant" hypothesis (CD/CV) (60). If this
were true, genetic association studies would be expected to be successful and to lead to
the identification of susceptibility variants. Others, however, argue that, although
counter-intuitive, common diseases are more likely to be caused by a highly complex
interaction of numerous genetic variants, most of them very rare, interacting among
themselves and with the environment. This hypothesis is known as "common disease -
rare variant" hypothesis (CD/RV), and would largely undermine currently proposed
efforts to identify disease susceptibility genes using genetic association studies (3). It
would promote the view that it is not realistic to expect one or a few mechanisms of
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pathogenesis per disease, but that there are many "private" mutations coupled with a
diversity of environmental exposures.
The patterns of human genetic diversity are of interest as it is thought that the
variants in our genomes make individuals susceptible to specific late-onset diseases.
Firstly, in more than 99% of our genome sequence there is practically no diversity, and
the variants at those loci are fixed (i.e. have a population frequency of 100%). However,
the figure of 100% is not entirely accurate, as it is possible that virtually any single
nucleotide in this "invariant" part of the genome may be changed ("mutated") in any
individual. However, this is not considered a true polymorphism, as such mutations have
incredibly low population frequencies, i.e. practically one in a number equaling twice
the total human population size for those occurring the first time in the autosomal part of
the genome. Such a newly arisen single nucleotide polymorphism (SNP) would have to
increase its frequency over the course of human population history from 1 in hundreds
of millions of people to 1 in 100, e.g. 6-7 orders of magnitude, to become a true
polymorphism in the population. If that occurred, this SNP can be considered a
"common" variant. It is predicted that about 12 million single nucleotides in the genome,
i.e. less than 1%, should be polymorphic (33,71). This magnitude of increase in
population frequency for the newly introduced mutations should only be possible
through 2 general mechanisms: long-time random genetic drift, or positive selection
favouring the carriers in each new generation due to the beneficial effects of such a
mutation in pre-reproductive life.
Going back to the "monomorphic" ("invariant") majority of the human genome,
it is possible that even this part could confer susceptibility to the development of late-
onset diseases. In that case, all humans would eventually get the disease after being
exposed to their environments for sufficiently long periods. The difference in age of
onset of disease cases would be determined solely by cumulative exposure to
environmental risk factors during their lifetime. This is a "common disease-fixed
variant" hypothesis (CD/FV), and there are good examples and plausible explanations
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why this would be the case for some diseases (42). For example, it is very likely that
starvation was a major selective pressure during most of human history, and that
selection strongly favoured new variants that were protecting humans from hunger
through more efficient food metabolism. If those variants became fixed, and everyone in
the present human population possesses them, the large environmental change in which
food became easily accessible in supermarket chains of the western world over the past
50 years would be expected to lead to a pandemic of obesity. This scenario is indeed
being observed nowadays. It is likely that atherosclerosis is another example of an
"universal" disease, the development of which depends only upon the sum of
environmental effects during lifetime.
Two important implications of the "CD/FV" hypothesis should be noted. Firstly,
in large outbred populations it would be useless to search for extremely rare variants in
this nearly "invariant" part of the genome that would additionally increase risk e.g. for
obesity or atherosclerosis above the "universal" risk shared by everyone. This is because
the population attributable fraction of disease cases due to those specific variants would
be negligible and would not lead to any feasible prevention of treatment strategies.
Secondly it is apparent that changing behaviour and reducing risky environmental
exposures would have much larger public health effects than any improvement in the
understanding of genetic basis of diseases under the CD/FV hypothesis. It is possible
that fixed variants do indeed play an important role in the genetic architecture of many
common complex diseases of late onset, which could partly explain the low genetic
variance and high environmental variance in many complex traits and diseases.
However, for other complex diseases of late onset, such as some types of cancer,
psychiatric and neurological diseases, it is clear that significant heritability can be noted,
and it is improbable that all humans would eventually develop those diseases after
enough time. In such diseases (e.g., breast cancer, manic depression or multiple
sclerosis), genetic factors are likely to play an important role in disease predisposition.
As there is variation among humans in their predisposition to developing those diseases,
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shown through demonstrated familial clustering in the population and increased disease
risk in relatives or twins of affected cases, it is thought that this variation is mediated
through polymorphic sites in the genome. The key question, however, remains whether
the predisposition to disease is a result of the action of variants at several loci
(oligogenic genetic architecture), all of which carry a reasonably large relative risk (e.g.
RR>2.0) and are common in a population (CD/CV hypothesis). The alternative
hypothesis is that there are many loci across the genome that interact among themselves
and with the environment (polygenic genetic architecture), most of which carry a very
small relative risk associated to individual variants (e.g. RR<1.5) and are very rare in a
population (CD/RV hypothesis). Under the first model, the identification of several
responsible variants of large effect would certainly provide clues into disease
pathogenesis, and enable genetic screening, prevention and gene-based therapy. Under
the second model, the identification of individual rare genetic variants that marginally
increase disease risk would contribute very little to an understanding of the disease
pathogenesis and would not lead to feasible diagnostic and therapeutic advances.
The two hypotheses are not necessarily mutually exclusive, and there are
arguments to support both. Lohmuller et al. reviewed the replicated gene-disease
associations in the world literature, the associated relative risks, and the frequencies of
the implicated variants in the population, and concluded that there is support for the
CD/CV hypothesis (72). However, the associated relative risks were usually
overestimated in the first published reports and they appear rather small, so that the
identified associations largely failed to improve the understanding of disease
pathogenesis. It is still thought, however, that the general lack of success in mapping
complex disease genes is due to most of the current studies being under-powered (using
too few cases and genomic markers to detect associations), and that improved designs
and meta-analyses should detect more common variants (8,73,74). Others doubt that
even the increase in number of subjects or number of markers should necessarily help
(3). They argue that if variants became common in a population, they are likely to either
be neutral during the pre-reproductive period (and thus increased in frequency by
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genetic drift), or to have beneficial effects on fitness in the pre-reproductive period (and
therefore be positively selected). This would imply that common variants with
detrimental effects in the post-reproductive period would have had to be very old in
evolutionary terms and neutral or even beneficial ("antagonistic pleiotropy" hypothesis)
in early life. The authors consider this to be unlikely, based on a summary of the
evidence from experimental organisms, or at least to not be a leading mechanism of
common disease pathogenesis. Finally, there is a third scenario in favour of the CD/CV
hypothesis which cannot be easily dismissed. It hypothesises that some very rare
variants became extremely useful in times of large pandemics of infectious diseases, and
rapidly increased in frequency over shorter periods of human history. A variant
physically close to (in tight linkage with) the protective variant could then also increase
in frequency via a "hitch-hiking" effect, as its detrimental effects on fitness were
considerably smaller than the beneficial effects of the linked protective variant under the
selective pressure of epidemics. This could explain at least some of the numerous
reported associations between specific HLA groups and some relatively common human
diseases (75).
The proponents of the CD/RV hypothesis mainly use arguments that rely on
decades of fundamental research in population genetics and human evolution. As the
human population underwent a massive expansion over the past several generations,
modelling the predicted number of newly arisen mutations during recent human history
implies that the majority of genetic variants contributing to current human genetic and
phenotypic variation is predicted to be rare (3). This argument has recently been
strengthened by the discovery that the estimate of the number of mutations per
generation per gamete could have been historically underestimated by an order of
magnitude (76). The recent work by Cohen et al. is the first prominent paper that
empirically shows that the high-risk tail of the distribution of a complex quantitative trait
- HDL cholesterol - is determined mainly by rare variants at the population level (77).
Although it may seem counter-intuitive to some scientists (and certainly less attractive
for industrial investment) that common diseases of late-onset are mainly caused by a
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large number of rare variants with small effects, this long neglected view appears to
finally be gaining some support.
To summarise the current state in this debate, it is generally accepted that the
allelic frequencies in the population and their effect size have an "L"-shaped
distribution. The alleles with very large effects, that could provide new insights into
disease pathways and mechanisms, are predicted to be very rare in the population. At the
same time, the alleles with tiny effects in pre-reproductive period are allowed by
selection to become more common (78). The effects of many rare and possibly some
common variants interacting among themselves and with the environment would
cumulatively lead to the breakdown of intrinsic compensation mechanisms of the human
organism and eventually manifest as the disease phenotype.
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1.1.7. Leading Current Approaches to Identify Common Complex
Disease Genes
Based on everything discussed so far, it can be concluded that two main
approaches to identify common complex disease genes are emerging in the post-genome
sequence era. The first approach, which currently represents mainstream research as
shown by the large number of publications of its proponents in high-profile journals in
recent years, is advocating expensive efforts in the general populations of western
countries, such as U.K. and U.S.A. ("BioBanks") (79,80). Such studies are attempting to
generate large population cohorts (of up to 1 million people) with great quantities of
information on individual genetic background and environmental exposures. Then,
massive genetic association studies are planned with tens of thousands of affected cases
and hundreds of thousands of unaffected controls. Their genomes would be scanned
using a large number of single-nucleotide polymorphisms (SNP), which may run into
hundreds of thousands ofmarkers per person. The key assumption that would eventually
determine the success of this general approach is that the genes underlying most
common complex diseases and their underlying haplotypes are common in the
population (common disease/common variant hypothesis, "CD/CV"). A recent meta¬
analysis of genetic association studies published to date was supportive of a significant
contribution of common variants to common disease susceptibility (72). The leading
current effort following this direction is the "International Hap-Map Project" (81). This
project assumes that most human genomic diversity is common, and is organised into
distinct "haplotype blocks". Those blocks are presumably also common in the
population, and so are the disease susceptibility mutations arising on those blocks.
Ultimately, the catalogue of all variants of haplotype blocks in the human genome would
enable associating them with common diseases, which would be a more feasible strategy
than a genome-wide scan if the initial assumptions are correct. Moreover, each
haplotype would be defined by a minimum informative number of SNPs needed to
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distinguish it from other haplotype variants ("haplotype tagging"), which would greatly
reduce the costs and effort of genotyping (82).
An alternative approach is based on the assumption that the key to success in
mapping complex disease genes will be through decreasing their aetiologic
heterogeneity, or subdivision by more detailed phenotyping into distinct disease
subgroups, and improving correlation between genotypes and phenotypes in populations
under study. This approach advocates the use of isolate human populations with a
defined number and origin of founders, known ethnic history, possibility to define
disease phenotypes, and reconstruct individual genealogical records (39,83). Some of the
obvious advantages of this approach are that it is orders of magnitude less costly, and
that linkage analyses and genetic association studies can be performed at the same time
to support each other and increase the power of the study. However, the main advantage
may be that this approach should work even if the variants underlying common complex
diseases are rare in general population. This is because such rare variants with large
effects may still be common enough in an isolate population to be detected by a genetic
association study. If they are also rare in an isolate population, they still may be detected
by linkage analysis, through an approach that is similar to the mapping of monogenic
(Mendelian) diseases in isolate populations, which already proved successful in the past.
Therefore, even if most of the genetic diversity underlying common diseases proves to
be rare, which is somewhat counter-intuitive but predicted by population genetic
theories (common disease/rare variant hypothesis, "CD/RV"), the variants could still be
identified (3). The problem with studying isolate populations are small sample sizes and
that the results may not be relevant for and applicable to wider, general populations.
However, it seems that this approach is being taken more seriously in the research
community due to recent successes in Iceland (65,66). This is especially true because
Iceland's most recent success, finding a gene that increases susceptibility to myocardial
infarction, was mapped on a rather common haplotype in Iceland. The association with
the suspected genomic location was later declared confirmed in the population of United
Kingdom by a candidate gene approach and genetic association study, but with a
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different and less common haplotype involved in the latter population. This was
presented as an example how the initial finding would not be possible in the general
U.K. population, but only in an isolated population of Iceland, although there is an open
remaining question whether finding an association with different alleles in the same
gene could indeed be considered "a replication" of the original finding. The results from
other isolate populations that are currently under study are eagerly expected, which
include the populations ofNewfoundland (84), the Saami (85), Sardinia (86), Israel (87),
Netherlands (88), Croatia (89) and Dagestan (90), to mention a few.
In addition to those two leading over-arching approaches that are attempting to
discover genetic variants underlying complex common diseases in a comprehensive
way, and to find genes for many different diseases and traits within the same study, there
are also other, more specific approaches that led to important advances. Many disease-
oriented groups throughout the world formed multi-centre initiatives to gather a large
number of patients with a specific diagnosed disease of interest, mainly using affected
sib-pair design. In such cases, unlike in the two approaches mentioned above, the
recruitment of the disease cases is not population-based, but rather hospital-based. When
an adequate number of cases is recruited for the study, the "candidate regions"
harbouring genetic variants of interest are initially sought for by relatively small number
of markers (usually several hundreds). These approaches are presumed especially
powerful if the diseases in collected cases were of early onset. This general approach,
although only single disease specific, and subject to a number of confounding effects
(such as population stratification) (91) and often disregarding environmental effects, has
still been quite successful. Some repeatable associations in the current literature were
reported after this initial approach (92,93). The comparative strengths and weaknesses of
pedigree-based approaches, affected sib-pair studies and genetic association studies were
already extensively discussed in Chapter 1.1.4.
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1.1.8. Translating Genomic Knowledge into Public Health Benefits
There are two main expectations from genetic epidemiology in terms of
delivering results that would have major impact on public health. The first one is the
association of different genetic variants with specific health risks and the translation of
that knowledge into the development of commercially available genetic tests that could
predict diseases. The second one is the understanding of disease mechanisms and
obtaining new insights in disease pathogenesis, which would reveal new targets for the
development of drugs that could prevent or reverse the course of human diseases (94).
Although several years ago those targets appeared far from reality, today there is a
growing economic sector of biotechnology, in which a large number of private
companies are attempting to deliver one or both of those goals, and some tests and
genome-based drugs are already being offered on the market. We will briefly address the
current status of advancement towards those two main goals of genetic epidemiology.
In terms of genetic testing, recently also called "genomic profiling", it is based
on an expectation that knowing most of the genetic variants that could increase the risk
of disease would enable the development of "DNA chips" containing this information.
Those chips could then scan for the presence of an extremely large number of such
variants in any individual's genome at birth. After the scan of the genome, the chip
would compute the lifetime risk of various diseases, thus being a powerful tool of a
"personalised medicine". Although a number of private companies already offer
genomic profiling for "oxidative stress", "susceptibility to obesity or osteopenia",
"nicotine or alcohol dependance", etc., these could hardly have any scientific basis, as
the genetic architecture of those traits and responsible variants are simply not known
with any accuracy at present. Therefore, the problem of regulating the marketing of such
tests is growing recently, as it is entirely unlikely that we could have useful and reliable
genetic tests that could predict individual risk of common complex diseases in the
foreseeable future (94). However, in the meantime it is certain that the ease of marketing
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of those tests, coupled with the desire of consumers in some western countries to
actively control their health at any cost, may result in the creation of a smaller market for
these tests of unproven value. Similar or even more dramatic examples have already
been seen with the popularity of various diets and food supplements (20,21,95,96).
However, although predicting complex diseases in individuals based on their
unique genome sequence may still be far from reality, there have been some positive
developments in achieving the second target - associating genes with diseases to
understand aetiology which eventually led to new drug discoveries. The two frequently
cited examples are imatinib and trastuzumab (97,98). Imatinib (Gleevec) was developed
following the discovery that a chromosome translocation created a new gene structure in
some patients with chronic myeloid leukaemia, and the drug binds to the protein product
of this gene and fights disease progression where other treatments fail (97). Trastuzumab
(Herceptin) did not appear to significantly improve the survival of breast cancer patients,
until it was realised that it is very efficient, but only in a subset of Her-2 positive breast
cancer cases. Those examples based on a molecular understanding of disease
pathogenesis may seem spectacular, but the more general view is that the successes in
finding the genes underlying common complex diseases have been very modest in
relation to the unprecedented investments into this research from both industry and the
academic community. Although numerous associations of various genes with a spectrum
of diseases have been reported, only a few of those associations have been replicable.
Moreover, the risks associated with implicated variants were usually very modest. The
findings to date promised little hope for contributing to an improvement in the
understanding of disease aetiology. As the current level of investment in unsustainable,
it is becoming apparent that the successes in mapping genes for Mendelian diseases will
not be easily repeated with complex diseases, and that more rational strategies for
associating genes and disease phenotypes will need to be developed.
Based on these premises, the recent review by Merikangas and Risch (99)
provided a more sober assessment of the current status of research for common complex
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disease genes and strategies for future investments. The authors argue that investments
are justified for the diseases that are: (i) common in the population (associated with
substantial public health burden); (ii) can be diagnosed precisely (to avoid
misclassification of cases, which dramatically reduces the power of genetic association
and linkage studies); (iii) show substantially increased risk in relatives of diseased cases
(to demonstrate the role of genetic effects as opposed to environment); and (iv) for
which no preventable environmental risks are known. It is worrying that enormous funds
are being invested in searching for the genetic basis of diseases or conditions that hardly
show any heritability, cannot be diagnosed with any precision, or for which the funds
would be far better placed in fighting environmental risks rather than searching for
genetic clues. For example, investing funds in finding genes for increased individual
"nicotine dependence" or "alcohol dependence" is entirely misplaced, as those traits
have been shown to cluster more strongly in social groups of different genetic
background rather than in families. In addition, the benefit of public health intervention
on reducing nicotine and alcohol consumption in a population, which are cheaper than
gene searches, far outweigh any possible benefit that could come out of knowing genes
that predispose an individual to alcohol consumption or smoking. The majority of cases
of cardiovascular diseases or diabetes type II in a population can probably be explained
by environmental risks such as unhealthy diet, lack of physical activity and smoking. It
is unlikely that finding genetic variants that mildly increase the risk of those diseases,
and even developing therapies based on that knowledge, would lead to an appreciable
decrease of their public health burden in a population.
Examples of diseases where the genomic revolution could prove helpful,
however, are Alzheimer's disease, multiple sclerosis, autism or schizophrenia, where the
relatives of diseased individuals are clearly at greater risk, there are no known
preventable environmental risks, and which are sufficiently common in the population to
justify large investments. For other diseases, the funds would be better placed into
research of determinants of human behaviour and motivation for leading more healthy
lifestyles. This is all particularly relevant for the population of western countries, where
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an estimated 150 million people already have type II diabetes and are overweight.
However, only a minority of world's population lives in developed countries. In recent
years, calls have been made upon the international scientific community not to forget the
majority of world's population that does not represent a lucrative market for the
pharmaceutical industry, but could also perhaps benefit from new genomic and
molecular technologies, even more than the western world (100). The fact that 11
million children under five years still die annually of mainly preventable or easily
treatable causes, such as pneumonia, diarrhoea, malaria or malnutrition, and that more
than two thirds of people with AIDS live in countries with virtually non-existent health
systems, are more than worrying. Those people could greatly benefit from recombinant
vaccines that use genomic technology, or from molecular tests that could precisely
diagnose the aetiology of their infections and thus enable more efficient use of sparse
medicines available to those populations. It remains to be seen whether the genomic
revolution of the 21st century will truly revolutionise medicine and result in major public
health benefits for all of humanity. The alternative scenario is that it may only deliver
partial successes which will become available to the rich minority and thus further
increase the gap between the world's rich and the poor, as was the case with recent
revolutions in informatics and telecommunication technologies in 1980s and 1990s.
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1.2. STUDYING THE EFFECTS OF INBREEDING ON
HUMAN TRAITS AND DISEASES
1.2.1. Introduction
In many parts of the developing World and in many communities within the
developed World large proportions of all marriages are still among close relatives.
The reasons include geographic, tribal, cultural or religious isolation or socio¬
economic motivation such as preservation of property, particularly the land
(101,102). The degree of inbreeding in offspring of such marriages can be measured
by the genetic term "inbreeding coefficient" (F), which indicates the proportion of
the autosomal genome which is expected to be homozygous through inheritance of
identical genes from common ancestors (i.e. proportion of alleles identical by descent
(IBD) or "autozygosity"). The F value is calculated from genealogical information
and it amounts to about 6% in the offspring of first cousin parents and 25% in the
offspring of incestuous unions of first-degree relatives (103). The apparent risk in the
individuals with a considerable proportion of their genes homozygous for identical
allelic variants is the occurrence of "Mendelian" (monogenic) diseases caused by rare
and recessive deleterious autosomal mutations (104).
The effects of inbreeding have historically focused on early-onset diseases,
mainly recessively inherited monogenic (Mendelian) diseases, birth defects,
decreased fertility and early mortality. This was due to the long-term experience that
consanguineous unions were more likely to result in genetic diseases of children,
most of which had an apparent phenotype that was very notable in the communities.
Therefore, the vast majority of research on inbreeding effects had been focused on
pre-reproductive health problems, and the risks have been thoroughly evaluated by
numerous groups and individual authors (102,105-111).
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During recent years, the rapid development of molecular genetic techniques
enabled precise measurement of genetic characteristics of humans. This has led to the
discovery of many genes responsible for Mendelian (monogenic) diseases which
usually have early onset and are very rare. However, success in finding the genes
responsible for the susceptibility to complex chronic diseases that currently represent
most of the public health burden in both developed and developing world has been
limited (8,10). The genetic architecture underlying late-onset diseases such as
cardiovascular diseases, malignancies, adult-type diabetes and psychiatric disorders
is still the matter of open debate. The genetic model that has recently begun to
emerge from the experiments in plants, animals and human studies favours the
hypotheses that the genetic variants associated with the increased risk of complex
chronic diseases are more likely to be: (a) rare than common in the population
(73,74); (b) numerous than rare across the genome (3); (c) of a small than of a large
effect (72); (d) recessive than dominant (18).
The concern is that those hypotheses, if valid, imply that inbreeding in
humans could have a considerable effect on the occurrence of complex late-onset
diseases. The proposed mechanisms will be discussed in detail in the discussion part
of this thesis, but the main reasons why this may be the case are presented here. First,
modest levels of inbreeding observed in human populations are expected to have
much larger effects on the population distributions of polygenically determined traits
than on oligogenic traits and diseases. Second, inbreeding is predicted to have larger
effects on the population-attributable fraction of disease cases if the underlying
variants are rare rather than common. This is because common recessive variants will
occasionally become homozygous in the population by chance, without a need for
inbreeding to bring them together. If the variants are very rare in the population, and
inbreeding is almost the only realistic scenario under which they can become
homozygous in an individual, then the fraction of disease cases in the population
who are the offspring of related parents will be much larger. Third, the risk of
genetically determined disease in pre-reproductive age may be rather minor because
the responsible mutations are dramatically reducing fitness and are therefore
constantly being cleared from the gene pool by selection. In the post-reproductive
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period, however, it is possible that numerous rare and recessive genetic variants
underlying complex traits and susceptibility to common late-onset diseases have not
been selected against during the human history, and that the genomic target for the
effects of inbreeding is an order of magnitude larger. Fourth, the inbreeding
depression (a change, usually a decrease, of the value of the trait due to the effect of
increased homozygosity of the genes underlying the trait) should, at the same time,
affect many phenotypes that are known as late-onset disease risk factors, such as
blood pressure, body mass index, and possibly cholesterol and glucose levels. Even if
the effect of inbreeding depression on each of those phenotypes individually is rather
small, their risk is mediated in multiplicative manner, so the cumulative net effect of
inbreeding depression on all the risk phenotypes during a lifetime could be more
substantial than appreciated (112,113).
The concern over the proposed risk mechanisms of inbreeding on late-onset
diseases is exaggerated by the fact that remarkably few publications addressed it, as
the research into inbreeding was focused on assessing the risk of early mortality due
to rare recessive deletorious mutations. In this chapter, a review of the literature is
presented from 1965 onwards to assess the human population exposure to the "risk"
of inbreeding, i.e. to assess the prevalence of inbreeding in contemporary human
populations. Also, the empirical evidence on the effects of inbreeding on human
biology and health is reviewed in detail, especially concerning biomedically relevant
quantitative traits and late-onset complex diseases. After empirical evidence is
reviewed, theoretical arguments on how inbreeding studies can improve an
understanding of the genetic architecture of late-onset complex traits and diseases
will be presented, which was the main aim of this thesis.
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1.2.2. Global Prevalence and Distribution of Inbreeding
To estimate the global prevalence and distribution of inbreeding, a thorough
search of the PubMed database was performed, looking for the references published
from 1965 to date mentioning the terms "inbreeding", "consanguinity", "identity by
descent" and/or "autozygosity", with a limit set to "human". This yielded more than
10,000 references, but only about 800 were relevant to the scope of this estimation
process. Another 200 important references that were either book chapters or
published before 1965 and found in bibliography of the 800 primarily identified
references. However, the most informative resource on which I heavily relied to
double-check my own abstraction process was a comprehensive web-site edited by
Professor Alan H. Bittles, which can be found at
www.consang.net/global_prevalence/tables/.
The populations studied in the retrieved references range from entire
continents (Europe, Iberoamerican populations), countries and subcontinents (India,
Pakistan, Oman, Jordan, Kuwait), to specific geographic, religious or ethnic isolates
(114,115). As the aim of this review was to produce estimates at the level of specific
countries, and the large majority of identified studies focused on specific isolates and
minorities, only a limited number of studies was eventually informative for this work
(116-165). Table 1 -1 reviews the studies which aimed to assess the proportion of
consanguineous marriages and/or coefficient of inbreeding in different countries or
their sub-populations using community-based study designs, so their results can be
considered representative for the populations under study. For countries without
published information on the prevalence of inbreeding, conservative estimates were
based on information available for neighbouring countries with a similar ethnic
structure.
Table 1-1 presents the country-level prevalence of consanguineous marriages
defined (according to WHO) as a union of spouses that are related at the level of
second cousins or closer (114). The prevalence of consanguineous marriages
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presented in this table is always conservative, in a way that it was consistently
rounded to the closest multiple of 5% that was lower than the actual estimate from
the study. This was done as the aim was to assess the lower limit of the persons
globally who are inbred at the level corresponding to offspring of second-cousin
marriage or greater, i.e. have an inbreeding coefficient of 1.56% or greater. Under
the assumption that consanguineous unions produce a similar number of offspring to
those from non-consanguineous unions, this could then be translated into an estimate
of the proportion of the population of those countries who are inbred. This
assumption was recently supported with empirical data, because although there were
studies implying decreased fertility in consanguineous marriages and increased
childhood mortality of their children, these marriages tend to compensate these
effects by having more children (166). It should be noted that in countries where
inbreeding is most prevalent, the large majority (over 70%) of marriages tend to be
between first cousins (expected inbreeding coefficient in offspring of 6.25%)
(106,125,128,132,137). Therefore, it is reasonable to assume that the total share of
the human population that show inbreeding as defined by WHO criteria are expected
to have an average inbreeding coefficient greater than 3.0%. This estimate is based
on the expected ^200 million people in Arab countries being inbred according to
WHO criteria, with more than 70% of them being the offspring of first-cousin
marriages (F=0.0625). Another «200 million people are from India, with a
substantial share of them also being the offspring of first-cousin marriages. With
some 250 million people having F value of at least 0.0625 only in Arab nations and
India, and the rest of those fulfilling WHO criteria having F greater than or equal to
0.0156 (by definition), it becomes apparent that those who we refer to as "inbred"
have an average F value of greater than 0.03 when this is considered globally.
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Table 1-1: Conservative estimates (multiples of 5%) of the proportion of
consanguineous marriages for different countries and regions (using WHO criteria of
consanguineous marriages - second cousins or closer) and WHO population
estimates for 2000 classified by WHO regions*.










Algeria 31.5 20% 116 6.3






































Panama, Paraguay, St Kitts
and Nevis, St Lucia, St









71.3 2% 118,119 1.4
EMROB
Iran 67.7 30% 120 20.3
Jordan 6.7 40% 121 2.7
Kuwait 2.0 35% 122 0.7
Lebanon 3.3 25% 123 0.8
Oman 2.5 30% 124 0.8
Saudi Arabia 21.6 40% 125 8.6
Tunisia 9.6 25% 126 2.4
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Egypt 68.5 25% 128,129 17.1
Iraq 23.1 45% 130,131 10.4
Pakistan 156.5 50% 132-136 78.3
Sudan 29.5 50% 137 14.8
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Indonesia 212.1 15% 145 31.8
Sri Lanka 18.8 20% 146 3.8
Thailand 61.4 **5% — 3.1
SEARO D
Bangladesh 129.2 10% 147 12.9





Australia 18.9 1% 158,159 0.2
Japan 126.7 5% 160,161 6.3





China 1,284.5 5% 162-165 64.2





Nauru, Niue, Palau, Papua
New Guinea, Philippines,




Tuvalu, Vanuatu, Viet Nam
TOTAL - ALL REGIONS
World 6,044.9 11.8% 116-165 718.7
* The regions are defined by WHO region and child and adult mortality stratum (see statistical annex
ofWorld Health Report 2000 at http:/www.who.int/whr2001/2001/archives/2000/en/pdf/Statistical
Annex.pdf). Thus, Afr, Amr, Emr, Sear and Wpr refer to the United Nations African, American,
Eastern Mediterranean, South East Asian and Western Pacific regions; and the B-E suffixes refer to
the economic grouping of the country according to UN classifications, with E being the group with the
lowest level of economic development
** Conservative estimates based on information available for neighbouring countries with similar
ethnic structure
Table 1-1 summarises conservative estimates of the prevalence and
distribution of consanguineous unions and inbred individuals globally, based on the
reviewed material (116-165). The countries are grouped according to the statistical
annex of World Health Report published by the WHO in 2000 (167). Although the
relative share of consanguineous unions is estimated to be largest in Pakistan and
Sudan, the greatest number of inbred individuals is certainly found in India (about
200 million people). Pakistan (78 millions), China (64 millons), Nigeria (56 millions)
and the rest of sub-Saharan Africa (81 millions) are thought to harbour at least 275
million additional inbred persons. Large numbers of inbred individuals can also be
found in Indonesia (nearly 32 millions), Iran (20 millions), Egypt (17 millions),
Sudan (15 millions), Turkey (13 millions) and Bangladesh (13 millions). They are
followed by Afghanistan, Morocco and Somalia jointly (16 millions), Iraq (10
millions), Saudi Arabia (9 millions), Yemen (7 millions), Japan (6 millions), Algeria
(6 millions) and former Soviet Union republics with Muslim population majorities
(10 millions). Along with sporadic cases in Latin America, Asia and Eastern Europe
and geographic, ethnic and religious isolate communities of the Western world, the
conservative estimate of the number of inbred persons in the World amounts to 718.7
million (11.8%).
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These are just the people with apparent recent consanguinity in their
genealogies, at the level of second cousin marriage or closer. They are thought to
have, on average, about 3% of their genome additionally identical by descent (see
page 45 for calculation of this estimate; it should be very robust and apply to the
current human population). With a recently corrected estimate of the number of
human genes to 25,000 (168), and a mutation rate estimate per generation increased
by an order of magnitude (169), this translates into these individuals having about
750 more autosomal genes autozygous in comparison to general population of their
respective countries, which is the only relevant variable needed when assessing the
population attributable fraction of the inbreeding effects. This is to say that the
absolute levels of inbreeding are not as important as defining the relative increase in
autozygosity in the subgroup of inbred individuals in comparison to the general
population of similar genetic background that is exposed to the similar effects of the
environment. As the estimated figure of 3% brings to homozygosity potentially
numerous recessive mutations in those 750 genes that are mildly deleterious, the
effects of this late in life are uncertain, but should not be neglected. For example, if
each of those 750 genes would have a highly deleterious mutation in the population
in frequency of 1:1000, there would be about 75% chance for each consanguineous
individual to develop a disease, assuming the full penetrance.
To complicate things further, the demographic history of the entire human
species allows the possibility that contemporary humans are more inbred than it is
generally appreciated, but the amount of cryptic relatedness ("hidden" or
"background" autozygosity) is difficult to estimate. Broman and Weber
demonstrated that the amount of IBD homozygosity at the genome level in families
sampled from isolate populations worldwide is up to several times greater than the
genealogies in the last 4-5 generations would suggest (170). Still, it is not clear if this
could also be true for the large outbred populations. Recent modelling of the period
since the most recent common ancestor (MRCA) of all humans also showed that this
time was surprisingly much shorter than widely anticipated (171). The most
illustrative proof of this hidden autozygosity are probably the autosomal recessive
Mendelian diseases in Western societies that are caused by extremely rare variants
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showing no allelic heterogeneity, as their sheer occurrence in population is in many
cases a reminder of cryptic autozygosity present in contemporary populations.
These hypotheses still must be taken with caution. Although I tried to
estimate the "minimum" prevalence of inbred individuals globally, there is a chance
that a significant portion of the studies from Table 1-1, upon which the estimates are
based, are likely to be biased as they usually studied the population in which
inbreeding was prevalent. Therefore, their results may not be applicable to countries
as a whole. Also, the countries in which there were no studies of inbreeding
prevalence may have a smaller prevalence of inbreeding than the neighbouring
countries, from which their estimates were eventually derived. Still, it is not
questionable that the number of people globally who are the offspring of related
parents is substantial and that it runs into hundreds of millions. It is also likely that
incestuous relationships still occur in many parts of the world, both developing and
developed, especially in rural areas. Such cases are characterized by the highest
values of individual inbreeding coefficients, and thus form the upper tail of the
distribution of the values of inbreeding coefficients in human populations.
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1.2.3. Effect of Inbreeding on Pre-Reproductive Traits and
Diseases
1.2.3.1. EARLY MORTALITY
Most inbreeding studies have addressed the problem of early mortality, as the
main concern over the effects of inbreeding focused on the possibility that every
person carries at least several rare recessive genes which if homozygous would result
in death before reproductive age in any and all environments ("lethal-equivalents").
Historically, reviews implied that the offspring of first-cousin marriages were 1.41
times more likely to die before they reach adulthood, but when the miscarriages and
stillbirths were included, the relative risk of dying before the age of 16 increased to
as much as 2.0 (104). However, it is possible that combinations of non-genetic
factors such as lower socio-economic status of inbred families and generally high
incidence of childhood mortality contributed considerably to those estimates. The
most serious attempt to resolve this problem was carried out by Bittles and Neel, who
reanalysed the reports on mortality increase in children of first-cousin marriages
from 38 populations representing all major ethnic groups. The increase in mortality
was assessed starting from about six months gestation (which included late
miscarriages) to a median age of 10 years. The authors concluded that the increase in
mortality in offspring of first-cousin marriages as compared to non-inbred controls is
fairly constant across all populations and mortality rates. In their study it only
amounted to about 4.5%, a significant deflation from previous estimates. This equals
to an average human being heterozygous for 1.4 lethal equivalents (13). Later,
Cavalli-Sforza et al. derived an even lower estimate through an extensive research
conducted among the first cousin offspring in Italy (172).
1.2.3.2. EARLY MORBIDITY
The most comprehensive reviews of the effects of inbreeding on early
morbidity were presented by Freire-Maia and Elisbao (173) and Khlat and Khoury
(111). The studies of non-lethal childhood morbidity related to inbreeding are usually
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confined to attempts to investigate the increase in the proportion of consanguineous
unions among parents of children with rare recessive monogenic (Mendelian)
diseases in comparison to the proportion of consanguineous unions in general
population. This can then be used to compute a population-attributable risk for such
diseases that is due to recent inbreeding. The complete list of all reported rare
monogenic (Mendelian) diseases and syndromes is being regularly updated by the
Online Mendelian Inheritance in Man (OMIM) service (4), and inbreeding usually
represents a significant risk factor for those disorders that are recessively inherited.
The diseases and syndromes most frequently studied in this context were cystic
fibrosis, cystinosis, spinal muscular dystrophy, albinism, eye defects and hearing
anomalies. However, although there are at least several thousands of such diseases, it
should be understood that their impact on the total health burden is still relatively
small, regardless of the prevalence of inbreeding in a population, although it may be
more significant in terms of child health burden in certain areas where inbreeding is
prevalent (102).
It is worth mentioning that in human isolates several population genetic
mechanisms (that usually include inbreeding) act together to expose the phenotypic
effects of rare recessive mutations, which proved to be very useful during the recent
years in finding the genes responsible for monogenic (Mendelian) diseases. Due to
the small number of founders of such populations, the allelic frequency of rare
recessive mutations carried by founders increases by several orders of magnitude in
comparison to general populations. Then, in these (usually very small) populations
genetic drift can lead to further increase in the allelic frequency of a mutation of
interest. If the populations are not small, genetic drift can only have an effect over a
longer period and is therefore more important in older populations, and not in the
new isolates. Finally, consanguinity (due to a reduced number of potential mates in a
small population) brings those recessive alleles to homozygosity, exposing a disease
phenotype in an affected individual. The theory behind this process helped molecular
geneticists and genetic epidemiologists developing a "homozygosity mapping"
approach which proved highly successful in mapping genes responsible for a large
number of monogenic (Mendelian) diseases (38), although success with complex
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chronic diseases of late onset has been limited to date.
1.2.3.3. COGNITIVE PERFORMANCE
Although intelligence can be considered a quantitative trait, while mental
retardation is a qualitative trait that falls under the category of early morbidity, they
are presented here separately as in many societies and cultures there is a strong belief
that inbreeding affects these traits. There is a high degree of consistency between
numerous reports in suggesting that inbreeding leads to a depression in IQ value with
a mean regression coefficient of about b - -45 (174). Studies of the effects of
inbreeding on mental retardation show that the absolute risk in children of apparently
unrelated parents amounts to 0.012 and it increases to 0.062 in the offspring of first-
cousin mating, a relative risk of about 5 (175).
Using this information, Morton (174) suggested that both the decline in IQ
and the increase in mental retardation are consistent with a highly polygenic model
of inheritance of these traits, and that there is little evidence that natural selection
throughout human history favoured the individuals with greater IQ values in any
way. The responsible genetic variants under Morton's model were rare, recessive and
numerous. As a considerable reported effect of inbreeding was the consistent result,
this further underscores the problem of the potential effect of inbreeding on highly
polygenic late-onset complex diseases that were not subjected to natural selection
throughout human history (175).
1.2.3.4. OTHER EFFECTS
The studies conducted on the effects of inbreeding in human populations
showed a large variety of aims, and many of them do not fall within any of the
categories mentioned in this review. As the increase in prenatal mortality was
expected as a result of autozygosity, a number of studies investigated the effects on
fertility and sterility. It is generally accepted that the risk of abortions and
miscarriages is greater among consanguineous couples (176-177), but it has also
been shown that those couples tend to have more children, possibly as a result of
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reproductive compensation (166,178). Other interesting papers included studies of
inbreeding effects on maternal-zygotic gene conflict over sex determination (179),
twinning rate (180-182), developmental stability (183), erythrocyte antigen
incompatibility (184) and X-heterosis (185). Some studies even investigated the
frequency of consanguineous matings due to multiple use of donors in artificial
insemination (186). The results ofmost of these studies were usually consistent with
the hypotheses of some effects that could possibly be attributed to inbreeding, but
those were predominantly of small size.
Another (indirect) way to point to the importance of inbreeding effects is to
demonstrate that outbreeding and admixture between isolated populations and
individuals of reduced genetic diversity increases fitness, improves health, and
affects biological quantitative traits in the direction opposite to inbreeding
depression. This phenomenon is called "heterosis" ("hybrid vigour"), and is well-
established in plants and animals, although the studies in human populations are very
rare (187).
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1.2.4. Effects of Inbreeding on Post-Reproductive Traits and
Diseases
1.2.4.1. QUANTITATIVE TRAITS
The predicted effects of inbreeding on quantitative traits (QT) were
summarised by Falconer (188) and further discussed by Charlesworth and
Charlesworth (189). As yet, only a few studies addressed this problem empirically in
human populations. The most frequently investigated traits were simple
anthropometrical traits (e.g. height) and some physiological traits (such as blood
pressure). Here, the interest in reviewing the effects of inbreeding on human
quantitative traits will be restricted only to those traits that are bio-medically relevant
as they represent known risk factors for late-onset diseases in human populations. In
2002, the World Health Organization identified 5 leading risk factors for human late-
onset mortality and disease burden globally. Three of them were human biological
quantitative traits that represent leading risk factors for cardiovascular diseases, the
most frequent cause of death in the world (190): high blood pressure, cholesterol and
obesity (which can be thought of as high body mass index). In this chapter, the
known effects of inbreeding on those 3 traits will be reviewed.
In a review of more than 8,000 references from 1961 to date only a few that
studied the relationship between inbreeding and blood pressure (BP) were found.
Most of them had an ecologic epidemiological design, i.e. they reported an increased
prevalence of hypertension in populations that were inbred, without correcting for
further potential confounding effects, such as specific controls being included taking
into account e.g. socio-economical variables (191-194). In Table 1-2, the results of
the three studies that included large number of examinees and reported a regression
of BP values on inbreeding coefficient (F) estimated from genealogies are presented
(195-197). This design, which is based on measures of both variables (F and BP) in
many individuals, is superior to the ecologic design. All three studies were based on
observations on several thousand examinees. All three studies reported a large
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increase in blood pressure values with inbreeding, with the effect apparent on both
systolic and diastolic blood pressure.
Several studies reported the effects of inbreeding on body mass index, or on
components of its computation (height, weight). It should be stated that the effect on
height is more important, as its value is factored into the calculation of BMI to the
second power. Similar to the blood pressure example, there were studies
investigating the effects on height using an ecologic design (198-200), but the same
three studies from the previous blood pressure example were also used here to
present this relationship (195-197). Although the effects reported on height and
weight weren't consistent, in all three studies the net effect on BMI was showing an
increase in value in persons with higher inbreeding coefficients.
Finally, only a single study investigating the effects of inbreeding on
cholesterol levels could be identified (196). This study showed an effect known in
human evolution studies as "antagonistic pleiotropy", i.e. opposing effects in early
and later life, with decreased values in young age (<20 years) and significantly
increased values later in life (>= 40 years).
Studying the effects of inbreeding on human quantitative traits can be
potentially informative of the genetic architecture underlying those traits. Given the
likely multifactorial determination of QT values in humans and the large
environmental and genetic differences between populations, it will be difficult to
disentangle the contributing effects of genetic and environmental factors on the
observed distributions. A good discussion on this problem was provided by Rose
(201). The most valuable information will probably come from populations that
represent extremes either in their genetic structure, environmental exposures or
unusual phenotypic mean and/or variance in QT. The methods and strategies to
address the problem of variance component analyses of human quantitative traits in
isolate population using available genealogical records are rapidly developing (202-
204).
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Table 1-2: Review of the studies investigating the effect of inbreeding on
quantitative traits that represent known risk factors for late-onset diseases in human
populations.
Quantitative Author& Ref* Reported
trait Year effect
Blood Krieger 195 Significant increase in diastolic blood pressure
pressure 1968 (BP) values, systolic not measured.
Martin et al. 196 Significant increase in systolic BP, no consistent
1973 significant effect on diastolic BP.
Badaruddoza 197 Significant increase in systolic and diastolic
2004. blood pressure.
Body mass Krieger 195 In 3,465 children, no significant effects on height
index (height, 1968 or weight, increase in body mass index
weight) Martin et al. 196 In 12 age-gender defined samples ranging from
1973 166 to 657 subjects, increase in weight, decrease
in height, increase in body mass index
Badaruddoza 197 In 3,253 children, decrease in height and weight,
2004. increase in body mass index
Cholesterol Martin et al. 196 Decrease in population <20 years, large increase
levels 1973 in population >=40 years
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1.2.4.2. COMPLEX LATE-ONSET DISEASES
Table 1-3 summarizes the effects of inbreeding on late-onset complex
chronic diseases. It seems that only 15 studies provided direct information on the
relationship between inbreeding and adult-age diseases to date (205-219). Study
designs included an ecological comparison between more and less inbred populations
in 4 studies, a population-based case-control design in 7 studies, a hospital-based
case-control design in 3 cases, and self-reporting for disease and inbreeding status by
questionnaire in 1 study. Only three studies did not detect possible effects of
inbreeding on the diseases under study, but those were also the ones using a study
design prone to multiple confounding effects. In the studies by Jaber et al. (207) and
Denic and Bener (212), self-reporting of inbreeding status could have been a likely
cause of misclassification. Also, in the study by Saugstad and Odegard in Norway
(214) the authors reported that a change of diagnostic practice for psychiatric
illnesses (especially schizophrenia) during the period of study could have acted as a
major confounding effect. All other studies report inbreeding effects on many late-
onset diseases, and the estimated or projected risks were considerable. It appeared
that in the inbred communities, individuals or affected cases the relative risk ranged
from 1.5 to 4.5 when compared to non-inbred controls (205,206,208-211,213,215-
219).
Table 1-3: Review of the studies investigating the effect of inbreeding on complex
late-onset diseases. (*These studies are based on self reported consanguinity, which
in our experience tends to be of low reliability, as most "inbreeding loops" are found
in the third and fourth parental generations and thus unknown to most people).
Disease Author/Reference Study Design
Coronary Shami et al. (205)
heart
disease
Reported effect of inbreeding
Case-control study Hospital cases had significantly greater
Hospital-based inbreeding coefficients than controls
(individuals in population from which
they were recruited)
Ecological study Increased risk ofmyocardial ischaemia
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Puzyrev et al. (206)
among endogamous males
Jaber et al.* (207) Case-control study No difference in self reported
(self-reported prevalence among students with or
exposure and without consanguineous parents
outcome status)
Ismail et al. (208) Case-control study Increased risk (OR 3.8) ofmyocardial
Hospital-based infarction South Asians under 45 years
related to parental consanguinity
Cancer Simpson et al. (209) Case-control study Increased risk of breast, endometrial
Population-based and ovarian cancer associated with
greater inbreeding coefficient in
women under 45 years
Lebel & Gallagher Case-control study Increased risk associated with greater
(210) Population-based inbreeding coefficient, (especially for
multiple and early-onset cancers)
Shami et al. (205) Case-control study Hospital cases had significantly greater
Hospital-based inbreeding coefficients than controls
(individuals in population from which
they were recruited)
Rudan (211) Ecological study Stepwise increase of 20-year cancer
incidence associated with greater
inbreeding in 5 island communities
Denic & Bener * Case-control study Decreased risk of breast cancer among
(212) Population-based women who self-reported being
(self-reported offspring from consanguineous unions,
exposure status) no effect on cervical cancer
Psychi- Abaskuliev & Skoblo Case-control study Increased frequency of consanguinity
atric (213) Population-based among parents of schizophrenia cases
Disorders
Saugstad & Odegard Case-control study No increase in first-cousin matings
(214) Population-based among parents of psychiatric patients
(major changes in diagnostic criteria
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over time reported by authors as
important confounder)
Gindilis et al. Ecological study Severe schizophrenia 2-3 times more
(215) prevalent in inbred communities
Alzhei- Vezina et al. Case-control study 205 autopsy-confirmed cases of late-
mers (216) Hospital-based onset Alzheimer's disease significantly
Disease more inbred than controls
Multiple Roberts et al. Case-control Average inbreeding coefficient greater
sclerosis (217) population-based among cases than controls; increased
(with parallel prevalence in genetic isolate
ecological study) population)
Roberts et al. Case-control Average inbreeding coefficient greater
(218) population-based among cases than controls; increased
(with parallel prevalence in genetic isolate
ecological study) population)
Type 2 Jaber et al.* Case-control study No difference in self reported
diabetes (207) (self-reported prevalence among students with or
exposure and without consanguineous parents
outcome status)
Gout Ombra et al. Ecological study Increased prevalence of hyperuricemia
(219) and uric stones in a highly inbred
community
Asthma Jaber et al.* Case-control study No difference in self reported
(207) (self-reported prevalence among students with or
exposure and without consanguineous parents
outcome status)
Peptic Jaber et al.* Case-control study No difference in self reported
ulcer (207) (self-reported prevalence among students with or
exposure and without consanguineous parents
outcome status)
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1.2.5. Inbreeding Studies can Improve Understanding of Genetic
Architecture of Late-Onset Complex Traits: Theoretical
Considerations
It is widely accepted that one of the main reasons why genetic association
studies of late onset complex diseases did not yield more success is a relatively poor
understanding of the genetic architecture underlying susceptibility to those diseases.
Many studies have been based on assumptions of the number of susceptibility alleles
underlying those diseases, their population frequency, effect size, penetrance,
dominance/recessivity and the population frequency of underlying haplotypes.
However, it is fair to say that none of those parameters is currently known with any
degree of certainty, which is why most of the studies showing adequate power to
detect disease susceptibility alleles under a set of assumptions eventually failed.
Obtaining any insight into the parameters of the genetic architecture of complex
human traits and diseases, such as the number of susceptibility alleles underlying
those diseases and the distribution of their effect size, would therefore be very
valuable. This information would help in improving the design of future studies into
the genetic basis of complex late-onset diseases.
Late-onset complex diseases can be considered to result when a threshold of
quantitatively varying risk or liability is exceeded (3,188). Liability is thought to
result from the net effect of many quantitative traits that are influenced by genes and
the environment. These genetic effects can be described collectively by analysing the
components of genetic variance. Those components can be estimated based on a
measurement of resemblance between relatives for disease or a quantitative trait. The
total genetic variance (Vg) of a complex trait can be partitioned into its components
(3,188): (a) additive genetic variance (Va), the component of variance due to genetic
effects that are directly transmissible from parent to offspring; (b) dominance
variance ( Vd), the component of variance due to interactions (departures from
additivity of effects) between alleles at the same locus; and (c) epistatic variance (Vj),
the component of variance due to interactions between alleles at different loci
(3,188). The total phenotypic variance (V» in the trait is the sum of Vg and any non-
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genetic effects (Vr), together with the effects of interactions between genotype and
environment (Vge)- The heritability is the ratio of Va to Vp. These components can be
estimated from correlations between relatives, such as parents and offspring, and
full-sibs. In practice, it is difficult to separate Vd and V/, and they are often treated as
a single component of non-additive variance. For example, fitness-related traits
generally show substantial additive variance; whereas relatively few show non-
additive variance. Late-onset traits are predicted to show higher values of Va and Vd.
(113, 220). It is, however, very difficult in practice to disentangle environmental
from genetic variance using nuclear family information to compute heritabilities, as
nuclear families share common environments. This usually results in an over-
estimation of genetic effects.
Therefore, one of the rare feasible approaches to obtain information on
genetic variation influencing complex late-onset traits and diseases is to measure the
effects of inbreeding. Inbreeding can contribute to disease prevalence in a population
and to the inbreeding depression of complex quantitative traits (13,221). This results
from increased homozygosity of trait alleles, which either show recessive effects on
the trait acting in the same direction (directional dominance), or show heterozygous
advantage. The value B, which is the negative of the regression coefficient of trait
mean on inbreeding coefficient, F, provides a useful summary statistic for the
genetic damage that would occur if all deleterious recessives were made
homozygous (equals to F - 100%). When fitness components, such as survival to
adulthood, are measured on a scale of natural logarithms, B provides a measure of
the deleterious effect of complete homozygosity, often called the "inbreeding load".
Theory shows that the value of B due to deleterious mutations depends only
on the genomic mutation rate and the dominance of individual mutations (221,222). If
all mutations have the same effects, B for a given trait that is positively correlated
with fitness is:
B=U{(\/h)-2} a (Eq. 1)
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where U is the mutation rate per diploid individual to deleterious alleles
affecting the trait; h is the extent to which fitness is reduced in heterozygous mutation,
relative to its effect in homozygotes; and a is a constant of proportionality relating the
effect of a mutant allele on the trait in question to its effect on fitness. Relating the
measurement of variance components and inbreeding effects to the predictions of
models of the maintenance of genetic variation provides an important means of testing
the models, which will be one of the main aims of this thesis (12,221,222).
Apart from providing information on genetic variation influencing disease
through testing the above model based on genetic load computations, inbreeding
studies can be useful for the estimation of the number of genetic loci influencing a
complex trait or disease. In theory, this can also be achieved through two other
aproaches: (a) to cross inbred or natural populations that show a large difference in
trait value and estimate the number of "equivalent effect" genes accounting for the
difference on the basis of the trait variances in the hybrid offspring (Fl, F2 and
backcross generations); (b) to undertake systematic genetic mapping of trait loci
distinguishing a pair of lines, yielding a direct estimation of gene numbers. In
practice, however, those estimates often have large sampling variances and require
assumptions that are not always met. Neither of those two methods provides a direct
estimate of the number of loci segregating within a population. If the lines concerned
have been derived from a population, they at least provide a lower bound to the
number of such loci (12,223).
However, another method based on studying inbreeding effects can be
applied directly to population data and is useful for estimating the number of
recessive or partially recessive loci contributing to a trait that shows inbreeding
depression (222). The effect of inbreeding, B, and the dominance variance, Vd, are
measured as suggested earlier in the text (Eq. 1). Then, a lower bound to the number
of genes, n, affecting the trait is provided by:
n > B2 / VD (Eq. 2)
To conclude, properly designed inbreeding studies can be used to assess both
genetic variation influencing complex traits and late-onset disease susceptibility, and




2.1. STUDY POPULATION: THE CROATIAN ISLAND
ISOLATE RESOURCE
In this part of the thesis, the study population (Croatian island isolate resource)
will be described and its apparent advantages for the analyses of inbreeding effects on
human traits and diseases listed. In further sections, the methods of recruitment of the
examinees, determination of their individual inbreeding coefficients (risk exposure) and
measurements of quantitative traits of interest and diagnosis of diseases will be
presented, along with study designs and statistical methods of data analyses. As the
study population, study designs and methodological approaches were chosen in order to
maximise the potential of analysis of the effect on each particular trait or disease, the
methods will be presented accordingly, by studied traits / diseases.
Croatia has 15 Adriatic Sea islands with a population greater than 1,000. The
villages on the islands have unique population histories and have preserved their
isolation from other villages and the outside world through many centuries. The history,
demography and genetic structure of those villages have been investigated for more than
50 years. The research, mainly carried out by the Institute for Anthropological Research
in Zagreb, Croatia, resulted in over 100 publications in international journals
(89,224,225). Figure 2-1 shows the geographic location of the main inhabited islands
that will be mentioned in this research. Table 2-1 provides a comprehensive review of
the reference sources with detailed information on population genetic structure and
variation, monogenic (Mendelian) diseases and rare genetic variants identified in
particular islands and reported in the literature (226-252).
It can be noted that there is continuity in the research of these unique
populations. The initial investigations of population structure were performed using
classic genetic polymorphisms such as blood group antigens (238-241), HLA markers
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and immunoglobulin allotypes (234-237). These findings have been later supported by
more informative analyses, using STR and VNTR polymorphisms (226-230), and more
recently mtDNA and Y-chromosome based analyses (231-233). At least seven rare
Mendelian diseases characteristic for particular islands have been reported (242-249),
which are believed to be due to a combination of founder effect (increasing population
frequency of rare mutations in an isolate) and subsequent inbreeding (which increases
the probability of the recessive rare variants becoming homozygous). Reports of high
population frequencies of several extremely rare genetic variants found in these islands
support this explanation (231, 250-252).
Figure 2-2 presents a brief overview of ethnic history of Croatian island
populations. The earliest inhabitants known with any degree of certainty are thought to
be proto-Illyrians, inhabiting the islands around 2,000 B.C. During the B.C. era, they
were succeeded by Illyrians, who admixed with Greeks and succeeding Romans to form
the population "sub-stratum". In 7th century AD the first Croats immigrated into the area
and admixed with the other "sub-stratum" populations. The populations then remained
relatively isolated for centuries, adopting the "ca" dialect of Croatian language, until the
next immigration wave ("super-stratum") occurred during medieval period, with
arriving immigrants who fled the mainland in fear of Ottoman (Turkish) expansions and
brought the "sto" dialect (89,224,225,253). The present-day population structure, "ad-
stratum" was then formed by very limited population movements from 1800 onwards,
which ensured gene flow between the settlements, and further immigration from the
mainland on a small scale.
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Table 2-1: Brief review of population genetic research undertaken in Croatian island
isolates in the past 25 years.
TYPE OF RESEARCH ISLAND REF.
A. Studies of population genetic variation
STR polymorphysms Krk, Brae, Hvar, Korcula 226-229
VNTR polymorphysms Hvar 230
Y-chromosome haplogroups Krk, Brae, Hvar, Korcula 231
MtDNA haplogroups Krk, Brae, Hvar, Korcula 232,233
HLA markers or Immunoglobuline allotypes Krk, Hvar, Silba, Olib, Pag 234-237
Serogenetic polymorphisms Brae, Hvar, Korcula, Silba, Olib, 238-241
B. Reports on autochtonous Mendelian diseases
Dwarfism Krk 242-244
Albinism Krk 244
Progressive spastic quadriplegia Krk 244
Familial cognitive dysfunction Susak 245
Familial congenital hip dislocation Lastovo 246
Familial ovarian cancer Lastovo 247,248
Keratoderma palmoplantaris transgrediens Mljet 249
C. Reports of high population frequencies of extremely rare genetic variants
Deleted/triplicated alpha-globin gene Silba 250
PGM1*W3 phosphoglucomutase-1 variant Olib 251
MtDNA haplogroup F Hvar 252
Y-chromosome haplogroup P* Hvar 231
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Figure 2-1: Geographic location of the island populations that were studied to
investigate inbreeding effects on various quantitative traits and late-onset diseases in this
research.
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Figure 2-2: Brief schematic presentation of long-term population history of island

































The tendency towards inbreeding in each village has been influenced by several
factors. The first one was geographic isolation, which limited mate choice in the villages
leading to frequent marriages between relatives. Even nowadays, in most of these
settlements the levels of parental and grand-parental endogamy are among the highest
reported for human populations (89,224,225). Other important factor were political
("Pastrovic") privileges given to residents of certain communities for serving the
Venetian Republic. These privileges introduced large social differences and contributed
to subdivision of the populations on particular islands. Finally, inbreeding was also
favoured due to purely socio-cultural reasons (89,224,222), as in times of great poverty
and very limited resources the individuals on the islands were forced into
consanguineous unions in order to preserve the land and resources within the families.
Therefore, the Croatian island populations present a range of inbreeding patterns at both
individual and subpopulation levels, as documented in previous studies reporting
endogamy, isonymy, mating choice, genealogical information, and genetic marker
distributions (254-257).
The relevance of the study population for the research undertaken in this thesis
will be discussed in detail in the following sections, as study designs, samples and
methods differed and were tailored to appropriately address each specific research
question. The author's specific role in data collection processes in these populations was
explained in detail in the Foreword of the thesis, and partly also in the
acknowledgement.
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2.2. INVESTIGATION OF THE EFFECTS OF
INBREEDING ON BLOOD PRESSURE
2.2.1. Sample Selection
Blood pressure, height and weight were measured in the late 1970s and early
1980s in 2,760 adult individuals selected at random from voting lists from 25 isolate
villages on the 3 islands (Brae, Hvar and Korcula) in middle Dalmatia, Croatia. The
detailed geographic location of all 25 villages is presented in Figure 2-2. The recruited
sample represented about 20% of the total village populations. In addition, data were
collected on body mass index, diet, education level, occupation and smoking status. This
was carried out with the informed consent of participants by the Institute for
Anthropological Research in Zagreb, Croatia in collaboration with the Smithsonian
Institute in Washington, USA. None of the examinees had ever received
antihypertensive treatment.
2.2.2. Computation of Individual Inbreeding Coefficients in 25
Villages
A single researcher (author of the PhD thesis) computed individual inbreeding
coefficients independently and blind to BP status for each study participant. The
computation of the inbreeding coefficient was initially based on pedigree information on
2-3 ancestral generations collected during the initial field work in 1970s and 1980s.
These genealogical data were expanded by a study of parish registries stored in local
churches during 1997-2000, to 4 ancestral generations for each individual (five
generations where these occurred over a similar timeframe). The coefficients (F) were
computed according to Wright's path method (258) and gave values ranging from zero to
0.125. In addition, average inbreeding measures for each of the 25 villages based on
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isonymy were calculated, as it is widely accepted that those estimates provide an upper
limit to the true inbreeding estimate in a population (259,254,255).
2.2.3. Blood Pressure Measurements
Blood pressure (BP) was measured by a single observer in local health centres
and dispensaries between 6 am and 12 noon. Blood pressure was measured on the right
forearm in a sitting position. Two measurements of both systolic and diastolic blood
pressure were taken 5 minutes apart in each individual following standard procedures
(260). Hypertension was defined as systolic BP > 160 or diastolic BP > 95 mmHg.
Individual BP values were adjusted for the major determinants of BP: age, height,
weight and smoking status in the analyses and reported separately in males and females,
before the relationship with inbreeding status was investigated. The basic distribution of
all 2,760 examinees by village (and island) of residence, gender, mean value of
inbreeding coefficient in each village (estimated from genealogies and isonymy) and
body mass index and environmental covariates is presented in Table 2-2.
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Figure 2-2 (next page): Exact location of 25 villages from the islands of Brae, Hvar and
Korcula in which the sample of 2,760 adult individuals previously untreated for
hypertension was recruited during the field work in 1970s and 1980s.
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Table 2-2: The basic distribution of all 2,760 examinees by village (and island) of
residence, gender, mean value of inbreeding coefficient in each village (estimated from
genealogies and isonymy), body mass index. Environmental covariates are presented as
proportion with university degree (EDU), employed in agriculture / fishery (OCU),
consuming Mediterranean diet (DIE), and smokers (SMO).
VILLAGE Sex N AGE F F BMI EDU OCU DIE SMO
(x (SD)) (gen) (iso) (x (SD)) (%) (%) (%) (%)
l.Gdinj (H) M 54 53.6(10.9) 0.048 0.107 24.4 (3.3) 3.7 92.6 94.4 9.3
F 76 53.1 (11.7) 0.049 25.6 (4.7) 1.3 72.4 93.4 1.3
2. Pupnat (K) M 46 42.8 (12.9) 0.046 0.034 27.3 (3.6) 2.2 89.1 95.7 13.0
F 51 44.4(11.8) 0.043 26.1 (3.7) 2.0 90.2 88.2 5.9
3. Cara (K) M 63 44.3 (11.7) 0.035 0.040 26.1 (3.7) 3.2 90.5 95.2 36.5
F 74 45.6(12.5) 0.030 26.6 (3.8) 0.0 87.8 94.6 10.8
4. Poljica (H) M 28 42.3 (9.1) 0.032 0.037 25.5 (2.7) 0.0 89.3 92.9 10.7
F 20 43.0 ( 7.6) 0.032 25.4 (4.2) 0.0 85.0 85.0 0.0
5. Dracevica (B) M 20 46.8(16.4) 0.026 0.031 27.0 (4.2) 5.0 90.0 90.0 35.0
F 22 50.9(14.2) 0.036 30.0 (4.3) 0.0 81.8 90.9 13.6
6. Racisce (K) M 40 43.6(11.2) 0.029 0.034 27.8 (4.0) 2.5 82.5 92.5 25.0
F 64 43.2(11.8) 0.026 27.0 (4.1) 1.6 90.7 78.1 21.9
7. Bogomolje (H) M 48 57.6(15.9) 0.025 0.030 22.4 (2.6) 2.1 87.5 95.8 8.3
F 33 57.7(13.4) 0.025 23.9 (4.1) 3.0 78.8 90.9 0.0
8. Zrnovo (K) M 98 45.0(13.0) 0.022 0.029 26.3 (2.9) 5.1 79.6 92.3 42.9
F 104 45.0(13.9) 0.019 26.8 (4.3) 2.9 78.9 85.6 19.2
9. Lozisca (B) M 17 56.9(12.2) 0.022 0.029 26.3 (4.3) 5.9 82.4 88.2 35.3
F 55 49.9(14.1) 0.018 28.7 (4.4) 1.8 72.7 90.9 9.1
10. Vrbanj (H) M 65 38.2(10.4) 0.020 0.010 26.5 (2.7) 4.6 90.8 95.4 10.8
F 53 42.3 ( 9.6) 0.018 26.8 (3.9) 1.9 86.8 88.7 1.9
11. Selca (B) M 117 54.4(14.4) 0.016 0.026 26.8 (3.3) 4.3 78.6 89.7 41.9
F 185 52.0(14.9) 0.016 27.7 (4.4) 2.2 76.8 90.8 17.8
12. Povlja(B) M 25 56.3 (14.7) 0.014 0.024 27.6 (3.2) 0.0 84.0 92.6 40.0
F 47 54.1 (14.3) 0.017 27.5 (4.8) 2.1 85.1 87.2 10.6
13. Vrisnik (H) M 52 38.0(10.4) 0.012 0.023 24.6 (2.6) 3.8 90.4 94.2 19.2
F 44 42.4 ( 9.6) 0.019 26.5 (3.6) 0.0 72.7 88.6 6.8
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14. Gornji Humac (B) M 32 51.0 12.5) 0.014 0.016 25.7 (3.5) 3.1 87.5 90.6 59.4
F 48 47.4 13.6) 0.012 28.3 (4.5) 2.1 77.1 85.4 25.0
15. Zastrazisce (H) M 70 49.6 14.8) 0.013 0.013 24.7 (2.8) 4.3 85.7 94.3 12.9
F 54 50.7 12.1) 0.013 25.6 (3.9) 3.7 87.0 92.6 0.0
16. Lumbarda (K) M 54 43.4 11.3) 0.014 0.025 26.8 (2.7) 7.4 85.1 90.7 37.0
F 54 43.0 12.4) 0.010 25.6 (3.2) 1.9 85.2 88.9 5.6
17. Novo Selo (B) M 27 46.6 16.6) 0.011 0.014 26.6 (3.9) 0.0 85.2 88.8 33.3
F 30 54.6 13.3) 0.009 28.5 (4.3) 0.0 80.0 86.7 16.7
18. Praznice (B) M 53 48.7 13.2) 0.012 0.016 27.2 (3.8) 3.8 88.7 94.3 45.3
F 67 53.0 14.6) 0.007 28.9 (4.5) 1.5 82.1 89.5 10.4
19. Sutivan (B) M 61 50.2 15.3) 0.009 0.012 27.9 (3.7) 6.6 72.1 90.2 27.9
F 88 50.5 15.1) 0.009 28.0 (4.6) 3.4 68.1 89.8 23.9
20. Smokvica (K) M 52 43.2 10.5) 0.009 0.019 25.8 (3.0) 3.8 84.6 90.4 42.3
F 45 45.7 12.5) 0.008 26.2 (3.6) 2.2 77.8 71.1 11.1
21. Svirce (H) M 74 40.2 11.0) 0.008 0.008 25.6 (2.5) 2.7 91.2 93.2 18.9
F 75 38.5 10.9) 0.007 25.8 (3.5) 1.3 69.3 73.3 6.7
22. Dol Hvarski (H) M 53 41.1 10.7) 0.005 0.004 26.5 (2.5) 5.7 79.2 94.3 13.2
F 42 42.4 9.9) 0.005 25.6 (3.9) 2.4 71.4 76.2 2.4
23. Skrip (B) M 47 51.4 10.8) 0.003 0.008 27.7 (3.2) 2.1 85.1 93.6 31.9
F 56 49.8 14.5) 0.005 29.6 (4.7) 1.8 83.9 87.5 16.1
24. Dol Bracki (B) M 41 44.7 15.3) 0.003 0.005 28.0 (3.2) 2.4 85.4 92.7 29.3
F 24 41.8 15.5) 0.001 27.8 (4.3) 0.0 79.2 75.0 25.0
25. Nerezisca (B) M 50 44.7 12.9) 0.002 0.004 27.3 (3.4) 4.0 66.0 90.0 54.0
F 62 44.9 11.9) 0.002 28.5 (5.0) 0.0 56.5 71.0 19.4
2.2.4. Statistical Analyses
Comparisons of BP among villages were based on systolic and diastolic BP
measurements adjusted for age, body mass index (weight / height2) and smoking status.
A step-down multiple regression analysis was performed using MINITAB 12.21
software to investigate the correlation between individual BP measurements and
inbreeding coefficients. The model explored the relationship between systolic and
diastolic blood pressure (as dependent variables) and a number of explanatory variables:
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individual inbreeding coefficient (F), island and village of residence, smoking status and
the major known risk factors for hypertension - age, sex, (log transformed) height and
(log transformed) weight. Variables which made the least contribution to the explained
variation were dropped one at a time until all the remaining variables were statistically
significant (defined as P<0.05 for main effects and P<0.01 for higher order effects).
A lower bound, nL, for the number of genetic loci of equivalent effect
contributing to the variability in BP, was calculated as
nL = Dt2 / VG = DT2 / (H2 x Vp)
where Dt is the overall slope of the regression on F, Vc is the total genetic variance, Vp
is the residual phenotypic variance and H2 is the broad-sense heritability. To correct for
possible unobserved background inbreeding preceding the earliest generation of which
we had knowledge, we inflated F-values by a factor equal to the ratio of the median of
village inbreeding levels based on isonymy methods to the median based on pedigree
methods. The above statistical analyses were planned, designed and performed under the
leadership and in collaboration with Dr Andrew Carothers from the Human Genetics
Unit, Medical Research Council, Edinburgh, UK, and then repeated under his guidance
by the author of this thesis.
The population attributable fraction (PAF) was calculated by multiple logistic
regression allowing for individual differences in the variables: village, sex, age, height,
weight and smoking. The appropriate regression was determined as a function of all
associated variables (including F). After that, each individual's probability of being
hypertensive if their F was set equal to 0 was noted. The sum of all such probabilities,
Psum, is an estimate of the number affected in the absence of inbreeding, but with other
variables remaining unaltered. Then, population attributable fraction (PAF) is computed
as: PAF = 1 - Psum/Npop, where Npop is the total population size.
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2.3. INVESTIGATION OF THE EFFECTS OF
INBREEDING ON CORTICAL INDEX AND
OSTEOPOROSIS
2.3.1. Sample Selection
During the field research between 1979 and 1981, undertaken by the Institute for
Anthropological Research in Zagreb, Croatia, the measurements of cortical index were
performed in 14 villages: Dracevica, G. Humac and Nerezisca (Brae island), Gdinj,
Bogomolje, Vrisnik, Zastrazisce, Svirce and Dol (Hvar island), and Pupnat, Cara,
Racisce, Lumbarda and Smokvica (Korcula island). The sample included 1,389 adult
individuals (682 males and 707 females). They were selected randomly from voting lists
to form approximately 20-30% of the total population of these 14 villages. The sample
represents the subset of 14 (of 25) villages presented in Table 2-2. The collected data
characterizing environmental variation included the proportion of inhabitants with some
college education (EDU), occupation in agriculture and fishery (OCU), regular
consumption of traditional Mediterranean diet (DIE), smoking habits (SMO) and
measurement of body mass index (BMI). As this population cohort is a sub-sample of
that presented in detail in Table 2-2, all the relevant epidemiological parameters
presented there are also reflected in this sub-sample.
Table 2-3 supports the hypothesis of decreased variation in most of the studied
characteristics related to environment. This is important, as socio-economic status,
occupation, diet, obesity and climate are usually highlighted as potential environmental
risk factors for many common late onset diseases.
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Table 2-3: Genetic and environmental characteristics of 14 village populations (N(sam),
N(pop)) ranked according to average inbreeding coefficient computed from genealogical
data (F(gen)). Also presented: average inbreeding coefficients computed from isonymy
(F(iso)) and serogenetic polymorphisms (F(sgp)), proportion of examinees with some
college education (EDU), working in agriculture and fishery (OCU), regularly
consuming traditional mediterranean diet (DIE) and smoking (SMO), and the average
body mass index (BMI).
VILLAGE* N1 N* F F BMI EDU OCU DIE SMO
(sam) (pop) (gen) (iso) (avg) (%) (%) (%) (%)
Gdinj (H) 135 153 0.049 0.107 25.1 2.3 80.8 93.8 4.6
Pupnat (K) 96 326 0.044 0.034 26.7 2.1 89.7 91.8 9.3
Cara (K) 139 464 0.032 0.040 26.4 1.5 89.0 94.9 22.6
Dracevica (B) 20 66 0.031 0.031 28.6 2.4 85.7 90.5 23.8
Racisce (K) 103 290 0.027 0.034 27.3 1.9 87.5 83.6 23.1
Bogomolje (H) 90 102 0.025 0.030 23.0 2.5 84.0 93.8 4.9
Vrisnik (H) 105 216 0.015 0.023 25.5 2.1 82.3 91.6 13.5
G. Humac (B) 43 214 0.013 0.016 27.3 2.5 81.3 87.5 38.8
Zastrazisce (H) 133 210 0.013 0.013 25.1 4.0 86.3 93.6 5.9
Lumbarda (K) 59 354 0.012 0.025 26.2 4.7 85.2 89.8 21.3
Smokvica (K) 97 866 0.008 0.019 26.0 3.1 81.4 81.4 27.8
Svirce (H) 152 375 0.008 0.008 25.7 2.0 80.1 83.2 12.8
Dol (H) 102 154 0.005 0.004 26.1 4.2 75.8 86.3 8.4
Nerezisca (B) 65 106 0.002 0.004 28.0 1.8 60.7 79.5 34.8
distributions by sex and age not shown as later results were standardized by those two variables;
1 sample obtained between 1979-1981 as random 20-30% of the total village populations;
"total village populations in the year 2000, in which disease prevalence was determined;
55 blood sample for the analysis was obtained from 88.8% of the examinees.
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2.3.2. Computation of Individual Inbreeding Coefficients in 14
Villages
This has been done using pedigree information on 4 ancestral generations (five
generations where these occurred over a similar timeframe), recorded during the initial
field work and supplemented by a study of parish registries stored in local churches
during 1997-2000, as described in Section 2.2.2. The individual inbreeding coefficients
(F) were then computed according to Wright's path method (258):
F— E(i_>c)(l/2)(ni+mi+1)
where m and n refer to the number of paths from a common ancestor, and c refers to the
number of common ancestors. The genealogical inbreeding coefficient for each village
was then computed as the average of all individual F values. To further support these
estimates, F was calculated from isonymy as suggested by Tay and Yip (259), and mean
values were derived for each of the 14 villages. Estimates based on isonymy are
generally thought to be positively biased, and so to provide an upper bound for true F
values.
2.3.3. Cortical Index Measurements and the Definition of
Osteoporosis
The osteometric dimensions of metacarpal bones are an efficient and practical
method for the investigation and monitoring of bone mass. At the time when data used
in the present analysis was gathered, the radiological measurements of the metacarpal
bones was widely used as the best available screening method of bone status in
population studies. The procedure of osteometry of metacarpal bones, as thoroughly
described by Barnett and Nordin (261), was followed in field studies performed on all
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three investigated islands. Hand-wrist radiographs were taken using a single portable X-
ray. Total diaphysis width (D) and medullary canal width (d) of the second left
metacarpal bone was determined by a single, experienced observer (261, 262).
Measurements were performed by one investigator using a millimeter ruler and a
magnifying glass (xlO) with a scale permitting 0.05-mm accuracy. Measurements were
rounded to 0.1 mm. For each individual and for each bone, the cortical index (CI) was
computed as:
CI = (D-d)* 100/D.
Table 2-4. Descriptive statistics of age and cortical index by village in male examinees
(see Table 2-3 for comparative inbreeding levels in villages under study).
Age Cortical index
Village N X SD Min. Max. X SD Min. Max.
Gdinj (H) 51 54.53 11.72 24 81 55.97 7.89 37.78 72.22
Pupnat (K) 46 42.76 12.91 23 71 55.17 6.84 44.85 68.35
Cara (K) 63 42.59 11.87 20 71 53.11 8.42 32.37 72.07
Dracevica (B) 20 46.80 16.37 23 74 66.28 7.15 47.62 80.00
Racisce (K) 40 43.30 11.22 20 62 55.14 7.30 36.23 73.11
Bogomolje (H) 46 57.85 15.65 24 81 48.90 6.17 32.14 64.44
Vrisnik (H) 44 37.68 10.52 23 54 57.22 6.77 42.11 69.89
G. Humac (B) 27 51.04 16.81 22 85 62.87 6.92 49.49 76.14
Zastrazisce (H) 69 50.09 14.78 20 77 53.41 7.45 32.43 76.09
Lumbarda (K) 53 43.21 11.36 22 77 59.70 7.60 41.09 77.83
Smokvica (K) 52 40.87 10.53 24 59 53.46 7.36 37.75 69.41
Svirce (H) 70 39.94 11.10 21 55 59.36 9.78 39.81 82.76
Dol (H) 50 41.44 10.37 20 56 56.73 6.15 40.00 70.51
Nerezisca (B) 51 45.59 13.86 22 81 62.31 9.07 44.12 82.02
Total 682 45.25 13.73 20 85 56.50 8.59 32.14 82.76
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Table 2-5. Descriptive statistics of age and cortical index by village in female
examinees (see Table 2-3 for comparative inbreeding levels in villages under study).
Age Cortical index
Village N X SD Min. Max. X SD Min. Max.
Gdinj (H) 71 53.48 12.28 27 82 55.64 9.99 37.21 84.15
Pupnat (K) 50 44.76 11.74 21 61 56.84 8.67 34.53 75.00
Cara (K) 75 43.63 12.38 20 63 56.29 8.74 37.63 83.09
Dracevica (B) 23 52.48 15.82 21 87 65.11 12.46 42.22 92.41
Racisce (K) 63 43.29 11.83 21 71 58.22 8.58 40.18 77.14
Bogomolje (H) 32 58.50 15.62 19 78 50.44 9.89 29.35 75.00
Vrisnik (H) 28 41.43 8.69 23 54 61.20 9.28 43.37 76.40
G. Humac (B) 44 49.09 13.81 25 82 64.93 11.24 39.76 91.21
Zastrazisce (H) 54 52.37 12.93 24 83 54.46 9.41 37.76 83.33
Lumbarda (K) 55 43.09 12.27 22 74 59.58 9.94 37.70 80.00
Smokvica (K) 42 44.48 12.41 23 61 58.28 11.17 32.08 82.45
Svirce (H) 65 39.25 10.88 20 55 63.90 9.81 40.26 87.18
Dol (H) 43 41.86 10.08 22 56 63.30 9.29 46.07 84.00
Nerezisca (B) 62 44.76 12.15 19 77 65.02 10.82 37.21 91.55
Total 707 46.15 13.21 19 87 59.31 10.60 29.35 92.41
The cortical index is a useful and precise measure that could be used as a
predictor of osteoporosis development. It measures the thickness of the bone mass by
analyzing the relationship between total diaphysis width and the width of the medullary
canal in which there is no bone mass. Tables 2-4 and 2-5 show the sample sizes and
descriptive statistics of age and cortical index by village in male and female examinees.
As expected, a larger effect of age on cortical index and on osteoporosis prevalence is
observed in females than in males (Figures 2-3 and 2-4). It is apparent that the effects
of age are minimal in younger subjects (plateau) and around menopausal ages a decline
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in cortical index could be observed. This trend is more pronounced in females, which is
in accordance with the findings in other populations (262).
The prevalence of osteoporosis was established according to statistical criteria. It
was based on the distribution of cortical index values in people under the age of 45 in
each gender separately. A "cut-off value of cortical index was defined as the mean
minus two standard deviations of the distribution in each sex, which is a suggested
criterion for osteoporosis when predicted by cortical index (260-262). As this criterion
has been widely used, and the measurements were performed by a single device and
technician and analyzed by a single experienced assessor, I suggest that the likelihood of
substantial procedural errors is minimal.
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Figure 2-4: Effect of age on cortical index in females.
Females: Age and cortical index (707cases)
r = -0.4303,p <0.001
Cortical index = 75,251-0,3453 *x
Age
2.3.4. Statistical Analyses
To investigate the relationship between inbreeding and the cortical index and
prevalence of osteoporosis, the ecologic epidemiological design was used. The
prevalence of osteoporosis was compared between the villages with various levels of
mean inbreeding. As the expected prevalence of the disease could be considerably
influenced by variations in sex and age distribution of the different village populations
under study, the prevalence rates were presented separately for each gender, and
standardized by age and age according to the regressions presented in Figures 2-3 and
2-4.
The mean values of cortical index and prevalence rates were adjusted
accordingly in all 14 villages included in this part of the study, using the regression of
prevalence in the entire sample on combined effect of sex and age, and weighted
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according to sample size (5). The statistical significance of correlations between the
standardized means of cortical index values, standardized prevalence of osteoporosis and
mean inbreeding coefficients were determined in a linear regression model using
"Statistica" software.
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2.4. INVESTIGATION OF THE EFFECTS OF
INBREEDING ON LEARNING DISABILITY
2.4.1. Sample Selection
The prevalence of learning disability (LD) was determined in 10 isolate villages
on 5 different Croatian islands: G. Humac (Brae island), Gdinj and Svirce (Hvar island),
Pupnat, Cara, Racisce, Lumbarda and Smokvica (Korcula island), Susak (Susak island),
and Lastovo (Lastovo island) (see Figures 2-1 and 2-2). Those 10 villages are
characterised by reduced environmental variation and their inhabitants share very similar
environmental factors (climate, nutrition, socio-economic status, occupation, education,
housing), as has been demonstrated in previous studies (see Table 2-2). In theory this
should create a favourable setting for the study since it should help limit socio-economic
and cultural bias in the interpretation of the results. Another favourable characteristic of
these populations for our study is the diversity of the attitudes towards inbreeding, as
was discussed in section 2.1.
2.4.2. Estimation of Inbreeding Coefficients in 10 Villages
Genetic characterisation of these villages included the computation of average
inbreeding coefficient of each village based on reconstruction of genealogies of a sample
of examinees which formed 20-30% of adult village population, as detailed in section
3.2.2. The individual inbreeding coefficients (F) were then computed according to
Wright's path method (258):
F=Z(i_^c)(l/2)(ni+mi+1)
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where m and n refer to the number of paths from a common ancestor, and c refers to the
number of common ancestors. The genealogical inbreeding coefficient for each village
was then computed as the average of all individual F values.
2.4.3. Estimation of Learning Disability Prevalence
For the purpose of this study, learning disability was defined as the inability to
attend the public school system. As the elementary schools (grade 1-8) in the place of
the study are both public and compulsory, the assessment of child's ability to attend the
school is performed at the age of six, based on a combination of IQ score measurement
and behavioural assessment. The assessment is based on standard set of tests, as required
by Croatian Ministry of education and culture (263). These tests include: (a) perception
test, test of point linkage, test of knowing facts, drawing test and numerical test; (b)
intelligence test based on drawing a human image; (c) "Bender Gestalt" test; (d) Raven's
progressive coloured matrices (263). Data on the individuals unable to attend school
were retrieved from local general practitioners and were considered to be complete. The
prevalence of LD was calculated as the proportion of individuals unable to attend school
in the total population of each village (as of January 2001). Ethical approval for this
study was obtained from the Ethics Committee of the University Medical School in
Zagreb, Croatia.
2.4.4. Statistical Analyses
Linear regression analysis of LD prevalence on F was performed using the data
from all ten villages. The corresponding Pearson's coefficient of correlation (r) and the
regression coefficient (b) were determined using the SYSTAT 7.0 software. The
observed prevalence of LD in each of the studied populations was considered to
approximate reasonably well the absolute risk of LD at pre-school age in each
population. The relative risk for each unit increase of 5% inbreeding was inferred from
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the slope of the linear regression curve as the ratio of the expected LD prevalence at the
points ofF= 5% and F = 0%.
As pointed out by Freire-Maia (264), in certain instances the absolute and
relative risk measures can be artificially low. An index - called "the genetic effects of
inbreeding" (GEI) - was suggested as an alternative (264), and is calculated as:
GEI = (Pi-Po) / (1-Po),
where Pi is a probability of the event (in this case LD) in an inbred person (in this case a
village with an average F greater than 3%), and Po is the probability of the event in a
non-inbred person (in this case a village with an average F less than 1%).
The population-attributable fraction (PAF) was calculated by defining each
village's LD prevalence value if their F was set equal to zero (P) according to the
regression line. The intercept of the regression line on the Y-axis when F equals zero
(X-axis) is an estimate of the LD prevalence in the absence of inbreeding. Then:
PAF = 1 - Psum / Npop,
where Npop is the total population size.
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2.5. INVESTIGATION OF THE EFFECTS OF
INBREEDING ON 10 COMMON COMPLEX DISEASES OF
LATE ONSET (CORONARY HEART DISEASE, STROKE,
CANCER, SCHIZOPHRENIA, UNI/BIPOLAR
DEPRESSION, ASTHMA, TYPE II DIABETES, GOUT,
PEPTIC ULCER, EPILEPSY)
2.5.1. Sample Selection
This study was undertaken in a subset of the original 25 villages described in
Section 2.2.1. and in presented in Table 2-2 and Figure 2-2. In 14 of the 25 villages, a
field study was undertaken between 1997-2000 to compute the inbreeding coefficients of
1,339 adult individuals recruited during the initial field study in the late 1970s and early
1980s. At the same time, the disease status of the 10 most frequent complex diseases of
late onset was determined in the entire current population of those 10 villages. The
comparison of prevalence between the group of villages with "high", "moderate" and
"low" inbreeding was then performed, as an ecologic study. Special attention was
devoted to finding the examinees from the original 1,339 who were still alive and living
in the same village today, i.e. nearly 30 years after the initial study. A total of 480 such
individuals could be found, and they were used for a cohort study at the individual level.
Table 2-3 lists the villages chosen for the study, presents their categorization
according to inbreeding prevalence into "high", "moderate" or "low" group, and shows
the average inbreeding coefficients computed from genealogies (F(gen)) and isonymy
(F(iso)). The six villages categorized into "high inbreeding" group were located in all
three studied islands, and the mean individual inbreeding coefficient in the sample from
each village was between 0.025 and 0.049. The four villages categorized into the
"moderate inbreeding" group had mean individual inbreeding coefficients between
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0.012 and 0.015, and were also situated on all 3 islands. Similarly, the "low inbreeding"
group also included four villages from all three studied islands, and the mean inbreeding
coefficient of their populations was not greater than 0.008. All these estimates weew
based on F(gen), while F(iso) are overestimates of F(gen) by an average factor of 1.53.
The variables defined in each village to control for non-genetic confounding
effects, especially socio-economic status, were the proportion of examinees with some
college education (13 or more years in school) (EDU), the proportion of the population
working in agriculture or fishery (OCU), the proportion regularly consuming a
traditional mediterranean diet (DIE) and the proportion regularly smoking (SMO), and
the average body mass index (BMI) (Table 2-3). The data on these variables were
collected by a single researcher through a questionnaire (yes/no answers to the first four
questions), and the height and weight of all examinees were measured by a "Hospitalija"
anthropometer according to standard procedures defined in a guide to field methods
(260).
The figures in Table 2-3 are based on the initial sample of 1,339 adult
individuals recruited during the initial field study in late 1970s and early 1980s.
Population census data in 1981, 1991 and 2001 from the study villages show significant
depopulation with minimal immigration over the last two decades. Thus only 480
individuals still resident in the study villages were available for follow up from the
initial sample of 1,339 adult individuals recruited during the field study in the late 1970s
and early 1980s.
2.5.2. Computation of Individual Inbreeding Coefficients in 14
Villages
This has been done using pedigree information on 4 ancestral generations (five
generations where these occurred over a similar timeframe), recorded during the initial
field work and supplemented by a study of parish registries stored in local churches
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during 1997-2000. The individual inbreeding coefficients (F) were then computed
according to Wright's path method (258):
F = E(i_>c)(l/2)(ni+mi+1)
where m and n refer to the number of paths from a common ancestor, and c refers to the
number of common ancestors. The genealogical inbreeding coefficient for each village
was then computed as the average of all individual F values. To further support these
estimates, f was calculated from isonymy as suggested by Tay and Yip (259), and mean
values were derived for each of the 14 villages. Estimates based on isonymy are
generally thought to be positively biased, and so provide an upper bound for true F
values.
Table 2-6: Criteria adopted for establishing diagnoses of 10 selected late-onset diseases.
1. CORONARY HEART DISEASE: Includes angina pectoris and/or myocardial infarction. Angina
pectoris may be diagnosed by a GP and represents a clinical syndrome due to myocardial ischaemia
characterised by repeating episodes of precordial discomfort or pressure, typically precipitated by
exertion or relieved by rest or sublingual nitroglycerine with or without reversible ischaemic ECG
changes. Myocardial infarction must be diagnosed by a consultant in a local general hospital based on
presenting symptoms (deep substernal radiating pain) and supported by a combination of ECG
findings (e.g. deep Q-waves, elevated or depressed ST segments, deeply inverted T-waves), elevated
white blood cell count and elevated myocardial component of creatine kinase and lactic
dehydrogenase with or without myocardial imaging.
2. CEREBRAL STROKE: It must be diagnosed by a consultant in a local general hospital based on
presenting symptoms. These include variable neurological defects that increase over 24-48 hours due
to an enlarging infarction of the brain caused by stenosis, embolism or thrombosis of the intra- or
extracranial arteries. Clinical diagnosis may be supported by CT/MRI scan or arteriography.
3. CANCER: It must be diagnosed by a consultant in a local general hospital. It is defined as any
abnormal cellular growth of any site which was histologically confirmed as malignant.
4. DIABETES TYPE II: It may be diagnosed by a GP. Diagnosis can be established in persons older than
30 years if any of the following conditions are met: symptomatic hyperglycaemia (polyuria,
polydipsia, polyphagia, weight loss) or diabetic ketoacidosis or non-ketotic hyperglycaemic-
hyperosmolar coma or plasma (or serum) glucose level greater than 140 mg/dL after an overnight
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fast on 2 occasions or the development of any of the late complications (e.g. retinopathy,
nephropathy, atherosclerotic changes on peripheral or coronary arteries, neuropathy).
5. SCHIZOPHRENIA: It must be diagnosed by a consultant in a local general hospital. It is a mental
disorder with a tendency towards chronicity which impairs functioning and is characterised by
psychotic symptoms involving disturbances of thought, perception, feeling and behaviour. Six
specific criteria include psychotic symptoms such as delusions, hallucinations and formal thought
disorder; deterioration from previous level of functioning; continuous signs of illness for at least 6
months; a tendency toward onset before the age of 45 years; symptoms not due to mood (affective)
disorder; symptoms not due to organic mental disorder or mental retardation.
6. UNI/BIPOLAR DEPRESSION: It must be diagnosed by a consultant in a local general hospital.
Diagnosis is based on a combination of symptomatic picture of depression, chronic course, family
history, response to treatment, TRH stimulation test, dexamethasone suppression test and sleep
EEG.
7. EPILEPSY: It must be diagnosed by a consultant in a local general hospital. It is a recurrent paroxysmal
disorder of cerebral function characterised by sudden brief attacks of altered consciousness, motor
activity, sensory phenomena or inappropriate behaviour caused by abnormal excessive discharge of
cerebral neurones. Diagnosis may be supported by abnormalities in EEG, CT, or MRI.
8. ASTHMA: It may be diagnosed by a GP. It is a lung disease characterised by three features: airways
obstruction that is usually reversible, presenting with attacks of tachypnoea, tachycardia and
audible wheezes; airway inflammation; and increased airways responsiveness to a variety of
stimuli. Diagnosis may be supported by a family history of allergy or asthma.
9. GOUT: It may be diagnosed by a GP. Diagnosis is based on a characteristic set of clinical features of
acute gouty arthritis (recurrent acute mono/polyarticular pain in peripheral joints, often nocturnal,
progressively more severe, with swelling, warmth, redness and tenderness). It may be supported by
any of the following: elevated serum urate (greater than 7 mg/dl), demonstration of urate crystals in
tissue or synovial fluid, or dramatic response (within 24 hours) to colchicine.
10. PEPTIC ULCER: It must be diagnosed by a consultant in a local general hospital. It is a circumscribed
ulceration of the gastric or duodenal mucous membrane causing a chronic and recurrent burning,
gnawing, aching, soreness or empty feeling in the epigastrium. Diagnosis must be supported by
endoscopic findings and/or X-ray studies with barium.
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2.5.3. Defining Disease Status and Estimating Prevalence
Inspection of local medical records revealed that the 10 most commonly reported
medical conditions (other than minor self-limiting disorders) with adult onset were
coronary heart disease, stroke, cancer, schizophrenia, epilepsy, uni/bipolar depression,
asthma, adult-type diabetes, gout and peptic ulcer. Specific diagnostic criteria were
established for each of these 10 conditions following those presented in the 16th edition
of Merck's Manual (see Table 2-6 for details). Two medical doctors, who were blind to
the inbreeding status of each individual, inspected the medical records of the 480
individuals and recorded whenever appropriate diagnostic criteria were met. The doctors
visited each village between March and October 2000 and reviewed the medical records
of all inhabitants in collaboration with local general practitioners, who typically had
lived in the community for a number of years and were familiar with each patient's
history. Diagnoses were supported wherever possible by medical records from
consultant specialists at the local general hospital in Split.
2.5.4. Statistical Analyses
The effects of inbreeding on the prevalence of 10 complex diseases were first
studied through an ecologic study design. In this approach, the prevalence of diseases
were simply compared between the groups of villages of "high", "moderate" and "low"
inbreeding. Disease prevalence rates were standardized by sex and age to the total
population of all 14 villages included in the study, using 10-year age intervals and a
direct standardisation method. The statistical significance of the differences between the
groups were assessed using a Chi-square test for independent samples.
In an attempt to overcome the possible confounding effects of unmeasured
environmental exposures or population stratification, the relationship between individual
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inbreeding coefficients and disease outcomes was investigated among the 480
individuals from the original cohort who were still alive and resident in the study
villages in 1997-2000. Data on age, sex, smoking status, village of residence, height,
weight, and individual inbreeding coefficient (F) were analysed in a logistic regression
with disease status as the outcome. Age and sex were forced into the prediction model
irrespective of whether they were formally significant. Other main effects (inbreeding,
smoking, height, weight and village) were entered with p=0.05 and all higher order
effects and interactions with p=0.01. The statistical analyses in this cohort study design
were planned, designed and performed under the leadership and in collaboration with Dr
Andrew Carothers from the Human Genetics Unit, Medical Research Council,
Edinburgh, UK, and then repeated under his guidance by the author of this thesis.
Population attributable fraction (PAF) estimates for inbreeding were calculated
by logistic regression allowing for individual differences in the variables: village, sex,
age, height, weight and smoking. The appropriate regression was determined as a
function of all associated variables (including F), then the probability for each individual
of having the disease outcome was calculated assuming an F value set at 0. The sum of
all such probabilities, Psum, is an estimate of the number affected in the absence of
inbreeding, but with other variables remaining unaltered. Then
PAF = 1 - Psum/Naff,
where Natf is the actual number of affected individuals. In deriving the PAF
values, the effects estimated from the subset of 14 villages were applied to the full data
set from all villages.
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2.6. INVESTIGATION OF THE EFFECTS OF HETEROSIS
ON MATING SUCCESS, FITNESS, HEIGHT, BLOOD
PRESSURE, CHOLESTEROL AND TRIGLYCERIDE
MEASUREMENTS
2.6.1. Sample Selection
The studies of inbreeding effects up to this point were based on a historic sample
from the islands of Brae, Hvar and Korcula, from about one generation ago. In attempt
to repeat the main effects of inbreeding observed in that setting and to reaffirm the
arguments by investigating the effects of heterosis (also known as "hybrid vigour",
theoretically expected to result from admixture and outbreeding due to an increase in
individual heterozygosity), a new study was designed and conducted. During 2002 and
2003, the field work was carried out in 9 villages on the four neighbouring Adriatic
islands (Rab, Vis, Lastovo and Mljet) (Figure 2-5).
Figure 2-5 presents the location of 9 villages on the islands, while the 10th
population was deliberately recruited from immigrants from the Croatian mainland into
all the studied villages, to represent a genetically diverse and outbred control population
inhabiting a similar environment. The 9 settlements were carefully chosen in 2002 to
present a wide range of differing ethnic histories, fluctuations in population size,
admixture and bottleneck events, known founding times, accessibility of genealogical
records and population willingness to participate in the research program.
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Figure 2-5: Location of 9 populations from the islands of Rab, Vis, Lastovo and Mljet
in which an additional sample of 1,001 adult individuals was recruited during the field











Mljet - B. Polje (V9)
LASTOVO ISLAND
Lastovo (V8)
Table 2-7 shows some of the basic demographic variables for each studied
village. The sources of the data for Table 2-7 were derived from more than 30 data
sources in Croatian, which included multiple books on the ethnic history of these
populations, demographic records and statistical yearbooks of the Institutes and
Ministries of the Croatian government. I believe that the data presented in the table are
robust, as they were consistent throughout the data sources from the authorities of the
Venetian Republic, the Austrio-Hungarian Empire, the Dubrovnik Republic and
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Croatian authorities, who all governed those populations at various periods in history.
Two variables (proportion of inbred population and proportion of grandparental
endogamy) were derived from the field study undertaken under my supervision in 2002
and 2003.
Table 2-7: Some of the basic demographic variables for each studied village (Pop. size
= total population in 2001; Admix, episodes, time since last = number ofmajor
admixture episodes in history and time elapsed since the last such episode; Last
bottleneck and % Reduc. pop. size = Percentage of population that vanished during last
bottleneck event and the corresponding percent reduction in population size; Trend
(year): demographic index describing population increase or decrease, defined as the
ratio of current population size and that in the given year; % inbred pop. = proportion of
consanguineous examinees in the sample; % GP endog. = proportion of examinees'
grandparents born in the village under study).
Village Barbat Banjol Lopar Rab S. Draga Vis Komiza Lastovo Mljet
(1) (2) (3) (4) (5) (6) (7) (8) (9)
Sample 100 100 100 100 100 100 100 100 100
size
Pop. size 1,205 1,971 1,191 554 1,164 1,776 1,523 835 1,111
(2001)
% inbred 13 % 7% 10% 4% 5 % 12 % 27% 3% 11 %
populat.
% GP 90.3 41.9 98.4 39.4 46.9 87.7 91.3 71.7 93.5
endog.
Founded 1,450 1,600 1,600 3,000 950 3,000 640 1,200 1,200
(ybp)




350 yrs 350 yrs 350 yrs 350 yrs 350 yrs 350 yrs 640 yrs 1200 yrs 1200 yrs
Last bot¬
tleneck
550 ybp 550 ybp 550 ybp 550 ybp 550 ybp 50 ybp 50 ybp 1200 ybp 1200 ybp
% Reduc. 60% 60% 60% 95% 60% 53 % 44% 0% 0%
pop. size
Maxim. 1,300 1,971 1,500 5,000 1,164 4,300 3,572 1,602 2,106
populat.
Maxim. 1950 AD 2001 AD 1400 AD 1400 AD 2001 AD 1910 AD 1910 AD 1931 AD 1948 AD
(year)
Trend 402 % 340 % 657 % 55% 333 % 127% 585 % 76% 101 %
(1750)
Trend 280 % 229 % 505 % 62% 162% 58 % 68% 83% 77%
(1875)
Trend 110% 167% 208 % 64% 116% 55 % 46% 58% 57%
(1925)
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Two villages (Rab and Vis) date back to Illyrian period (e.g. some 1,000 years
B.C.) and were later fortified by arriving Greeks and the succeeding Romans. By that
time, both villages already experienced two major admixture events - first between
Illyrians and Greeks, and later between Greeks and Romans. Banjol and Lopar were
both founded by Greeks in 4th century as military camps. Two centuries later, Romans
founded Barbat as their place of worship. The first Croats arrived to the region in the 7th
century AD, admixing with populations of all existing settlements and establishing four
more of the settlements under study - Lastovo and Mljet (9th century), S. Draga (11th
century) and Komiza (14th century).
Finally, wars with the Turkish Empire in the Balkans forced immigrant refugees
from the Croatian mainland to the islands. This occurred between 1570-1650 AD and
resulted in the last major admixture event. It affected mainly Rab and Vis, i.e. the
fortified settlements, but also the other villages, with the exception of Komiza, Lastovo
and Mljet (Table 2-7). For the purpose of this study, a population bottleneck was
considered a reduction in population size that occurred within the maximum time of 2
generations (50 years) and resulted in a decrease in population size greater than 40%. In
1449 and 1456, two plague epidemics killed or made refugees of 95% of the inhabitants
of Rab village and 60% of the inhabitants from the other Rab island villages. Due to
their geographic isolation from the mainland, the villages Vis, Komiza, Lastovo and
Mljet avoided the epidemics. However, the isolation that saved the latter four villages
during the 15th century attributed to economic hardship during the 20th century and a 44-
88% reduction in population size. The degree of recent isolation of the villages studied
was assessed as the percentage of the subject's grandparents who were born in the same
village, ranging from 39.4% to 98.4%, and it loosely correlated with the prevalence of
inbred individuals in the sample, showing that limited mate choice was not necessarily
the main determinant of inbreeding in the villages. The current population size in the
villages studied ranged from about 500 to about 2,000. The fluctuations in size through
history were large, even during the 20th century (265,266). The percentage of persons
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who are apparently inbred based on 2-generation parental genealogy ranged from 3% to
27%.
The field work to collect the data of interest - on marital status, number of
children, height, blood pressure, serum cholesterol and triglycerides - was performed
during 2002 and 2003. It was carried out by a team that included employees of the
School of Public Health "Andrija Stampar" of the University of Zagreb Medical School
and the Institute for Anthropological Research in Zagreb, Croatia. In each of the nine
villages, a random sample of 100 adult inhabitants has been collected. Sampling was
based on computerised randomisation of the most complete and accessible population
registries in each village, which included medical records (Mljet and Lastovo islands),
voting lists (Vis island) and household numbers (Rab island). An additional 101
examinees were recruited from second-generation immigrants into all 9 villages who
volunteered to take the part, to form a genetically diverse control population that shares
the same environment. The details on the ethical issues are presented in Section 2.7. The
Ethics approvals, information sheets and informed consent forms are attached to the
thesis as Appendix 1.
2.6.2. Defining Inbred, Endogamous, Admixed and Outbred
Individuals in the Study Sample
Several days before the field examinations were performed in each settlement, all
of the subjects selected for the study were sent a form to complete their individual two-
generation pedigree, including the dates and places of birth and full names and marital
surnames of both parents and all 4 grandparents. With respect to their genetic
background, examinees were divided into 5 categories:
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(a) inbred: when the same original (non-marital) surname, specific to the
settlement, was found in at least one of father's and one of mother's parents, and
further genealogical information revealed inbreeding;
(b) endogamous: when all four grandparents were born in the subject's village
of residence, but there was no signal of inbreeding from surnames;
(c) admixed: when both father's parents were born in one village, and both
mother's parents in another, different village;
(d) outbred: when less than four of the grandparents were born in the subject's
village of residence, with some born in other village(s) or mainland Croatia.
(e) immigrants: when all 4 grandparents were born outside the four
investigated islands.
The predicted individual heterozygosity is expected to be greatest in the admixed
group, followed by outbred examinees. Endogamous individuals are expected to have
smaller average individual heterozygosity, while the inbred group should have the
lowest levels of heterozygosity.
2.6.3. Data Collection and Trait Measurements
All of the examinees were first interviewed by one of the trained surveyors,
based on a questionnaire that was developed for this research program. The
questionnaire collected extensive information on personal data (e.g. name, date and
place of birth, gender, occupation and different lifestyle variables), with a special
interest in marital status (single / married / divorced / widowed) and number of children.
Information was retrieved on health complaints, drug intake and hospitalisation records.
The survey also included the WHO (Rose) angina questionnaire (267), the WHO
claudication questionnaire (268), the WHO non-communicable diseases questionnaire
(269), the EU respiratory health questionnaire (270), two simple questionnaires on
socio-economic status and nutrition habits developed for this specific population, and
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the SF-36 questionnaire on quality of life (271). It usually took 25-40 minutes per
examinee to complete the entire questionnaire. The copy of the large questionnaire
comprising all these aforementioned questionnaires is attached to the thesis as Appendix
2.
Blood pressure (mmHg), height (mm) and weight (kg) were each measured by a
single observer in local health centres and dispensaries between 8 and 11 AM following
standard procedures (260). Blood pressure was measured on the right forearm in a sitting
position. Two measurements of both systolic and diastolic blood pressure were taken 5
minutes apart in each individual. The resting time before each measurement was 5
minutes, systolic pressure was defined as the level (mmHg) at the 1st Korotkoff sound,
and diastolic as the level at the 5th sound. Stature (height) and body mass (weight) were
measured using a single anthropometer ("Hospitalija", Zagreb; height scale in
millimeters, weight in decagrams). Biochemical analyses of total cholesterol and
tryglicerides were measured from a blood sample that was first drawn into the 10 ml BD
Vacutainer tube. This was performed in fasting individuals between 8:30 and 9:30 AM.
Those tubes were then stored in the freezer at -20°C in all cases, and transported frozen
to a single biochemical laboratory based in Zagreb. The laboratory was chosen as it had
been internationally accredited for performing the analysis of interest and included in
quality assessment and monitoring program RIQAS (www.riqas.com, accessed on June
1st, 2005).
2.6.4. Statistical Analyses
Analyses of the effects of inbreeding, admixture and outbreeding were performed
on mating success (measured as entering at least one marriage and having at least 1 child
in that marriage), average number of children (in examinees over 40 years, as this was
justified as the age of completed family size in the overwhelming majority of cases from
genealogical records; the average age difference between males and females at marriage
was 2.1 years), mean height, blood pressure, cholesterol and triglyceride values. The
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hypothesis was that heterosis may enhance "positive" effects, such as success in finding
a spouse, number of children and personal height, while inbreeding should lead to
increased blood pressure, cholesterol and triglycerides. All the measured individual
values for studied QTs were first standardised for the effects of age using a standard




Ethical approval for this research was sought from appropriate research ethics
committees in Croatia and Scotland. Both approvals were granted, and they are attached
in Appendix 1. The approval in Croatia was obtained from Ethics Committee of the
Faculty of Medicine of the University Medical School in Zagreb, Croatia, on May 7th,
2001. The approval in Scotland was obtained from Multi-Centre Research Ethics
Committee (MREC) for Scotland on October 24th, 2001.
All the examinees enrolled in the study have read the information booklet
(attached in Appendix 1). In each village, this booklet was sent to 120 persons randomly
chosen to form the sample representative of the village. The information booklet
explained why has their village been chosen for the project, what were the aims of the
project, who lead the project, what would they be asked to do, what examinations were
involved, what results would they be given, how would they benefit from the study,
were there plans for further work, and whether there had been an ethical approval
granted.
Informed written consent was obtained from all participants in the study, where
they agreed to take part based on information provided in information booklet. The
consent form is attached in Appendix 1. Participation rate was over 85% in all villages,
thus enabling us to obtain a desired sample size of 100 in all of the villages under study
by including the first 100 invited examinees that agreed to participate in the study.
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3. RESULTS
3.1. EFFECTS OF INBREEDING ON BLOOD PRESSURE
3.1.1. Ecologic Study at the Village (Population) Level
Measurements recorded during a survey in 1979-81 in an untreated population
permitted the analysis of BP as a quantitative trait. The prevalence of hypertension
among non-inbred individuals in the study population was ~ 20%. Average inbreeding
measures for each of the 25 villages were based on Wright's path method and isonymy.
A highly significant linear correlation was found between mean inbreeding coefficient of
study individuals in each village and the prevalence of hypertension (Figure 3-la,b).
3.1.2. Regression Analysis at the Individual Level
To explore this observation further, multiple regression analysis of systolic and
diastolic BP and individual inbreeding coefficients (F) was performed on the data from
2760 individuals in the 25 Dalmatian villages, controlling for the main recognised
determinants of BP (age, sex, height and weight), village of residence and smoking
status. A strong linear correlation between F and adjusted systolic and diastolic BP was
found in both males and females (Figure 3-2a,b).
Figure 3-1 (next page): Relationship between prevalence of hypertension and average
genealogical inbreeding coefficient in 25 villages from the islands of Brae, Hvar and
Korcula.
Figure 3-2 (page after next): Relationship between measured blood pressure (BP) and
individual genealogical inbreeding coefficients (F) in 25 villages from the islands of
Brae, Hvar and Korcula (individual residual values on BP on F plotted for 2,760 study












































































































The multiple regression model which incorporated all the predictors from Table
2-2 showed that both systolic and diastolic BP levels correlated positively with age,
weight and individual inbreeding coefficients and negatively with height and smoking
status in both males and females. The regression model explained 40-50% of the
phenotypic variance in BP. The strongest effect was clearly individual inbreeding
coefficients, which alone explained approximately 15% of the variance in males and
10% in females in both systolic and diastolic levels. An increase in F of 0.01
corresponded to an increase of approximately 3 mm Hg in systolic and 2 mm Hg in
diastolic BP in both sexes (Carothers A, personal communication and Appendix 3).
Assuming the effect of inbreeding (F) on BP depends on the number and
dominance properties of QTL alleles, the equation (2) from section 1.2.5 uses the slope
of the regression of F on BP to predict the minimum number of QTL (n) affecting the
trait, assuming equal effects. The value B, which is the negative of the regression
coefficient of trait mean value in a population under study on inbreeding coefficient, F,
provides a useful summary statistic for the genetic damage that would occur if all
deleterious recessives were made homozygous ("inbreeding load", equals to F— 100%).
The value of B due to deleterious mutations depends only on the genomic mutation rate
and the dominance of individual mutations (221,222). If all mutations have the same
effects, B for a given trait that is positively correlated with fitness is:
B= U{ (1//0-2) a (Eq. 1)
where U is the mutation rate per diploid individual to deleterious alleles affecting
the trait; h is the extent to which fitness is reduced in heterozygous mutation, relative to
its effect in homozygotes; and a is a constant of proportionality relating the effect of a
mutant allele on the trait in question to its effect on fitness. If the dominance variance,
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VD, of the trait is known, a lower bound to the number of genes, n, affecting the trait is
provided by:
n > B2 / VD (Eq. 2)
Taking the total phenotypic variance as an upper limit for the value of Vd, this
analysis shows that the genetic component of blood pressure variability in this
population is influenced by not less than several hundred QTL. The predicted number of
equal-effect loci from these equations is 306 and 405 for systolic BP and 375 and 615
for diastolic BP in males and females, respectively (Carothers A, personal
communication and Appendix 3). There were more QTL contributing to effects in
females than in males, which may be partially explained by the substantial gender
differences in physiological regulation of traits such as blood pressure or bone mass
index (see later in the example of the effects on osteoporosis), which also leads to
significant differences in life expectancy between the sexes.
Height was analysed in a similar fashion (Figure 3-2c) since it shows additive
variance but no major dominance component (195,272). Therefore, it seemed as an ideal
"control" quantitative trait, which is known to be considerably affected by socio¬
economic factors, but should not be expected to be affected by inbreeding (due to its low
dominance variance and high additive variance). The results showed that the slope of the
regression of F on height did not differ significantly from zero, as predicted. This is a
very important finding, which shows that the observed effects of inbreeding are not
easily explained by the positive correlation between inbreeding and socio-economic
status of the examinees.
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3.2. EFFECTS OF INBREEDING ON CORTICAL INDEX
AND OSTEOPOROSIS
Another quantitative trait was studied, which is an important intermediate
phenotype for a common late-onset disease (osteoporosis) (260-262). Figures 3-3 to 3-6
show the results of an ecologic-epidemiological study of the association between the
mean inbreeding coefficient in 14 villages (F) and mean standardized cortical index (CI)
and osteoporosis (OP) prevalence. The coefficient of correlation (r) between F values
and CI was -0.28 in males (p=0.08) and -0.42 in females (p=0.005). The "outlier" village
in males (Figure 3-3), Dracevica, has the smallest sample size (N<20), so it is possible
that chance deviation due to small sample size is responsible for high average values of
CI and without that village the association would also formally reach statistical
significance in males.
This relationship is much clearer in females (Figure 3-4), where the same small
sample from Dracevica is again an "outlier", but the other examined villages followed
the predicted relationship of CI and average inbreeding more closely than was observed
in males. This may point to greater heritability or a more polygenic nature of bone mass
loss control in females, than in males. However, the fact that the measured average
inbreeding correlates significantly with the two biomedically important quantitative
traits (blood pressure and cortical index), that are not significantly correlated mutually in
this analysis at either population or individual level, makes it more likely that the effect
is real. This points to conclusion that the villages characterized by higher rates of
consanguinity indeed have greater prevalence of hypertension and osteoporosis.
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Figure 3-3: Effect of average inbreeding coefficient (F) on cortical index (standardized
age-adjusted residuals weighted according to sample size) in male examinees in 14
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Figure 3-4: Effect of average inbreeding coefficient (F) on cortical index (standardized
age-adjusted residuals weighted according to sample size) in female examinees in 14
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Figure 3-5: Effect of average inbreeding coefficient (F) on prevalence of osteoporosis
(standardized by age, weighted according to sample size) in male examinees in 14
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Figure 3-6: Effect of average inbreeding coefficient (F) on prevalence of osteoporosis
(standardized by age, weighted according to sample size) in female examinees in 14
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The coefficients of correlation between F and OP prevalence were 0.32 in males
(p<0.001) and 0.43 in females (p<0.001) (Figure 3-5,3-6). These results may indicate a
significant inbreeding depression on a biomedically important quantitative trait (CI),
which leads to an increase in susceptibility to osteoporosis and its prevalence in inbred
communities of Croatian islands. All the correlations were more significant in females.
Furthermore, there is a general concordance between values for both males and females
from the same village, which supports the hypothesis that the findings are indeed due to
village-specific effects rather than chance findings.
There is a possibility that the high prevalence of large-effect variants have
substantial effect on cortical index in particular villages, making them the apparent
outliers. An example is the village of Cara in Figure 3-5. There is a concern that such
outliers may considerably affect the regression and thus drive the conclusions. Also,
there are many other possible confounding effects due to different levels of exposure to
risk factors in different villages. It is not possible to obtain information on prevalence of
main risk factors for osteoporosis in the population under study in this historic sample.
Still, the consistency of the effects of inbreeding on the two non-correlated quantitative
traits and the plausibility of the effect based on a large body of evidence on inbreeding
depression in animals and plants argues that the observed effects may indeed be real.
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3.3. EFFECTS OF INBREEDING ON LEARNING
DISABILITY
Previously conducted studies of inbreeding effects on cognitive performance in
the literature compared the prevalence of LD in an inbred cohort with non-inbred
controls (174). This raised issues about social and cultural comparability of controls and
the possible clustering of a Mendelian disease (a single large effect gene) in the inbred
cases. In contrast, this study investigated 10 populations with similar environments and
culture but with a spectrum of inbreeding coefficients and quite different founding
populations. If this study found a comparable prevalence of LD in all 10 populations,
this would not support inbreeding effect and the LD prevalence would be assumed to be
determined mainly by factors related to the environment. However, if a positive
correlation between inbreeding levels and LD prevalence would be found across 10
villages, this would imply effects of inbreeding. A further advantage of having 10
distinct populations under investigation is to rule out the possibility of a rare Mendelian
disease clustering, as it is unlikely that the same rare variant would be present in all 10
populations having very different founding populations and ethnic history.
Another hypothesis tested through this analysis was that if a modest increase in
sharing the variants identical by descent leads to a significant change in prevalence of
LD across several isolate populations that share very similar environmental effects, this
would be consistent with a very large number of genomic loci influencing the condition.
An in-depth theoretical consideration of the problem was presented by Morton (174).
Table 3-1 presents the villages studied, their respective total populations (in the
year 2000), the average coefficients of inbreeding (computed as above), the number of
cases of learning disability (LD) and the prevalence of LD in each village. The
inbreeding coefficients in these villages ranged from 0.8% to 4.9%, and the prevalence
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of LD from 0.43% to 2.47%. The mean prevalence of LD of 1.0% is somewhat below
the world average figures for this type of population (174).
Table 3-1: Total population of 10 studied villages (as of January 2001), average
population inbreeding coefficient (F) determined from genealogies, number of learning
disability (LD) cases and the prevalence of learning disability.
VILLAGE, N F LD LD
ISLAND (population) (genealogical) cases prevalence
Gdinj (Hvar) 153 0.049 2 1.31%
Susak (Susak) 81 0.047 2 2.47%
Pupnat (Korcula) 326 0.044 6 1.84%
Cara (Korcula) 464 0.032 2 0.43%
Racisce (Korcula) 290 0.027 3 1.03%
G. Humac (Brae) 214 0.013 1 0.47%
Lumbarda (Korcula) 354 0.012 3 0.85%
Lastovo (Lastovo) 899 0.011 5 0.56%
Smokvica (Korcula) 866 0.008 4 0.46%
Svirce (Hvar) 375 0.008 2 0.53%
Figure 3-7 presents the relationship between F and LD and the corresponding
Pearson's correlation coefficient, which amounted to 0.80 (p<0.01). Although the
relative risk per increase of inbreeding coefficient from 1% to 5% appeared to be quite
high (about 4-5), the absolute risk only increased from 0.5% to 2.0%. This means that in
the absence of inbreeding only 1 in more than 200 births should be expected to result in
some form of learning disability in this population. When inbreeding reaches the level
close to that of first-cousin matings (6.25%), some form of learning disability may be
expected only in about 1 in every 50 births.
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Figure 3-7: Plot of the values of prevalence of learning disability against average
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The genetic effect of inbreeding (GEI) was 0.69%, which is derived from the
difference in expected prevalence of LD when the villages with F greater than 3% and
less than 1% are compared. The population-attributable fraction of cases due to
inbreeding in all ten populations was very high, and it amounted to 76.6% (Table 3-2).
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Table 3-2: Pearson's coefficient of correlation between inbreeding coefficient and
prevalence of learning disability, regression coefficient, estimates of relative risk,
genetic effect of inbreeding (GEI) and population attributable fraction (PAF).
MEASURE VALUE
Pearson's coefficient of correlation (r) 0.80
Regression coefficient (b) 0.33
Relative risk (F=5% vs. F=0%) 10.23
GEI (F>3% vs. F<1%) 0.69%
Population attributable fraction 76.6%
The estimates in Table 3-2 should still be taken with caution, as when only a
single risk factor is studied, especially in a study of an ecological design such as this
one, which is especially prone to confounding effects, it is more likely that the effects
are overestimated than underestimated. However, a large number of studies in the
literature using different designs in different time periods, populations and in different
settings already confirmed a strong negative association between inbreeding and
cognitive performance and positive association with learning disability, which makes it
likely that the effects observed in this study are also real, and that inbreeding is prevalent
enough in the populations under study to enable thorough investigations of inbreeding
effects.
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3.4. EFFECTS OF INBREEDING ON 10 COMMON
COMPLEX DISEASES OF LATE ONSET (CORONARY
HEART DISEASE, STROKE, CANCER,
SCHIZOPHRENIA, UNI/BIPOLAR DEPRESSION,
ASTHMA, TYPE II DIABETES, GOUT, PEPTIC ULCER,
EPILEPSY)
3.4.1. Ecologic Study at the Village (Population) Level
Table 3-3 presents village data in three groups ("high", "moderate" and "low")
defined by the average level of inbreeding which was presented in detail in Table 2-2.
The allocation of villages to these three groups according to the estimates of F based on
genealogy (Fgen) is broadly consistent with those based on isonymy (Fiso). On a log
scale, the correlation between the two measures of inbreeding across villages was 0.92,
with Fiso exceeding Fgen on average by a factor of 1.53. To explore the confounding
effects of other variables, such as socio-economic factors, differences in nutritional
factors and smoking, the prevalence of these risk factors was presented for each village
in Table 2-2. Overall, this presentation confirmed the low levels of higher education and
the high proportion of the population eating a traditional diet and employed in
agriculture and fishing, with very little variation across the villages. Levels of reported
smoking, however, varied widely from village to village.
In Table 3-3, the prevalence of 10 complex diseases standardized by age and sex
to the total population of all 14 villages is presented separately for the groups of villages
with relatively "high", "moderate" and "low" average inbreeding coefficient values. The
levels of disease prevalence were consistently higher in the groups of villages with
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"moderate" in comparison to those with "low" average inbreeding. The differences
reached statistical significance for gout, uni/bipolar depression, peptic ulcer,
schizophrenia and cancer.
Table 3-3:
Age and sex-standardised prevalences of 10 complex diseases in groups of villages with
relatively "high", "moderate" and "low" average inbreeding coefficient values. Fgen =
weighed average inbreeding coefficient computed from genealogical data; Fiso =
weighed average inbreeding coefficient computed from isonymy data; Statistical
significance (p values) in highly and moderately inbred groups is calculated against the
low inbreeding group (*p<0.05; **p<0.01; ***p<0.001).
"High inbreeding" "Moderate inbreeding" "Low inbreeding"
(N = 1,401) (N = 998) (N= 1,501)
Average (Fgen)=0.036 Average (Fgen)=0.013 Average (Fgen)=0.006
Average (Fiso)= 0.052 Average (Fiso)= 0.019 Average (Fiso)= 0.009
Coronary heart disease 13.28% 11.95% 11.23%
(95% confid. intervals) (11.50%- 15.06%) (9.94% - 13.96%)
Stroke 2.43% 2.79% 1.73%
(95% confid. intervals) (1.62%-3.24%) (1.77% -3.81%) (1.07% - 2.39%)
Cancer *** 4.54% * 3.44% 1.93%
(95% confid. intervals) (3.45% - 5.63%) (2.31% - 4.57%) (1.23% - 2.63%)
Schizophrenia *** 1.23% * 0.96% 0.14%
(95% confid. intervals) (0.65%- 1.81%) (0.35% - 1.57%) (0.00% - 0.33%)
Uni/bipolar depression *** 10.26% ** 7.63% 4.51%
(95% confid. intervals) (9.45% - 11.07%) (5.98% - 9.28%) (3.46%- 5.56%)
Asthma 3.63% 2.64% 2.60%
(95% confid. intervals) (2.65%-4.61%) (1.64% - 3.64%) (1.79% - 3.41%)
Type 11 diabetes 6.02% 7.35% 6.77%
(95% confid. intervals) (4.77% - 7.27%) (6.01% -- 8.69%) (5.50% - 8.04%)
Gout *** 9.25% *** 7.19% 3.96%
(95% confid. intervals) (7.75%- 10.77%) (5.58% - 8.80%) (2.97% - 4.95%)
Peptic ulcer *** 6.92% ** 4.29% 2.18%
(95% confid. intervals) (5.59% - 8.25%) (3.03% - 5.55%) (1.44% - 2.92%)
Epilepsy *** 1.47% 0.78% 0.31%
(95% confid. intervals) (0.84%-2.10%) (0.23% - 1.33%) (0.03% - 0.59%)
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Villages in the "high" inbreeding group showed further increases in disease
prevalence compared to the "moderate" group for all disorders except type 2 diabetes
and stroke. Thus, the following disorders showed a stepwise increase in disease
prevalence across villages stratified by average inbreeding coefficient: gout, depression,
peptic ulcer, schizophrenia, cancer, epilepsy, coronary heart disease and asthma (the last
two not statistically significant).
3.4.2. Cohort Study at the Individual Level
Table 3-4 shows the results when the analysis was repeated at the individual
level (rather than village level), similar to the analysis of effects on blood pressure
(Section 3.4.1.). The analysis included data from 480 individuals from 14 villages for
whom individual coefficients of inbreeding were available, as they were included in the
original (historic) sample. The aim was to explore if inbreeding coefficients represent a
variable with a significant effect on the "disease presence" variable. Age and sex were
forced into the multiple logistic regression model on the basis that these would be
expected to be relevant in all conditions. Other main effects (inbreeding, smoking and
log_weight) were entered with p=0.05, and all higher-order effects and interactions with
p=0.01. Schizophrenia and epilepsy were excluded from this analysis because of the
small numbers of outcome events and therefore low study power to investigate
predictors for these conditions.
Table 3-4:
Summary of results of multiple logistic regression (* excludes village effects, even
though they were significant in the data set from 14 villages, since they could not be
estimated for the remaining 11 villages in the full set;1 Population attributable fraction
(PAF) estimated from individual inbreeding levels (see Text)).
Disease Predictor Coefficient SE p value PAF (%)
C.H.D. Constant Ak20 E27 0.000 34.3 *
SEX 0.47 0.26 0.070
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AGE 0.69 0.14 0.000
VILLAGE — — 0.022
F1 26.63 4.88 0.000
Stroke Constant -3.28 0.71 0.000 26.3
SEX -0.30 0.40 0.464
AGE 0.34 0.20 0.095
F 13.37 5.85 0.022
Cancer Constant 10.17 6.27 0.105 23.2
SEX 0.83 0.54 0.128
AGE 0.02 0.20 0.909
LNWT -3.49 1.40 0.013
F 13.0 6.17 0.035
Depression Constant -3.86 0.58 0.000 42.2
SEX 0.69 0.31 0.028
AGE 0.02 0.14 0.896
F 24.54 4.43 0.000
Asthma Constant -3.74 0.80 0.000 47.7
SEX -0.40 0.45 0.374
AGE 0.36 0.23 0.110
F 23.10 6.04 0.000
Diabetes Constant -28.16 4.58 0.000 0.0
(type II) SEX 0.97 0.31 0.002
AGE 0.31 0.14 0.027
LNWT 5.60 0.99 0.000
Gout Constant -14.90 4.08 0.000 31.0
SEX -0.17 0.29 0.552
AGE 0.38 0.14 0.006
LNWT 2.85 0.89 0.001
F 17.69 4.16 0.000
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Table 3-4 shows that inbreeding coefficient (F) remained a significant (positive)
predictor for every condition except type 2 diabetes. The forced inclusion of age and sex
in the model acted to reduce slightly the significance of the effect of inbreeding, because
of a small positive correlation between inbreeding and age. Village of residence was
found to be a significant predictor only for coronary heart disease (CHD). Body weight
(LN_WT) was a significant negative predictor for cancer, and positive for type 2
diabetes and gout.
In terms of health impact, the results on population attributable fraction (PAF)
show that as much as 23-48% of the prevalence of these disorders (other than type 2
diabetes) in this population can be attributed to recent inbreeding. However, the highest
PAF estimates are associated with the least common diseases, so there may be
considerable uncertainty around them and some of them are likely to be overestimates.
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3.5. EFFECTS OF INBREEDING, ENDOGAMY,
ADMIXTURE AND OUTBREEDING ON FITNESS,
MATING SUCCESS AND QUANTITATIVE TRAITS
(HEIGHT, BLOOD PRESSURE, CHOLESTEROL AND
TRIGLYCERIDES)
To support the observed effects of inbreeding on quantitative traits and complex
diseases of late onset in a historic sample from the islands of Brae, Hvar and Korcula
islands, a new large-scale field study was undertaken between 2002-2003. During this
investigation, samples of 100 individuals of the present-day population were recruited
from 9 different villages from the neighbouring islands of Rab, Vis, Lastovo and Mljet
(see Figure 2-1) - a total of 900 persons. An additional 101 persons were recruited as
genetic controls from the immigrants into the villages, although for 10 of them it was
later realised through genealogical investigation that one of the four of their
grandparents was born in the village of study.
The purpose of this analysis was to repeat the analysis of the relationship
between inbreeding and blood pressure. In this study, values of triglycerides and
cholesterol were also measured, which are additional established risk factors for
cardiovascular diseases. However, to make the case stronger, the aim was to also show
that admixed and outbred individuals had experienced certain benefits from their
presumed increased heterozygosity in comparison to inbred or autochtonous
("endogamous") populations. Therefore, the individuals included in the study were
categorized according to their individual genetic history (1GH). One of the important
theoretically predicted effects of heterosis on humans ("hybrid vigour"), which has
already been shown in a large number of studies in animals and plants, is improved
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fitness (which can be measured as the average number of children per "IGH" category in
persons who are of reproductive age). Others include increased average height per
category in adults, and even the improved chance of finding a spouse (which can be
measured as the proportion of married persons within each "IGH" category).
In order to undertake this investigation, the sample of 910 non-immigrant
individuals were divided into "IGH" categories according to the expectation of the level
of their predicted heterozygosity as follows:
HI: inbred individuals (N=92) - genealogy revealed consanguinity, the category
with the largest expected homozygosity;
H2: "endogamous" individuals (N=436) - all 4 grandparents were born in same
village, but no signal of consanguinity in the genealogy;
H3: outbred: (N=312): mixture of heritage of different villages and outside
world; expected heterozygosity greater than H1 and H2 categories, less than
H4.
H4: "admixed" individuals (N=70): offspring of 2 (H2) individuals from
different villages, and should have the maximal expected heterozygosity.
Table 3-2 shows that, when the hypothesized beneficial effects of heterosis were
analysed, the H4 category (with highest presumed heterozygosity) was consistently
showing the most favourable results with respect to fitness, mating success and height in
both males and females. Furthermore, the lowest mean values of systolic blood pressure
and triglycerides and the second lowest mean value of cholesterol were also noted in this
group of admixed individuals. These effects (except height in males) were statistically
significant across the groups, and the number of observed 1st ranks for this group (for six
of seven measured variables) was significantly greater than expected under the null
hypothesis (p<0.05).
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Category HI (92 inbred individuals), however, showed increased values of
systolic blood pressure, triglycerides and cholesterol in comparison to the other three
groups. The average height in this group of individuals was also lower than in other 3
groups for both sexes. Mean fitness was significantly lower than in the H3 and H4
categories, while no major difference was seen in mating success.
Table 3-5:
Comparison of the effects of inbreeding (HI category), endogamy (H2), outbreeding
(H3) and admixture (H4) on mean fitness, mating success, height, systolic blood
pressure, cholesterol and triglycerides in 910 present-day examinees from the islands of
Rab, Vis, Lastovo and Mljet. Ranks are assigned according to the positive outcome (e.g.
greater fitness, mating success and height; lower blood pressure, triglycerides and
cholesterol)./7-value across groups (columns) tests if the value in any of the categories
significantly differs from other categories; jo-value across variables (columns) tests
whether any rank is observed more frequently within the group than under the null-
hypothesis.
HI category H2 category H3 category H4 category p-value*
(N=92) (N=436) (N=312) (N=70)
MEAN FITNESS
(average number of chil¬ 2.024 2.016 2.193 2.196 <0.01
dren in >=40 years old) (3rd) (4th) (2nd) (1st)
MATING SUCCESS
(% married in >=40 years 96.93 94.95 95.10 97.80 <0.05
old) (2nd) (4th) (3rd) (1st)
AVERAGE HEIGHT
(adults only, 174.7 175.2 175.3 176.3 N.S.
male gender, in cm) (4th) (3rd) (2nd) (1st)
AVERAGE HEIGHT
(adults only, 161.6 162.8 162.4 165.0 <0.001
female gender, in cm) (4th) (2nd) (3rd) (1st)
AVERAGE SYSTOLIC
BLOOD PRESSURE 148.0 142.8 140.6 139.7 <0.001
(standardized, mmHg) (4th) (3rd) (2nd) (1st)
log (TRIGLYCERIDES)
(regression- standardized, 0.33 0.21 0.32 0.20 <0.001
in mmol/L) (4th) (2nd) (3rd) (1st)
log (CHOLESTEROL)
(regression- standardized, 1.83 1.76 1.80 1.77 <0.001
in mmol/L) (4th) (1st) (3rd) (2nd)
p-value** <0.10 N.S. N.S. <0.05
* The mean values were compared across 4 groups of examinees using ANOVA (N.S. - not significant);
** The ranks expected in each group (1st, 2nd, 3rd or 4th) were counted in each column (observed
frequency) and compared to predicted frequency under null-hypothesis using chi-squared test.
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When the two intermediate groups ("endogamous" vs. "outbred") with greatest
sample sizes (436 vs. 312) were compared, the "outbred" group (H3) had significantly
greater mean fitness, but other differences were not striking. We conclude that the H2
group and H3 group do not differ sufficiently in their heterozygosity to reveal
considerable differences. However, when compared to the H2 and H3 categories, the
inbred individuals seemed to fare worse in most aspects, while the admixed individuals
fared better.
Although most of the effects indeed confirmed the a priori hypotheses, we again
have to take these results with a degree of caution, as the sample sizes used to test the
hypotheses are relatively small. Also, it is likely that some of the studied outcomes are
correlated, such as male height and their mating success (273). The most convincingly
demonstrated effect, however, was again the increased systolic blood pressure among




4.1. AIMS AND SCOPE
The aim of this work was to investigate the effects of inbreeding on human
quantitative traits and complex diseases of late onset. In the first part of the introduction,
the current understanding of the genetic basis of human diseases was reviewed. It was
stated that one of the greatest current interests in biomedical sciences was to improve the
understanding of the genetic basis of common human diseases of late-onset. This
improved knowledge could then help the design of genetic epidemiological studies that
are being undertaken by numerous groups. The success of genetic association studies
could improve our understanding of disease pathogenesis and lead to the development of
new methods of early diagnosis and treatment, which may become individualized and
tailored to specific patients.
One of the approaches that could be helpful in improving our understanding of
the genetics of susceptibility to common complex diseases of late onset are studies of
inbreeding effects on the incidence and prevalence of such diseases. The measurement
of those effects could provide some empirical evidence to support one of the two
opposing (but not necessarily mutually exclusive) views on the genetic basis of complex
late-onset diseases: the common disease/common variant hypothesis (CD/CV) and the
common disease/rare variant hypothesis (CD/RV). Under the first hypothesis, major
effects of inbreeding should not be expected, but under the second hypothesis, where it
is presumed that the susceptibility variants are extremely numerous, rare in the
population, partially recessive and likely to be of small effect, inbreeding could
substantially affect disease prevalence.
In the second part of the introduction, the results of the extensive literature
review on the documented effects of inbreeding on human health in the pre-reproductive
and post-reproductive periods were presented. It was shown that the main focus of
interest of a large majority of previous studies were diseases of early onset (pre-
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reproductive), that have been selected against during the course of human history.
However, it was surprising to note a paucity of investigations studying the effects on
human late-onset traits and diseases.
There are several possible reasons why the effect of inbreeding on late-onset
complex chronic diseases has not been widely evaluated to date. Firstly, in countries
where inbreeding is prevalent in the population, life expectancy is generally
considerably shorter than in western communities, and late-onset diseases did not
historically represent research priorities. Therefore, the effects of inbreeding were
mostly investigated in small isolated communities (geographic, cultural, linguistic,
ethnic or religious isolates) in developed countries, which could be more easily reached.
In most developed countries, however, the isolated human populations characterized by
inbreeding often do not have the same level of access to health care as the general
(especially urban) population where the public health sector is well developed and the
majority of epidemiological studies are being undertaken. Therefore, the health status of
human isolates is not easily evaluated from medical records or communicated with their
local physicians. In addition, there are not many isolate populations world-wide with
well-preserved parish registries from which reliable estimates of inbreeding coefficients
can be determined, based on the familial relationships over at least several ancestral
generations. Furthermore, there are usually multiple concerns over confounding factors,
as it is often quite difficult to find a non-inbred control population which would match
the studied inbred isolate in environmental exposures and differed significantly only in
genetic structure. Contemporary isolates usually share specific climate and environment,
as well as a multitude of common socio-cultural factors such as diet, lifestyle, religious
practices and socio-economic status for which it is very difficult to control. In small and
isolated communities the phenomena such as founder effect, genetic drift and inbreeding
can significantly affect allele and genotype frequencies, which invalidates comparisons
with control populations where genotype frequencies follow Hardy-Weinberg
equilibrium (274). Khoury et al. concluded that, despite rare attempts, there is still
hardly any study that would satisfactorily deal with all the usual concerns including
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small sample sizes, unreliable inbreeding estimates, doubtful disease diagnoses and
inappropriate control populations (6).
The analysis of the prevalence of inbreeding as a potential risk factor in the
human population showed that up to 1 billion people globally (nearly 15% of the total
population) are likely to be offspring of consanguineous unions and have an average
inbreeding coefficient of about 3%. Given the number of 25,000 genes in the human
genome, this would imply that those 15% of humans have about 800 more genes
identical by descent than all other humans. It is therefore surprising that the possible
effects of this have not been investigated, as the increase in relative risk of those people
to develop a common complex disease of late onset could substantially affect the global
burden of disease. As an example, an increase in the relative risk of cancer among
recently inbred humans of about 2.0, similar to that found in this study, would increase
the global burden of cancer (using the simple formula for potential impact fraction) by
(RR-1) x 12% (which is the conservative estimate of the prevalence of inbred
individuals globally), i.e. by 12%, assuming that those people would survive to the age
of disease onset.
This consideration becomes even more worrying when the evidence from animal
studies and evolutionary and population genetic arguments are considered. In the last
part of the introduction, it was implied through several lines of theoretical and empirical
evidence that the effects of inbreeding in post-reproductive age would be expected to be
considerably larger than in pre-reproductive age. This is mainly due to the invisibility of
genetic variants underlying late-onset traits to selection, leading to their accumulation in
the genome as a consequence. Due to these reasons, the study into the effects of
inbreeding on biologically relevant quantitative traits (blood pressure, cortical index,
biochemical measurements), learning disability and complex diseases of late onset
(coronary heart disease, stroke, diabetes type II, psychiatric disorders, epilepsy, gout,
asthma, peptic ulcer, osteoporosis) was undertaken in this work.
133
4.2. PROPOSED THEORETICAL MECHANISMS OF
INBREEDING EFFECTS ON HUMAN LATE-ONSET
TRAITS AND COMMON DISEASES
The genetic architecture underlying late-onset diseases such as cardiovascular
diseases, cancer, adult-onset diabetes and psychiatric disorders, which represent the
major health burden globally, is still a matter of open debate (3,10,18,44,72,78). A
genetic model that is finding increasing support from both animal experiments and
human studies is one in which the genetic variants underlying complex chronic diseases
are more likely to be rare rather than common in the population. They are also likely to
be numerous (a highly polygenic architecture) and of a small individual effect (3,78). If
this view of the genetic architecture of common complex diseases is correct then it
would be important to consider the predicted effect of inbreeding. I will propose five
reasons why inbreeding may have a considerable effect on post-reproductive human
health.
4.2.1. Deleterious Effects of Inbreeding Depression on Quantitative
(Endo)Phenotypes that Confer Risk for Late-Onset Diseases
May Be Multiplicative
Inbreeding depression is a recognised phenomenon that is common to polygenic
traits in all living organisms (189). It is thought to result from increased homozygosity
of recessive alleles that act in the same direction at loci that influence the phenotype of
interest ("directional dominance") (222). In an inbred individual, inbreeding depression
is predicted to affect many polygenic endophenotypes (quantitative [patho]-
physiological intermediates involved in physiological or disease processes). Many of
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these are established risk factors for late-onset diseases, such as blood pressure, body
mass index, cholesterol and glucose levels. A substantial effect of inbreeding acting to
increase human blood pressure has been shown directly in at least four studies (195-
197), and implied indirectly in several more studies (191-194). Effects on body mass
index and cholesterol levels have also been implied (191,192,194). Similarly, the effects
on various measures of intelligence have been consistently shown (174,175). It is known
that the risk of e.g. increased blood pressure, body mass index and cholesterol levels on
cardiovascular diseases is not threshold-dependent, but increases across the entire range
of values observed in the population (201). Thus, one important consequence is that
inbred individuals are expected to be at slightly increased risk relative to the outbred
general population to develop a late-onset disease, regardless of the absolute
measurement of their blood pressure, body mass index and cholesterol. Furthermore,
even if the effect of inbreeding depression on each of those phenotypes individually was
rather small, it is known that the concurrent presence of several risk factors for the same
disease increases risks in a multiplicative rather than additive manner. Therefore, the
joint effect of inbreeding depression on all the potential quantitative phenotypes that
confer the risk of late-onset disease during a lifetime could be more substantial than is
widely appreciated (112,113).
4.2.2. Effects of Inbreeding on Rare Variants With Large Effect in
Post-Reproductive Adults ("Invisible Mendelian Diseases" of
Late Onset)
Inbreeding is predicted to have larger effects on the population-attributable
fraction of disease if the underlying variants are rare rather than common. This is
because common recessive variants will occasionally become homozygous in the
population by chance, without a need for inbreeding to bring them together. If the
variants are very rare in the population, and inbreeding is almost the only realistic
scenario under which they can become homozygous in an individual, then the fraction of
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disease cases in the population who are the offspring of related parents will be much
larger. This was shown to be the case with the population attributable fraction of early-
onset monogenic (Mendelian) diseases in the presence of inbreeding: it has been shown
that the prevalence of autosomal dominant Mendelian disorders is constant in all world
populations, but the prevalence of autosomal recessive Mendelian disorders is increased
by 3-4-fold in regions where inbreeding is prevalent (102,107) Therefore, the great
majority of Mendelian disease that is caused by rare recessive variants of large effect
and early age of onset is due to inbreeding in those countries. However, these diseases
manifest in the pre-reproductive period, so they are "visible" to selection. Although
these variants continuously arise through mutations, most of the affected cases never
reproduce, so they are being effectively removed from the gene pool by selection. Thus,
their overall public health burden is reasonably low. Bittles and Neel estimated that each
human carries about 1.4 such recessive lethal mutations in the genome (13).
However, rare variants of large effect also act in Mendelian fashion to cause late-
onset complex diseases. For nearly all late-onset diseases, clustering in families has been
reported and, in some, rare high-penetrance variants have been found which are
associated with an extremely increased lifetime risk of disease (10,18,44). Examples of
this include variants in BRCA1 and BRCA2 and breast cancer (69), hMLHl and hMSH
and colorectal cancer (275), and GCK (glucokinase) and maturity-onset diabetes of the
young (MODY) diabetes (276). In large outbred populations, it is estimated that up to
15% of disease cases such as cardiovascular, cancer, diabetes and psychiatric disorders
cluster in families, while 85% or more are due to combined effects of polygenic
susceptibility and cumulative environmental exposures (67). However, in countries
where inbreeding is common, the prevalence of all recessively inherited monogenic
forms of complex diseases could be expected to increase by at least as much as seen
jointly for all recessive early-onset Mendelian diseases, i.e. 3-4-fold (102). In theory,
this could greatly increase both the overall disease prevalence and the proportion of the
late-onset disease burden caused by rare recessive variants.
136
It is also known that these rare variants can affect quantitative phenotypes, such
as blood pressure or cholesterol (familial hypertension, familial hypercholesterolaemias)
(77,191), which represent "invisible Mendelian diseases", as their phenotypes are not
clinically apparent. Most of the Mendelian diseases were defined by their apparent
clinical phenotype, but the number of human phenotypes is endless, and it is possible
that some genetic variants affect traits that are not obvious during the visual inspection
of a patient, such as blood pressure or cholesterol levels. These quantitative phenotypes
are associated with increased morbidity and mortality from diseases of public health
importance such as stroke and coronary heart disease. It is conceivable that there are
many more such "invisible" Mendelian diseases affecting metabolic pathways at
different levels and predisposing individuals to complex diseases in the post-
reproductive period. The joint effect of inbreeding on all of these variants could be
expected to be of a magnitude of at least that seen for early-onset Mendelian diseases.
Indeed there are reasons to believe that the number of rare and recessive Mendelian
variants with large effect on late-onset complex diseases is much larger than the
estimated number with early effects. These rare variants have accumulated in the
genome through mutations that are either neutral in early life, or even beneficial, but
show deleterious effects in post-reproductive period ("antagonistic pleiotropy")
(112,113). There is no known mechanism that would be expected to remove these
mutations from the genome or act against their accumulation, as they become deleterious
in the post-reproductive period and therefore should be invisible to selection. Thus there
are cogent reasons why the effects of inbreeding on late-onset Mendelian diseases
should be carefully considered in the same way as has been done for early-onset diseases
4.2.3. Autozygosity in Many Rare Recessive Variants of Small Effect
Could Result in Epistatic Effects that Could Jointly Impair
Capacity to Compensate Against Environmental Risks
Modest levels of inbreeding observed in human populations are expected to have
much larger effects on the population distributions of polygenic traits than on oligogenic
traits and diseases. This is because an excess in autozygosity of 6.25% of the genes in
human genome (i.e. about 2,000 genes), which would be expected in a child from a first-
cousin marriage, will lead to autozygosity of rare recessive mutations of small effect in
those 2,000 genes. In a polygenic trait, it is expected that some of the genes that
determine its expression would be affected even with only 6.25% of the genome
autozygous. We have argued that the genetic component of late-onset diseases may be
due principally to large numbers of rare variants in numerous genes - the common
disease/rare variant (CD/RV) hypothesis (3). Recent estimates (277) imply that each
person carries, on average, 500-1200 slightly deleterious mutations, most of which are
rare and present in heterozygous form. Those mutations are more likely to also be
recessive, as dominant mutations are continuously being removed from the gene pool by
selection, while the rare and recessive mutations remain invisible to selection unless
exposed by inbreeding (3). In an offspring of first-cousin marriage, 30-75 of these
variants would be expected to become homozygous, with uncertain effects (278). If the
mutations are numerous and of small deleterious effect, their autozygosity throughout
the genome might not lead to apparent syndromes of early onset, but may mildly impair
the function of affected genes. As a result, the compensatory potential to oppose the
harmful environmental stimuli would be non-specifically impaired. This impairment of
homeostasis or repair capacity could lead to an earlier age at diagnosis of a late-onset
complex disease. This is consistent with the model of these diseases arising over long
periods of time, and becoming clinically apparent when the compensatory potential is
exhausted (113,189).
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This theoretical mechanism is difficult to study in humans, but has been clearly
demonstrated in animals, where a greater sensitivity of homeostatic mechanisms to
inbreeding in later life has been suggested (113,189). In an experiment with inbred and
non-inbred mice strains, the two strains did not show large differences in survival when
the animals were kept in the laboratories. However, when both groups were released into
their natural habitat, the inbred mice strains had a dramatically reduced chance of
survival in comparison to non-inbred group (279). The effects of inbreeding are
therefore thought to be much greater in natural populations (exposed to a less uniform
and more challenging environment) than in those studied in laboratories.
4.2.4. Heterozygote Advantage in Loci Under Balancing Selection is
Expected to Reduce by Inbreeding
At some genomic loci, there may not be variants present in a population that are
clearly deleterious, but the heterozygous genotype may be more favourable than either
homozygous genotype. This effect is widely known as the "heterozygote advantage",
"hybrid vigour" or simply "heterosis". The effects of heterosis usually act in an opposite
way from those of inbreeding depression and they have been demonstrated in humans
(280,281), and widely in animals and plants (282,283). The type of selection that tends
to maintain more than one allele in the population at intermediate frequencies, thus
maximising the frequency of heterozygous genotypes in a population, is known as
"balancing selection" (3). It is clear that balancing selection probably has an important
role in shaping diversity in the genes that are important for defence against unknown and
unpredictable environmental risks, such as infectious diseases (280). Populations that are
more genetically diverse are at less risk from diverse environmental threats (since it is
more likely that someone would carry a rare protective variant) (284). It is therefore
likely that inbreeding leading to autozygosity in several hundred genes will affect some
of these genomic loci under balancing selection, thus reducing the beneficial effects of
heterosis in those individuals. This mechanism could be more important than generally
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thought, since recent evidence suggests that loci under balancing selection may be
surprisingly common in the genome (285-288).
4.2.5. Empirical Evidence of Inbreeding Effects in Humans and
Other Organisms
The most extensive research into the effects of inbreeding in general, and
particularly on genetic variation related to senescence has been carried out in Drosophila
spp. A review of 25 years of this research has concluded that deleterious alleles
generated by mutation and kept at low frequency by selection contribute between 33%
and 67% of the genetic variation in a typical fitness-related trait. This supports a
polygenic model of genetic architecture of most phenotypes and suggests that the
common disease / rare variant mechanism contributes to a substantial share of complex
disease aetiology (222,289). A recently published experiment in Drosophila spp. (112)
showed that genetic variation and inbreeding effects increase dramatically with age,
supporting these hypotheses. Numerous recent studies of other animals, some of them
performed in populations of large mammals, have also consistently reported that
inbreeding negatively affected key components of fitness, resulting in increased
morbidity and decreased life span (290-293). A meta-analysis (294) and a critical review
and re-examination of these studies (287) have both concluded that, although
unexpected and in some aspects against current understanding, their findings could not
be easily dismissed on grounds of publication bias or apparent flaws in methodology.
Finally, my own intensive review of the human literature since 1965 has
managed to identify very few case-control studies of late-onset diseases in which
inbreeding status was not determined by self-reporting, and disease status determination
was based on a clear diagnostic criterion which did not change during the period of
study. These studies investigated the effects of inbreeding on coronary heart disease
(205,208), cancer (209, 210), psychiatric disorders (213) and Alzheimer's disease (216).
140
All those studies reported considerable relative risks associated with inbreeding,
typically between 2.0-5.0, which persisted after adjustment for known or suspected
confounding factors. Although the available evidence is surprisingly sparse, it appears to
support the hypothesis that inbreeding could have a considerable effect on human health
and disease occurrence in post-reproductive age adults. However, it is also possible that
large publication bias could be responsible for such conclusion: the early reports are, as
a rule, more likely to over-estimate the effect size, and the subsequent lack of
publications and scarcity of available data could also imply that those initial findings
were difficult to repeat.
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4.3. SUMMARY OF THE INVESTIGATED EFFECTS OF
INBREEDING ON HUMAN QUANTITATIVE TRAITS
AND LEARNING DISABILITY
4.3.1. Blood Pressure
It is widely recognised that essential hypertension is under considerable genetic
influence. However, apart from isolated successes in mapping rare monogenic loci,
which account for less than 5% of hypertension, no major progress has been made in
defining the genetic basis of essential hypertension (295). A common, often implicit,
assumption in mapping studies of such complex traits is that relatively few genetic loci
of moderate to large effect account for a large component of the underlying genetic
variance despite the paucity of empirical data to support this. This study has provided an
insight into the possible highly complex genetic architecture of blood pressure variation,
showing that the effects of recessive QTL on BP are likely to be widespread, accounting
for 10-15% of the total variation in BP in this population. These effects are attributable
to a very large number of loci (at least 300-600) which will almost certainly show a
range of effects on BP.
The model used for the calculation of the estimated number of QTL that underlie
blood pressure levels (see Sections 1.2.5. and 2.2.4.) makes several assumptions which
may influence these estimates. Firstly, the inbreeding coefficient is based on measures of
recent inbreeding (over 4-5 generations). We therefore calculated isonymy estimates for
each village (Table 1), and found that their median value exceeded the median F value
by a factor of 1.53. Since isonymy is widely recognised to over-estimate inbreeding
(259), this represents an upper bound to the inbreeding estimate. This is plausible, as it
has recently been shown by mathematical simulations that individual inbreeding
coefficient estimates based on 4-5 ancestral generations are expected to capture 85-90%
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of expected autozygosity, regardless of the possible ancestral relatedness earlier in the
past (287). Inflating the F values by 153% in the model, which is certainly an
overestimate of individual F values, would reduce the estimates of minimum QTL
numbers by a factor of 1.532 (=2.34). On the other hand if, as seems likely, the ratio of
dominance variance (Vd) and total phenotypic variance (VP) is less than the assumed
100%, the effect would be to increase the estimates by a factor (VP / VD), which could
be 2-4 times. Cavalli-Sforza and Bodmer (296), for example, estimated Vd/Vp to be 0.38
and 0.33 for systolic and diastolic blood pressure respectively, using the data of Miall
and Oldham (297), which would double or even triple the estimates in this study.
Secondly, as in many genetic models, all loci were assumed to have equal
effects, whereas both theory (298) and empirical data in animals (299) show that the
QTL effects vary widely and may even be of opposite sign. Ignoring this fact would
again result in under-estimating the true number of QTL. Thirdly, the model assumes bi-
allelic loci. However, for multi-allelic loci the estimate of minimum QTL numbers is
unaffected, except in the unlikely situation that high degrees of over-dominance occur at
all, or most, loci (189). Fourthly, if a substantial proportion of the phenotypic variance is
due to epistatic effects, additive and dominance variances may be upwardly biased, with
an uncertain effect on the estimated number of QTL. However, many studies suggest
that epistatic QT effects are uncommon (299), although some have recently expressed a
different opinion, suggesting that epistatic effects are too often neglected (278). It is fair
to say that the magnitude of epistatic effects is still uncertain, but regardless of its
importance, it should not affect the overall conclusion of this study (i.e. that the genetic
basis of blood pressure variation is polygenic and highly complex). Fifthly, this study
assumed that recombination between adjacent loci was sufficiently frequent that the IBD
status of any locus could be considered independent of its neighbours. In effect, the
method treats tightly-linked loci as a single "super-locus" (300), leading to further
underestimation of the true number of loci.
143
Finally, the model assumed random mating within the total population of 25
villages, although this criterion was certainly not met due to population subdivision. The
studied population was in fact a "metapopulation", composed of a larger number of
isolated small populations. However, village of residence showed a strong independent
effect on BP suggesting either village-specific patterns of inbreeding or other local
effects. Multiple regression performed separately in each village population revealed
that the mean within-village slope (for the regression ofF on BP) did not differ from the
pooled-village slope for either systolic or diastolic BP. This would seem to support a
common disease/common variant model (60) in which individual villages share a
common genetic diathesis influencing BP. Random samples representing about 20% of
each village did not seem to underestimate the total number of QTL within the whole
population. An alternative explanation is that, due to the metapopulation nature of the
investigated sample, each village had an excess frequency of at least a few recessive
variants that are village-specific and otherwise rare, and had moderate to large effect on
blood pressure. When "exposed" by inbreeding, those variants could be responsible for
the observed increase of blood pressure values among inbred individuals within each
village.
The magnitude of the inbreeding effect on BP is large (equivalent to a rise in
systolic BP of ~20mm Hg and diastolic of ~12 mm Hg in the offspring of first cousin
marriages; F=0.0625). This increase is, however, very similar to estimates of inbreeding
effects on diastolic (195) and systolic (196) BP in other isolate populations. One of the
explanations for the large observed effect may be because inbreeding has a greater
influence on late-onset traits than on traits that are subject to early selection (222). It is
also possible that low environmental variation, or underestimation of F due to
individuals being related through multiple lines of descent, contribute to the size of
inbreeding effect in this isolate population (194-196,202). Finally, the effect of
inbreeding in a "metapopulation" may be much stronger than in a non-subdivided,
outbred population, as greater allele frequencies of rare alleles of large effect and their
expression are possible in each isolate through interaction of founder effect and
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subsequent inbreeding and genetic drift (283). The mechanism is the same in each
isolate, although it affects different variants: initially, a small group of founders
introduces a number of very rare and deleterious variants from the general population, in
which those variants were insignificant for the overall disease burden. However, in the
newly created gene pool of an isolate population those variants become common, and
they may even continue to increase in frequency over generations due to genetic drift.
Their effects in a population are also considerably more pronounced because inbreeding,
characteristic of human isolate populations, increases the chance for their homozygosity.
Therefore, in population of such genetic structure (many rare alleles brought to common
frequencies in individual villages) the effect of inbreeding on the population-attributable
fraction of any trait or disease is predicted to be much stronger. All these mechanisms
may help explain the observed effect size of inbreeding, which may be lesser in more
environmentally diverse or outbred populations. The unidirectionality of the effect is
also striking and consistent with a linear unidirectional effect seen in an S-Leut isolate
population (196), but the mechanism is unclear. A change in BP with inbreeding is
predicted as a consequence of recessive or partially recessive variants with the direction
of change towards the value of the more recessive alleles. Physiological homeostasis
may also act to support a directional change in BP, for example through selection against
variants tending to reduce BP in order to maintain circulatory viability.
The estimate of several hundred QTL relevant to human hypertension is realistic
and indeed conservatively low. Some additional theoretical work by Carothers
(Carothers A, personal communication) showed that this general conclusion remains
unchanged even under a wide variety of assumptions related to the distribution of size
effects of QTL, e.g. even under the assumption of the presence of a number of loci with
large effect. The conclusion of a highly polygenic genetic architecture of blood pressure
regulation is consistent with a complex and genetically highly variable (301) system of
blood pressure control mediated by cardiac output, blood vessel architecture, renal
function and CNS integration, and requiring the interaction of homeostatic systems,
including baroreceptors, natriuretic peptides, renin-angiotensin-aldosterone, kinin-
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kallikrein, adrenergic receptors, and local vasodilator mechanisms (295). Furthermore,
published work from animal models of hypertension support a polygenic rather than
oligogenic basis for hypertension (295) and yet these probably underestimate the genetic
complexity, since they are typically bred towards fixation of a small subset of the
diversity found in wild populations (300). The greater genetic complexity of a diverse
and outbred human population would seem to be self-evident, despite the fact that
humans show less haplotype and polymorphic diversity than several other species,
including other primates (29).
The present study demonstrates an important effect of inbreeding on the
genetically complex late-onset disorder, hypertension, which appears to be mediated by
a large number of recessive QTL alleles as a result of increased homozygosity. Several
factors support the validity of the data and reinforce the conclusions. Firstly, the
standard measurement procedures adopted and exclusion of known confounding factors,
coupled with the fact that hypertension was untreated in this historic sample. Secondly,
the consistency of findings in diverse populations (194-196). Thirdly, the linear increase
in BP with increasing F (prevalence of hypertension rises by 10% for every increment in
Fof 0.01 up to F=0.06). Fourthly, the overall strength of the effect. Fifthly, the existence
of biologically plausible mechanisms, all of which point to a causal relationship between
inbreeding and hypertension. Moreover, the consistency of the observation in a random
sample of individuals across 25 villages is not explicable by a kinship effect. This is to
say, if the effect of inbreeding on hypertension was observed in a single isolate
population, it could be argued that there is clustering of hypertension among the
relatives, who are also more inbred, so the observed effect was that of familial
clustering, and therefore possibly even environmental. Flowever, my results showed that
across 25 different villages on 3 different islands the inbred individuals are always those
who are also more likely to be hypertensive, which cannot be attributed to familial
clustering. In terms of health impact, the results show that 36% of the hypertension
incidence in this population can be attributed to inbreeding (population attributable
fraction). The population prevalence of hypertension among non-inbred individuals is
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approximately 20%, similar to most outbred populations, but it increases steeply among
50 year olds as the inbreeding coefficient rises.
4.3.2. Cortical Index
One of the ways to support the conclusion that the increasing effect on blood
pressure was indeed due to inbreeding was to investigate the inbreeding effect on
another quantitative trait unrelated to blood pressure, using a similar design in the same
population. Cortical index was chosen as that trait can be measured objectively, and it
represents the most important intermediate phenotype for a common late-onset disease,
i.e. osteoporosis. A subset of the same population (14 of 25 villages) used for the blood
pressure study in which cortical index was also measured was investigated. The
subdivision of the islanders of the eastern Adriatic into small villages and diversity of
their attitudes towards inbreeding influenced by geographic isolation, political privileges
in the past, as well as socio-cultural reasons, resulted in a range of inbreeding
coefficients at both the individual and population level. This has already been shown as
a favourable setting for the blood pressure study.
The bone X-rays were performed in local village health clinics during the field
work in 1970s and early 1980s, using the same device and computed from the scans by
the same assessor from the Institute of Anthropological Research in Zagreb. This was
performed at the same time as blood pressure measurements were being taken.
Therefore, the cortical index represents an objective measurement of an intermediate
disease phenotype. An attempt was also made to avoid the significant confounding
effects of genetic drift and founder effect in specific villages. This has been achieved by
including several villages of similar inbreeding levels from different islands into the
groups with "high", "moderate" and "low" inbreeding, as it is unlikely that the two
population genetic phenomena would affect gene frequencies in the same direction in all
villages.
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The results showed a significant decreasing effect of inbreeding on cortical index
(initially standardised by age) across 14 villages (Figures 3-3 and 3-4). Similarly, the
prevalence of osteoporosis found in these villages appeared to increase from about 1.3%
in villages with low inbreeding prevalence to nearly 4.0% in villages with average
inbreeding coefficient close to F=0.05, i.e. a 3-fold increase (Figures 3-5 and 3-6).
Analysis by village showed that the standardised prevalence of osteoporosis follows the
increase in average inbreeding coefficients, although this correlation is not really linear
as there are villages with an extremely increased prevalence in both sexes (e.g. Cara,
with an OP prevalence of about 10%). In addition, not all villages with higher rates of
inbreeding reveal a high prevalence of osteoporosis (e.g. Pupnat in males). These
observations might be due to the specific genetic structure of those villages which are
characterised by increased or decreased frequencies of rare alleles with large effects
mediating susceptibility to osteoporosis, possibly due to the combined effect of genetic
drift and founder effect.
If we accept the conclusion that the increase in average inbreeding coefficient of
about 2-3% (from F=0.005 to 0.03) could be, to some extent, responsible for the
observed increase in prevalence of osteoporosis, the central question becomes what does
it tell us about the genetic basis of the disease? Similarly as in the analysis of effects of
inbreeding on hypertension, the susceptibility seems to be controlled, at least partly, by
recessive genetic variants that are more likely to be rare than common, as the inbreeding
effects on rare variants are more apparent. Major effect genes arise after mutations that
are considered to be very rare, as the probability of random mutation causing small
effect is much greater. Therefore, even if such mutations were present in some of the
studied villages, it is extremely unlikely that similar effects of inbreeding would be
observed across several villages, as our results indicated. The results provide further
evidence on a polygenic basis of susceptibility for osteoporosis with detectable effects of
recessive genes. The finding of the significant effect on both blood pressure and cortical
index, i.e. two seemingly unrelated quantitative traits, reinforced the conclusions that
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inbreeding is indeed responsible for the observed effects. An analysis of the association
between inbreeding and cortical index is planned at the individual level to further
strengthen these findings.
4.3.3. Learning Disability
The study of the effects of the average inbreeding coefficient in 10 communities
on the prevalence of learning disability further reinforced the findings of the effect on
blood pressure and cortical index. The association between inbreeding coefficient and
learning disability has been consistently demonstrated and repeated in more than 20
independent studies performed in very different populations and time periods, and the
findings in the Croatian island isolates are in line with all previously reported results
(174,175). The consistency between the effects observed on blood pressure, cortical
index and learning disability both between themselves and with the results of other
studies supports the hypothesis that the "metapopulation" of Croatian island isolates is
particularly favourable for investigating the inbreeding effects on human quantitative
traits and complex diseases.
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4.4. SUMMARY OF THE INVESTIGATED EFFECTS OF
INBREEDING ON HUMAN LATE-ONSET COMPLEX
DISEASES
The extensive literature on the health effects of inbreeding has not examined
late-onset phenotypes such as hypertension to the same extent as traits such as
reproduction, childhood mortality or Mendelian disorders (13,106). In other species, an
increase with age in the deleterious effects of inbreeding has been reported. It has been
suggested that this may be due to increasing sensitivity to genetic effects with advancing
age caused by loss of selective elimination of deleterious effects on homeostatic
mechanisms (113). In this research, the studies conducted on blood pressure and cortical
index indicated that inbreeding may affect biomedically relevant intermediate
phenotypes that are considered major risk factors for late-onset complex diseases. It was
intriguing to evaluate the inbreeding effects on the prevalence ofmost common complex
diseases of late onset in Croatian island isolates.
The impact of inbreeding on reproduction, childhood mortality and Mendelian
disorders is well-documented (189,222). In contrast, very little has been published on the
effects of inbreeding on late-onset diseases. This is despite the fact that inbreeding may
have a greater influence on late-onset traits than on traits that are subject to early
selection (112,113), as discussed earlier. This study demonstrated an important effect of
inbreeding on a number of genetically complex late-onset diseases that are of major
public health importance. The results are consistent with the hypothesis that a major
genetic influence on these disorders is mediated by numerous deleterious recessive
alleles, suggesting that inbreeding increases disease risk as a result of increased
homozygosity (3).
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It is important to consider again whether these results can be explained by
chance, bias or confounding. The effects of inbreeding were expected, as this was the
main a priori hypothesis (based on four different theoretically possible mechanism and
empirical evidence in other species, discussed in Section 4.2.). This taken together with
the levels of statistical significance reported argues strongly against chance as an
explanation for the observed findings that consistently showed a significant inbreeding
effect on nearly all of the investigated late-onset diseases.
With respect to possible selection bias when inbreeding effects were investigated
at the individual level, the 480 individuals on whom it was possible to obtain disease
outcome data were a subset of the original cohort from the 1970s and 1980s. However,
census data revealed that the major reason for loss to follow-up, other than deaths of
cohort members, was emigration from the villages over the 20-year period. It is
presumed that this emigration was random in terms of the genetic structure of the
remaining population, so the selection of the sub-sample of the original population
should not result in substantial bias.
Measurement bias is also unlikely, as disease outcomes were not ascertained or
recorded differently among individuals who differed by inbreeding status. Explicit,
standard clinical criteria were adopted by the two study doctors. They were both blind to
the inbreeding status of all the individuals - in fact, they systematically scanned the
complete medical records of all current village populations and did not have any
information on who participated in the initial field work 20 years ago. Furthermore, the
results cannot be explained by different diagnostic practices in different villages, as the
village term was not found to be statistically significant in the multiple logistic
regression analysis (except for coronary heart disease).
As chance and bias are unlikely explanations for the observed findings, the
potential confounding effects also need to be addressed. A number of potential
confounding factors (age, sex, smoking status, education level, general diet,
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occupational group, height, weight) were measured and their effects adjusted for in the
multivariate analysis. Although a degree of imprecision is inevitable in measuring some
of these factors, we do not believe that confounding could have accounted for the large
and consistent effects demonstrated.
There is also a concern that there could have been an interaction between age and
inbreeding, and that older people in the population were more likely to be inbred and ill.
However, the multiple regression model used in the analysis investigated this correlation
and corrected for it in all cases. The correlation was generally not significant in the large
majority of the analyses, showing that inbreeding was still prevalent in all age groups
included in this historic cohort. Also, the lack of the statistical significance of the effect
of age on some diseases where it would be expected, e.g. stroke, shows that there are
other independent factors in this metapopulation that may contribute to earlier age of
onset of stroke patients: inbreeding (through increase in blood pressure levels) and
smoking.
Several factors support the validity of the data: firstly, the findings support our
prior hypothesis and are consistent with similar findings on hypertension in the same
population and with other reports of inbreeding effects on blood pressure (191-196).
Secondly, the overall strength of the effect argues against bias or confounding. Thirdly,
we have presented detailed arguments that biologically plausible mechanisms
underpinning this effect are consistent with population genetic theory and observations
in a wide range of organisms (see Section 4.2.). Finally, the data are consistent with the
few other published reports of inbreeding effects on late-onset diseases in which
inbreeding was measured rather than self-reported (205-219,302,303).
The magnitude of the inbreeding effect on disease prevalence was large.
However, the effect on the prevalence of stroke and coronary heart disease, for example,
is consistent with our estimate of a rise in diastolic BP by 2mmHg for an increase in F of
0.01. Both cohort studies and randomized trials show that an increase of 5mmHg
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diastolic BP is associated with a 33% increase in stroke risk and a 20% increase in risk
of ischaemic heart disease (304). The large effect may be due to the greater influence of
inbreeding on late-onset traits than on traits that are subject to early selection (112,113).
It is also possible that low environmental variation, underestimation of F due to
individuals being related through multiple lines of descent, and "metapopulation"
structure contribute to the size of inbreeding effect in these isolate populations, which
has all been discussed earlier. Thus, the magnitude of the inbreeding effect relative to
the overall variation may be smaller in outbred and more environmentally diverse
populations.
The effect of inbreeding was shown in 7 of the other 8 diseases studied, with
epilepsy and schizophrenia revealing too few cases for an analysis in a multiple
regression model. The lack of observed effect of inbreeding on type 2 diabetes may
reflect the lower heritability and stronger environmental influences involved in the
aetiology of this condition (189,222). The observed effect of inbreeding on the
prevalence of several different late-onset diseases is consistent with the presence of
many deleterious recessive alleles, located throughout the genome. It is also consistent
with a more general effect of inbreeding with increased homozygosity at these loci
leading to an accumulation of small deleterious effects on homeostatic pathways, which
cumulatively increase disease risk. This suggests a greater sensitivity of homeostatic
mechanisms to inbreeding in later life, as predicted by findings in animals (106,113).
Decay of homeostatic capacity would also be expected to lead to reduced capacity to
respond appropriately to diverse stimuli. This is supported by the recently reported
observation that the reduced survival found in inbred animals is greater in the natural
habitat than in a controlled laboratory environment (279).
The inbreeding data do not allow an easy distinction to be made between the
relative contributions of common versus rare variants but do inform two somewhat
neglected aspects of the genetic architecture underlying complex diseases (3). Firstly,
the results provide indirect evidence in support of a major polygenic component to
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disease susceptibility. The inbreeding coefficient is shown to be a significant predictor
of CHD, stroke, cancer, depression, asthma, gout and peptic ulcer with population
attributable risks varying between 23% and 48%. An upward bias affecting these
estimates is possible, as only a few covariates were available for this historic cohort, and
inbreeding was among those few variables included in the regression model, which was
likely to increase its overall importance.
Secondly, the recessive or partially recessive nature of complex disease
susceptibility has received little emphasis. Both factors have implications for the
identification of individual disease susceptibility alleles. If disease susceptibility is
indeed highly polygenic then it implies the necessity to reduce the phenotypic
complexity of "disease" by means of genetically simpler but contributory quantitative
traits (QT) or disease subgroups. Those with extreme values of QT distributions or early
disease age-of-onset will be those most likely to harbour susceptibility alleles of large
effect and hence to provide a realistic possibility of gene identification. Secondly, a
significant component of genetic susceptibility appears to result from variants that are
recessive or partially recessive. This implies that the study of inbred populations would
be advantageous since the increased gene dosage of such variants in inbred individuals
will tend to amplify their phenotypic effects compared with outbred populations, where
most alleles are present in heterozygotes.
The population attributable risk estimates from this study suggest that 23-48% of
the incidence of the disorders showing an inbreeding effect in this population can be
attributed to inbreeding. The study of inbreeding effects on blood pressure showed that
36% of hypertension incidence in this population could be attributed to inbreeding.
Those estimates are likely to be biased upwardly, and should probably not be expected
in general populations, for a number of reasons already discussed: (i) very few
covariates were available for investigation from the historic sample, which is likely to
overestimate the inbreeding effect; (ii) a "metapopulation" nature of the studied
population, which has a strong genetic sub-structure and therefore the effects of
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inbreeding are expected to be stronger; (iii) lack of understanding of a possible effect of
"background inbreeding" in the most isolated and the smallest villages, specific to the
entire village population, which would imply that the inbreeding coefficients in those
villages are actually underestimates, and therefore the observed size effects of
inbreeding are overestimates.
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4.5. SUMMARY OF THE INVESTIGATED EFFECTS OF
ADMIXTURE AND OUTBREEDING ON HUMAN
HEALTH AND DISEASE
The global human population has experienced dramatic changes in population
genetic structure on both regional levels and at the global scale relatively recently. After
having been organized in small and sparsely scattered isolate communities tied to the
land they harvested throughout their entire history, enormous changes have occurred
within the last 5-6 generations. Primarily, measures to reduce childhood mortality
(vaccination, antibiotic treatment of infections, improved nutrition and sanitation) have
led to an unprecedented increase in population size, from about 1 billion (in 1850) to
more than 6 billion (in 2000). This relaxing of selection that kept the human population
size reasonably constant for centuries is predicted to help in retaining new rare genetic
variants introduced through mutations, rather than efficiently eliminating them by
genetic drift in sub-structured populations (3). Therefore, increase in population size is
the likely cause of the recently increased genetic diversity of contemporary human
populations in comparison to those that lived only two centuries ago. The effects of
population expansion on the changes in current genetic diversity are expected to be
largely due to the introduction of rare and recent mutations that are being retained in the
absence of genetic drift.
Apart from large and sudden population expansion, admixture and outbreeding,
there are other population genetic mechanisms that have occurred relatively recently and
on a massive scale. The organization of humans in small rural communities limited mate
choice, and there are several reasons to believe that inbreeding was common throughout
human history. First, in our contemporary set of isolate populations used for the
admixture and outbreeding analyses (the 10 village dataset), all of them reasonably large
156
in terms of population size (Npop=800-1500), it was apparent that about 10% of all
individuals were inbred, although inbreeding was generally discouraged in these Roman
Catholic communities. In smaller villages, such as those found throughout history, and
with a deeper look into genealogies, it is certain that this percentage would be
considerably greater. Strong positive selection (through high childhood mortality) of
infectious diseases on rare variants that were shared by relatives in closed communities
was causing a so-called "selective sweep", where genetic variation in the population was
being decreased through the constant positive selection of relatives carrying rare
protective alleles (305). Finally, up to year 1900 about 98% of the World's population
lived in villages, and even today up to 2 billion people globally are living in areas with a
considerable prevalence of consanguineous marriages (102,306). The process of
urbanization that took place in both developed and developing countries suddenly
shifted a substantial proportion of the human population from villages into the cities. At
first, there is often tendency of the migrants to preferentially marry people from the
same or very similar background, with so-called "chain migration" a very common
phenomenon. However, eventually, their offspring will mate with individuals of a
genetically different background, which is predicted to cause a massive outbreeding at
the global scale.
Finally, international travel and large inter-continental migrations of people
during the second half of 20th century led to the third effect on a global scale: "gene
flow" and "admixture". The effects of urbanization at regional levels are now repeated
through international migrations and mating between people from different origins at the
global scale. Taking into account the relatively sudden occurrence and enormous
magnitude of all four effects - increase in population size, outbreeding, gene flow and
admixture - it is very surprising that the possible public health effects of changes in
genetic structure of populations have hardly been addressed, let alone investigated. A
careful review of the literature performed during 2003 implied only a handful of
attempts to address various elements of this hypothesis (307-309).
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The World Health Organisation recently defined major disease risk factors in the
developed world that attribute most to the disease burden in the population (190). Apart
from smoking, other major risks include increases in body mass index, blood pressure,
cholesterol levels and blood glucose, all of them readily measurable quantitative traits.
There is a plausible theoretical argument why inbreeding (decreased heterozygosity) and
outbreeding (increased heterozygosity) should cause changes in mean population values
of quantitative traits, as discussed in Section 4.2. (3,189,310). Associations between
heterozygosity and biologically important quantitative traits and their cumulative effect
on fitness have been convincingly demonstrated in a number of plant and animal
populations (279,291,292,311-315). However, we could only identify a handful of
studies in human populations that provided any data on these effects in post-
reproductive age (196,316,317). The only important human quantitative trait that has
been frequently associated with decreased heterozygosity is intelligence, with a
reasonably large number of supportive studies from various parts of the world showing
strikingly large effects on the trait (174).
Therefore, in this study our main aim was to investigate if changes in population
structure could be associated with shifts in the population distribution of quantitative
traits identified as major disease risk factors, such as blood pressure, cholesterol and
triglycerides. However, an even more scientifically intriguing aim was to investigate if
the effects of appreciable magnitude predicted from evolutionary and population genetic
viewpoints could be observed in a present-day human metapopulation: effects of
heterosis on fitness, mate choice and height. The study mainly suggested that inbred
individuals generally had higher pathologic values of biomedically relevant QTs than the
examinees of more diverse genetic background. This could be explained through the
action of numerous rare and recessive variants of slightly deletorious effect that have not
been selected against in childhood, as they mostly affect the variation in late-onset traits.
Therefore, those variants could reach appreciable frequencies at numerous quantitative
trait loci and show a non-specific pathologic effect on a number of QTs even in the
presence of small levels of inbreeding, as it was in our study. Also, heterosis seemed to
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positively influence height and increase fitness by 10%. Although seemingly small, this
rate of increase in fitness tends to rapidly increase the population share of outbred
individuals with each new generation, while keeping the absolute number of inbred and
endogamous individuals constant.
These observations are likely to be genuine, as the standardization excluded a
number of potential biases and confounding effects present at the level of between-
population comparisons. Standardizing the individuals in each category (inbred,
endogamous, admixed and outbred) by gender, age and village of residence eliminated
potential biases such as seasonality, assessor-related differences, isolate-specific effects
of environment, and any differences in data collection between populations. Methods to
measure inbreeding from genomic information are currently being developed, to support
the findings reported here with genomic measures of gene diversity (at population level)
and average heterozygosity (at individual level) calculated from genome-wide scans
using several hundred ofmicrosatellite polymorphisms (318).
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4.6. CRITICAL ASSESSMENT OF THE RELIABILITY OF
THE FINDINGS
The potential sources of chance, bias and confounding specific to the design of
each individual study on inbreeding effects presented in this thesis (i.e., hypertension,
osteoporosis, learning disability, complex diseases of late onset and several quantitative
traits) were discussed under appropriate headings. This is because study designs,
selected samples and methods used in each one of those studies differed considerably,
and they were all selected appropriately to the study question. However, there are also
considerations related to the validity and reliability of the findings in this thesis that are
more fundamental and therefore relevant to all five individual studies that were
undertaken. They could all provide alternative explanations to the observed results, and
therefore should be carefully considered.
Firstly, there is a concern over the causes of diversity of attitudes towards
inbreeding in different villages. If this was systematically influenced by an unmeasured
variable, that variable could perhaps also correlate with all the traits that were measured.
One of such variables is, for example, clerical approval of the marriage between the
close relatives. If some villages systematically differed from the others, that could point
to the general role of the cultural factors, such as more intense role or practice of religion
in some villages, contributing to better health over time. Still, we consider this factor
highly unlikely, as the records showed that the priests generally migrated between the
villages quite often, or were in charge of religious practices in a number of villages at
the same time, that it is difficult to believe that some villages differed in inbreeding
practices from the others consistently and during larger periods of time due to clerical
(dis)approval of consanguineous unions.
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To extend this argument, there is always a concern in any epidemiological study
which is ecological in design on whether the chosen predictor variable (i.e., preferential
and random inbreeding, due to village endogamy) is really the sole parameter under
investigation, or does inbreeding act as some form of surrogate measure for a composite
collection or other mainly non-genetic variables. For example, when comparing
inbreeding levels and effects within a community, it is possible that there were
differences between consanguineous and non-consanguineous families, especially in
terms of disease prevalence. For example, certain families could more commonly marry
their cousins because of recognized "frailty" that effectively excludes them from the
wider marriage pool. This may indeed be the case, but the extent of its effect is very
difficult to estimate. 1 believe that, under the specific circumstances (e.g., using the
historic cohort sample), as much has been done in terms of identification, definition and
inclusion of the covariates into the analyses as realistically possible. Another argument
in favour of the inbreeding effects being real is the consistency of the observed effects
on the wide range of unrelated outcomes using tailored study designs, varying samples
and different methods, coupled with the support for these effects in the literature that
studied the effects of inbreeding in animals and plants.
Then, there is a bias in this thesis towards only considering and discussing the
negative health effects of inbreeding, although one may also anticipate the positive ones,
assuming these exist. For example, it is unclear why should the increased levels of
identity by descent apparently focus on the expression of genes with this increased, and
not on reduced blood pressure. One explanation of this unidirectional effect could be the
so-called antagonistic pleiotropy, e.g., that factors that contribute to greater reproductive
success among inbred couples early in life also make them more susceptible to diseases
later in life. I will try to explain why this was the case. However, I would argue that the
explanation of the unidirectional and generally negative effects of inbreeding has to do
with a metapopulation nature of the studied population, the intra-village rare gene
specificity and the population sub-division, leading to the Wahlund effect. When the
Wahlund effect is present, inbreeding values are affected by internal geographic
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subdivision of the population, with social and cultural factors, such as avoidance of or
preference for consanguineous marriages, being less important. Now, let us consider the
effects of population subdivision and structuring: the founder effect will immediately
become important, and gene frequencies will start to change in each particular isolate
and to diverge from each other. However, the only net effect consistently present under
this scenario is that all new mutations arising over time within each particular isolate
will actually be increasing in frequency in all the isolates, due to effects of genetic drift
in small population and the absence of gene flow. Those frequencies of newly
introduced mutations will, in time, reach the levels that are orders of magnitude greater
than it would b possible in large general populations with constant gene flow. Although
the effects of those new mutations depends on the interaction with the particular
environment, and some of them may be beneficial and others silent, it is nevertheless
predicted that the large majority of those new mutations would still be slightly
deleterious. When such metapopulations practice inbreeding, they "expose" the effects
of otherwise silent recessive mutations, both "old" (founder) ones and "new" (isolate-
specific) ones, the large majority of which is predicted to be deleterious. So, although
the mutations leading to beneficial effects must also exist in these isolates, the majority
of the observed effects on health-relevant traits across all the studied isolates are
expected to be negative and unidirectional.
In considering the disease prevalence data, there is always a concern that none of
them are mainly determined by either inbreeding or the environment, as there is always a
possibility of the presence of unmeasured factors, such as e.g. possible influence of
prenatal factors on the conditions investigated (also known as "the Barker hypothesis").
The Barker hypothesis states that there may be fetal origins of diseases that are
important in adulthood. The hypothesis is primarily based on reported epidemiological
associations between indicators of fetal malnutrition and mortality and morbidity
recorded during the adulthood. The associations were reported between birth weight and
coronary heart disease, stroke, hypertension, type 2 diabetes mellitus, insulin resistance
and serum lipids. This association appears even stronger in developing countries of the
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world (319,320). It is not possible to speculate about the Barker hypothesis as an
alternative explanation of the findings in this thesis, but given that genomic imprinting
was suggested as one of the possible mechanisms contributing to those effects, perhaps
it would be an interesting line of research in the future to study how inbreeding affects
genomic imprinting in fetal period and possibly affects the predictions under the Barker
hypothesis.
There is a general concern about the structure of the emigrants and the
immigrants that could affect the design of parts of this thesis. In studying the effects on
late-onset diseases, the validity of the assumption that post-1980 migration from the
islands was random is questionable, as it may be possible that the migrants were better
educated, healthier, more ambitious or conversely less advantaged in their lives on the
islands. In general terms, emigrants are very seldom truly representative of those who
either elect or are forced by circumstances to remain sedentary. Therefore, the presented
results could only be valid for a group of people that remained, and not necessarily for
those who left the island. The similar concern extends to the selection of the 2nd
generation immigrants from the Croatian mainland as an outbred control group in the
study of outbreeding effects on a number of quantitative traits.
Finally, a fundamental question remains: if outbreeding is a universally more
successful mating strategy than inbreeding, then why does consanguinity continue to be
favoured by many populations? 1 believe that the preference of inbreeding practices has
strong cultural, social and economic roots, and that in the poor communities its benefits
far outweigh the costs. Knowing that the health risks of inbreeding in pre-reproductive
age were shown to be modest at the level of population, and negligible at the level of
individual couples, it is not surprising that the harsh economic realities or deep cultural
traditions still motivate large number of people globally to choose spouses among their
close relatives. In those communities, the overall life expectancy is usually too low to
even consider the possible risks of inbreeding in post-reproductive period. However,
there is a balance of advantages and disadvantages offered by inbreeding under different
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socioeconomic circumstances, and it is likely that with economic improvements and
urbanization of the poor regions of the world, we may expect inbreeding practices to
slowly become abandoned in the segments of the society that accept an active role in
economic transition, as was the case in several countries in South America, Asia and
north Africa, where inbreeding was relatively prevalent before the economic transition.
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4.7. WIDER IMPLICATIONS OF CONDUCTED
RESEARCH
4.7.1. Inbreeding and Global Burden of Disease
Inbreeding is generally decreasing among non-immigrant Western societies but it
is still prevalent globally. In Section 1.2.2., it has been conservatively estimated that
about 12% of the total human population are the progeny of consanguineous marriages,
defined as unions between individuals related as second cousins or closer (equivalent to
F > 0.0156 in their progeny). Further analysis showed that the average F-value in those
12% of individuals is expected to be at least about 0.03. Based on the recently revised
estimate of 25,000 genes in the human genome (168), this suggests that those
individuals, in their respective populations, have an excess of nearly 800 autozygous
genes. The effects of these genes on their health in older age are uncertain, and the
theoretically predicted consequences were explained in Section 4.1.
Let us now consider the implications of the estimated inbreeding prevalence on
the global burden of Mendelian diseases first. It is known that there are thousands of
genes in which mutations of large effect can lead to Mendelian syndromes in early life.
The joint effect of inbreeding on all of them is a 3-fold increase in the prevalence of
autosomal recessive syndromes in World regions characterized by inbreeding (102),
while the prevalence of all other early-onset genetic disorders is constant across all
regions of the World. This is very informative, as the effect of inbreeding on highly
polygenic late-onset disease could be viewed as an effect on many Mendelian variants
underlying the disease and the effect on a larger predicted number of genes with modest
effect size. It therefore seems plausible that for less heritable diseases the effects of
inbreeding will be modest (e.g. relative risks of 1.2-1.5 in individuals with TM1.03), as
shown in our study (e.g. for coronary heart disease or stroke). For other late onset
165
diseases that still may be polygenic, but more heritable (e.g. schizophrenia, epilepsy,
some forms of cancer), this risk may be greater (e.g. 2.0-3.0). It is easy to compute that
the relative risk of 2.0 present in 12% of individuals globally would increase the global
burden of that particular disease by 12%, which is not a negligible effect, and it is
derived from relatively conservative estimates. Therefore, further attention to this issue
may be ofwider general interest.
4.7.2. The Outbreeding Theory
Throughout this thesis, it was pointed that the human population was rather
small, subdivided and inbred up to several generations ago, and that it has undergone
massive changes in genetic structure at regional and global level due to expansion in
size, urbanization and outbreeding, gene flow and admixture. The effects of those
changes on public health have not been addressed, although a number of plausible
theoretical hypotheses and empirical observations imply that they should be expected. It
has been shown that a large portion of increase in life expectancy in both developed and
developing world between the years 1930 and 1960 could not be explained by known
environmental improvements and economic factors (321,322). Therefore, perhaps the
dramatic changes in the genetic structure of human population could represent a
"forgotten" variable that may be at least partly responsible for the observed trends.
Global outbreeding could, theoretically, lead to increased fitness of the human race
(possibly partially explaining the human population expansion), and an increase in
height, overall health and cognitive performance, i.e. the trends which have all been
observed and reported during the past 150 years.
The elements to support this theory rely on at least four independent premises
that will need to be proven. The first one is to establish that the appreciable portion of
the global increase in life expectancy has not been explained by social, economic and
environmental causes. This premise has received some support in the papers of Preston
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et al. (321) and Caldwell et al. (322). It is mainly based on the observation that the
economic progress has not been nearly equal in all regions of the world over the past
century, and yet the observed trends have been nearly equally observed in both
developed and developing countries.
The second premise of the theory that will be particularly difficult to prove is
that most human populations were considerably inbred until the past 150-200 years. This
is consistent with a life in small, isolated communities attached to the land they
harvested. In such communities it is predicted that 10-50% of persons were inbred, as
this is still true for many rural areas in the developing world. In addition, there had been
an unknown, but possibly considerable prevalence of incestuous relationships. Finally, a
factor that could have contributed strongly to the inbreeding in historic populations was
positive selection of relatives who shared rare resistance alleles against infectious
diseases or starvation during historic disasters leading to population bottlenecks. All of
these mechanisms could have contributed to inbreeding historically.
The third element of the theory that would be reasonably easy to prove is that the
human population achieved sudden outbreeding through urbanization during 19th and
20th century in both the developed and developing world. The percentage of humans
living in cities globally was negligible in the year 1850. However, in 2000 up to a half of
all humans moved to cities (323). This demographic trend was simultaneously
happening in both the developed and developing world, so it does not contradict the
observed trends of increase in height, cognitive performance and lifespan in both rich
and poor countries simultaneously. Furthermore, changes in inbreeding practices led to a
decrease in recessively inherited monogenic disorders at the level of communities,
regions and continents. It should be noted that the effects of urbanisation on health and
fitness are expected after a "delay" of one average lifespan, until the inbred people who
migrate to cities produce the admixed offspring in which the beneficial effects can be
measured.
167
Finally, the fourth independent postulate of the theory would be to prove that
inbreeding has a negative predicted overall effect on traits such as fitness, height,
cognitive performance, post-reproductive health and life expectancy. The large number
of experiments in animals living in natural populations have consistently showed that
inbreeding reduces fitness. Also, in natural animal and plant populations inbreeding was
shown to increase susceptibility to infectious diseases and other pathologic conditions,
which has all been discussed earlier. In humans, inbreeding is consistently linked with
an increase in early morbidity and mortality. Outbreeding was shown to increase height
and improve scores for cognitive functioning, which were both documented to improve
through the 20th century. The latter was even showed to positively correlate with life
expectancy (324), although it appears tha the initially negative correlation between life
expectancy and moderate to severe intellectual disability, but through time a
disproportionate increase in the mean life expectancy of people with intellectual
disability. The research in the Croatian isolate resource is currently underway to test
whether there is indeed any significant correlation between inbreeding, admixture and
life expectancy in the appropriately chosen cohort from within these isolate populations.
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4.8. CONCLUSION
I have argued in this work that there is a coherent theoretical basis for a role for
inbreeding in late-onset diseases of public health importance in humans. The available
data from animal and plant studies strongly support the proposed disease mechanisms
put forward in this thesis and suggest that these phenomena may be common across
species. The available data on the effects of inbreeding in humans has focused on
assessing the risk of early mortality and morbidity due to rare recessive deleterious
mutations. In an extensive review of inbreeding literature in humans, it was possible to
find only a few publications on inbreeding effects on late onset traits or diseases. It is
possible that this may be explained to some extent by the fact that in areas of the world
where inbreeding is prevalent, late-onset diseases have not until recently represented the
main public health problem (e.g. Mediterranean countries, parts of India and sub-
Saharan Africa). In western societies, however, inbreeding is not prevalent enough to be
studied in a large-scale epidemiological investigation, unless it is undertaken within a
large group of immigrants from the countries where it is practiced widely (e.g. the
Pakistani population of the United Kingdom). Nevertheless, this may be an important
epidemiological risk to evaluate, as with improving life expectancy in large human
populations where inbreeding is prevalent these effects could substantially contribute to
disease burden and life expectancy.
In a present-day metapopulation of distinct genetic isolates that seems to be well-
suited for inbreeding studies due to range of inbreeding values, accessible genealogical
records and known demographic history, I have observed the effect of inbreeding on the
prevalence of several different late-onset diseases and quantitative traits. The observed
effect on blood pressure was strong and not easy to explain by any other variable but
inbreeding. This observation has also been reported previously, using similar study
design, by at least three more studies in three different continents (South America,
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Brazil; North America, USA; and Asia, India). To support the hypothesis that the
observed effect was-indeed due to inbreeding, I undertook a separate analysis in the
same study population using the same design, but investigating the effect on another
quantitative trait. This trait, cortical index, can be very precisely measured and
represents an intermediate phenotype for a common late-onset disease (osteoporosis),
but should not be expected to correlate with blood pressure. This analysis again found
the correlation between inbreeding and the quantitative trait of interest, supporting the
hypothesis that both observations represent a genuine effect. Another observation in
support of genuine inbreeding effects is the increasing prevalence of learning disability
in more inbred communities, an effect that has been well documented in many societies
previously.
The next step in this thesis was to investigate effect of inbreeding on late-onset
diseases of complex etiology, which represent the greatest public health burden in
developed countries and are increasing in importance in the developing world. The
interest in studying this effect was justified, as there is a sound theoretical background
for a potentially large effect of inbreeding on the occurrence of those diseases, which
was reviewed. Due to the remarkably few published studies, hardly anything was known
about the potential size of this effect in human populations, and the conducted studies
seemed to agree about the presence of the effect that, in some instances, was fairly
substantial. This work demonstrated significant effects of inbreeding on most of the
studied diseases, with those presumed to more heritable and less environmentally
influenced showing a greater effect of inbreeding on their prevalence. These findings
were not unexpected, because if the uniformity with which inbreeding depression is
observed in animals and plants is considered, it would be striking if those effects would
not be observed in human populations. Still, there is a need for more studies of better
design to be conducted in different world populations and to try to yield the objective
estimates of an increase in complex disease prevalence attributable to inbreeding.
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A substantial proportion of human populations in the world still practice
consanguinity. With an expected increase in life expectancy and prevalent inbreeding,
complex chronic diseases could become more common in those regions and thus
significantly contribute to the global burden of disease. In addition, the findings of this
work could perhaps help mounting further evidence that could show that outbreeding,
admixture and heterosis achieved through urbanization during the 19th and 20th
centuries could have been partly responsible for some of the secular trends reported
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major changes made by the funding body. The Committee would expect to see a copy of the
Chairman Professor Charles R Cillis
Vice-Chairman Professor Patricia Peattie
NHS
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final questionnaire before it is used.
• You must promptly inform the Committee of:
• deviations from or changes to the protocol which are made to eliminate immediate hazards to
the research subjects;
• any changes that increase the risk to subjects and/or affect significantly the conduct of the
research;
- all adverse drug reactions that are both serious and unexpected;
• new information that may affect adversely the safety of the subjects or the conduct of the trial.
• You must complete and return the standard progress report form to the Committee one year
from the date on this letter and thereafter on an annual basis. This form should also be used to
notify the Committee when your research is completed.
ICH GCP Compliance
The Committee is fully compliant with the International Conference on Harmonisation/Good
Clinical Practice (ICH GCP) Guidelines for the Conduct of Trials Involving the Participation of
Human Subjects as they relate to the responsibilities, composition, function, operations and records
of an Independent Ethics Committee/Independent Review Board. To this end it undertakes to
adhere as far as is consistent with its Constitution, to the relevant clauses of the ICH Harmonised
Tripartite Guideline for Good Clinical Practice, adopted by the Commission of the European Union
on 17 January 1997. The Standing Orders and a Statement ofCompliance were included on the
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Mr I Smith (Lay)
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STUDY OF RISK FACTORS FOR COMMON DISEASES IN KOMIZA
VILLAGE
Andrija Stampar School of Public Health




We are informing you that a team from the Andrija Stampar School of Public
Health, Faculty of Medicine, University of Zagreb, will be investigating the
population of Komiza between February 15th, 2002 and February 19"', 2002.
Men from the population are invited to take part on odd dates, and women on even
dates, anytime they find it convenient within the period above.
This booklet has been issued to answer the most frequently asked questions about the
investigation. If you require any additional information, you can ask:
(a) your local general practitioner, or
(b) contact persons at the Andrija Stampar School of Public Health:
(PAGE 3)
1. Why has Komiza been chosen for this project?
In the first phase of the project in 2002, a health status of several village populations
in islands ofRab, Vis, Lastovo, Korcula and Susak was analysed by the team of
Andrija Stampar School of Public Health.
Komiza was chosen after a comparative review of health data showed that it would
benefit most from the continuation of the project, as the prevalence of health problems
such as elevated plasma lipids and blood pressure is the highest.
It was also decided that the history of the population in Komiza and its structure were






This study is carried within the project "Genetic, social and behavioural determinants
of health and disease" of the Ministry of Science and Technology ofCroatia.
Another important reason was also that the first part of the study in Komiza in
February 2002 was among the most successfully completed in all islands, with a good
turnout of the population and a great hospitality received.
(PAGE 4)
2. What are the aims of the project?
The project aims to continue to study the causes of the some of the most important
causes of disease in the Croatian islands. It will do this by gathering information on
health behaviours such as diet and physical activity, by making some health
measurement such as blood pressure and taking blood for biochemical and genetic
analysis.
By studying all these aspects in detail it is hoped that causes of disease can be found.
The long term hope is that this may lead in future to the development of better ways
of treating these diseases. The project will also study the population structure of
Komiza and compare the frequency of health hazards with several other regions of
Croatia.
(PAGE 5)
3. Who will lead this project?
The work in Komiza will be carried out by a team from the Andrija Stampar School
of Public Health of the Medical Faculty in Zagreb and Croatian Institute ofPublic
Health.
This research team has very extensive experience carrying out similar work in these
islands.
This group will collaborate with doctors and researchers from Scotland from the
University ofEdinburgh and from the UK Medical Research Council (the main
government research agency in the UK). The project is funded jointly by the Ministry
of Science and Technology of the Republic ofCroatia and the UK Medical Research
Council.
(PAGE 6)
4. What will I be asked to do?
We hope to study about 1,000 adults aged 18 years or more in Komiza. This will be
entirely on a voluntary basis and with written consent. The research team will make
contact with village authorities to discuss the project and allow questions about the
project to be discussed.
You will be given time to make up your mind after reading this information sheet and
you will be able to approach team members to discuss any questions you may have
before deciding to take part.
If you agree to take part, just sign a consent form at the end of this booklet and bring
the booklet with you to investigation any day you find convenient. A team of 24
Croatian researchers (medical doctors, biologists) will then arrange to examine men
on odd dates and women on even dates.
(PAGE 7)
5. What examinations will be involved?
The examination will take about 60 minutes and will take place in the mornings. It
will involve:
1. completion of a health questionnaire based on standard questionnaires
recommended by international bodies such as the World Health Organisation and
covering general health (GHQ), disease symptoms and psychological factors
(EPQ-R);
2. gathering information of about you (such as age, family members), dietary habits,
physical activity, health behaviours (e.g. smoking)
3. Measurement of height, weight and other body measurements such as waist and
chest measurements;
4. Measurement of blood pressure (at elbow and ankle) and lung function
5. Obtaining a blood sample for biochemical and genetic tests
(PAGE 8)
6. What results will I be given?
The research team will give you details of your height, weight, blood pressure and
lung function and details of a large number of biochemical tests that will be carried
out in Zagreb: cholesterol, tryglicerides, blood glucose, insulin, haemoglobin,
fibrinogen, creatinine, uric acid and calcium.
Results of these tests will be given to your doctor free of charge within one month of
your examination.
This project will be carried out in conjunction with your village doctor and any
abnormalities found can be discussed with him so that appropriate treatment can be
given. Any genetic tests will be solely for research purposes. The members of the
research team would keep them in confidence according to European Union Data
Protection Act related to biomedical research, which has also been accepted by the
University ofZagreb Medical School, so they will not be shared with anyone.
(PAGE 9)
7. How will I benefit from this study?
You will be given a "health check" as described under question 5, and results of your
blood pressure and atherosclerosis degree assessment, lung function examinations and
biochemical tests in value of at least 350 kn per person will be made available to your
personal general practitioner free of charge.
Any new information about the history of your village that we discover will be made
available to the village authorities. Your blood sample will be received as a gift and
stored in strict confidence, and if used for research purposes it would be in accordance
with European Union Data Protection Act, which has also been accepted by the
University of Zagreb Medical School.
The data collected in this study may only be used for scientific research into causes of
disease in your village. In case of substantial discoveries, the collaboration with other
research groups is possible, and even with industry if the information from your
village may help in the future lead to the development of new treatments. However, in
all these eventualities it may be only under the rules of the European Union Data
Protection Act, which guarantees you anonymity of your personal data.
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8. What if I already took part in the study last year? And are their plans for
further research work in Komiza?
Those who already took part last year are especially invited to repeat their health
check-up from 2 reasons. Firstly, we will be able to see if their health status improved
or not over 1 year. Secondly, this time we are offering to do more biochemical tests
then in the initial round, such as haemoglobin, insulin and calcium tests.
It is important to note that if this study is successful again as the first one, we plan to
approach the village authorities again to conduct a third study during the fall of 2003.
This will involve:
1. Detailed tests of eyesight and hearing (visual acuity, hearing threshold, corneal
tonometry and eye photograph);
2. Biochemical analysis of saliva and urine samples;
3. Measuring heart function and predisposition to heart disease (ECG and measures
of blood vessel stiffness using ultrasound waves)
In case of a successful second phase, we will issue a new information booklet on these
tests, similar to this one, and ask for consent again later this year. Once again people
will be entirely free to choose whether or not to take part.
(PAGE 11)
9. Has the project been given ethical approval and will all information be
confidential?
The project has been granted ethical approval by appropriate Ethics Committees in
both Croatia and Great Britain. All data will be held on computer in an anonymous
fashion so that no names are kept together with personal or health information.
In Croatia, all data will be held securely at the Andrija Stampar School ofPublic
Health in Zagreb and kept in strictest confidence. With your permission your data will
be made available to your personal general practitioner who will inform you of the
results upon your request.




Andrija Stampar School ofPublic Health
Faculty ofMedicine, University of Zagreb
Rockefellerova 4, 10000 Zagreb, Croatia
(PAGE 12):
I declare that I read and understood the information from this information booklet,
and that I'm willing to take part in the investigation.
Name and surname:
Signature:
(Please do not forget to bring this booklet with filled genealogical form attached to the
investigations. As our investigators can only study up to 50 persons per day, we ask
for your understanding if in case of overcrowding we have to offer you the next most
convenient date for your participation).
Consent Form
STUDY OF RISK FACTORS FOR COMMON DISEASES IN KOMIZA
4ndrija Stampar School of Public Health
Faculty of Medicine, University of Zagreb, 2002
Principal Investigators in Croatia:
[gor Rudan MD, MPH
\ndrija Stampar School ofPublic Health
Faculty of Medicine, University of Zagreb
Elockefellerova 4, 10000 Zagreb, Croatia





Explanation of consent procedure
After you have had time to read the information sheet (version x/xx/2003) discuss the study
with the member of our research team and consider whether you might wish to take part in the
study, we would be grateful if you would complete this consent form. All individual results
will be confidential and only made available to the research team. Blood samples will be
coded to remove identifying information.
Please tick4
1 I have read this consent form and information sheet (version x/xx/2003, and have had the
opportunity to ask questions about them.
2 I understand that taking part is voluntary and that a decision not to take part will not alter




3 I agree to take part in this study:
a) by completing questionnaires about lifestyle and diet
b) by giving a family history
c) by giving a blood sample
d) by agreeing to storage of that sample for medical research in the future
e)
4 I give permission for someone from the research team to look at my medical records. I
understand that the information will be kept confidential by the research team. I |
5 I agree that the sample I give and the information gathered about me can be stored by the
research team for possible uses in future research, as described in the information sheet. I I j
understand some of these projects may be carried out by other medical research groups
(with appropriate ethical approvals first being obtained) including researchers working for
commercial companies.
6 I understand that my General Practitioner will be notified about my participation in the } ]
study.
7 I understand that I am free to withdraw from the study at any time without giving a |~j
reason.
8 I understand that the results of the genetic investigations in this study will have no direct i—i
medical benefit to me but rather will help in the overall understanding of the causes of '—'
diseases in Croatia. Other results from the medical examination or from blood test that
may be of medical benefit to me will be given to my general practitioner within one
month for discussion with me.
9 I understand that I will not benefit financially if this research leads to the development of Q j
a new treatment or medical test
Name of patient Signature Date Date ofBirth
(please print)
Name of researcher Signature Date
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•ate of birth: Place of birth:
ledical record number: Physician:
.ddress:
ccupation:
larital status: Number of children:
Basic Health Information:
amily history of diseases:
ersonal disease status (from medical records - please see criteria in the appendix to this














Taich medication do you take (for diabetes, please specify: diet / insulin - oral / injected):






























































Subject's other marriages or
sibs (please list the name,



















1). WHO Angina Questionnaire:
1. Do you ever feel pain or discomfort in your chest?
YES NO
(if "NO", please proceed to question 8)
2. Does this pain or discomfort develop when you walk uphill or very fast?
YES NO
(if "NO", please proceed to question 8)
3. Does this pain or discomfort develop even when you are walking in
your normal rhythm on the flat surface?
YES NO
4. What do you do when you feel the pain or discomfort in your chest?
You stand still You slow down You keep walking at the same pace
5. Does this pain or discomfort go away once you stand still or sit down?
YES NO
6. If yes, after how much time?
More than 10 minutes 10 minutes or less
7. Can you mark on the chest diagram below where exactly does the pain appear?
8. Have you ever had a large pain across the entire front chest which lasted longer than 30 minutes?
YES NO
9. If yes, what was the cause?
(Chest diagram for question 7)
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WHO Claudication Questionnaire:
Do you ever feel the pain in one or both legs while walking?
YES NO
fN(), please proceed to Question 8)
Does this pain ever begin when you stand still or sit?
YES NO
Do you ever feel the pain in your lower leg muscles?
YES NO
Do you ever feel this pain while walking at a regular pace?
YES NO
Does this pain ever go away while you walk?
YES NO
What do you do when you feel this pain while walking?
iu stand still You slow down You keep walking at the same pace
If you stand still, what happens?
lsually lasts longer than 10 minutes it usually goes away in 10 minutes or less
Have you ever had a surgery on the arteries or nerves of your legs, with the exception of the
ious varices?
YES NO
/es, what was the reason:
Have you ever had a surgery involving the amputation of:
„ toe (or several of them)
YES
__ NO
art of the leg below knee
YES NO
art of the leg above knee
YES NO
6
European Union Respiratory Health Survey:
Have you, over the past 12 months, ever had "heavy breathing" or wheeze in your chest?
YES NO
fNO, please proceed to Question 4)
When you heard the wheeze, would you also be short of breath?
YES NO
Do you have "heavy breathing" or wheeze when free of a cold or the inflammation
airways?
YES NO
Did you ever wake up due to the feeling that your airways are "narrowed" during the last 12
:>nths?
YES NO
Did you ever wake up due to shortness of breath during the last 12 months?
YES NO
Did you ever wake up due to an attack of cough during the last 12 months?
YES NO
Did you have an asthma attack during the last 12 months?
YES NO
Do you currently take any asthma-related medications (including inhalators, aerosols or tablets)?
YES NO
Do you have any allergies of upper respiratory tract or "hay fever"?
YES NO
7
, WHO Diabetes and Chronic Non-Communicable Diseases Questionnaire
Do you smoke?
Yes No Ex-smoker
If yes, what do you smoke:
Cigarettes __ Pipe Cigars
How many per day?
Over how many years?
Have you ever smoked?
YES NO
If yes, for how many years and how many per day?
How many years ago did you stop smoking?
How many alcohol units do you consume per week?
Physical activity during your everyday's work:
sitting light moderate hard
. Physical activity during the remainder of the day:
sitting light moderate hard
. The female health questionnaire:
tge at menarche:
)o you still have regular periods?
f not, at what age did they stop?
low many deliveries have you had?
low many miscarriages?
low many spontaneous abortions?
low many artificial abortions?
The highest degree of education:
) no school, incomplete elementary school
) complete elementary school
) craftswork or industrial school
) high school
) faculty (includes higher school, art academy)
I postgraduate study, doctorate









) other (specify: )
Job category:
I agriculture





I other (specify: )
How would you assess the economic status ofyour household?
Much worse than average
i Somewhat worse than average
Same as average
iSomewhat better than average
Much better than average
9
What is the surface area of your household?
) up to 40 m2
) 41 - 50 m2
) 51 -60 m2
) 61 - 70 m2
) 71 - 80 m2
I 81 - 100 m2
) 101 -150 m2
) more than 150 m2




) elsewhere (specify: )
The number of distinct rooms in your household (including the living room)?
I 3 4 5 6 and more
Do you have a balcony, terrace or a garden?
I No
) Yes
Wfiich of these do you posess in your household?
iter pipeline













>CIO-ECONOMIC INDEX (SES) = the sum total of these 16 factors;
w SES (bottom 25% of the population); Medium SES (25-75%); High SES (top 25%)
Indicators ofNutrition:
thin the last month, how many portions of the following foods did you consume in each week
ease use the attached album with photographs to choose correct portion size):
od Portion Size Number of Portions
>h
lite fish fried
lite fish grilled, poached or boiled
y fish fried
y fish grilled, poached or boiled
iwns, crabs, etc
issels, oysters, cockles, scallops
uid, octopus fried
uid, octopus grilled, poached or pickled
;at & poultry
ef
rk or lamb (not cured/salted)























k - unpasteurised & bovine
k - pasteurised & bovine















ot exc. potato (carrots, parsnips etc)
afy (cabbage, spinach, etc.)
ans, peas
ler green vegetable (broccoli, leeks etc)
lions, garlic
>'eet peppers
jsh fruit (apples, bananas, oranges, etc.)
ied fruit (raisins, figs etc)
its - fresh
its - salted & roasted
inks
iter from the public pipeline













ded salt at table







e are interested to know if you have had any medical complaints,a nd how your health has been
general over the past few weeks. We want to know about present and recent complaints, and not
Dse that you had in the past. Have you recently:
been able to concentrate on whatever you're doing?
lost much sleep over worry?
felt that you are playing a useful part in things?
felt capable ofmaking decisions about things?
felt constantly under strain?
felt you couldn't overcome your difficulties?
been able to enjoy your normal day-to-day activities?
been able to face up to your problems?
been feeling unhappy and depressed?
. been losing confidence in yourself?
. been thinking of yourself as a worthless person?
, been feeling reasonably happy, all things considered?
Better Same Less Much less
than usual as usual than usual than usual
Not No more Rather more Much more
at all than usual than usual than usual
More so Same Less useful Much less
than usual as usual than usual useful
More so Same Less so Much less
than usual as usual than usual than usual
Not No more Rather more Much more
at all than usual than usual than usual
Not No more Rather more Much more
at all than usual than usual than usual
More so Same Less so Much less
than usual as usual than usual than usual
More so Same Less so Much less
than usual as usual than usual able
Not No more Rather more Much more
at all than usual than usual than usual
Not No more Rather more Much more
at all than usual than usual than usual
Not No more Rather more Much more
at all than usual than usual than usual
More so About same Less so Much less
than usual as usual than usual than usual
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EPQ-R:
:ase, answer all the questions circling the answer you feel best describes you. Answer the
estions honestly and do not spend too much time thinking about them.: Yes No
Does your mood often go up and down?
Do you take much notice of what people think?
Are you a talkative person?
If you say you will do something, do you keep promise no matter how incon.?
Do you ever feel "just miserable" for no reason?
Would being in debt worry you?
Are you rather lively?
Were you ever greedy by helping yourself to more than your share of anyth.?
Are you an irritable person?
. Would you take drugs which may have strange or dangerous effects?
. Do you enjoy meeting new people?
. Have you ever blamed someone for doing sth. you knew was your fault?
. Are your feelings easily hurt?
. Do you prefer to go your own way rather than act by the rules?
. Can you usually let yourself go and enjoy yourself at a lively party?
. Are all your habits good and desirable ones?
. Do you often feel "fed-up"?
. Do good manners and cleanliness matter much to you?
. Do you usually take initiative in making new friends?
. Have you ever taken anything (pin, button) that belonged to someone else?
. Would you call yourself a nervous person?
. Do you think marriage is old-fashioned and should be done away with?
. Can you easily get some life into a rather dull party?
. Have you ever broken or lost something belonging to someone else?
. Are you a worrier?
. Do you enjoy co-operating with others?
. Do you tend to keep in the background of social occasions?
. Does it worry you if you know there are mistakes in your work?
. Have you ever said anything bad or nasty about anyone?
. Would you call yourself tense or "highly-strung"?
. Do you think people spend too much time safeguarding future with sav./ins.?
. Do you like mixing with people?
. As a child were you ever cheeky to your parents?
. Do you worry too long after an embarassing experience?
. Do you try not to be rude to people?
. Do you like plenty of bustle and excitement around you?
. Have you ever cheated at a game?
. Do you suffer from "nerves"?
. Would you like other people to be afraid of you?
. Have you ever taken advantage of someone?
. Are you mostly quiet when you are with other people?
, Do you often feel lonely?
. Is it better to follow society's rules than go your own way?
, Do other people think of you as being very lively?
. Do you always prectice what you preach?
, Are you often troubled about feelings or guilt?
, Do you sometimes put off until tomorrow what you ought to do today?
, Can you get a party going?
14




4. Systolic blood pressure (1 st measurement): (mmHg)
5. Diastolic blood pressure (1st measurement): (mmHg)
6. Systolic blood pressure (2nd measurement): (mmHg)
7. Diastolic blood pressure (2nd measurement): (mmHg)
8. Forced vital capacity (FVC):
9. Forced expiratory volume (FEV1):
10. Skinfold thickness 1: (mm)
11. Skinfold thickness 2: (mm)
12. Waist circumference: (mm)
13. Waist to hip circumference ratio:
14. Bioimpedance:
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Five Reasons why Inbreeding May
Have Considerable Effect on
Post-Reproductive Human Health
Igor Rudan1-2 and Harry Campbell2
1 Department of Medical Statistics, Epidemiology and Medical Informatics, School of Public
Health »Andrija Stampar«, School of Medicine, University of Zagreb, Zagreb, Croatia
2 Department of Public Health Sciences, The University of Edinburgh Medical School,
Edinburgh, Scotland, UK
ABSTRACT
As the genetic architecture ofcommon complex diseases of late onset is emerging thro¬
ugh intensive research, it is intriguing to assess the predicted effect of inbreeding on those
diseases. In this paper, we propose five reasons why we believe inbreedingmay have a con¬
siderable effect on post-reproductive human health, (i) The joint effect of inbreeding dep¬
ression on all polygenic quantitative phenotypes that confer risk for late-onset diseases is
predicted to be multiplicative rather than additive, (ii) The »genetic load« ofrare »Mende-
lian« variants with large deleterious effects in post-reproductive adults is unknown, but
could be much greater than expected as these variants were invisible to selection through
human history. (Hi) Deleterious effects resulting from autozygosity in hundreds ofaffected
rare recessive variants of small effect under common disease I rare variant (CD/RV) hy¬
pothesis could result in epistatic effects that could jointly impair capacity to compensate
against environmental risks, (iv) Heterozygote advantage in loci under balancing selec¬
tion could be reduced by inbreeding, (v) Published empirical evidence in animals and hu¬
mans consistently report large inbreeding effects on late-onset traits. Since inbreeding is
common in many populations and the effects of inbreeding depression could substantially
contribute to disease burden and reduced life expectancy we believe there is now a clear
need for further genetic epidemiological research in humans to investigate this issue.
Key words: inbreeding, consanguinity, late-onset diseases, complex diseases, post-
reproductive age, inbreeding depression, genetic load, balancing selection, heterosis
Introduction
In many parts of the developingWorld veloped World large proportions of all
and in many communities within the de- marriages are still among close relatives.
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The reasons for this include geographic,
tribal, cultural or religious isolation or so¬
cio-economic motivation such as preserva¬
tion ofproperty, particularly land rights1'2.
The degree of inbreeding in offspring of
such marriages can be measured by the
genetic term "inbreeding coefficient'* (F),
which indicates the proportion of the au¬
tosomal genome which is expected to be
homozygous through inheritance of iden¬
tical genes from common ancestors (i.e.
proportion of alleles identical by descent
(IBD) or »autozygosity«). The F value is
calculated from genealogical information
and it amounts to about 6% in the offspring
of first cousin parents and 25% in the off¬
spring of incestuous unions of first-deg¬
ree relatives1-3. The apparent risk in the
individuals with a considerable propor¬
tion of their genes homozygous for identi¬
cal allelic variants is the occurrence of
»Mendelian« (monogenic) diseases caused
by rare and recessive deleterious autoso¬
mal mutations of large effect'1-9.
Research on the effects of inbreeding
on human health has historically focused
on early-onset diseases, mainly recessive-
ly inherited monogenic (Mendelian) dis¬
eases, birth defects, decreased fertility
and early mortality. This was due to the
widespread recognition that consanguin¬
eous unions were more likely to result in
genetic diseases of children, most ofwhich
had a distinctive phenotype that was rea¬
dily identifiable. Therefore, the great ma¬
jority of research on inbreeding effects
had been focused on pre-reproductive
health problems, and the risks have been
thoroughly evaluated by numerous groups
and individual authors3-12.
However, the genetic architecture un¬
derlying late-onset diseases such as car¬
diovascular diseases, cancer, adult-onset
diabetes and psychiatric disorders, which
represent the major health burden glob¬
ally, is still a matter of open debate13-18. A
genetic model that is finding increasing
support from both animal experiments
944
and human studies is one in which the ge¬
netic variants underlying complex chronic
diseases are more likely to be rare rather
than common in the population. They are
also likely to be numerous (highly polyge¬
nic architecture) and of a small individ¬
ual effect13,18. If this view of the genetic
architecture of common complex diseases
is correct then it would be important to
consider the predicted effect of inbreed¬
ing. In this paper, we put forward and
discuss five reasons why we believe in¬
breeding may have a considerable effect
on post-reproductive human health.
Reason #1:
The deleterious effects of
inbreeding depression on
quantitative (endo)phenotypes
that confer risk for late-onset
diseases may be multiplicative
Inbreeding depression is a recognised
phenomenon that is common to polygenic
traits in all living organisms19. It is thought
to result from increased homozygosity of
recessive alleles that act in the same di¬
rection at loci that influence the pheno¬
type of interest ("directional dominance«)20.
In an inbred individual, inbreeding depres¬
sion is predicted to affect many polygenic
endophenotypes (quantitative [patho]-phy-
siological intermediates involved in phys¬
iological or disease processes). Many of
these are established risk factors for late-
-onset diseases, such as blood pressure,
body mass index, cholesterol and glucose
levels and bone mineral density. A sub¬
stantial effect of inbreeding acting to incre¬
ase human blood pressure has been shown
directly in at least four studies21-24, and
implied indirectly in several more stu¬
dies26-28. Effects on body mass index and
cholesterol levels have also been impli-
e(j25,26.28 Simiiariy( effects on various me¬
asures of intelligence have been consis¬
tently shown29-31, and in this issue we re¬
port on an effect on cortical index, a
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predictor of susceptibility to osteoporo¬
sis32. It is known that the risk of e.g. in¬
creased blood pressure, body mass index
and cholesterol levels on cardiovascular
diseases is not threshold-dependent, but
is increasing across the entire range of
values observed in the population33. Thus,
one important consequence is that inbred
individuals are expected to be at slightly
increased risk relative to the outbred ge¬
neral population to develop a late- onset
disease, regardless of the absolute measu¬
rement of their blood pressure, body mass
index and cholesterol. Furthermore, even
if the effect of inbreeding depression on
each of those phenotypes individually
was rather small, it is known that the
concurrent presence of several risk fac¬
tors for the same disease increases risks
in a multiplicative rather than additive
manner. Therefore, the joint effect of in¬
breeding depression on all the potential
quantitative phenotypes that confer risk
to late-onset disease during lifetime could
be more substantial than widely appre¬
ciated34-36.
Reason #2:
Effects of inbreeding on rare
variants with large effect in post-
reproductive adults ("invisible
Mendelian diseases« of late onset)
Inbreeding is predicted to have larger
effects on the population-attributable frac¬
tion of disease if the underlying variants
are rare rather than common. This is be¬
cause common recessive variants will oc¬
casionally become homozygous in the po¬
pulation by chance, without a need for
inbreeding to bring them together. If the
variants are very rare in the population,
and inbreeding is almost the only realis¬
tic scenario under which they can become
homozygous in an individual, then the
fraction of disease cases in the population
who are the offspring of related parents
will be much larger. This was shown to be
the case with population attributable
fraction of early-onset monogenic (Men¬
delian) diseases in the presence of inbree¬
ding: it has been shown that the preva¬
lence of autosomal dominant Mendelian
disorders is constant in all world popula¬
tions, but the prevalence of autosomal re¬
cessive Mendelian disorders is increased
by 3-4-fold in regions where inbreeding is
prevalent.2-7 Therefore, the great majori¬
ty of Mendelian disease that is caused by
rare recessive variants of large effect and
early age of onset is due to inbreeding in
those countries. However, these diseases
manifest in pre-reproductive period, so
they are »visible« to selection. Although
these variants continuously arise through
mutations, most of the affected cases ne¬
ver reproduce, so they are being effective¬
ly removed from the gene pool by selec¬
tion. Thus their overall public health
burden is reasonably low, and Bittles and
Neel estimated that each human carries
about 1.4 such recessive lethal mutations
in the genome12.
However, rare variants of large effect
also act in Mendelian fashion to cause late-
onset complex diseases. For nearly all late-
-onset diseases, clustering in families has
been reported and, in some, rare high- pe¬
netrance variants have been found which
are associated with an extremely increa¬
sed lifetime risk of disease14-16. Examples
of this include variants in BRCA1 and
BRCA2 and breast cancer36, hMLHl and
hMSH and colorectal cancer37, and GCK
(glucokinase) and maturity-onset diabe¬
tes of the young (MODY) diabetes38. In
large outbred populations, it is estimated
that up to 15% of disease cases such as
cardiovascular, cancer, diabetes and psy¬
chiatric disorders cluster in families, while
85% or more are due to combined effects
of polygenic susceptibility and cumulative
environmental exposures39. However, in
countries where inbreeding is common,
the prevalence of all recessively inherited
monogenic forms of complex diseases could
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be expected to increase by at least as much
as seen jointly for all recessive early-on-
set Mendelian diseases, i.e. 3-4-fold. In
theory, this could greatly increase both
the overall disease prevalence and the
proportion the late-onset disease burden
caused by rare recessive variants.
It is also known that these rare vari¬
ants can affect quantitative phenotypes,
such as blood pressure or cholesterol (fa¬
milial hypertension, familial hyperchole-
sterolaemias)25'40, which represent "invis¬
ible Mendelian diseases** as their pheno¬
types are not clinically apparent. These
quantitative phenotypes are associated
with increased morbidity and mortality
from diseases of public health importance
such as stroke and coronary heart disea¬
se. It is conceivable that there are many
more such "invisible** Mendelian diseases
affecting metabolic pathways at different
levels and predisposing individuals to
complex diseases in the post-reproductive
period. The joint effect of inbreeding on
all these variants could be expected to be
of a magnitude of at least that seen for
early-onset Mendelian diseases. Indeed
there are reasons to believe that the num¬
ber of rare and recessive Mendelian vari¬
ants with large effect on late-onset complex
diseases much larger than the estimated
number with early effects. These rare va¬
riants have accumulated in the genome
through mutations that are either neut¬
ral in early life, or even beneficial, but
show deleterious effects in post-reproduc¬
tive period ("antagonistic pleiotropy**)34'35.
There is no known mechanism that would
be expected to remove these mutations
from the genome or act against their ac¬
cumulation, as they are invisible to selec¬
tion. Thus there are cogent reasons why
the effects of inbreeding on late-onset
Mendelian diseases should be carefully
considered in the same way as has been
done for early-onset diseases12.
Reason #3:
Autozygosity in many rare recessi¬
ve variants of small effect could re¬
sult in epistatic effects that could
jointly impair capacity to compen¬
sate against environmental risks.
Modest levels of inbreeding observed
in human populations are expected to ha¬
ve much larger effects on the population
distributions of polygenic traits than on
oligogenic traits and diseases. This is be¬
cause an excess in autozygosity of 6.25%
of the genes in human genome (i.e. about
2,000 genes), which would be expected in
a child from a first-cousin marriage, will
lead to autozygosity of rare recessive mu¬
tations of small effect in those 2,000 ge¬
nes. In a polygenic trait, it is expected
that some of the genes that determine its
expression would be affected even with
only 6.25% of the genome autozygous. We
have argued that the genetic component
of late-onset diseases may be due princi¬
pally to large numbers of rare variants in
numerous genes - the common disease/
rare variant (CD/RV) hypothesis.13 Rece¬
nt estimates41 imply that each person
carries, on average, 500-1200 slightly de¬
leteriousmutations, most ofwhich are ra¬
re and present in heterozygous form. In
an offspring of first-cousin marriage, 30-
75 of these variants would be expected to
become homozygous, with uncertain ef¬
fects42. If the mutations are numerous
and of small deleterious effect, their auto¬
zygosity throughout the genome might
not lead to apparent syndromes of early
onset, but maymildly impair the function
of affected genes. As a result, the compen¬
satory potential to oppose the harmful
environmental stimuli would be non-spe-
cifieally impaired. This impairment of ho¬
meostasis or repair capacity could lead to
an earlier age at diagnosis of a late-onset
complex disease. This is consistent with
the model of these diseases arising over
long periods of time, and becoming clini-
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cally apparent when the compensatory
potential is exhausted19-35.
This theoretical mechanism is difficult
to study in humans, but has been clearly
demonstrated in animals, where a grea¬
ter sensitivity of homeostatic mechanisms
to inbreeding in later life has been sug¬
gested19-35. In an experiment with inbred
and non-inbred mice strains, the two
strains did not show large differences in
survival when the animals were kept in
the laboratories. However, when both
groups were released into their natural
habitat, the inbred mice strains had a
dramatically reduced chance of survival
in comparison to non-inbred group43. The
effects of inbreeding are therefore thought
to be much greater in natural populations
(exposed to a less uniform and more chal¬
lenging environment) than in those stud¬
ied in laboratories.
Reason #4:
Heterozygote advantage in loci
under balancing selection is
expected to reduce by inbreeding
At some genomic loci, there may not
be variants present in a population that
are clearly deleterious, but the heterozy¬
gous genotype may be more favourable
than either homozygous genotype. This
effect is widely known as the »heterozygo-
te advantage^ »hybrid vigour« or simply
»heterosis«. The effects of heterosis usu¬
ally act in an opposite way from those of
inbreeding depression and they have been
demonstrated in humans'14-45, and widely
in animals and plants46-47. The type of se¬
lection that tends to maintain more than
one allele in the population at intermediate
frequencies, thus maximising the fre¬
quency of heterozygous genotypes in a po¬
pulation, is known as »balancing selec¬
tion"13. It is clear that balancing selection
probably has important role in shaping
gene diversity in the genes that are im¬
portant for defence against unknown and
unpredictable environmental risks, such
as infectious diseases44. Populations that
are more genetically diverse are at less
risk from diverse environmental threats
(since it is more likely that someone
would carry a rare protective variant)48.
It is therefore likely that inbreeding lead¬
ing to autozygosity in several hundred ge¬
nes will affect some of these genomic loci
under balancing selection, thus reducing
the beneficial effects of heterosis in those
individuals. This mechanism could be
more important than generally thought,
since recent evidence suggests that loci
under balancing selection may be surpri¬
singly common in the genome49"62.
Reason #5:
Empirical evidence of inbreeding
effects in humans and other
organisms
The most extensive research into the
effects of inbreeding in general, and par¬
ticularly on genetic variation related to
senescence has been carried out in Dro-
sophila spp. A review of 25 years of this
research has concluded that deleterious
alleles generated by mutation and kept at
low frequency by selection contribute be¬
tween 33% and 67% of the genetic varia¬
tion in a typical trait. This supports a po¬
lygenic model of genetic architecture of
most phenotypes and suggests that the
common disease / rare variant mecha¬
nism contributes to a substantial share of
complex disease aetiology20-53. A recently
published experiment in Drosophila spp34
showed that genetic variation and inbree¬
ding effects increase dramatically with
age, supporting these hypotheses. Nume¬
rous recent studies of other animals, so¬
me of them performed in populations of
large mammals, have also consistently
reported that inbreeding negatively affec¬
ted key components of fitness, resulting
in increased morbidity and decreased life
span54"57. Ameta-analysis58 and a critical
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review arid re-examination of these stu¬
dies51 have both concluded that, although
unexpected and in some aspects against
current understanding, their findings
could not be easily dismissed on grounds
of publication bias or apparent flaws in
methodology.
Finally, our own intensive review of
human literature since 1965 has mana¬
ged to identify very few case-control stud¬
ies of late-onset diseases in which inbree¬
ding status was not determined by self-
reporting, and disease status determina¬
tion was based on a clear diagnostic crite¬
ria which did not change during the pe¬
riod of study. These studies investigated
the effects of inbreeding on coronary heart
disease59'60, cancer61,62, psychiatric disor¬
ders63 and Alzheimer's disease64. There
was only one longitudinal epidemiological
study investigating the effects of inbreed¬
ing on 10 complex late-onset diseases65.
All seven studies reported considerable
relative risks associated with inbreeding,
typically between 2.0-5.0, which persis¬
ted after adjustment for known or suspec¬
ted confounding factors. Although the
available evidence is surprisingly sparse,
it appears to support the hypothesis that
inbreeding could have a considerable ef¬
fect on human health and disease occur¬
rence in post-reproductive age adults.
Conclusion
We have argued that there is a coher¬
ent theoretical basis for a role for inbree¬
ding in diseases of public health impor¬
tance in humans. Available data from
animal and plant studies strongly support
the disease mechanisms put forward in
this paper and suggest that these pheno¬
mena may be common across species.
Available data on the effects of inbreed¬
ing in humans has focused on assessing
the risk of early mortality due to rare re¬
cessive deleterious mutations. In an ex¬
tensive review of inbreeding in the Pub-
Med database from 1965 to date (nearly
10,000 references), we were able to find
very few publications on inbreeding effects
on late onset traits or diseases in humans.
It is possible that this may be explained
to some extent by the fact that in areas of
the world where inbreeding is prevalent,
late-onset diseases have not until recen¬
tly represented the main public health
problem (e.g. Mediterranean countries,
parts of India and sub-Saharan Africa).
In western societies, however, inbreeding
is not prevalent enough to be studied in a
large-scale epidemiological investigation.
Nevertheless, we call for more genetic ep¬
idemiological research in humans to ad¬
dress this potential problem, and invite
related papers from all regions of the
world where this issue can be studied. We
believe this to be an important epidemio¬
logical risk to evaluate, as with improving
life expectancy in large human populations
where inbreeding is prevalent these effects
could substantially contribute to disease
burden and life expectancy.
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PET RAZLOGA ZBOG KOJIH BI SRODIVANJE MOGLO
ZNACAJNO UTJECATI NA LJUDSKO ZDRAVLJE NAKON
ZAVRSETKA GENERATIVNOG RAZDOBLJA
SAZETAK
Kako intenzivnim istrazivanjima pocinjemo nazirati genetsku arhitekturu kom-
pleksnih bolesti starije dobi, zanimljivo je razmotriti kako bi srodivanje trebalo utjeca-
ti na pojavnost tih bolesti. U ovom clanku, predlazemo pet razloga zasto bi srodivanje
moglo imati znatan utjecaj na ljudsko zdravlje nakon zavrsetka generativnog razdob-
lja. (i) Ukupan ucinak »depresije srodivanjem« na sve poligenski odredene kontinuira-
ne ljudske fenotipove koji se povezuju s rizikom za bolesti starije dobi trebao bi biti
multiplikativan, a ne aditivan. (ii) »Genetski teret« rijetkih (tzv. Mendelskih) alela s ja-
kim negativnim ucinkom na zdravlje u post-generacijskom razdoblju nije poznat, no
mogao bi biti znatno veci od ocekivanog jer su te varijante bile nevidljive utjecajima se-
lekcije tijekom ljudske povijesti. (iii) Nepozeljni ucinci kao rezultat autozigotnosti u
stotinama zahvacenih rijetkih recesivnih genetskih varijanti malog ucinka u okviru hi-
poteze »cesta bolest/rijetka varijanta«, gdje bi rezultirajuci epistatski ucinci mogli za-
jednicki umanjiti sposobnost kompenziranja protiv okolisnih cimbenika rizika. (iv)
Srodivanje bi moglo utjecati na gubitak povoljnih ucinaka heterozigotnosti na lokusi-
ma koji su pod utjecajem balansirajuce selekcije. (v) Sistematski pregled rijetkih empi-
rijskih dokaza u literaturi u eksperimentalnih zivotinja i ljudi konzistentno upucuje na
snazne ucinke srodivanja na svojstva karakteristicna za stariju dob. Pozivamo na do-
datna geneticko-epidemioloska istrazivanja u ljudskim populacijama kako bi se ovaj
problem istrazio, jer rastom ocekivanog trajanja zivota u velikim podrucjima svijeta
gdje je srodivanje ucestalo, navedeni bi ucinci mogli znacajno pridonijeti ukupnom po-
bolu i umiranju od bolesti starije dobi.
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ABSTRACT
Considerable uncertainty exists regarding the genetic architecture underlying common late-onset human
diseases. In particular, the contribution of deleterious recessive alleles has been predicted to be greater
for late-onset than for early-onset traits. We have investigated the contribution of recessive alleles to human
hypertension by examining the effects of inbreeding on blood pressure (BP) as a quantitative trait in
2760 adult individuals from 25 villages within Croatian island isolates. We found a strong linear relationship
between the inbreeding coefficient (F) and both systolic and diastolic BP, indicating that recessive or
partially recessive quantitative trait locus (QTL) alleles account for 10-15% of the total variation in BP
in this population. An increase in F oi 0.01 corresponded to an increase of ~3 mm Hg in systolic and
2 mm Hg in diastolic BP. Regression ofFon BP indicated that at least several hundred (300-600) recessive
QTL contribute to BP variability. A model of the distribution of locus effects suggests that the 8-16 QTL
of largest effect together account for a maximum of 25% of the dominance variation, while the remaining
75% of the variation is mediated by QTL of very small effect, unlikely to be detectable using current
technologies and sample sizes. We infer that recent inbreeding accounts for 36% of all hypertension in
this population. The global impact of inbreeding on hypertension may be substantial since, although
inbreeding is declining in Western societies, an estimated 1 billion people globally show rates ofconsanguin¬
eous marriages >20%.
''HE extensive literature on the health effects of
inbreeding has largely focused on its impact on
reduction, childhood mortality, and Mendelian dis-
ers (Bittles et al. 1991; Bittles and Neel 1994).
narkably little has been published on the effects of
reeding on geneucally complex late-onset disorders
t account for most of the public health burden of
:ase. This is despite the observation in other species
t the deleterious effects of inbreeding may increase
l age, suggesting greater sensitivity of homeostatic
zhanisms to inbreeding in later life (Charlesworth
1 Hughes 1996; Charlesworth and Charles-
rth 1999).
Ve postulated that the quantitative trait, blood pres-
2 (BP), and the related late-onset disorder, essential
iertension, might be mediated by recessive and par¬
ly recessive quantitative trait locus (QTL) alleles,
ch would be influenced by the increased homozygos-
found in inbred individuals. In support of this hy-
hesis, several studies of small inbred communities
ldwide have reported an increased prevalence of
ertension (Krieger 1968; Martin et al. 1973; Hur-
;h et al. 1982; Thomas et al. 1987; Wahid Saeed et
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'ersity of Edinburgh Medical School, Tcviot PI., Edinburgh EH8
, Scotland, UK. E-mail: harry.campbell@ed.ac.uk
al. 1996; Halberstein 1999). In addition, analogous
observations have come from experiments in inbred
("spontaneous") and engineered animal models of hy¬
pertension (Stoll et al. 2000). To investigate the rela¬
tionship between inbreeding and BP we studied a large
population sample from well-characterized genetic iso¬
lates from the Dalmatian islands, Croatia (Figure 1).
SUBJECTS AND METHODS
Study population: The village populations of three
neighboring islands in the eastern Adriatic, Middle Dal-
matia, Croatia (Brae, Hvar, and Korcula—see Figure 1)
represent well-characterized genetic isolates. Over 100
publications describe the ethnohistory, migration pat¬
terns, genealogical reconstruction, biological trait mea¬
surements, disease prevalence, and environmental and
sociocultural characteristics of this population (Rudan
et al. 1987, 1992, 1999; Waddle et al. 1998). Population
genetic characteristics of the study population based on
a number of serogenetic polymorphisms were reported
by Roberts et al. (1992) and Janicijevic et al. (1994).
Subsequent analyses of variable number of tandem re¬
peat and short tandem repeat DNA polymorphisms and
mtDNA characterized genetic variation in specific is¬
lands (Martinovic et al. 1998, 1999; Klaric et al.
2001a,b; Tolk et al. 2001). The results indicated that
tics 163: 1011-1021 (March 2003)
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ure 1.—Map of middle Dalmatia, Croatia, showing villages and islands.
e populations in these islands have preserved sepa-
:haracteristics over the course of history to the
lit day. Measures of genetic kinship and genetic
ices revealed isolation of individual villages or vil-
rroups from each other and from the mainland,
fic village clustering was noted on Brae and Hvar
Is, which coincided with known historic processes,
ipreciable degree of genetic homogeneity within
udied villages has been noted, which is especially
or the most geographically isolated villages. The
ages chosen for this study were founded during one
ee periods: the BC era (by admixture of Illyrians,
s, and succeeding Romans), the 7th century AD
roats who immigrated from Asia), and the 16th
th centuries AD (by Croats who left the Balkan
sula fearing Ottoman expansion). The subse-
: tendency toward inbreeding in each village has
influenced by geographic isolation, political ("Pas-
) privileges given to residents of certain communi-
md by sociocultural factors (Rudan et al. 1992).
: island populations present a range of inbreeding
ns at both individual and subpopulation levels, as
nented in previous studies reporting endogamy,
ny, mating choice, genealogical information, and
ic marker distributions. High inbreeding levels
teen implicated in at least three Mendelian disor¬
ders characterized in neighboring island populations:
Mai de Meleda in Mljet (Fischer etal. 2001), hereditary
dwarfism in Krk (Kopajtic et al. 1995), and hereditary
mental retardation in Susak (Bohacek 1964). Measures
of diet and lifestyle factors show restricted variation in
this population, suggesting its suitability for genetic
studies of hypertension (Rudan et al. 1992).
Blood pressure and other measurements: We mea¬
sured blood pressure, height, and weight between 1979
and 1981 in 2760 adult individuals selected at random
from voting lists from 25 isolate villages on three islands
(Brae, Hvar, and Korcula) in middle Dalmatia, Croatia
(representing a 20% sample of the village populations).
In addition, we collected data on body mass index, diet,
education level, occupation, and smoking status. This
was carried out with the informed consent of partici¬
pants by the Institute for Anthropological Research in
Zagreb, Croatia, in collaboration with the Smithsonian
Institute in Washington, DC. None of the examinees had
ever received antihypertensive treatment. Blood pressure
was measured by a single observer in local health centers
and dispensaries between 6 am and 12 noon following
standard procedures as described by Weiner (Weiner
and Lourif. 1969). BP values were adjusted for the major
determinants of BP (age, height, weight, and smoking
status in the analyses) and were reported separately in
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les and females. Hypertension was defined as systolic
si60 or diastolic BP >95 mm Hg.
Computation of individual inbreeding coefficients: A
jle researcher (I. Rudan) computed individual in-
eding coefficients independently and blind to BP
us for each study participant on the basis ofpedigree
imitation on four ancestral generations (five genera-
is where these occurred over a similar time frame)
orded during the initial field work and supple-
nted by study of parish registries stored in local
irches during 1997-2000. The individual inbreeding
fficients (F) were then computed according to
ight's path method,
C / I \Wl,+ Ttj+1
right 1922), where rn, and n, refer to the number
laths from the 7th common ancestor, and c refers to
number of common ancestors. The genealogical
reeding coefficient for each village was then com- *
ed as the average ofall individual /'"values. To further
port these estimates, Fwas calculated from isonymy
iroposed by Crow (1980),
/--S+(l--S)^-^,4 \ 4/ 4(1 - S)
:re 5 = 2/^, pk, qk are the frequencies of the surname
males and females, respectively, Pis the proportion
narriages between spouses carrying the same sur-
le among all marriages, and the summation is over
surnames. We calculated average inbreeding mea-
;s for each of the 25 villages on the basis of isonymy,
ch provides an upper bound (Roguljic et al. 1997)
ble 1).
tatistical analysis and modeling: Comparisons of BP
>ng villages were based on systolic and diastolic BP
isurements adjusted for age, body mass index (weight/
jht2), and smoking status. A step-down multiple re-
ision analysis was performed using MINITAB 12.21
ware to investigate the correlation between individ-
BP measurements and inbreeding coefficients. The
lei explored the relationship between systolic and
tolic blood pressure (as dependent variables) and a
aber of explanatory variables: individual inbreeding
fficient (F), island and village of residence, smoking
as, and the major known risk factors for hyperten-
—age, sex, (log-transformed) height, and (log-trans-
ned) weight. Variables that made the least contribu¬
te the explained variation were dropped one at a
; until all the remaining variables were statistically
ificant (defined as P < 0.05 for main effects and
0.01 for higher-order effects; Table 2). A model
developed from quantitative genetic theory to derive
wer bound, nL, for the number of genetic loci of
ivalent effect contributing to the dominance vari-
; in BP, as
where DT is the overall slope of the regression on F, VG
is the total genetic variance, Vr is the total phenotypic
variance, and H2 is the broad-sense heritability (see the
appendix). This extends to multiallelic loci the result
given by Charlesworth and Hughes (1999) for the
biallelic case and is valid except in the unlikely case of
strong overdominance at all, ormost, loci. To correct for
possible unobserved background inbreeding preceding
the earliest generation of which we had knowledge, we
inflated F values by a factor equal to the ratio of the
mean of village inbreeding levels based on isonymy
methods to the mean based on pedigree methods.
Population-attributable fraction: The population-
attributable fraction (PAF) for hypertension (defined
as either systolic >160 mm Hg or diastolic >90 mm
Hg) was calculated by multiple logistic regression
allowing for individual differences in the variables: vil¬
lage, sex, age, height, weight, and smoking. We deter¬
mined the appropriate regression as a function of all
associated variables (including F) and then noted each
individual's probability of being hypertensive if their F
was set equal to 0. The sum of all such probabilities,
PMm, is an estimate of the number affected in the absence
of inbreeding, but with other variables remaining unal¬
tered. Then PAF = 1 — Pium/N,,n, where 1Vafr is the actual
number affected.
Modeling the effects of individual QTL loci: For bial¬
lelic loci, the relation between the true number, n say,
of recessive QTL loci affecting a trait and nL (see above)
is n = nL( 1 + y2), where y denotes the coefficient of
variation of the frequency distribution of locus effects.
Following Zeng (1992), we modeled this as gammawith
parameter is 1; i.e., f(x) = xL~le~'/T(L). This family
of distributions has y2 = L~l. Since the contribution of
a biallelic locus with nonadditive effect, x (or in the
notation of the appendix), to the dominance variance
is just x2, the distribution of such contributions is also
gamma, but with parameter L + 2. Hence, for given
L, we can compute the minimum proportion of loci
contributing any specified proportion of the overall vari¬
ance. Finally for given nL, we obtain an estimate of the
actual minimum number of loci by multiplying this pro¬
portion by nl(1 + L~x). As shown by Zeng (1992) this
number is relatively insensitive to L in the range Vi6 :£
L < 1.
RESULTS
Measurements recorded during a survey in 1979-1981
in an untreated population permitted analysis of BP as
a quantitative trait. Body mass index, diet, education
level, occupation, smoking status, and inbreeding values
among study participants are shown in Table 1 by village
of residence. The prevalence of hypertension among
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TABLE 1
Ranking of study villages by mean value of F computed from genealogical information
[F (gen)] and isonymy [F (iso)]
Age F F Edu Ocu Die Smo BMI
Village" Sex N [X (SD)] (gen) (iso) (%) (%) (%) (%) [X (SD)]
Gdinj (H) M 54 53.6 10.9) 0.048 0.107 3.7 92.6 94.4 9.3 24.4 3.3)
F 76 53.1 11.7) 0.049 1.3 72.4 93.4 1.3 25.6 4.7)
Pupnat (K) M 46 42.8 12.9) 0.046 0.034 2.2 89.1 95.7 13.0 27.3 3.6)
F 51 44.4 11.8) 0.043 2.0 90.2 88.2 5.9 26.1 3.7)
Cara (K) M 63 44.3 11.7) 0.035 0.040 3.2 90.5 95.2 36.5 26.1 3.7)
F 74 45.6 12.5) 0.030 0.0 87.8 94.6 10.8 26.6 3.8)
Poljica (H) M 28 42.3 9.1) 0.032 0.037 0.0 89.3 92.9 10.7 25.5 2.7)
F 20 43.0 7.6) 0.032 0.0 85.0 85.0 0.0 25.4 4.2)
Dracevica (B) M 20 46.8 16.4) 0.026 0.031 5.0 90.0 90.0 35.0 27.0 4.2)
F 22 50.9 14.2) 0.036 0.0 81.8 90.9 13.6 30.0 4.3)
Racisce (K) M 40 43.6 11.2) 0.029 0.034 2.5 82.5 92.5 25.0 27.8 4.0)
F 64 43.2 11.8) 0.026 1.6 90.7 78.1 21.9 27.0 4.1)
Bogomolje (H) M 48 57.6 15.9) 0.025 0.030 2.1 87.5 95.8 8.3 22.4 2.6)
F 33 57.7 13.4) 0.025 3.0 78.8 90.9 0.0 23.9 4.1)
Zrnovo (K) M 98 45.0 13.0) 0.022 0.029 5.1 79.6 92.3 42.9 26.3 2.9)
F 104 45.0 13.9) 0.019 2.9 78.9 85.6 19.2 26.8 4.3)
Lozisca (B) M 17 56.9 12.2) 0.022 0.029 5.9 82.4 88.2 35.3 26.3 4.3)
F 55 49.9 14.1) 0.018 1.8 72.7 90.9 9.1 28.7 4.4)
Vrbanj (H) M 65 38.2 10.4) 0.020 0.010 4.6 90.8 95.4 10.8 26.5 2.7)
F 53 42.3 9.6) 0.018 1.9 86.8 88.7 1.9 26.8 3.9)
Selca (B) M 117 54.4 14.4) 0.016 0.026 4.3 78.6 89.7 41.9 26.8 3.3)
F 185 52.0 14.9) 0.016 2.2 76.8 90.8 17.8 27.7 4.4)
Povlja (B) M 25 56.3 14.7) 0.014 0.024 0.0 84.0 92.6 40.0 27.6 3.2)
F 47 54.1 14.3) 0.017 2.1 85.1 87.2 10.6 27.5 4.8)
Vrisnik (H) M 52 38.0 10.4) 0.012 0.023 3.8 90.4 94.2 19.2 24.6 2.6)
F 44 42.4 9.6) 0.019 0.0 72.7 88.6 6.8 26.5 3.6)
Gornji Humac (B) M 32 51.0 12.5) 0.014 0.016 3.1 87.5 90.6 59.4 25.7 3.5)
F 48 47.4 13.6) 0.012 2.1 77.1 85.4 25.0 28.3 4.5)
Zastrazisce (H) M 70 49.6 14.8) 0.013 0.013 4.3 85.7 94.3 12.9 24.7 2.8)
F 54 50.7 12.1) 0.013 3.7 87.0 92.6 0.0 25.6 3.9)
Lumbarda (K) M 54 43.4 11.3) 0.014 0.025 7.4 85.1 90.7 37.0 26.8 2.7)
F 54 43.0 12.4) 0.010 1.9 85.2 88.9 5.6 25.6 3.2)
Novo Selo (B) M 27 46.6 16.6) 0.011 0.014 0.0 85.2 88.8 33.3 26.6 3.9)
F 30 54.6 13.3) 0.009 0.0 80.0 86.7 16.7 28.5 4.3)
Praznice (B) M 53 48.7 13.2) 0.012 0.016 3.8 88.7 94.3 45.3 27.2 3.8)
F 67 53.0 14.6) 0.007 1.5 82.1 89.5 10.4 28.9 4.5)
Sutivan (B) M 61 50.2 15.3) 0.009 0.012 6.6 72.1 90.2 27.9 27.9 3.7)
F 88 50.5 15.1) 0.009 3.4 68.1 89.8 23.9 28.0 4.6)
Smokvica (K) M 52 43.2 10.5) 0.009 0.019 3.8 84.6 90.4 42.3 25.8 3.0)
F 45 45.7 12.5) 0.008 2.2 77.8 71.1 11.1 26.2 3.6)
Svirce (H) M 74 40.2 11.0) 0.008 0.008 2.7 91.2 93.2 18.9 25.6 2.5)
F 75 38.5 10.9) 0.007 1.3 69.3 73.3 6.7 25.8 3.5)
Dol Hvarski (H) M 53 41.1 10.7) 0.005 0.004 5.7 79.2 94.3 13.2 26.5 2.5)
F 42 42.4 9.9) 0.005 2.4 71.4 76.2 2.4 25.6 3.9)
Skrip (B) M 47 51.4 10.8) 0.003 0.008 2.1 85.1 93.6 31.9 27.7 3.2)
F 56 49.8 14.5) 0.005 1.8 83.9 87.5 16.1 29.6 4.7)
Dol Bracki (B) M 41 44.7 15.3) 0.003 0.005 2.4 85.4 92.7 29.3 28.0 3.2)
F 24 41.8 15.5) 0.001 0.0 79.2 75.0 25.0 27.8 4.3)
Nerezisca (B) M 50 44.7 12.9) 0.002 0.004 4.0 66.0 90.0 54.0 27.3 3.4)
F 62 44.9 11.9) 0.002 0.0 56.5 71.0 19.4 28.5 5.0)
Column heads show the number of male and female examinees in each village (N), means and standard
deviations for age (Age), average inbreeding coefficient computed from genealogical data [F (gen)] and
isonymy [F(iso)] as described in subjects and methods, the proportion with some college education (Edit),
proportion working in agriculture and fishery (Ocu), proportion regularly consuming traditional mediterranean
diet (Die), proportion of smokers (Smo), and the means and standard deviations for body mass index (BM1).
" H, Hvar; K, Korcula; B, Brae.
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cure 2.—Relationship between average inbreeding coef-
nts (F) computed from genealogical information and









X A * * *
1 30- % y«£-
%
(A 1^5'i |n' 'jl0)















V*. J *. ... • . •...*■ " • . •
t •• • '*
•••
?«•. v.*.
W' *7 ' ■ •
I | | | | | |
0.00 0.02 0.04 0.06 0.08 0.10 0.12
Inbreeding coefficient,F
Figure 3.—Multiple regression analysis: plot of residuals
against inbreeding for (a) systolic BP and (b) diastolic BP
after adjusting for effects of village, sex, age, height, weight,
and smoking and (c) height after adjusting for village, sex,
and age.
viduals with no known inbreeding in their recent
;stry in the study population was ~20%, and the mean
i of those males and females were, respectively, 45.9
13.9) and 47.0 (SD 13.9) years. Average inbreeding
tsures for each of the 25 villages based on Wright's
l method and isonymy gave a consistent pattern of
dng of villages by level of inbreeding. This supports
use of F values as a means of ranking individuals
villages by inbreeding coefficient (Table 1).
re found a highly significant linear correlation be-
:n mean inbreeding coefficient of study individuals
ach village and the prevalence of hypertension (Fig-
2). To explore this further, we performed multiple
ession analysis ofsystolic and diastolic BP on individ-
nbreeding coefficients (F), controlling for the main
ignized determinants of BP (age, sex, height, and
;ht), village of residence, and smoking status. We
id a strong linear correlation between F and ad-
jd systolic and diastolic BP in both males and fe¬
males (Figure 3). Both systolic and diastolic BP levels
correlated positively with age, weight, and individual
inbreeding coefficients and negatively with height and
smoking status in both males and females. The regres¬
sion model explained 35-50% of the phenotypic vari¬
ance in BP. The strongest effect was clearly individual
inbreeding coefficients, which alone explained ~15%
of the variance in males and 10% in females in both
systolic and diastolic levels (Table 2). An increase in F
of 0.01 corresponded to an increase of ~3 mm Hg in
systolic and 2 mm Hg in diastolic BP in both sexes.
The effect of inbreeding (F) on BP depends on the
number and dominance properties ofQTL alleles, their
frequencies, and average effects on the trait (Mukai et
al. 1974; Falconer and Mackay 1996). Using result
(1) and taking the total phenotypic variance as an upper
limit for the value of Vj), we found the genetic compo¬
nent of blood pressure variability in this population to
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TABLE 2
Summary of multiple regression analysis for systolic and diastolic BP in males and females: percentage
decrease in residual mean square (rms) under different models
Males Females
Model d.f. rms" % deer.
% deer,




Model A 1232 210.8 41.1 38.5 1392 249.7 52.6 49.9
Model B 1256 221.6 38.1 36.6 1417 264.9 49.7 47.8
Model C 1257 268.4 25.0 23.3 1418 310.0 41.1 38.9
Model D 1286 357.8 — — 1472 526.6 — —
Diastolic BP
Model A 1232 69.7 46.5 44.2 1416 74.8 48.7 46.6
Model B 1256 72.3 44.6 43.2 1441 78.4 46.2 45.0
Model C 1257 95.5 26.7 25.1 1442 92.5 36.5 35.2
Model D 1286 130.4 — — 1472 145.7 — —
Model A, full model, allowing F, F2, and all two-way interactions between F and other factors; model B,
allowing F, but excluding F2 and all two-way interactions between F and other factors; model C, excluding all
terms in F\ model D, null model. Models A, B, and C also allow all other factors and two-way interactions,
apart from F.
" In units of (mm Hg)2.
'% deer, (adj.) is the percentage decrease in rms compared with the rms from model D, but adjusting for
the reduction in degrees of freedom.
fluenced by not less than several hundred recessive
with 405 and 306 loci for systolic BP and 615 and
oci for diastolic BP in males and females, respec-
e distribution of recessive QTL effects can be ap-
mated as gamma-type with mode at zero and pa¬
ter L < 1 (Zeng 1992). From our data, if the
ated minimum QTL number is ~400, and L is
;en '/l6 and 1, then the minimum numbers contrib-
the upper 25th and 50th percentiles of the distri-
n are, respectively, 8-16 and 30-55 (Figure 4).
ight was analyzed in a similar fashion since in many
lations it shows additive variance but no major
nance component (Krieger 1968; Tambs et al.
I. The results showed that the slope of the regres-
>fTon height did not differ significantly from zero,
sdicted (Figure 3), supporting our interpretation
2 data.
DISCUSSION
s widely recognized that essential hypertension is
r considerable genetic influence. However, apart
isolated successes in mapping raremonogenic loci,
l account for <5% ofhypertension, no major prog-
las been made in defining the genetic basis of
tial hypertension (Lifton et al. 2001). A common,
implicit, assumption in mapping studies of such
lex traits is that relatively few genetic loci ofmoder-
) large effect account for a large component of
nderlying genetic variance despite the paucity of
rical data to support this. We have demonstrated
that the effects of recessive QTL on BP are widespread,
accounting for 10-15% of the total variation in BP in
this population. These effects are attributable to a very
large number of loci (at least 300-600), which will al¬
most certainly show a range of effects on BP.
The model makes several assumptions that may in¬
fluence these estimates. First, the inbreeding coefficient
is based on measures of recent inbreeding (over four
to five generations). We therefore calculated isonymy
estimates for each village (Table 1) and found that their
mean value exceeded the median L value by a factor of
1.35. Since isonymy is widely recognized to overestimate
inbreeding (Tay andYip 1984), this represents an upper
bound to the inbreeding estimate. Inflating the Lvalues
by 135% in the model reduces the above estimates of
minimum QTL numbers by a factor of 1.352 ( = 1.83).
On the other hand, if, as seems likely, V^/V? is nearer
33% than the 100% assumed here, the effect would be
to triple the estimates. Cavalli-Sforza and Bodmer
(1971), for example, estimated Vn/Vf to be 0.38 and
0.33 for systolic and diastolic blood pressure, respec¬
tively, using the data of Miall and Oldham (1963).
Second, as in many genetic models, all loci were as¬
sumed to have equal effects, whereas both theory
(Brink 1967) and empirical data in animals (Mackay
2001) show that the QTL effects vary widely and may
even be of opposite sign. Ignoring this again results in
underestimating the true number of QTL. Third, if a
substantial proportion of the phenotypic variance is due
to epistatic effects, additive and dominance variances
may be upwardly biased and lead to an underestimation
of the number of QTL. However, many studies suggest
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100 90 50 40 30
% of variance explained
Figure 4.—The effect ofTon the min¬
imum numbers of loci contributing
specified proportions of the overall
dominance variance, assuming i\ = 400.
% BP variance 10% 25% 50% 75% 90%
No. QTL 2-4 8-16 33-55 98-142 215-266
; epistatic QTL effects are uncommon (Mackay
1). Finally, we assume that recombination between
icent loci is sufficiently frequent that the identity-
lescent (IBD) status of any locus can be considered
^pendent of its neighbors. In effect, the method
ts tightly linked loci as a single "superlocus" (Flint
Mott 2001), leading to further underestimation
he true number of loci.
he magnitude of the inbreeding effect on BP is large
jivalent to a rise in systolic BP of ~20 mm Hg and
tolic of ~12 mm Hg in offspring of first-cousin mar¬
es; F= 0.0625) but very similar to the only other two
lished estimates we could identify in other isolate
ulations. Krieger (1968) found a 35 mm Hg in-
ise in diastolic BP associated with a 0.1 increase in
a study of 3465 children in Brazil and Martin et
1973) reported a 7-28 mm Hg increase in systolic
in adult Hutterites associated with an increase in F
.0625. This may be because inbreeding has a greater
lence on late-onset traits than on traits that are
ect to early selection (Charlesworth and Hughes
5). It is also possible that low environmental varia-
, or underestimation of F due to individuals being
ted through multiple lines of descent, contributes to
size of inbreeding effect in these isolate populations
ieger 1968; Martin et al. 1973; Halberstein 1999;
ey et al. 2001). Thus the observed effect size may
;ss in more environmentally diverse or outbred pop-
ions. The unidirectionality of the effect is also strik-
and consistent with a linear unidirectional effect
seen in an S-Leut isolate population (Martin et al.
1973), but the mechanism is unclear. A change in BP
with inbreeding is predicted as a consequence of reces¬
sive or partially recessive variants with the direction of
change toward the value of the more recessive alleles.
Physiological homeostasis may also act to support a di¬
rectional change in BP, for example, through selection
against variants tending to reduce BP to maintain circu¬
latory viability. Directional dominance may also occur
in late-onset traits when environmental factors are direc¬
tional (e.g., increase in adult blood pressure due to dietary
salt) and when selective constraints are weak compared
with blood pressure maintenance in early life.
The estimate of several hundred recessive QTL rele¬
vant to human hypertension is realistic and indeed may
be conservatively low. It is consistent with a complex
and genetically highly variable (Halushka et al. 1999)
system of blood pressure control mediated by cardiac
output, blood vessel architecture, renal function, and
central nervous system integration and requiring the
interaction of homeostatic systems, including barore-
ceptors, natriuretic peptides, renin-angiotensin-aldoste¬
rone, kinin-kallikrein, adrenergic receptors, and local
vasodilator mechanisms (Lifton et al. 2001). Further¬
more, published work from animal models of hyperten¬
sion supports a polygenic rather than oligogenic basis
for hypertension (Lifton et al. 2001) and yet these mod¬
els probably underestimate the genetic complexity,
since they are typically bred to achieve fixation of a
small subset of the diversity found in wild populations
I. Rudan et al.
t and Mott 2001). The greater genetic complex-
a diverse and outbred human population would
to be self-evident, despite the fact that humans
less haplotype and polymorphic diversity than sev-
ither species, including other primates (Reich et
01).
r minimum estimates of the number of recessive
nfluencing blood pressure control do not in them-
reveal the relative magnitudes of locus effects.
: is, however, good evidence for an L-shaped (lep-
totic) distribution of allelic-effect sizes (Shrimp-
.nd Robertson 1988; Tanksley 1993; Bost et al.
Hayes and Goddard 2001; Mackay 2001; Bar-
ind Keightley 2002). In addition, as shown by
(1992), their distribution can be approximated
nma-type with mode at zero {i.e., with parameter
), implying that most loci contribute little to the
II genetic variation and that the number contribut-
arge proportion is both small and relatively insen-
to L. The model developed from our data predicts
linimum QTL numbers contributing the upper
ind 50th percentiles of the distribution are, respec-
8-16 and 30-55 (Figure 4). Thus, the QTL with
rgest effect account individually for a small propor-
>f the total dominance variation and 50-75% of
iriation is mediated by many QTL of very small
, which are probably undetectable using current
ids (Terwilliger and Goring 2000).
s study demonstrates an important effect of in-
ing on the genetically complex late-onset disor-
[ypertension, which appears to be mediated by a
number of recessive QTL alleles as a result of
ised homozygosity. Several factors support the va-
of the data and reinforce the conclusions: first,
tndard measurement procedures that were adopted
.le exclusion of known confounding factors; sec-
he consistency of findings in diverse populations
ger 1968; Martin etal. 1973; Halberstein 1999);
the linear increase in BP with increasing F (preva-
of hypertension rises by 10% for every increment
F 0.01 up to F — 0.06); fourth, the overall strength
effect; fifth, the existence ofbiologically plausible
inisms, all ofwhich point to a causal relationship
en inbreeding and hypertension. Moreover, the
tency of the observation in a random sample of
duals across 25 villages is not explicable by a kin-
ffect. In terms of health impact, the results show
6% of hypertension incidence in this population
e attributed to inbreeding (population-attribut-
•action). The population prevalence of hyperten-
mong individuals with no known inbreeding in
ecent ancestry is ~20%, similar to most outbred
ations, but it increases steeply among 50-year-olds
inbreeding coefficient rises (Figure 5).
eeding is generally decreasing among nonimmi-
tVestern societies but it is highly prevalent globally,
nguineous marriages, defined as a union between
luals related as second cousins or closer (equiva-
Inbreeding coefficient, F
Figure 5.—Prevalence of hypertension as a function of
inbreeding. The data are shown for nonsmokers of age 50
years, height 1.7 m, and weight 75 kg and with mean village
effect, after adjusting for the effects of these variables by binary
logistic regression. The dashed lines are 95% confidence
limits.
lent toFs 0.0156 in their progeny), has been conserva¬
tively estimated to occur at 1-10% prevalence among
2.811 billion and at 20-50% prevalence among 911 mil¬
lion people globally (Bittles 1988; Bittles etal. 2001).
In addition, the extent of homozygosity by descent in
outbred populations may have been underestimated
(Broman and Weber 1999). The global impact of in¬
breeding on hypertension (and stroke) could therefore
be significant in health economic terms. In addition,
the results provide new insights into the genetic archi¬
tecture of a common disorder, which should inform
and improve the design of QTL-mapping studies and
explain some of the observed differences in trait distri¬
butions among different populations.
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APPENDIX: THE EFFECT OF INBREEDING ON
A MULTILOCUS PHENOTYPE
Model, notation, and assumptions: The phenotype of
the ith individual is modeled by
I. Rudan el al.
TABLE A1
Computation of the components of genetic variance at locus j








2 (a,k + Tjk + S, - \x,j)
A - 27}*
2M*'








7j» 7}*' + dju,
(X + Xfl 4- X,'2 + . . . + xin + 8,, (Al)
: Xy denotes the contribution to the phenotype of
rnotype at the jth locus (j = 1, . . . , n), and e( is
dom "environmental" contribution, uncorrelated
en individuals and with mean 0 and variance cr2.
locus is assumed to have ^alleles, Ap with frequen-
)k (k = 1, . . . , Kj), and loci are assumed to act
vely and independendy. Individuals with geno-
AjiAjk and A)kAp (k ¥= k') are distributed around
phenotypic values of 2a]k and ajk + dp + dp',
:tively. Thus, dp — 0 represents addidvity, and
a]k — Ojk' complete dominance of A]k over Ap.
: effect of inbreeding: Assuming Hardy-Weinberg
brium (HWE),








4 denotes summation from k — 1, . . . , Kj, and
se for 2*-. (Note that formathematical conformity,
mme djkk = 0, V k.) If the two alleles at locus j are
:hen
^(XyllBD) = 2Sj. (A5)
s, if the level of inbreeding, P(IBD), of the zth
dual is F„ we have
E(y.) = (x + 2S5; + 2A, - |2A,|F„ (A6)
: 2j denotes summation from j — 1, . . . , n. Thus,
of y, against I'] is linear with slope ~^jDj.
; components of genetic variance: Table Al shows
:eps needed to compute the additive (14;) and
tance (VDj) components of total genetic variance
it locus j, defining




s a generalization of Falconer's treatment for the
biallelic case (Falconer 1964). By adding the squared
deviations weighted by their frequencies and simpli¬
fying, we find
14, = 2. IpMk + Tjk)2 - (Si + Dj)'
and
where
Vuj = Dj - 22pjkTjk + Ej,





Since loci are assumed to be independent the overall
components of variance are derived by summing over
ally. Hence,
Var(^) = Eg; + (WG] - fy, + D])F, - D)F2, (A12)
where
WcGj Var(x,;|IBD) = 4(2afa - Sj (A13)
Lower limit for the number of loci, n: We make use
of the mathematical result that, for any two sets of real
numbers {z,, i = 1, . . . , n] and {w„ i — 1, . . . , n}, if
w, (i = 1, . . . , n) then
(zi + . . . + y2
Wi + . . . + w„
(A14)
This is an application of Cauchy's inequality (see, e.g.,
Hardy 1960). In the present context, if we set z, = D}
and Wj = Vj (where Vj can denote any component of
variance, VKj, VDp or Vg;, as required), and provided that
we can show that Df < Vj for all j, then we have a





is a lower bound for n. Here, LF = —'EPj and VT = 2;Vj
denote the overall slope and variance, respectively, the
additivity of both relationships being a consequence of
assuming that different loci act independently.
Special cases: The condition Dj ^ V) does not hold
in all circumstances. However, consideration of special
cases suggests that the circumstances under which it
Inbreeding and Human Hypertension 1021
;aks down are rather exceptional. In the biallelic case
lodel BA), the condition always holds since Dj is iden-
al to VDj. For the multiallelic case we consider two
>dels (MAI and MA2), in both of which all alleles at
:ry locus have equal frequency and successive homo
;otes are evenly spaced—that is, pjk = 1 /Kj and ajh =
h- {Kj+ l)/2] (k = 1, . . . , Kj, j = 1, . . . , «). In
>del MAI, the dominance effects are assumed to be
Lial in absolute magnitude, i.e., = ajdj (V j and
k¥= k!), whereas in model MA2 they are assumed to
proportional to the interhomozygote distances; i.e.,
• = apjI k — k'\ (V j, k, k'). With this definition, Ip;I =
:orresponds to full dominance of one allele in each
ssible pair, and I pyl = 0 to complete absence of domi-
nce. By analogy, it seems logical in model MAI to
,le djM by half the mean interhomozygote distance,
, a/K, + l)/3.
3y straightforward though tedious algebra it can be
>wn that the condition Df < VG] is satisfied under all
•dels unless the level of dominance exceeds V(%)
odel MAI) or ^3 (model MA2). These asymptotic
•its are bounded from above as K; —^ ■». Since such
els imply a considerable degree of overdominance
the same direction and between all pairs of alleles,
s unlikely to apply in most situations. For example,
sickle-cell anemia, in perhaps the most widely quoted
i extreme case ofoverdominance in human genetics,
lconer (1964) quotes relative fitness values of 0.80,
0, and 0.25 for the "normal" homozygote, the hetero-
;ote, and the sickling-trait homozygote, respectively,
e implied level of overdominance (p) is then 1.73.
ixtreme overdominance: In the most extreme form
overdominance, all homozygotes have one assigned
ue (0, say), and all heterozygotes have another (d,
). Then at a single locus, and dropping the suffix j,
have
D = -d( 1 - R2) (A16)
TA = 2d2(Rs - Rl) (A17)
VD = d2(R2 - 2R3 + Rl) (A18)










since — K '. On summing over all loci and applying
Cauchy's inequality, we obtain
2 (Kj ~ 1) = total number of alleles
D\
Vgt j
— total number of loci. (A22)
Note that this depends in turn on the easily proved
result that, for A, > 0,
2 2
—A, < Bj < Aj V j => < (2a) • (A2S)
Conclusions: The models explored here suggest that
a sufficient condition for nL (with yT = yGT = S>yG;.) to
be a lower bound for n is likely to be satisfied in most
practical circumstances and will fail only in situations
of extreme overdominance. In the most extreme such
situation, when all homozygotes have the same genetic
value and all heterozygotes have a different one, Cau¬
chy's inequality leads to the result that
Total number of alleles - total number of loci (re) s reL.
(A24)





On the other hand, because the condition is sufficient
but not necessary it will in practice be more widely appli¬
cable than the above models suggest. For example, in
the multiallelic models, the requirement that the abso¬
lute dominance is less than a certain limit may allow
dominance to be much greater for some pairs of alleles
than for others and even ofopposite sign, so long as the
average dominance remains within the required limit.
Finally, it should be borne in mind that the present
method reveals nothing about the relative magnitude of
the dominance effects at different loci or of course
about the presence of additive effects.
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ibreeding and risk of late onset complex disease
Rudan, D Rudan, H Campbell, A Carothers, A Wright, N Smolej-Narancic, B Janicijevic, L Jin,
Chakraborty, R Deka, P Rudan
J Med Genet 2003;40:925-932
nbreeding has been shown in almost all species to be
associated with impairment of function because of homo¬
zygosity of recessive alleles. This occurs across a wide range
traits and suggests a large number of deleterious alleles in
e human genome. This has been predicted from the
duced early survival of offspring in first cousin marriages
id from similar results in other organisms.'"5 As most
entified genetic variants causing complex disease in
imans are partially recessive' we predict that inbreeding
humans might influence a wide range of complex diseases.
Numerous reports on the health effects of inbreeding have
cused mainly on its impact on reproduction, childhood
ortality, and rare Mendelian disorders.2 5 For example, a 4-
& increase in childhood mortality has been found in the
fspring of first cousin marriages, and similar results have
:en reported in other species.2 4 5 However, the effects of
breeding on late onset disorders are largely unknown,
ispite the fact that deleterious effects of inbreeding in other
lecies are known to increase with age, as predicted by
lection theory.6 7 The reported finding of greater inbreeding
fects for traits such as blood pressure and serum cholesterol
middle age compared with early adult life is consistent
ith this."
In order to investigate the hypothesis that the heritable
rnponent of late onset diseases includes a major class of
Jeterious recessive alleles,' we recently studied the effects
inbreeding on blood pressure among 2760 adult indivi-
tals from 25 villages in a Dalmatian island isolate. The
udy showed a large effect of inbreeding on blood pressure
[uivalent to a rise in systolic blood pressure of —20 mm Hg
id diastolic blood pressure of —12 mm Hg in offspring of
st cousin marriages. The effect appeared to be mediated by
veral hundred recessive alleles as a result of increased
imozygosity.10 In support of this finding, several studies of
lall inbred communities worldwide have reported an
creased prevalence of hypertension." ""'5
In the present study, we extend this observation by
vestigating the relation between inbreeding and the
evalence of 10 late onset complex diseases of public health
tportance. The study was carried out in 14 of the original 25
rlate villages on three neighbouring islands in middle
ilmatia, Croatia. These island populations present a wide
nge of levels of inbreeding and endogamy, reduced genetic
riation at both individual and (sub)population levels, and
lative uniformity of environment,1016"18 and thus provide a
iod setting for investigating inbreeding effects.
ETHODS
udy cohort
ie village populations of three neighbouring islands in the
stern Adriatic, part of Middle Dalmatia, Croatia (Brae,
/ar, and Korcula, see fig 1), represent well characterised
netic isolates. The tendency towards inbreeding in each
lage has been influenced by geographic isolation, political
Pastrovic") privileges given to residents of certain commu-
ties, and sociocultural factors."^18 A survey of 1339 adult
Key points
• From arguments derived from population genetics, we
propose that the genetic basis of common late onset
diseases includes a major class of deleterious recessive
alleles. Inbreeding is therefore predicted to increase the
incidence of such diseases.
• Among 10 late onset conditions studied in a genetic
isolate population, inbreeding was found to be a
significant (positive) predictor for coronary heart
disease, stroke, cancer, uni/bipolar depression,
asthma, gout, and peptic ulcer, but not for type 2
diabetes
• It appears that inbreeding causes an increase in
homozygosity at many genetic loci with small deleter¬
ious effects on homeostatic pathways, resulting in
increased disease risk.
• The results indicate that between 23% and 48% of the
incidence of these disorders in this population sample
(other than type 2 diabetes) could be attributed to
recent inbreeding. The global impact of inbreeding
could thus be substantial, as an estimated one billion
people globally show rates of consanguineous mar¬
riages greater than 20%.
individuals selected randomly from voting lists to form
approximately 20-30% of the total population of these 14
villages was undertaken in late 1970s and early 1980s by the
Institute for Anthropological Research in Zagreb in collabora¬
tion with the Smithsonian Institute, Washington, USA. The
mean adult ages in individual villages varied from 41 to 65
years (detailed age/sex profiles for each village are given in
appendix 1). For each individual, information was collected
on the highest level of education, occupation, diet, smoking
habits, and body mass index (table 1).
Computation of individual inbreeding coefficients
A single researcher (IR) computed individual inbreeding
coefficients for each study participant, based on pedigree
information on four to five ancestral generations, recorded
during the initial field work and supplemented by a study of
parish registries. The individual inbreeding coefficients (F)
were then computed according to Wright's path method":
F = E(^c)(i)(n,+mi+,)
where m; and ni refer to the number of paths from a common
ancestor, and c refers to the number of common ancestors.
The genealogical inbreeding coefficient for each village was
then computed as the average of all individual F values. To
further support these estimates, F was calculated from
isonymy as suggested by Tay and Yip,20 and mean values
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igure 1 Map of the Dalmatian island genetic isolate showing study islands and villages (numbered 1 to 14).
/ere derived for each of the 14 villages. Estimates based on
tonymy are generally thought to be positively biased, and so
3 provide an upper bound for F (table 1).
ollow up data on disease status of cohort individuals
opulation census data in 1981, 1991, and 2001 from study
illages show significant depopulation with minimal immi-
ration over the last two decades. Thus only 480 individuals
/ho were still resident in the study villages were available for
tllow up in the year 2000. Specific diagnostic criteria were
stablished for each of 10 commonly occurring disorders in
lis population (coronary heart disease, stroke, cancer,
rhizophrenia, epilepsy, uni/bipolar depression, asthma, adult
type diabetes, gout, and peptic ulcer) following those
presented in Merck's Manual. In collaboration with local
general practitioners, two medical doctors, who were blind to
the inbreeding status of each individual, inspected the
medical records between March and October 2000 and
recorded whenever appropriate diagnostic criteria were met.
Diagnoses were supported wherever possible by medical
records from the local general hospital in Split.
Statistical analysis and modelling
Disease prevalence was first investigated by comparisons
between villages grouped by the level of inbreeding as high,
moderate, or low (table 2). Disease prevalence rates were
Table 1 Genetic and environmental characteristics of 14 village populations ranked according to average inbreeding
coefficient computed from genealogical data
Village (island) N(sam) N(pop) F(gen) F(iso) Edu (%) Occu |%) Diet (%) Smo (%) BMI (avg)
Gdinj (H) 135 153 0049 0-107 2 3 80-8 93-8 4-6 25-1
Pupnat (K) 96 326 0044 0-034 2-1 89-7 91-8 9-3 26-7
Cara (K) 139 464 0032 0-040 1-5 890 94-9 22-6 26-4
Dracevica (B) 20 66 0-031 0-031 2-4 85-7 90-5 23-8 28-6
Racisce (K) 103 290 0027 0-034 1-9 87-5 83-6 23 1 27-3
Bogomolje (H) 90 102 0-025 0-030 2-5 84-0 93-8 4-9 23-0
Vrisnik (H) 105 216 0-015 0-023 2-1 82-3 91-6 13-5 25-5
G Humac (B) 43 214 0-013 0-016 25 81-3 87-5 38-8 27-3
Zastrazisce (H) 133 210 0-013 0-013 4-0 86-3 93-6 5-9 25 1
Lumbarda (K) 59 354 0-012 0-025 4-7 85-2 89-8 21 -3 26-2
Smokvica (K) 97 866 0-008 0-019 3-1 81-4 81-4 27-8 26-0
Svirce (H) 152 375 0-008 0-008 2-0 80-1 83-2 12 8 25-7
Dol (H) 102 154 0-005 0-004 4-2 75-8 86-3 8-4 26-1
Nerezisca (B) 65 106 0-002 0-004 1-8 60-7 79-5 34-8 28-0
Islands: H, Hvar; B, Brae; K, Korcula.
BMI (avg), average body mass index among examinees; Diet, proportion of examinees regularly consuming traditional Mediterranean diet; Edu, proportion of
examinees with some college education; F(gen), average inbreeding coefficients computed from genealogical data; F(iso), average inbreeding coefficients
computed from isonymy; N(pop), number of individuals in the village population in year 2000 (year in which disease prevalence was determined); N(sam),
number of individuals in the sample (represents 20-30% random samples of total village population obtained between 1979 and 1981); Occu, proportion of
examinees working in agriculture and fishery; Smo: proportion of examinees smoking (smoking recorded using Brinkman index*).






Age and sex standardised prevalences of 10 complex diseases in groups











































Average Fg,„ = 0.006











Statistical significance |p values) in highly and moderately inbred groups is calculated against the low inbreeding
group: *p<0.05; **p<0.01; *"p<0.001.
Fgem weighed average inbreeding coefficient computed from genealogical data; F;M/ weighed average inbreeding
coefficient computed from isonymy data.
tndardised by sex and age to the total population of all 14
lages included in the study, using 10 year age intervals and
rect standardisation.
In an attempt to overcome the possible confounding effects
unmeasured environmental exposures or population
atification, the relation between individual inbreeding
efficients and disease outcomes was investigated among
e 480 individuals. Data on age, sex, education, occupation,
et, smoking status, village of residence, height, weight, and
dividual inbreeding coefficient (F) were analysed in a
gistic regression with disease status as the outcome. Age
id sex were forced into the prediction model irrespective of
aether they were formally significant. Other main effects
ibreeding, smoking, height, weight and village) were
tered with p = 0.05, and all higher order effects and
teractions with p = 0.01.
ipulation attributable risk
ipulation attributable risk (PAR) estimates for inbreeding
ire calculated by logistic regression, allowing for individual
fferences in the variables village, sex, age, height, weight,
d smoking. The appropriate regression was determined as a
nction of all associated variables (including F), then the
obability for each individual of having the disease outcome
ts calculated assuming an F value set at 0. The sum of all
ch probabilities, PSUm' is an estimate of the number
fected in the absence of inbreeding, but with other
riables remaining unaltered. Then PAR — 1 — Psum/Naff,
tere Nalf is the actual number of affected individuals. In
riving the PAR values, the effects estimated from the
bset of 14 villages were applied to the full dataset from all
lages.
The original survey was carried out with the informed
nsent of the participants and ethical approval for the recent
Id work and analyses was granted by the appropriate
search ethics committees in Scotland and Croatia.
iSULTS
ble 1 presents selected characteristics of the study villages:
imber and name of village, island, average inbreeding
efficients computed from genealogical data and from
mymy, education level, occupation, diet, smoking, and
dy mass index. The table presents village data in three
aups defined by the average level of inbreeding. The
ocation of villages to these three groups according to the
timates of F based on genealogy (Fgen) is broadly consistent
with those based on isonymy (F{so). On a log-log scale, the
correlation between the two measures of inbreeding across
villages was 0.92, with Fiso exceeding Fgcn on average by a
factor of 1.32.
Table 2 presents age and sex standardised disease
prevalence data for each of the 10 diseases under investiga¬
tion. A stepwise increase in disease prevalence across villages
stratified by (increasing) average inbreeding coefficient was
found for gout, depression, peptic ulcer, schizophrenia,
cancer, epilepsy, coronary heart disease, and asthma (the
last two not statistically significant).
Table 3 includes data from 480 individuals from 14 villages,
with age and sex forced into the multiple logistic regression
model. Other main effects (inbreeding, smoking, log_weight,
log height, and village) were entered with p = 0.05, and all
higher order effects and interactions with p = 0.01.
Schizophrenia and epilepsy were excluded from this analysis
because of the small number of cases (four each) and thus
low study power to investigate predictors for these condi¬
tions. Inbreeding remained a significant (positive) predictor
for every condition except type 2 diabetes. The forced
inclusion of age and sex in the model acted to reduce slightly
the significance of the effect of inbreeding, because of a small
positive correlation between inbreeding and age. Village of
residence was found to be a significant predictor only for
coronary heart disease. Weight was a significant positive
predictor for type 2 diabetes and gout and a significant
negative predictor for cancer.
In terms of health impact, the results on population
attributable risk (table 3) show that 23-48% of the incidence
of these disorders (other than type 2 diabetes) in this
population can be attributed to recent inbreeding.
DISCUSSION
The impact of inbreeding on reproduction, childhood
mortality, and Mendelian disorders is well documented.2 3
In contrast, very little has been published on the effects of
inbreeding on late onset diseases. This is despite the fact that
inbreeding may have a greater influence on late onset traits
than on traits that are subject to early selection.6 7 This study
shows an important effect of inbreeding on several geneti¬
cally complex late onset diseases which are of major public
health importance. This is consistent with our proposal that
an important genetic influence on these disorders is mediated
by numerous deleterious recessive alleles, suggesting that
www.jmedgenet.com
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Table 3 Summary of results of multiple logistic regression
Disease Predictor Coefficient SE p Value PAR (SE) (%)t
CHD Constant -6.20 1.27 0.000 34.3 (6.6)*
SEX 0.47 0.26 0.070
AGE-1 0.69 0.14 » 0.000
VILL - - 0.022
F-l 26.63 4.88 0.000
Stroke Constant -3.28 0.71 0.000 26.3(12.3)
SEX -0.30 0.40 0.464
AGE-1 0.34 0.20 0.095
F-l 13.37 5.85 0.022
Cancer Constant 10.17 6.27 0.105 23.2(11.7)
SEX 0.83 0.54 0.128
AGE-1 0.02 0.20 0.909
IN WT -3.49 1.40 0.013
F-l 13.0 6.17 0.035
Depression Constant -3.86 0.58 0.000 42.2 (7.6)
SEX 0.69 0.31 0.028
AGE-1 0.02 0.14 0.896
F-l 24.54 4.43 0.000
Asthma Constant -3.74 0.80 0.000 47.6 (12.6)
SEX -0.40 0.45 0.374
AGE-1 0.36 0.23 0.110
F-l 23.10 6.04 0.000
Diabetes Constant -28.16 4.58 0.000 0
(type II) SEX 0.97 0.31 0.002
AGE-1 0.31 0.14 0.027
LN_WT 5.60 0.99 0.000
Gout Constant -14.90 4.08 0.000 31.0 (7.6)
SEX -0.17 0.29 0.552
AGE-1 0.38 0.14 0.006
IN WT 2.85 0.89 0.001
F-l 17.69 4.16 0.000
Peptic ulcer Constant -3.23 0.63 0.000 30.6(10.5)
SEX -0.18 0.35 0.615
AGE-1 0.36 0.18 0.043
F-l 15.68 5.06 0.002
'Excludes village effects, even though they were significant in the dataset from 14 villages, as they could not be
estimated for the remaining 11 villages in the full set.
"{■Population attributable risk estimated from individual inbreeding levels (see text).
SEs calculated by "delta" method.
CHD, coronary heart disease; F-l, inbreeding; LN_WT, weight; PAR, population attributable risk; VILL, village.
ibreeding increases disease risk as a result of increased
omozygosity.9
alidity of findings
is important to consider whether these results can be
tplained by chance, bias, or confounding.
hance
be fact that this was our major a priori hypothesis, taken
tgether with the levels of statistical significance reported,
rgues strongly against chance as an explanation for these
ndings.
ias
Tith respect to selection bias, the 480 individuals on whom
e were able to obtain disease outcome data were a subset of
le original cohort from 1979-81. However, census data
wealed that the major reason for loss to follow up, other
lan deaths of cohort members, was emigration from the
Uages over the 20 year period, which should not result in
tbstantial bias.
With respect to measurement bias, we do not believe that
isease outcomes were ascertained or recorded differently
nong individuals who differed by inbreeding status,
tandard and explicit clinical criteria were adopted by the
vo study doctors, who were blind to the inbreeding status of
idividuals. Furthermore, the results cannot be explained by
Afferent diagnostic practices in different villages, as the
llage term was not found to be statistically significant in the
multiple logistic regression analysis (except for coronary
heart disease).
Confounding
Various potential confounding factors (age, sex, smoking
status, education level, general diet, occupational group,
height, weight) were measured and their effects adjusted for
in the multivariate analysis. Although a degree of imprecision
is inevitable in measuring some of these factors, we do not
believe that confounding could have accounted for the large
and consistent effects demonstrated.
Factors supporting the validity of the data
Several factors support the validity of the data. First, the
findings support our prior hypothesis and are consistent with
similar findings on hypertension in the same population10
and with other reports of inbreeding effects on blood
pressure." "~15 Second, the overall strength of the effect
argues against bias or confounding. Third, we have presented
detailed arguments that biologically plausible mechanisms
underpinning this effect are consistent with population
genetic theory and observations in a wide range of organ¬
isms.'' Finally, the data are consistent with the few other
published reports of inbreeding effects on late onset diseases
in which inbreeding was measured rather than self reported
(table 4).
Size of inbreeding effect in late onset diseases
The magnitude of the inbreeding effect on disease prevalence
was large. However, the effect on prevalence of stroke and
Aw.jmedgenet.com
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ronary heart disease, for example, is consistent with our
jvious report of a rise in diastolic blood pressure by
nm Hg for an increase in F of 0.01,10 and both cohort
idies and randomised trials show that an increase of
nm Hg diastolic blood pressure is associated with a 33%
:rease in stroke risk and a 20% increase in risk of ischaemic
art disease.2' The effect size is supported by the only two
wiously published estimates of inbreeding on blood pressure
it we could identify in other isolate populations.8 "
rhe large effect may reflect the greater influence of
>reeding on late onset traits than on traits that are subject
early selection.6 7 It is also possible that low environmental
riation, or underestimation of F because of individuals
ing related through multiple lines of descent, contribute to
i size of inbreeding effect in these isolate popula-
ns.8 " 15 22 Thus the magnitude of the inbreeding effect
ative to the overall variation may be smaller in more
vironmentally diverse populations.
The ecological analysis at the village level (table 2) suggests
an inbreeding effect on the prevalence of epilepsy and
schizophrenia, but there were insufficient outcome events
to permit an analysis at the individual level. The effect of
inbreeding was shown in seven of the other eight diseases
studied. The lack of observed effect of inbreeding on type 2
diabetes may reflect the lower heritability and stronger
environmental influences involved in the aetiology of this
condition23 or heritable components that are mainly additive
or dominant rather than recessive.
Mechanism of inbreeding effects in late onset diseases
We have argued that the genetic component of late onset
diseases may be due principally to large numbers of rare
variants in numerous genes—the common disease/rare
variant (CD/RV) hypothesis.9 The possibility that a significant
fraction of the genetic variation in complex traits is caused by
rare alleles maintained by mutation-selection balance is
Review of the studies investigating the effect of inbreeding on complex late onset diseases
Author/reference Study design Reported effect of inbreeding
Shami et al. Lancet
1991;338:954
Puzyrev et al. Arctic Med
Res 1992;51:136-42
Jaber et al.* Am JMed
Genet 1997,70:346-8
Rudan et al (present study),
2003
Simpson et al. Am J Obst
Gynecol 1981;141:629-36
Lebel & Gallagher. Am J
Med Genet 1989;33:1 -6




Denic & Bener *Br J Cancer
2001;85:1675-9




Sangstad & Odegard. Clin
Genet 1986;30:261-75
Gindilis et al. Genetika
1989;25:734-43
Rudan et al. (present study)
2003
Vezina et al. Genet
Epidemiol 1999;16:412-25
Roberts et al. J Epidemiol
Community Health
1979;33:229-35
Roberts et al. J Epidemiol
Community Health
1983;37:281-5
Jaber et al.* Am J Med
Genet 1997;70:346-8
Rudan et al. (present study)
2003
Ombra et al. Am J Hum
Genet 2001;68:1119-29
Rudan et al. (present study)
2003
Jaber et al* Am J Med
Genet 1997;70:346-8
Rudan et al. (present study)
2003
Jaber et al.* Am J Med
Genet 1997;70:346-8





Case-control study (self reported
exposure and outcome status)










based (self reported exposure status)












(with parallel ecological study)
Case-control population based
(with parallel ecological study)
Case-control study (self reported
exposure and outcome status)
Cohort study (with parallel
ecological study)
Ecological study
Cohort study (with parallel
ecological study)
Case-control study (self reported
exposure and outcome status)
Cohort study (with parallel
ecological study)
Case-control study (self reported
exposure and outcome status)
Cohort study (with parallel
ecological study)
Hospital cases had significantly greater inbreeding coefficients than
controls (individuals in population from which they were recruited)
Increased risk of myocardial ischaemia among endogamous
males
No difference in self reported prevalence among students
with or without consanguineous parents
Increased risk associated with greater inbreeding coefficient
(relative risk of 1.2 per 3% inbreeding)
Increased risk of breast, endometrial, and ovarian cancer associated
with greater inbreeding coefficient in women under 45 years
Increased risk associated with greater inbreeding coefficient,
(especially for multiple and early onset cancers)
Hospital cases had significantly greater inbreeding coefficients than
controls (individuals in population from which they were recruited)
Stepwise increase of 20 year cancer incidence associated with
greater inbreeding in five island communities
Decreased risk of breast cancer among women who self reported being
offspring from consanguineous unions, no effect on cervical cancer
Increased risk associated with greater inbreeding coefficient
(relative risk of 2 per 3% inbreeding)
Increased frequency of consanguinity among parents of
schizophrenia cases
No increase in first cousin matings among parents of psychiatric
patients (major changes in diagnostic criteria over time
reported by authors as important confounder)
Severe schizophrenia 2-3 times more prevalent in inbred
communities
Increased risk associated with greater inbreeding coefficient (relative
risk of 2.5 [depression] and 5 [schizophrenia] per 3% inbreeding)
205 necropsy confirmed cases of late onset Alzheimer's
disease significantly more inbred than controls
Average inbreeding coefficient greater among cases than
controls; increased prevalence in genetic isolate population)
Average inbreeding coefficient greater among cases than
controls; increased prevalence in genetic isolate population)
No difference in self reported prevalence among students
with or without consanguineous parents
No consistent increase in risk or prevalence associated with
greater inbreeding coefficient
Increased prevalence of hyperuricaemia and uric stones in
a highly inbred community
Increased risk associated with greater inbreeding coefficient
(relative risk of 2.5 per 3% inbreeding)
No difference in self reported prevalence among students
with or without consanguineous parents
Increased risk associated with greater inbreeding coefficient
(relative risk of 1.5 per 3% inbreeding)
No difference in self reported prevalence among students
with or without consanguineous parents
Increased risk associated with greater inbreeding coefficient
(relative risk of 3 per 3% inbreeding)
*These studies are based on self reported consanguinity which in our experience is unreliable as most "inbreeding loops" are found in the third and fourth parental
generations and are thus unknown to most people.
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insistent with extensive research into the genetics of
lantitative traits in simpler organisms.7 Recent estimates24
iggest that each person carries, on average, 500-1200
ightly deleterious mutations, most of which are rare
id present in heterozygous form. Many of these variants
ill become homozygous in inbred individuals, who are
:pected to show correspondingly large effects. We have
eviously reported an estimate of several hundred recessive
tnes underlying human hypertension,10 consistent with a
implex and genetically highly variable system of blood
essure control and with published work from
lontaneous and engineered animal models of hyperten-
an.25 26 The late onset disorders under investigation in this
udy are likely to be similarly complex at a physiological
vel so that significant effects of inbreeding are again
:pected.
The observed effect of inbreeding on the prevalence of
veral different late onset diseases is consistent with the
esence of many deleterious recessive alleles located
iroughout the genome. It is also consistent with a more
tneral effect of inbreeding, with increased homozygosity at
lese loci leading to an accumulation of small deleterious
fects on homeostatic pathways, which cumulatively
crease disease risk. This suggests a greater sensitivity of
rmeostatic mechanisms to inbreeding in later life, as
edicted by findings in animals.5' Decay of homeostatic
ipacity would also be expected to lead to reduced capacity to
spond appropriately to diverse stimuli. This is supported by
le recently reported observation that the reduced survival
iund in inbred animals is greater in the natural habitat than
. a controlled laboratory environment.27
The inbreeding data do not allow an easy distinction to be
ade between the relative contributions of common versus
re variants but do inform two somewhat neglected aspects
the genetic architecture underlying complex diseases.'
rst, the results provide indirect evidence in support of a
ajor polygenic component to disease susceptibility. The
breeding coefficient is shown to be a significant predictor of
>ronary heart disease, stroke, cancer, depression, asthma,
)ut, and peptic ulcer, with population attributable risks
trying between 23% ands 48% (table 3). Second, the
icessive or partially recessive nature of complex disease
isceptibility has received little emphasis. Both factors have
nplications for the identification of individual disease
xsceptibility alleles. If disease susceptibility is indeed highly
jlygenic then it implies the need to reduce the phenotypic
tmplexity of "disease" by means of genetically simpler but
tntributory quantitative traits (QT) or disease subgroups,
lose with extreme values of QT distributions or early
isease age of onset will be those most likely to harbour
isceptibility alleles of large effect and hence to provide a
:alistic possibility of gene identification. A significant
imponent of genetic susceptibility appears to result from
iriants that are recessive or partially recessive. This implies
lat the study of inbred populations would be advantageous,
; the increased gene dosage of such variants in inbred
idividuals will tend to amplify their phenotypic effects




The population attributable risk estimates from this study
suggest that 23-48% of the incidence of the disorders
showing an inbreeding effect in this population can be
attributed to inbreeding. We have previously reported that
36% of hypertension incidence in this population can be
attributed to inbreeding.10 These estimates are specific to this
population and may be absent or considerably smaller in
other populations. Nevertheless, inbreeding is highly pre¬
valent globally and inbreeding effects may explain some of
the observed differences in disease prevalence among
different populations. Consanguineous marriages, defined
as a union between individuals related as second cousins or
closer (equivalent to F 5*0.0156 in their progeny), have been
conservatively estimated to occur at 1-10% prevalence among
2811 million people globally and at 20-50% prevalence
among 911 million.28 29 In addition, the extent of inbreeding
even in outbred populations may have been underesti¬
mated.50 Further details, including updated tables of global
consanguinity studies, can be found at www.consang.net.
The global impact of inbreeding on late onset disorders of
public health importance could therefore be significant in
health economic terms. This effect may be mediated by the
observed inbreeding effect on important physiological traits
such as blood pressure1" and cholesterol,8 recently shown to
be two of the most important determinants of the global
burden of disease.31 As inbreeding declines owing to
increased population movement and admixture, the preva¬
lence of late onset disorders may also decline, and as
common late onset diseases are correlated with longevity,52
this may influence life expectancy.
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\ge/sex profiles of the 14 study villages
Village (No) Population Male Female M/F ratio Age (mean) Age (SD)
Dracevica (4) 66 37 29 1.2759 52.800 22.890
Nerezisca (14) 106 56 50 1.1200 51.640 22.820
G. Humac (8) 214 97 117 0.8291 53.450 21.550
Dal (13) 154 75 79 0.9494 55.930 21.440
Svirce (12) 375 179 196 0.9133 47.720 22.420
Vrisnik (7) 216 112 104 1.0769 51.220 20.150
Zastrazisce (9) 210 96 114 0.8421 53.620 21.560
Gdinj (1) 153 76 77 0.9870 65.940 17.060
Bogomolje (6) 102 35 67 0.5224 60.880 22.370
Smokvica (11) 866 411 455 0.9033 42.777 24.061
Cara (3) 464 240 224 1.0714 43.380 22.830
Pupnat(2) 326 173 153 1.1307 45.840 23.830
tumbarda (10) 354 169 185 0.9135 41.280 23.710
Racisce (5) 290 134 156 0.8590 43.310 27.030
No = tfie village number given in fig 1 and is equivalent to the rank according to average inbreeding coefficient
given in table 1.
\PPENDIX 2
Zriteria adopted in this study for establishing
Jiagnoses of 10 selected late onset diseases
I. Coronary heart disease (includes angina pectoris and
nyocardial infarction)
\ngina pectoris
May be diagnosed by GP.
Clinical syndrome characterised by repeating episodes of
precordial discomfort or pressure, typically precipitated by
exertion or relieved by rest or sublingual glyceryl trinitrate
with or without reversible ischaemic ECG changes.
Myocardial infarction
Must be diagnosed by a consultant in local general
hospital.
Based on presenting symptoms (deep substernal radiating
pain) and supported by combination of ECG findings
(deep Q waves, elevated or depressed ST segments, deeply
inverted T waves), and raised myocardial component of
creatine kinase and lactic dehydrogenase, with or without
myocardial imaging.
I. Cerebral stroke
Must be diagnosed by a consultant in local general
hospital.
Based on presenting symptoms including variable neuro¬
logical defects that increase over 24-48 hours.
Diagnosis may be supported by CT/MRI scan or arterio¬
graphy.
3. Cancer
Must be diagnosed by a consultant in local general
hospital.
Diagnosis requires abnormal cellular growth of any site to
be histologically confirmed as malignant.
4. Diabetes type II
May be diagnosed by GP.
Symptomatic hyperglycaemia (polyuria, polydipsia, poly¬
phagia, weight loss) or diabetic ketoacidosis or non-ketotic
hyperglycaemic-hyperosmolar coma; or plasma (or serum)
glucose level greater than 140 mg/dl after an overnight
fast on two occasions; or development of any of the late
complications (retinopathy, nephropathy, atherosclerotic
changes on peripheral or coronary arteries, neuropathy).
5. Schizophrenia
• Must be diagnosed by a consultant in local general
hospital.
• Chronic mental disorder (continuous signs of illness for at
least six months) characterised by psychotic symptoms
involving disturbances of thought, perception, feeling and
behaviour
• Psychotic symptoms such as delusions, hallucinations, and
formal thought disorder; deterioration from previous level
of functioning; a tendency toward onset before the age of
45.
• Diagnosis should exclude mood (affective) disorder,
organic mental disorder or mental retardation.
6. Manic depression
• Must be diagnosed by a consultant in local general
hospital.
• Combination of symptomatic picture of depression,
chronic course, family history, and response to treatment
• Diagnosis may be supported by TRH stimulation test or
dexamethasone suppression test.
7. Epilepsy
• Must be diagnosed by a consultant in local general
hospital.
• Recurrent paroxysmal disorder characterised by sudden
brief attacks of altered consciousness, motor activity,
sensory phenomena, or inappropriate behaviour caused
by abnormal excessive discharge of cerebral neurones.
• Diagnosis may be supported by abnormalities in EEG, CT,
or MRI.
8. Asthma
• May be diagnosed by GP.
• Airways obstruction that is usually reversible, presenting
with attacks of tachypnoea, tachycardia, and audible
vAvw.jmedgenet.com
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wheezes, airway inflammation, and increased airways
responsiveness to a variety of stimuli.
Diagnosis may be supported by a family history of allergy
or asthma.
9. Gout
May be diagnosed by GP.
Acute gouty arthritis (recurrent acute mono/polyarticular
pain in peripheral joints, often nocturnal, progressively
more severe, with swelling, warmth, redness, and tender¬
ness).
Diagnosis may be supported by any of the following:
raised serum urate (greater than 7 mg/dl), demonstration
of urate crystals in tissue or synovial fluid, or dramatic
response (within 24 hours) to colchicine.
10. Peptic ulcer
Must be diagnosed by a consultant in local general
hospital.
Circumscribed ulceration of the gastric or duodenal
mucous membrane causing a chronic and recurrent
burning, gnawing, aching, soreness, or empty feeling in
the epigastrium.
Diagnosis must be supported by endoscopic findings and/
or x ray studies with barium.
PPENDIX 3
st of variables entered into multiple logistic
tgression
Name Definition p Value to enter
Main
SEX I =male Forced
2 = female
AGE.1 0.1 "(AGE-50) Forced
VILL Village 0.05
F.l F/128 0.05
IX SMO.l Smoking index (1-5) 0.05
IN HT Ln(HEIGHT/m) 0.05
LN WT Ln(WEIGHT/kg) 0.05
EDU Education (see text) 0.05
OCU Occupation (see text) 0.05
NUT Nutrition (see text) 0.05
Higher order
AGE.2 (AGE. I)2 0.01
AGE.3 (AGE.l)3 0.01
IX SMO.2 (IX SMO.l)2 0.01
F.2 (F.l)2 0.01
Interactions
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ABSTRACT
The aim of this study was to investigate a recessive genetic component in susceptibili¬
ty to osteoporosis (OP) by comparing its prevalence in isolated villages ofthree Croatian
islands: Brae, Hvar and Korcula with different levels of inbreeding. A random sample
of20-30% adults from 14 villages was obtained, including a total of 1,389 examinees.
The average inbreeding coefficient (F) ofexaminees from each village population was es¬
timated using Wright's path method (based on genealogical information). The morpho¬
metry of the metacarpal bones was performed on hand-wrist radiographs of both hands
in all examinees. OPwas defined as values ofcortical index smaller than 2 standard de¬
viations based on distribution of values in examin ees of the same sex under 45 years of
age. Mean values ofcortical index (CI) and prevalence ofOP (both standardized by age
and weighted for the sample size) in each village were correlated to the mean inbreeding
coefficient (F). The coefficient of correlation (r) between F values and CI was -0.28 in
males (p=0.08) and -0.42 in females (p=0.005), and between F and OP prevalence 0.32
in males (p<0.001) and 0.43 in females (p<0.001). These results indicate a trend of in¬
creased susceptibility to osteoporosis with increasing level of inbreeding in isolated com¬
munities of Croatian islands.
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Introduction
Osteoporosis is a common public health
problem of post-reproductive age, charac¬
terized by reduced bone mass, changes in
micro-architecture of the bone tissue and
increased risk of fractures subsequent to
those changes1,2. Similarly to many other
common complex diseases of late onset,
most cases in population probably result
from the action of many different genes
and their interaction with the environ¬
ment2'3. However, osteoporosis seems to
have much stronger genetic basis than
most of the other late-onset diseases4-7.
Twin and family studies indicate that a
large majority of variance in quantitative
traits such as bone mineral density can
be explained by hereditary factors, and
there is also a high correlation between
siblings in skeletal geometry and bone
turnover1-4. Some cases in population
arise as a consequence of single-gene disor¬
ders, e.g. »osteoporosis-pseudoglioma syn¬
dromes Genome-wide linkage studies
identified multiple candidate loci on chro¬
mosomes 1, 2, 5 and 11, but those associa¬
tions seem to be modified by dietary cal¬
cium and vitamin D intake, which makes
them difficult to repeat4. Significant non-
hereditary risk factors include low cal¬
cium intake, vitamin D deficiency, physi¬
cal inactivity, cigarette smoking, excessi¬
ve consumption of protein, caffeine and
alcohol, low body mass index and use of
bone-resorbing medications8-13.
There is great current interest in un¬
derstanding genetic architecture of com¬
mon complex diseases such as osteoporo¬
sis, as this is expected to lead to the
development of genetic markers of in¬
creased disease risk and new therapeuti¬
cal targets3. In this paper, we present an
approach to study of osteoporosis that
could provide a support for its predomi¬
nantly genetic determination, with sus¬
ceptibility mediated through a number of
recessive genetic variants, most of them
having a small individual effect on disea¬
se risk. The reasoning is simple: if a mo¬
dest increase in number of genes identi¬
cal by descent (e.g. an increase of inbreed¬
ing coefficient from 0% to 3%, predicted to
affect about 800 genes) leads to significant
changes in prevalence of osteoporosis,
this is only consistent with large number
of genomic loci influencing the disease.
This conclusion is more valid if the study
is conducted in an isolate population, in
which the variation in environmental
pressures is minimal and consanguinity
is prevalent. Therefore, the studied popu¬
lation included 14 isolate villages from
the eastern Adriatic islands ofHvar, Brae
and Korcula, Croatia, an isolate resource
well characterized through long-term mul-
tidisciplinary researches14-17.
In this unique metapopulation of dis¬
tinct human isolates, there is a long his¬
tory of anthropological research into the
determinants of skeleton-related biologi¬
cal traits. Initially, comparisons ofwithin-
population and between-population vari¬
ation in traits such as metacarpal bone
dimensions were used along with a larger
number of other traits to assess popula¬
tion structure. The studies performed by
the staff of the Institute for Anthropologi¬
cal Research in Zagreb, Croatia, consis¬
tently showed excellent compliance with
models of population structure such as »i-
solation by distance« in several island po¬
pulations, i.e. better »fit« to the model
than observed for most of the other stud¬
ied biological, bio-cultural and socio-cul-
tural traits18-27. This group also characte¬
rized in detail the effects of gender and
aging on bone loss24-30 and reported on
specific populations in which the expec¬
ted effects of age and gender could not be
shown31. The effects of occupation on bo¬
ne loss and osteoarthritis were investiga¬
ted32'33. An attempt to analyse genetic ba¬
sis of the metacarpal bone dimensions
was initially made through the analyses
of their latent structure34. Recently, this
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Fig. 1. Map ofDalmatian island genetic isolates showing study islands and villages (1-14).
group has also made progress in studying
genetic determinants of bone-related me¬




Croatia has 15 Adriatic Sea islands
with population greater than 1,000. The
villages on the islands have unique popu¬
lation histories and relative isolation from
their neighboring villages and from the
mainland through centuries. The 14 vil¬
lage populations of the three neighboring
islands of the eastern Adriatic, Middle
Dalmatia, Croatia (Brae, Hvar and Kor-
cula, Figure 1) have been investigated by
the Institute for Anthropological Rese¬
arch in Zagreb since early 1970's. More
than 200 studies on these populations ha¬
ve been published to date in collaboration
with many international scientists. The
long-term researches included character¬
ization of ethnohistory, migration patterns,
genealogical reconstruction, analyses of
many quantitative and qualitative biolo¬
gical traits, records of medical problems
and study of environmental, socio-cultu-
ral and genetic characteristics. The most
informative overviews of the results can be
found in the papers of Rudan et al.14"16,27,
Bennett et al.17 and Waddle et al.36.
In Table 1, we list main sources that
provide detailed information on popula¬
tion structure, inbreeding effects, mono¬
genic (Mendelian) diseases and rare ge¬
netic variants found in particular islands
and reported in the literature37-69.
The 14 villages chosen for this study
on the islands of Brae, Hvar and Korcula
were founded during one of the three pe-
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TABLE 1
BRIEF REVIEW OF POPULATION GENETIC RESEARCH UNDERTAKEN IN CROATIAN
ISLAND ISOLATES IN THE PAST 33 YEARS
Type of research Island Ref.
A. Studies of population genetic variation
STR polymorphisms Krk, Brad, Hvar, Korcula 37-40
VNTR polymorphisms Hvar 41
Y-chromosome haplogroups Krk, Brad, Hvar, Kordula 42
mtDNA haplogroups Krk, Brad, Hvar, Korcula 43,44
HLA markers or immunoglobulin allotypes Krk, Hvar, Silba, Olib, Pag 45-48
Serogenetic polymorphisms Brad, Hvar, Korcula, Silba, Olib, 49-52
B. Reports on autochthonous Mendelian diseases
Dwarfism Krk 53-55
Albinism Krk 55
Progressive spastic quadriplegia Krk 55
Familial cognitive dysfunction Susak 56
Familial congenital hip dislocation Lastovo 57
Familial ovarian cancer Lastovo 58,59
Keratoderma palmoplantaris transgrediens Mljet 60
C. Reports of high population frequencies of extremely rare genetic variants
Deleted/triplicated alpha-globin gene Silba 61
PGM1*W3 phosphoglucomutase-1 variant Olib 62
mtDNA haplogroup F Hvar 63
Y-chromosome haplogroup P* Hvar 42
D. Studies of inbreeding effects
Incidence of cancer Brad, Hvar, Korcula, Vis, Lastovo 59
Prevalence of hypertension Brad, Hvar, Kordula 64,65
Prevalence of 10 complex chronic diseases Brad, Hvar, Korcula 66
Prevalence of learning disability Brad, Hvar, Korcula, Susak 67
Prevalence of nephrolithiasis Brad, Hvar, Korcula 68
Prevalence of malocclusion Hvar 69
riods: BC era (by admixture of Illyrians,
Greeks and succeeding Romans), 7th cen¬
tury AD (by Croats who immigrated from
Asia) and 16-18th century AD (by Croats
who fled from Balkans peninsula fearing
Ottoman expansion). The subsequent ten¬
dency towards inbreeding in each village
was influenced by a combination of geog¬
raphic reasons (isolation), political reasons
{«The Pastrovic Privileges«) and socio-cul-
tural reasons which were all extensively
discussed elsewhere14"17'27,70"72.
588
I. Rudan et al.: Inbreeding and Osteoporosis in Isolates, Coll. Antropol. 28 (2004) 2: 585-601
B. Field work and sample collection
During the field research between 1978
and 1987 undertaken by the Institute for
Anthropological Research in Zagreb, the
information was collected and various
measurements performed on 1,389 adult
individuals (682 males and 707 females)
selected randomly from voting lists to form
approximately 20-30% of the total popu¬
lation of these 14 villages. The collected
data characterizing environmental varia¬
tion included proportion of inhabitants
with some college education (EDU), occu¬
pation in agriculture and fishery (OCC),
regular consumption of traditional Medi¬
terranean diet (NUT), smoking habits
(SMO) and measurement of body mass
index (BMI) (Table 2). The details on nut¬
ritional status assessment based on BMI
are reported by Smolej Narancic73. Table
2 supports the hypothesis of decreased
variation in most of the studied characte¬
ristics related to environment. This is
important, as socio-economic status, oc¬
cupation, diet, obesity and climate are
usually highlighted as potential environ¬
mental risk factors formany common late
onset diseases.
C. Estimation ofmean inbreeding
coefficients in each village
Genetic characterization of the 14 vil¬
lages (Figure 1) included the computation
of average inbreeding coefficient of each
village based on three different methods:
(i) reconstruction of genealogies for each
examinee, (ii) analysis of parental iso-
nymy from surname distribution and (iii)
analysis of genotype distributions of MN,
Ss and Kk serogenetic polymorphisms
from blood samples obtained from all the
examinees. Individual inbreeding coeffi-
TABLE 2
PREVALENCE OF FACTORS RELATED TO SOCIO-ECONOMIC STATUS, LIFESTYLE AND
ENVIRONMENT IN 14 VILLAGES UNDER STUDY
Village1 EDU (%) OCC (%) NUT (%) SMO (%) BMI (x)
Gdinj (H) 2.3 80.8 93.8 4.6 25.1
Pupnat (K) 2.1 89.7 91.8 9.3 26.7
Cara (K) 1.5 89.0 94.9 22.6 26.4
Dracevica (B) 2.4 85.7 90.5 23.8 28.6
Racisce (K) 1.9 87.5 83.6 23.1 27.3
Bogomolje (H) 2.5 84.0 93.8 4.9 23.0
Vrisnik (H) 2.1 82.3 91.6 13.5 25.5
G. Humac (B) 2.5 81.3 87.5 38.8 27.3
Zastrazisce (H) 4.0 86.3 93.6 5.9 25.1
Lumbarda (K) 4.7 85.2 89.8 21.3 26.2
Smokvica (K) 3.1 81.4 81.4 27.8 26.0
Svirce (H) 2.0 80.1 83.2 12.8 25.7
Dol (H) 4.2 75.8 86.3 8.4 26.1
NereziSca (B) 1.8 60.7 79.5 34.8 28.0
EDU = percentage of the population with higher education degree; OCC = percentage of the popu¬
lation working in agriculture/fishery; NUT = percentage of the population consuming "Mediterra¬
nean diet«; SMO = percentage of the population smoking; BMI = mean value of body mass index.
The capital letters next to village names represent the islands (B=Brac, H=Hvar, K=Korcula).
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cients were computed independently for
each of 1,389 individuals. The pedigree
information on 2-3 ancestral generations
that was recorded for each examinee dur¬
ing the initial field work (1978-1987) was
expanded during 1997-2000 through in¬
sight into the parish registries stored in
local churches to allow the completion of
the information on 4 ancestral genera¬
tions in each examinee. The individual
inbreeding coefficients (F) were then com¬
puted according to Wright's path metr
hod74:
^=Za-,c,(V2)(wl)
where m and n refer to the number of
paths from a common ancestor, and c re¬
fers to the number of common ancestors.
The genealogical inbreeding coefficient for
each village was then computed as the av¬
erage of all individual F values. To further
support these estimates, Fwas calculated
from isonymy as75'76:
F = (P - T.pkqk) / 4(1 - Zpkqk) = &Pkqk) /
4 - (P - Zpkqk) (Zpkqk) / 16(1 - Zpkqk)
where pft is the frequency of the surname
k in males, qk in females, P is the proporti¬
on ofmarriages between spouses carrying
the same surname among all marriages,
and the summation is over all surnames.
Apparently, in this approach the units of
investigation are marital pairs of exami¬
nees' parents and not the examinees them¬
selves. Finally, the inbreeding in each vil¬
lage was also assessed from the departure
in the frequency of heterozygotes from the
expectations based on Hardy-Weinberg eq¬
uilibrium77, where F is calculated as:
F = 1 - (observed proportion of
heterozygotes / expected proportion
of heterozygotes)
and where the expected proportion of het¬
erozygotes calculated from allelic frequen¬
ciesp and q of 2 alleles present in the pop¬
ulation (MN, Ss and Kk) equals 2pq. F
values calculated from each of the 3 po¬
lymorphisms were added and divided by
3 to obtain the average F value for each
village. The process of blood sample col¬
lection, storage, transport and analysis at
the University of Newcastle upon Tyne
was described in detail by Roberts et al.49.
Table 3 reviews the average coefficients of
inbreeding obtained by the applied three
methods. Tables 2 and 3 indicate that the
selected village populations represent an
excellent model for studying effects of in¬
breeding, as a wide range of inbreeding
coefficients is present while the concern
over considerable confoundings related to
environmental variance is reduced.
D. Cortical index and osteoporosis
prevalence estimation
The osteometric dimensions of meta¬
carpal bones are an efficient and practical
method for investigation and monitoring
bone mass. At the time when data used in
the present analysis have been gathered,
the radiogrammetry of the metacarpal
bones has been widely used as the best
available screening method of bone sta¬
tus in population studies. Procedure of
metacarpal bones osteometry, as thoroug¬
hly described by Barnett and Nordin78,
was followed in field studies performed
on all three investigated islands. Hand-
wrist radiographs were taken using a sin¬
gle portable X-ray. Total diaphysis width
(D) and medullary canal width (d) of the
second left metacarpal bone was determi¬
ned by a single, experienced observer78.
Measurements were performed by one in¬
vestigator using a millimeter ruler and a
magnifying glass (xlO) with a scale per¬
mitting 0.05-mm accuracy. Measurements
were rounded to 0.1 mm. For each indivi¬
dual and for each bone, the cortical index
(CI) was computed as:
CI = (D-d) x 100 / D.
Tables 4 and 5 show the sample sizes
and descriptive statistics of age and corti-
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TABLE 3
GENETIC STRUCTURE OF 14 VILLAGES UNDER STUDY. THE VILLAGES ARE RANKED
ACCORDING TO THE ESTIMATED AVERAGE INBREEDING COEFFICIENT CALCULATED FROM
THE GENEALOGICAL DATA (Fgen)
Village F(gen) F(iso) F(sgp)
Gdinj (H) 0.049 0.107 0.041
Pupnat (K) 0.044 0.034 0.108
Cara (K) 0.032 0.040 0.016
Dracevica (B) 0.031 0.031 0.049
RariSce (K) 0.027 0.034 0.004
Bogomolje (H) 0.025 0.030 0.018
Vrisnik (H) 0.015 0.023 0.013
G. Humac (B) 0.013 0.016 -0.016
Zastrazisce (H) 0.013 0.013 -0.021
Lumbarda (K) 0.012 0.025 -0.010
Smokvica (K) 0.008 0.019 -0.107
Svirce (H) 0.008 0.008 -0.018
Dol (H) 0.005 0.004 -0.041
Nerezisca (B) 0.002 0.004 -0.076
The corresponding estimated based on isonymy (Fiso) and codominant serogenetic polymorphisms
MN, Ss and Kk (Fsgp) are presented to support the results obtained through Wright's »path«-met-
hod (Fgen). The capital letters next to village names represent the islands (B=Brac, H=Hvar,
K=Korcula).
cal index by village in male and female
examinees. As expected, the larger effect
of age on cortical index and on osteoporo¬
sis prevalence was observed in females
than in males (Figures 2 and 3). It is ap¬
parent that the effects of age are minimal
in younger subjects (plateau) and around
menopausal ages a decline in cortical in¬
dex could be observed. This trend is more
pronounced in females, which is in accor¬
dance with the findings in other popula¬
tions. Complex segregation analysis of
cortical index of the metacarpal bones
has been performed by Ginsburg et al.35
using pedigree data from the same popu¬
lations. CSA model implemented inclu¬
ded sex-specific parameterizations of in¬
flection points of cortical index data and
results - being 45 years for males and fe¬
males in two most parsimonious models -
which allows us to use 45 years as the re¬
liable referent point for current analysis.
Prevalence of osteoporosis was estab¬
lished according to the statistical criteria.
It was based on the distribution of corti¬
cal index values in people under the age
of 45 in each gender separately. A "cut¬
off* value of cortical index was defined as
the mean minus two standard deviations
of the distribution in each sex. As this cri¬
terion has been widely used, and the me¬
asurements were performed by a single
device and technician and analyzed by a
single experienced assessor, we believe
that the likelihood of substantial proce¬
dural errors is minimal.
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TABLE 4
DESCRIPTIVE STATISTICS OF AGE AND CORTICAL INDEX BY VILLAGE IN MALE EXAMINEES.
Age (yrs.) Cortical index (%)
Village N X SD Min. Max. X SD Min. Max.
Gdinj (H) 51 54.53 11.72 24 81 55.97 7.89 37.78 72.22
Pupnat (K) 46 42.76 12.91 23 71 55.17 6.84 44.85 68.35
Cara (K) 63 42.59 11.87 20 71 53.11 8.42 32.37 72.07
DraCevica (B) 20 46.80 16.37 23 74 66.28 7.15 47.62 80.00
Rafiisce (K) 40 43.30 11.22 20 62 55.14 7.30 36.23 73.11
Bogomolje (H) 46 57.85 15.65 24 81 48.90 6.17 32.14 64.44
Vrisnik (H) 44 37.68 10.52 23 54 57.22 6.77 42.11 69.89
G. Humac (B) 27 51.04 16.81 22 85 62.87 6.92 49.49 76.14
Zastrazisce (H) 69 50.09 14.78 20 77 53.41 7.45 32.43 76.09
Lumbarda (K) 53 43.21 11.36 22 77 59.70 7.60 41.09 77.83
Smokvica (K) 52 40.87 10.53 24 59 53.46 7.36 37.75 69.41
SviriSe (H) 70 39.94 11.10 21 55 59.36 9.78 39.81 82.76
Dol (H) 50 41.44 10.37 20 56 56.73 6.15 40.00 70.51
Nerezisca (B) 51 45.59 13.86 22 81 62.31 9.07 44.12 82.02
Total 682 45.25 13.73 20 85 56.50 8.59 32.14 82.76
TABLE 5
DESCRIPTIVE STATISTICS OF AGE AND CORTICAL INDEX BY VILLAGE IN FEMALE EXAMINEES.
Age (yrs.) Cortical index (%)
Village N x SD Min. Max. X SD Min. Max.
Gdinj (H) 71 53.48 12.28 27 82 55.64 9.99 37.21 84.15
Pupnat (K) 50 44.76 11.74 21 61 56.84 8.67 34.53 75.00
Cara (K) 75 43.63 12.38 20 63 56.29 8.74 37.63 83.09
Dracevica (B) 23 52.48 15.82 21 87 65.11 12.46 42.22 92.41
RaciSce (K) 63 43.29 11.83 21 71 58.22 8.58 40.18 77.14
Bogomolje (H) 32 58.50 15.62 19 78 50.44 9.89 29.35 75.00
Vrisnik (H) 28 41.43 8.69 23 54 61.20 9.28 43.37 76.40
G. Humac (B) 44 49.09 13.81 25 82 64.93 11.24 39.76 91.21
ZastraziSce (H) 54 52.37 12.93 24 83 54.46 9.41 37.76 83.33
Lumbarda (K) 55 43.09 12.27 22 74 59.58 9.94 37.70 80.00
Smokvica (K) 42 44.48 12.41 23 61 58.28 11.17 32.08 82.45
Svirce (H) 65 39.25 10.88 20 55 63.90 9.81 40.26 87.18
Dol (H) 43 41.86 10.08 22 56 63.30 9.29 46.07 84.00
Nerezisca (B) 62 44.76 12.15 19 77 65.02 10.82 37.21 91.55
Total 707 46.15 13.21 19 87 59.31 10.60 29.35 92.41
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Age (yrs.)
Fig. 2. Effect ofage on cortical index in males (r = -0.19, p<0.001, y = 61.932 - 0.120*x).
Age (yrs.)
Fig. 3. Effect of age on cortical index in females (r = -0.43, p<0.001, y = 72.251 - 0.345*x).
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E. Statistical analyses
To investigate the relationship betwe¬
en inbreeding and the cortical index and
prevalence of osteoporosis, the ecologic epi¬
demiological design was used79. The corti¬
cal index values and the prevalence of os¬
teoporosis were compared among 14
villages with various levels of mean in¬
breeding. The cortical index values were
adjusted for age effects in each sex by
means of multiple regression (age, age2)
and mean values of standardized residu¬
als were calculated for each village. As
the estimated OP prevalence could be
considerably influenced by variations in
sex and age distribution of the sample si¬
zes of different village they were adjusted
according to the age and sex distribution
in total sample and the results of the
weighted data were presented separately
for each sex. All statistical analyses were
performed using »Statistica 6« software.
Results
In present study, the possible influen¬
ce of inbreeding on bone mass was tested
using ecologic-epidemiological design. Cor¬
tical index of metacarpal bones has been
used as an indicator of total bone mass
and good screening tool for susceptibility
for osteoporosis appropriate for the popu¬
lation studies.
The coefficient of correlation (Figures
4 and 5) between F-values of each investi¬
gated village and mean values of the stan¬
dardized age-adjusted residuals of meta¬
carpal cortical index was —0.28 in males
(p=0.08) and -0.42 in females (p=0.005).
Correlations between F-values and esti¬
mated prevalence of osteoporosis weig¬
hted for sample sizes (Figures 6 and 7)
were 0.32 in males (p<0.05) and 0.43 in
females (p<0.001). Although the correla¬
tions in both traits were more significant
in females than in males, there is a gene¬
ral concordance between values obtained
in both sexes from the same village, which
supports the hypothesis that the findings
are indeed due to village-specific effects.
Obtained results clearly show a ten¬
dency of increased susceptibility to osteo¬
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Fig. 4. Effect ofaverage inbreeding coefficient (F) on cortical index (standardized age-adjusted
residuals weighted according to sample size) in male examinees in 14 villages
(r = -0.28, p = 0.077, y = 0.168 - 8.823*.x).
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Inbreeding (F - value)
Fig. 5. Effect ofaverage inbreeding coefficient (F) on cortical index (standardized age-adjusted
residuals weighted according to sample size) in female examinees in 14 villages
(r = -0.42, p = 0.005, y = 0.255 - 11.057*x).
in isolated communities of three Croatian
islands. However, few villages are dis¬
playing as outliers in this general trend:
Dracevica (Brae) with exceptionally high
cortical index values and Cara (Hvar) with
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Inbreeding (f - value)
Fig. 6. Effect of average inbreeding coefficient (F) on prevalence of osteoporosis (standardized by
age, weighted according to sample size) in male examinees in 14 villages
(r = 0.32, p<0.001, y = 1.269 + 74.598*x).
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rosis. We suspect that those villages are
the sites of some possibly very intriguing
genetic effects (drift) and therefore could
be the promising sites for incoming studies
of susceptibility/protection genes osteopo¬
rosis.
Discussion
There are several possible reasons
why the effect of inbreeding on late-onset
complex chronic diseases has not been wi¬
dely evaluated to date. Firstly, in coun¬
tries where inbreeding is prevalent in the
population, life expectancy is generally
considerably shorter than in western com¬
munities, and late-onset diseases do not
represent the main public health prob¬
lem. Therefore, the effects of inbreeding
were mostly investigated in small isola¬
ted communities (geographic, cultural,
linguistic, ethnic or religious isolates) in
developed countries, which could be more
easily reached. In most of the developed
countries, however, the isolated human
populations characterized by inbreeding
often do not have the same level of access
to health care as general (especially ur¬
ban) population where the public health
sector is well developed and the majority
of epidemiological studies are being un¬
dertaken. Therefore, the health status of
human isolates is not easily evaluated
from medical records or communicated
with their local physicians. In addition,
there are not many isolate popu- lations
world-wide with well-preserved parish
registries from which reliable estimates
of inbreeding coefficients can be determi¬
ned based on the familial relationships
over at least several ancestral generations.
Furthermore, there are usually multiple
concerns over confounding factors, as it is
often quite difficult to find a non-inbred
control population which would match
the studied inbred isolate in environmen¬
tal exposures and differ significantly only
in genetic structure. Contemporary isola¬
tes usually share specific climate and en¬
vironment, as well as a multitude of com¬
mon socio-cultural factors such as diet,
















Inbreeding (F - value)
0.044
0.040
Fig. 7. Effect of average inbreeding coefficient (F) on prevalence of osteoporosis (standardized by
age, weighted according to sample size) in female examinees in 14 villages
(r=0.43, p<0.001, y = 2.136 + 81.568H).
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nomic status for which it is very difficult
to control. In small and isolated communi¬
ties the phenomena such as founder effect,
genetic drift and inbreeding can signifi¬
cantly affect allele and genotype frequen¬
cies, which invalidates comparisons to
control populations where genotype fre¬
quencies follow Hardy- Weinberg equilib¬
rium68. Khoury concluded that, despite
rare attempts, there is still hardly any
study that would satisfactorily deal with
all the usual concerns including small
sample sizes, unreliable inbreeding esti¬
mates, doubtful disease dia- gnoses and
inappropriate control populations80. We
recently attempted to conduct a number
of studies that would satisfactorily deal
with those issues64-69.
In this study, several precautions were
taken to control for potential confounding
effects. Primarily, a unique population
was chosen, well characterized genetical¬
ly and epidemiologically through almost
3 decades of continuing research by both
local and international anthropologists.
The subdivision of the islanders of the
eastern Adriatic into small villages and a
diversity of their attitudes towards in¬
breeding influenced by geographic isola¬
tion, political privileges in the past, as
well as socio-cultural reasons resulted in
a range of inbreeding coefficients present
at both individual and population level.
At the same time, the environmental va¬
riation within and between these popula¬
tions is reduced (shared climate, religion,
lifestyle, nutrition, predominant occupa¬
tion and the level of education), as shown
in Table 2. Therefore, we believe that these
populations represent exceptionally good
setting for undertaking the study of the
effects of the inbreeding on complex chro¬
nic disease such as osteoporosis59,64-69.
Further advantage of Croatian island
isolates is that each of selected 14 villa¬
ges in this study has its own church with
well preserved records of births, marria¬
ges and deaths dating back to 1750,
which helped reconstruct the genealogies
and determine inbreeding coefficients. In
addition, each village also has its own
health clinic with the full-time local gene¬
ral practitioner and a nurse. The bone
X-rays were performed in these clinics by
the same device and same assessor from
the Institute ofAnthropological Research
in Zagreb, as a very objective measure¬
ment of phenotype. As the results were
later analyzed by a single and experien¬
ced observer, we believe that the like- li-
hood of substantial measurement errors
is minimal (both observer-related and vil¬
lage-specific). An attempt was also made
to avoid significant confounding effects of
genetic drift and founder effect in specific
villages. This has been achieved by inclu¬
ding several villages of similar inbreed¬
ing levels from different islands into the
groups with »high«, »moderate« and »low«
inbreeding, as it is unlikely that the two
population genetic phenomena would af¬
fect gene frequencies in the same direc¬
tion in all villages68.
The results showed a significant dec¬
reasing effect of inbreeding on cortical in¬
dex (initially standardized by age) across
14 villages (Figures 4 and 5). Similarly,
the prevalence of osteoporosis found in
these villages appeared to increase from
about 1.3% in villages with low inbreed¬
ing prevalence to nearly 4.0% in villages
with average inbreeding coefficient close
to F=0.05, i.e. a 3-fold increase. This resu¬
lt reaffirms the conclusion of our recent
study where non-specific risk of inbreed¬
ing has been reported for a number of
complex chronic diseases66. Analysis by
village (Figures 6 and 7) shows that the
standardized prevalence of osteoporosis
follows the increase in average inbreed¬
ing coefficients, although this correlation
is not really linear as there are villages
with extremely increased prevalence in
both sexes (e.g. Cara, with OP prevalence
of about 10%). In addition, not all villages
with higher rates of inbreeding reveal
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high prevalence of osteoporosis (e.g. Pup-
nat in males). Those observations might
be due to specific genetic structure of tho¬
se villages which are characterized by in¬
creased or decreased frequencies of rare
alleles with large effects mediating sus¬
ceptibility to osteoporosis, possibly due to
combined effect of genetic drift and foun¬
der effect.
Ifwe accept the conclusion that the in¬
crease in inbreeding of about 2-3% (from
F=0.005 to 0.03) could be, to some extent,
responsible for the observed increase in
prevalence of osteoporosis, the central
question becomes what does it tell us
about the genetic basis of the disease. Ap¬
parently, the susceptibility seems to be
controlled, at least partly, by the recessi¬
ve genetic variants that are more likely to
be rare than common, as the inbreeding
effects on rare variants are more appar¬
ent. In addition, ifwe accept that the total
number of genes in the human genome,
according to the most recent estimates, is
about 25,00081, then the increase in in¬
breeding of 3% would correspond to hav¬
ing about 800 random genes across the
genome identical by descent. If this unre-
combined autozygosity in only 3% of ge¬
nes could lead to a notable effect in the
prevalence of osteoporosis, there are two
main mechanisms that could explain it.
Firstly, inbreeding may mainly act throu¬
gh the rare variants ofmajor effect, that
may be enriched in frequency in each vil¬
lage by combined effects of founder effect
and subsequent genetic drift. Second, the
genes controlling this trait are of small
effect and very numerous, scattered ac¬
ross the entire genome. The design of this
study provides some arguments against
the first explanation. Major effect genes
arise after mutations that are considered
to be very rare, as the probability of ran¬
dom mutation causing small effect is
much greater. Therefore, even if such mu¬
tations were present in some of the stud¬
ied villages, it is extremely unlikely that
similar effects of inbreeding would be ob¬
served across several villages, as our re¬
sults indicated. In addition, under such
assumption the differences between in¬
bred and outbred individuals would nor¬
mally be much larger than it was the case
in our study. It is more plausible that the
genetic control of cortical index, bone
mass loss and susceptibility to osteoporo¬
sis in humans is at least partly controlled
by a larger number of genes of small indi¬
vidual effects68.
This study attempted to discuss the
genetic basis of susceptibility to osteopo¬
rosis through inbreeding study in relati¬
vely isolated communities. The results
provided further evidence on polygenic
basis of susceptibility for osteoporosis
with detectable effects of recessive genes.
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SRODIVANJE I SKLONOST OSTEOPOROZI U IZOLIRANIM
OTOCNIM POPULACIJAMA HRVATSKE
SAZETAK
Cilj ovog istrazivanja bio je analizirati recesivnu genetsku komponentu vrijednosti
kortikalnog indeksa druge metakarpalne kosti te procijenjenu prevalenciju osteoporoze
(OP) u 14 sela hrvatskih otoka Braca, Hvara i Korcule s razlicitom razinom srodivanja.
Slucajni uzorak ukljucio je 20-30% odraslog stanovnistva tih sela i obuhvatio ukupno
1389 ispitanika. Prosjecan koeficijent urodenosti (F) ispitanika svakog sela procijenjen
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jeWrightovom »path« metodom (temelji se na informacijama pohranjenima u rodoslov-
lju). Morfometrija metakarpalnih kostiju ucinjena je na rendgenskim snimkama sake i
rucnog zgloba na obje ruke u svih ispitanika. Osteoporozu smo definirali kao vrijednos-
ti kortikalnog indeksa manju od 2 standardne devijacije temeljenu na raspodjeli vrijed-
nosti u ispitanika istog spola i dobi ispod 45 godina. Prosjecne vrijednosti kortikalnog
indeksa i prevalencije osteoporoze u svakom selu (standardizirane s obzirom na dob is¬
pitanika te ponderirane s obzirom na velicinu uzorka) korelirane su s prosjecnim koefi-
cijentom urodenosti sela. Koeficijent korelacije (r) izmedu F vrijednosti i CI bio je -0,28
u muskaraca (p=0,08) i -0,42 u zena (p=0,005), a izmedu F vrijednosti i standardizira-
nih prevalencija OP iznosio je 0,32 u muskaraca (p<0,001) i 0,43 u zena (p<0,001). Ovi
rezultati ukazuju na znacajnu »depresiju srodivanja« kortikalnog indeksa kao pokaza-
telja smanjenja kostane mase, sto upucuje na povecanu sklonost osteoporozi u starijoj
zivotnoj dobi (OP) u srodenim zajednicama hrvatskih otoka.
601
Coll. Antropol. 26 (2002) 2: 421-428
UDC 572.026:616.89-008.454
Original scientific paper
Inbreeding and Learning Disability
in Croatian Island Isolates
I. Rudan1'2, D. Rudan3, H. Campbell2, Z. Biloglav1, R. Urek3, M. Padovan4,
L. Sibbett2, B. Janicijevic5, N. Smolej Narancic5 and P. Rudan5
1 School of Public Health »A. Stampar«, School of Medicine, University of Zagreb, Zagreb,
Croatia
2 Department of Public Health Sciences, University Medical School, Edinburgh, UK
3 General Hospital »Sveti Duh«, Zagreb, Croatia
4 General Hospital »Dubrovnik«, Dubrovnik, Croatia
5 Institute for Anthropological Research, Zagreb, Croatia
ABSTRACT
The aim of this study was to investigate the prevalence of learning disability (LD) in
isolate populations with different inbreeding coefficients (F). Prevalence of LD and F
were determined in 10 villages from five Croatian islands: Brae, Hvar, Korcula, Lastovo
and Susak. For the purpose of this study, LD was defined as the inability to attend the
public school system. As the elementary schools (grade 1-8) in the place of the study are
both public and compulsory, the assessment of child's inability to attend the school is
performed at the age ofsix. This is required by all children in the country based on stan¬
dard set of tests ofcognitive performance defined by the Ministry ofEducation and Cul¬
ture ofthe Republic ofCroatia. The average inbreeding coefficients in each village popu¬
lation (F) were estimated in a random sample of 20-30% adults in each of the 10
villages based on 4 ancestral generations and using Wright's path method. Prevalence
ofLD ranged from 0.43% to 2.47%, and the inbreeding coefficients ranged from 0.8% to
4.9%. The Pearson's correlation coefficient between F and LD prevalence was 0.80
(p<0.01). Although the relative risk per 5% inbreeding appeared veiy high (about 10),
the absolute risk only increased from 0.18% to 1.77%. The genetic effect of inbreeding
(GE1) was approximately 0.69% and the population-attributable fraction 76.6%. A re¬
view of the literature and the results of this study lead to a conclusion that a very large
number ofpredominantly recessive genetic factors might mediate the genetic suscepti¬
bility to various forms ofLD in these populations.
Received for publication September 12, 2002
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Introduction
Despite the common belief that con¬
sanguineous unions are associated with
increased risk of some form of learning
disability (LD) in their children, a review
of scientific evidence in support of this
association1"*22 failed to identify rigorous
evidence in its favor23'24. The origins of
this belief certainly lie in a distant past,
as this association has been widely men¬
tioned in various historical works of liter¬
ature in many cultures25. We were only
able to identify 22 well-designed studies
investigating the effect of inbreeding on
cognitive performance. Only 2 of these
were published after 1980, suggesting
that this has been a topic avoided by the
research community, possibly due to its
sensitive nature. This is unfortunate
since advances in the understanding of
human disorders made possible in this
post-genomic era provide realistic hope
that the mechanisms of disease may be
better understood and lead to new pre¬
vention and treatment strategies. We be¬
lieved that an investigation into whether
the observed increase in LD in inbred
communities was due to numerous reces¬
sive genetic variants of small effect, or a
small number of rare variants of large ef¬
fect, or simply cultural or socio-economic
bias would be a useful contribution to im¬
proving understanding of the disease
mechanisms which underlie LD.
In this paper, we present one approach
to the study ofLD that aimed to study the
relationship between inbreeding patterns
and LD whilst attempting to correct for
cultural and socio-economical bias. We
further aimed to determine the relative
and absolute risk of LD that might be at¬
tributable to inbreeding. The studied
population included 10 isolate villages
from the eastern Adriatic islands ofHvar,
Brae, Korcula, Lastovo and Susak, in
Croatia, a resource well characterized
through a long-term multidisciplinary
anthropologic and biomedical research26-30.
Materials and Methods
Study design
The prevalence of learning disability
was determined in 10 isolate villages on 5
different Croatian islands (Figure 1).
These villages are characterized by reduc¬
ed environmental variation and their inha¬
bitants share very similar environmental
factors (climate, nutrition, socio economic
status, occupation, education, housing), as
it has been demonstrated in previous
studies28-31. In theory this should create a
favorable setting for study since it should
help limit socio-economic and cultural bias
in the interpretation of the results.
Another favorable characteristic of
these populations for our study is the di¬
versity of the attitudes towards inbre¬
eding26'28. This was influenced by geo¬
graphic isolation, political privileges in
the past and socio-cultural reasons and
resulted in a range of inbreeding coeffi¬
cients present at both individual and pop¬
ulation level26'27.
Previously conducted studies compa¬
red the prevalence of LD in an inbred co¬
hort with non-inbred controls. This raises
issues about the social and cultural com¬
parability of controls and the possible
clustering of a Mendelian disease (a sin¬
gle large effect gene) in the inbred cases.
In contrast, this study investigated 10
populations with similar environment
and culture but with a spectrum of in¬
breeding coefficients and quite different
founding populations.
We hypothesized that if the study found
comparable prevalence of LD in all 10 pop¬
ulations, this would not support any in¬
breeding effect and the LD prevalence will
be assumed to be determined mainly by
factors related to environment. However,
ifwe found a consistently positive correla¬
tion between inbreeding levels and LD
prevalence across 10 villages, this would
clearly point to an effect of inbreeding. A
further advantage of having 10 distinct
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Fig. 1. Geographic location ofthe investigated islands ofBrae, Hvar, Korcula, Lastovo and Susak.
populations under investigation is to rule
out the possibility of a rare Mendelian
disease clustering, as it is unlikely that
the same rare variant would be present
in all 10 populations having very different
founding populations and ethnohistory.
We further hypothesized that if a mod¬
est increase in sharing of genes identical
by descent (e.g. an increase in inbreeding
coefficient at the level of entire popula¬
tion from 0% to 5%) led to a significant
change in prevalence of LD across several
isolate populations that share very simi¬
lar environmental effects, then this would
be most consistent with the model includ¬
ing a very large number of genomic loci
influencing the disease, as Morton has
suggested in his review of the problem19.
Estimation of the prevalence of learning
disability
For the purpose of this study, learning
disability was defined as the inability to
attend the public school system. As the
elementary schools (grade 1-8) in the
place of the study are both public and
compulsory, the assessment of child's
ability to attend the school is performed
at the age of six. The assessment is based
on standard set of tests, as required by
the Ministry of Education and Culture of
the Republic of Croatia32. These tests in¬
clude: (a) perception test, test of point
linkage, test of knowing facts, drawing
test and numerical test; (b) intelligence
test based on drawing a human image; (c)
»Bender Gestalt« test; (d) Raven's pro¬
gressive colored matrices32. Data on the
individuals unable to attend school were
retrieved from local general practitioners
and were considered to be complete. The
prevalence of LD was calculated as the
proportion of these individuals in the total
population of each village (as of January
2001). Ethical approval for this study was
obtained from the Ethics Committee of
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the Institute for Anthropological Research,
Zagreb, Croatia.
Computation of inbreeding coefficients (F)
Genetic characterization of these vil¬
lages included the computation of aver¬
age inbreeding coefficient of each village
based on reconstruction of genealogies of
a sample of examinees which formed
20-30% of adult village population. The
pedigree information on 2-3 ancestral ge¬
nerations was recorded for each exa¬
minee during the fieldwork between
1979-1981 performed by the Institute of
Anthropological Research in Zagreb. It
was later expanded during 1997-2000
through insight into the parish registries
stored in local churches to allow the com¬
pletion of the information on 4 ancestral
generations in each examinee. The indi¬
vidual inbreeding coefficients (F) were
then computed according toWright's path
method33:
F =I(iH>c)(l/2)(ni+mi+1)
where m and n refer to the number of
paths from a common ancestor, and c re¬
fers to the number of common ancestors.
The genealogical inbreeding coefficient
for each village was then computed as the
average of all individual F values.
Statistical data analysis
Linear regression analysis of LD prev¬
alence on F was performed using the data
from all ten villages. The corresponding
Pearson's coefficient of correlation (r) and
the regression coefficient (b) were deter¬
mined using the SYSTAT 7.0 software.
The observed prevalence of LD in each
of the studied populations was considered
to approximate reasonably well the abso¬
lute risk of LD in pre-school age in each
population. The relative risk for each unit
increase of 5% inbreeding was inferred
from the slope of the linear regression curve
as the ratio of the expected LD preva¬
lence at the points ofF = 5% and F = 0%.
As pointed out by Freire-Maia34, in
certain instances the absolute and rela¬
tive risk measures can be artificially low.
An index - called »the genetic effects of
inbreeding« (GEI) - was suggested as an
alternative34, and is calculated as:
GEI = (Pi-Po) / (1-Po),
where Pi is a probability of the event (in
this case LD) in an inbred person (in this
case a village with an average F greater
than 3%), and Po is the probability of the
event in a non-inbred person (in this case
a village with an average F less than 1%).
The population-attributable fraction
(PAF) was calculated by logistic regres¬
sion, noting each village's probability LD
prevalence value if their F was set equal
to zero. The sum of all such probabilities,
is an estimate of the LD prevalence in the
absence of inbreeding. Then:
PAF = 1 - Psum / Npop,
where Npop is the total population size35.
Results
Table 1 presents the data on studied
villages coded from A to J and their re¬
spective total populations, the average
coefficients of inbreeding (computed as
above), the number of cases ofLD and the
prevalence of LD in each village. The in¬
breeding coefficients in these villages
ranged from 0.8% to 4.9%, and the preva¬
lence of LD from 0.43% to 2.47%.
Figure 2 presents the linear regres¬
sion between F and LD and the corre¬
sponding Pearson's correlation coeffi¬
cient, which was 0.80 (p<0.01). Although
the relative risk per unit increase of 5%
inbreeding appeared to be quite high
(about 10), the absolute risk (defined as
prevalence at the intercept of the regres¬
sion line with F=0% and F=5%) only in¬
creased from 0.18% to 1.77%. The genetic
effect of inbreeding (GEI) was 0.69%
which relates to the difference in ex-
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TABLE 1
TOTAL POPULATION OF 10 STUDIED VILLAGES (AS OF JANUARY 2001), AVERAGE POPULATION
INBREEDING COEFFICIENT (F) DETERMINED FROM GENEALOGIES, NUMBER OF LEARNING
DISABILITY (LD) CASES AND THE PREVALENCE OF LEARNING DISABILITY
Village ■ N F LD LD
(island) (Population) (Genealogical) Cases Prevalence
A (Hvar) 153 0.049 2 1.31%
B(Susak) 81 0.047 2 2.47%
C (Korcula) 326 0.044 6 1.84%
D (Kortlula) 464 0.032 2 0.43%
E (Korfiula) 290 0.027 3 1.03%
F (Brae) 214 0.013 1 0.47%
G (Korcula) 354 0.012 3 0.85%
H (Lastovo) 899 0.011 5 0.56%
I (Korcula) 866 0.008 4 0.46%













PEARSON'S COEFFICIENT OF CORRELATION
BETWEEN INBREEDING COEFFICIENT AND
PREVALENCE OF LEARNING DISABILITY,
REGRESSION COEFFICIENT, ESTIMATES OF
RELATIVE RISK, GENETIC EFFECT OF
INBREEDING (GEI) AND POPULATION
ATTRIBUTABLE FRACTION (PAF)
Measure Value
0 0.01 0.02 0.03 0.04 0.05 0.06
F values
Fig. 2. Plot of the values ofprevalence of learn¬
ing disability (LD) against average coefficients
of inbreeding (F) in ten studied villages.
pected prevalence of LD when the vil¬
lages with F greater than 3% and less
than 1% are compared. The population
attributable fraction of cases due to in¬
breeding in all ten populations was high
and it amounted to 76.6% (Table 2).
Discussion
Early work on the relationship be¬
tween inbreeding and cognitive perfor¬
mance was reported by Penrose in 19381,
Pearson's coefficient of correlation (r) 0.80
Regression coefficient (b) 0.33
Relative risk (F=5% vs. F=0%) 10.23
GEI (F3% vs. Fl%) 0.69%
PAF 76.6%
but the most influential studies were car¬
ried out in 1970s by Schull, Neel and
their coworkers in Japan4,7'8'10-11-16, Dani-
elov in Russia1243-17 and Costeff in Isra¬
el9-16. These three groups published about
a half of all the available studies in the
world literature to date. The results of
these studies were in very close agree¬
ment: they all found statistically signifi¬
cant effects of the inbreeding on cognitive
performance (measured as a quantitative
trait) or the prevalence of learning dis¬
ability (measured as a qualitative trait).
Although the associated relative risks
were also rather large, it still needs to be
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understood that in absolute terms any
risk attributable to inbreeding was still
small. The average regression coefficient
of inbreeding on IQ found in these stud¬
ies, after weighting by the reciprocal vari¬
ance, was -44.0 (±12.3)15. In addition, the
risk of some form of LD in offspring of
non-inbred marriages was estimated to
about 1.2%, and in the offspring of
first-cousin marriages to about 6.2%19.
Although the risk in the latter is report¬
edly increased 5 times, this still means
that 94 of 100 children born in such un¬
ions did not suffer of any form of LD.
In our study, learning disability was
measured as a qualitative trait. The rela¬
tive risk (RR) per unit increase 5% in¬
breeding seemed to be about 10, although
this was based on the intercept of our lin¬
ear regression line with F = 0 as we only
studied inbred populations. However,
when this is replaced by the prevalence of
LD in general Croatian population,
kindly provided by the Croatian Ministry
ofEducation and Culture, the more realis¬
tic estimate of absolute risk in non-inbred
population of about 4.0 is observed. This
is in close agreement ofRR = 5 per 6.25%
inbreeding, reported in previous studies.
The basal prevalence of LD in non-inbred
populations in our study was somewhat
smaller than in other reports or in gen¬
eral Croatian population (0.43—0.56% in
comparison to about 1.2%), but this can
be explained by random fluctuations in
relatively small populations of the vil¬
lages in this study. Thus, if we accept the
conclusion that an absolute increase in
inbreeding of about 4-5%' (from F = 0.005
to 0.05) could be responsible for the ob¬
served 4-fold increase in prevalence of
LD, the central question becomes what
does it tell us about the genetic mecha¬
nisms underlying this complex syndrome.
An effect of inbreeding implies that the
susceptibility is most probably controlled,
at least partly, by recessive genetic vari¬
ants. In addition, ifwe accept that the to¬
tal number of human genes is between
30,000 and 40,000, then an absolute
increase in inbreeding of 5% would corre¬
spond to having about 1,750 random
genes across the genome identical by de¬
scent. If this unrecombined homozygosity
in only 5% of genes could lead to a mea¬
surable effect in the prevalence of LD, then
there are two main mechanisms that
could explain it: (a) this brings together
some rare major effect genes in a simple
Mendelian fashion, or (b) the genes con¬
trolling this trait are of small effect but
very numerous, scattered across the ge¬
nome. The design of this study provides
evidence against the first explanation.
Major effect genes arise after mutations
that are considered to be extremely rare,
as the probability of random mutation
causing a small effect is much greater.
Therefore, even if such mutations were
present in some of the studied villages, it
is extremely unlikely that similar effects
of inbreeding would be observed across
several villages, as our results indicate.
In addition, under this assumption the
differences between inbred and non-in-
bred individuals would normally be much
larger than was the case in our study,
where the differences were very small but
consistent across many distinct popula¬
tions. We conclude, therefore, that it is
more likely that the genetic susceptibility
to learning disability, a highly heteroge¬
neous group of syndromes, is at least in
part controlled by a large number of re¬
cessive genes.
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SRODIVANJE I POTESKOCE U UCENJU MEDU STANOVNISTVOM
HRVATSKIH OTOKA
SAZETAK
Cilj ovoga istrazivanja je odrediti prevalenciju poteskoca u ucenju (LD) u izoliranim
otocnim populacijama s razlicitim vrijednostima koeficijenta urodenosti (F). Prevale-
ncija poteskoca u ucenju i vrijednosti F odredene su u deset sela s pet razlicitih
hrvatskih otoka: Braca, Hvara, Korcule, Lastova i Suska. Za potrebe ovoga istrazi¬
vanja, LD je defmirana kao nemogucnost pohadanja sustava osnovnog obrazovanja.
Kako su osnovne skole (1.-8. razred) u mjestu istrazivanja drzavne i obvezne, procjena
nemogucnosti svakog djeteta da pohada osnovnu skolu vrsi se u dobi od 6 godina.
Testiranje je obvezno za svu djecu a temelji se na skupu testova kojeg propisuje Minis-
tarstvo prosvjete. Prosjecni koeficijent urodenosti u svakom selu izracunat je na teme-
lju genealoskih podataka 20-30% odraslog stanovnistva upotrebom Wrightove »path«
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metode. Prevalencija LD kretala se izmedu 0.43% i 2.47%, a vrijednost koeficijenata
urodenosti izmedu 0.8% i 4.9%. Pearsonov koeficijent korelacije izmedu F i preva-
lencije LD bio je 0.80 (p<0.01). Iako je relativni rizik za svakih 5% urodenosti bio velik
(oko 10), apsolutni rizik pritom raste s procijenjenih 0.18% na samo 1.77%. Geneticki
ucinak srodivanja procijenjen je na 0.69% a pripisivi populacijski udio na 76.6%.
Pregled raspolozive literature i rezultati ovoga istrazivanja ukazuju na zakljucak da bi
vrlo velik broj pretezno recesivnih genetskih cimbenika mogao biti odgovoran za
genetsku sklonost razlicitim tipovima LD medu stanovnistvom.
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biological basis of late-onset disease has been
ted by genetic factors subject to varying degrees of
utionary constraint. Late-onset traits are not only
e sensitive to environmental variation, owing to the
ikdown of homeostatic mechanisms, but they also
v higher levels of genetic variation than traits
:tly influencing reproductive fitness. The origin and
>re of this variation suggests that current strategies
>oorly suited to identifying genes involved in many
plex diseases.
ijor focus of current interest lies in the genetic vari-
r underlying susceptibility to common, late-onset
an diseases such as heart disease, diabetes and
er. These diseases result from the cumulative break-
l of many quantitatively varying physiological sys-
over the course of decades of life. They are orders of
nitude more common than individual mendelian
•ders and are typically more prevalent in post-
jductive life, which means that they may be less
jet to selective constraints (see Glossary). The
se mechanismsmaintaining genetic variation in such
s are poorly understood, but three broad categories
dentifiable [1], First, variants that are deleterious in
early and later life, which are therefore efficiently
;ned by natural selection and held at low population
lencies. Second, variants that are selectively neutral
trly life but show late deleterious effects; this means
they are subject only to weak selection and can reach
er frequencies. Third, variants that are favourable in
r life but deleterious later on; these can be maintained
election at intermediate frequencies. Strategies for
jfying disease susceptibility genes depend both on the
ice of common and rare variants maintained in the
lation, and on whether these occur at a limited
iogenic) or a large (polygenic) number of loci. In this
le, evolutionary and population genetic arguments
ised to examine these issues and to suggest that
mtly favoured strategies could be poorly suited to
ifying disease susceptibility genes,
le strategy assumes that most disease susceptibility
nts are common in the population (frequency >0.01)
l common disease/common variant (cd/cv) hypoth-
[2]. This proposes that individuals with disease have
responding author: Alan Wright (alan.wright@hgu.mrc.ac.uk).
js.trends.com 0168-9525/03/$ - see front matter © 2002 Elsevier Science Ltd. All rii
an excess of common susceptibility alleles, and that these
are potentially detectable in large-scale patient-control
association studies. However, if late-onset diseases are due
to large numbers of rare variants at many loci - the
common disease/rare variant (cd/rv) hypothesis - this
strategywould fail and the contribution ofmost individual
variants would be too small to further our understanding
of disease [3], To evaluate these issues, we first examine
our current knowledge of human genetic diversity.
Hidden genetic diversity
The human population is both evolutionarily young and
genetically uniform, with less diversity than most other
species, including other primates [4], The most abundant
differences between individuals are single nucleotide
polymorphisms (SNPs), which account for most of the
observed variability in typical sequence surveys [5]. The
great majority of SNPs occur outside coding regions and
their distribution is broadly consistent with selective
neutrality [6], There are —10 million predicted SNPs
with allele frequencies above 0.01 [7]. Under the CD/CV
hypothesis, these provide the major genetic substrate for
common diseases. However, this picture may give a
misleading impression of the genetic variation underlying
the emergent diseases of modern civilizations.
The principal reason is that the vast majority of
DNA sequence variants, including most of those with
functional effects, are expected to be rare [8]. Genetic
theory predicts that the distribution of neutral sites is
heavily skewed towards low-frequency variants with as
many below a frequency of 0.01 as above it [9]. But the
proportion of rare variants is even higher for two
reasons. First, most mutations with phenotypic effects
are deleterious [10], so that their frequency is reduced
by selection. Second, the human population has been
expanding, generating large numbers of rare alleles by
mutation [11] (Fig. 1). The overall pattern is therefore one
of relatively few common SNPs and many individually
rare single nucleotide variants.
The majority of disease-causing alleles in early-
onset mendelian disorders are recent, diverse and
rare, resulting in extreme allelic heterogeneity. This
is expected for deleterious alleles exposed to early
selection, but is also found in later-onset diseases,
including familial forms of cancer, coronary artery
disease and Alzheimer dementia [12]. For example,
reserved. Pll: S0168-9525(02)00033-1
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on disease results from a small number of common polymorphic
ts at one or more loci.
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Fig. 1. (a) Diagram of human population expansion illustrating (1) the large num¬
ber of 'young' mutations (filled circles) compared with polymorphic variants (open
circles), most of which are ancient (>100 000 years old) but some of which might
have become common within recent times as a result of a selective advantage;
and (2) the low number of alleles in human founder populations and high number
of alleles in large modern populations [11]: (b) Mutation rates and disease.
Mutation rates for human monogenic diseases vary from < 10-7 to 10-4 per locus
per generation. There appear to be more loci with low than with high mutation
rates resulting in disease. High mutation rates in genes causing Duchenne muscu¬
lar dystrophy (5x10-5 to 10x10-5) and neurofibromatosis type 1 (1 x 10~4)
account for their high incidence (at mutation-selection balance). Similarly, genes
with high mutation rates are predicted to contribute disproportionately to the gen¬
etic variance underlying common diseases [62]. The red boxes indicate accurately
estimated mutation rates for more common diseases, the blue boxes indicate
rates for rarer diseases, which are only known within an order of magnitude. The
data are taken, with permission, from [63,64] (© Springer, 1986).
according to the Breast Cancer Information Core (BIC)
database (http://research.nhgri.nih.gov/bic) the familial
breast cancer genes, BRCA1 and BRCA 2, show at least
1200 and 1400 different mutations of large effect, each of
which are rare, except in some founder populations. This is
despite the fact that well over half of these tumours occur
post-reproductively, so that causal alleles might reach
higher frequencies. Most of these mutations are likely to
be either of recent origin or to show direct or indirect
deleterious effects on fitness. By contrast, out of the five
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i) Cumulative lifetime risk of coronary artery disease in males [37], which
almost one in two and shows a late-age levelling in disease risk, consist-
some of the genetic models discussed, (b) Heritability changes with dis-
! of onset. Possible changes in the additive component of genetic variance
ige) in relation to the environmental variance (VE, blue) and heratibility
Die) with disease age of onset. Heritability is not an ideal measure of gen-
mce in this context, because of the increase in VE with age [1,27].
well-established common SNPs within BRCA1 and
2 coding regions (coding SNPs or cSNPs), only one
sen shown to exert a marginal (1.3-fold) increase in
; cancer risk [13]. A small increase in risk in many
s might account for a large fraction of cases. But this
so if such effects occur within highly interactive
c networks, with many other variants of similar or
ite effect at varying frequencies in different popu-
s, as expected under a CD/RV model. The pattern of
mds of recent and rare mutations, many with large
;, and a small number ofancient cSNPs is predictable
iut here it is argued that most cSNPs are common
ely because they have little or no functional effect
on disease or on reproductive fitness,
jding SNPs (comprising—1.5% ofall SNPs) are more
to influence physiological function (hence disease)
aoncoding ones, are they any less common? The
of cSNPs that change an amino acid and are also
ted on structural grounds to be deleterious, occur at
cantly lower frequencies than other SNPs, suggest¬
ing that they are indeed selected against [14,15], Analyses
of sequence divergence between humans and primates
suggest that ~ 20% of all cSNPs are selectively neutral,
most of which are common; of those predicted to be
deleterious, over 80% are likely to be at frequencies below
0.01 (i.e. not truly polymorphic) [14].
In summary, the genetic variants that are most readily
identified and studied inhumans are SNPs, butmostofthese
appear to have little orno effect eitheron reproductive fitness
or on any sort of function. By contrast, the majority of
deleteriousvariants,which areofmostpotential relevance to
disease, are rare and accordingly difficult to study.
Genetic variation in late-onset traits
Is the pattern of genetic diversity likely to be different for
variants influencing late-onset diseases? Unravelling the
genetics of complex traits often requires indirect infer¬
ences about what are believed to be the many genes
influencing them. Such 'polygenic' effects are thought to be
too small and numerous to be measured individually, so
their effects are measured collectively by partitioning
the phenotypic variance into genetic and environmental
components (Box 1).
How these components of genetic variance differ for
late- versus early-onset traits has been examined in some
detail theoretically. The intensity of selection on a gene
with a late effect on fitness declines with the age atwhich it
is expressed [16-19]. This implies that variants in such
genes could reach higher frequencies, which would favour
the CD/CV hypothesis. The 'mutation accumulation' (MA)
model [17,19-21] extends this idea by suggesting that
deleterious alleles with late effects accumulate in the
genome, contributing to senescence and, by extension, to
genetically influenced diseases that contribute to it. If
these alleles have deleterious effects during reproductive
life, they are still expected to be maintained at low
frequencies, despite the diminishing force ofselection with
age. The 'trade off' (TO) (or antagonistic pleiotropy)
model [18,19] provides an alternative, in which late-acting
deleterious alleles can spread and even become universal in
the population, if they also have favourable effects at an
early age. Most genes are expressed before the end of
reproductive life, and so are subject to selective scrutiny,
but many show effects on different traits (pleiotropy) at
different times, with variable effects on fitness [19].
The expected higher frequencies of deleterious alleles
with late-age effects are accompanied by increases in the
components of genetic variance, because alleles with
intermediate frequencies contribute more to these than
do rare alleles [20,21]. Under both MA and TO models, the
genetic variance components resulting from additive (Va)
and dominance (Vd) effects (Box 1) are expected to be
larger for late- than for early-onset traits influencing
fitness [20]. A late-age levelling in the rates ofgenetically
influenced diseases, such as cancer, diabetes and cardio¬
vascular disease, is also predicted by these models, much
as observed (Fig. 2) [21,22]. Are the models supported by
experimental data?
In Drosophila melanogaster, an increase in both Va
and Vd has been observed for several late-onset traits
[20,23,24], suggesting that allele frequencies do indeed
.trends.com
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x 1. Variance components and inbreeding effects
:e-onset diseases can be considered to result when a threshold of
antitatively varying risk or liability is exceeded [a]. Liability results
m the net effect ofmany quantitative traits (QT), which are influenced
genes and environment, often with small individual effects on risk,
d hence are difficult to identify. These genetic effects can, however, be
scribed collectively by analysing the components of genetic variance,
ich are estimated from the resemblance between relatives for
ease or QT. The total genetic variance (VG) of a complex trait can
partitioned into its components [a]:
Additive genetic variance (VA): the component of variance due to
genetic effects that are directly transmissible from parent to
offspring, and which are the main causes of resemblance between
relatives.
Dominance variance (VD): the component of variance due to
interactions (departures from additivity of effects) between alleles
at the same locus, such as partial or complete dominance or
recessivity.
Epistatic variance (V|): the component of variance due to interactions
between alleles at different loci.
rhe total phenotypic variance (VP) in a trait is the sum of VG and any
ngenetic (environmental) effects (VE), together with effects of
eractions between genotype and environment (VGE). The (narrow-
lse) heritability is the ratio of VAto VP.
Chese components can be estimated from correlations between
atives, such as parents and offspring or full-sibs. In practice, it is
icult to separate V0 and V,, and they are often treated as a single
nponent of nonadditive variance. Late-onset traits are predicted to
jw higher values of VA and VD [b,c],
Vnother source of information on genetic variation influencing
ease is to measure the effects of inbreeding. Inbreeding can
ltribute to disease [d,e] and to inbreeding depression [f]. This results
m increased homozygosity of trait alleles, which either show
essive effects on the trait acting in the same direction (directional
finance; see Glossary) or show heterozygous advantage. 8, the
gative of the regression coefficient of trait mean on inbreeding
ifficient F, provides a useful summary statistic for the genetic damage
t would occur if all deleterious recessives were made homozygous
= 1); it is often called the inbreeding load (see Glossary) [a,f].
f survival to adulthood is measured on a scale of natural logarithms, B
ivides an estimate of the number of deleterious mutations causing a
tetic death (lethal equivalents). In one human study, B was 0.7 per
nete [e], suggesting that each (diploid) individual is heterozygous for
lethal equivalents affecting juvenile mortality.
"he value of B for lethal mutations is similar in a variety of species.
:essive lethals contribute about half the inbreeding load for mortality
Jrosophilaup to the adult stage, the rest coming from mutations with
minor effects (detrimentals) [fj. A typical fly carries one lethal mutation
in the heterozygous state. A recent study of two fish species suggests
that, despite their greater genome size, a similar value applies to
vertebrates [g].
Theory shows that the value of B due to deleterious mutations
depends only on the genome-wide mutation rate and the dominance of
individual mutations [f,h]. If all mutations have the same effects, the
value of B for a disease-related trait that is positively correlated with
fitness is:
B = Ua{(Mh) - 2}
where U is the mutation rate per diploid individual to deleterious alleles
affecting the trait; h is the extent to which fitness is reduced in a
heterozygous mutation, relative to its effect in homozygotes; and a is a
constant of proportionality relating the effect of a mutation on the trait to
its effect on fitness.
Relating the measurement of variance components and inbreeding
effects to the predictions of models of the maintenance of genetic
variation provides an important means of testing the models [f,h,ij.
Variance component analysis is also used in quantitative trait locus
(QTL) mapping.
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ease for late-onset traits. Other evidence comes from
suring the detrimental effects of inbreeding (inbreed-
depression) (Box 1). Alleles with nonadditive effects
h as recessives) are expected to cause increased
eeding depression for late- compared with early-
it traits, which is a unique prediction of the MA
el. Age-related increases in and in inbreeding
■ession have both been found for fitness-related
ts in Drosophila [24]. If this is also true in humans,
jnificant fraction of the genetic variance underlying
i diseases with small effects on fitness could be due to
alleles [20]. However, the MA and TO models are not
ually exclusive and other Drosophila data support the
e-offmodel, implying the presence of alleles at higher
uencies as well [19]. The evidence from other species is
ty, but an increase with age in heritability (Box 1) of
luman late-onset trait longevity [25] is consistentwith
igs.trends.com
the prediction of increased genetic variance underlying
late-onset traits.
In short, the analysis of genetic variance components
suggests that there is an increase in the frequencies of
alleles influencing late-onset traits. But this does not
imply that such variants are at high enough frequency to
favour the CD/CV strategy; indeed, inbreeding effects
suggest that many of them are at low frequencies. We now
examine other evidence regarding the nature of such
genetic variance.
Mutation and rare variants
Complex traits are influenced by many genes and so
provide large mutational targets. Recent mutations
provide a rich source of low-frequency variants, which
account for a significant proportion of the standing
genetic variation in all organisms [10,26,27] (Box 2).
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2. The fate of new mutations
iverage time that newmutations persist in a population depends on
selective disadvantage, their dominance effects and the effective
lation size (A/e) (see text) [a-c].
>st deleterious mutations are destined for ultimate loss from
lopulation, within a time in generations of the order of the
al logarithm of Ne, unless their selection coefficients are smaller
the reciprocal of the effective population size [d]. Assuming an Ne
imans of —10 000 [e,f] this gives a mean persistence time of
id 10 generations, with a very wide distribution around the
i [d]. But the continual production of new mutations with each
ration will lead to the maintenance of most deleterious variants
given locus at low average frequencies close to those expected
luilibrium in an infinitely large population (mutation-selection
ice) [c].
lile they persist in the population, these alleles contribute genetic
nee to the traits that they affect. The extent of the contribution
nds on their mutation rates, their effects on the trait, the
onship between trait and fitness, and on Ne [c,g]. Most of these
ot known with any precision.
nulations suggest that loci with moderate to high de novomutation
contribute disproportionately to the genetic variance underlying
an disease [h]. The over-representation of human disease loci with
mutation rates is readily seen in monogenic diseases (see Fig. 1b in
text) and thismaybe accentuated in more complex traits where the
ational target' is considerably larger, including noncoding and
atory sequences, many with very small effects [i,j], neutral
es, such as the majority of SNPs, may reach higher frequencies
re predicted to make a substantially smaller overall contribution to
the disease variance, because they are likely to have very small effects
on the trait.
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is especially so for populations, such as humans,
lave undergone large and recent expansions. This
[tonal variance is a function of mutation rates,
;ional target size and population size. The effective
.ation size (Nc) refers to the number of individuals
contribute genes to succeeding generations, and
)ls the rate ofchance fluctuations in gene frequencies
tic drift). Long-term Ne has been estimated to be
)00 in humans, based on sequence diversity. Popu-
expansion means, however, that the number of rare
its of recent origin is greater than predicted for an
brium population with this value ofNe (Fig. 1). Such
t and rare mutations are clearly major contributors
man disease, and yet the inherent difficulty in
;ing them tends to overemphasize variants, such as
, that are readily detectable.
st mutations are deleterious and destined to be lost
i a few generations (Box 1). As a rule of thumb the
mcy of a mutation that reduces fitness by at least
,) is mainly controlled by selection rather than
ic drift [28]. Therefore, even disease alleles with
asurably small effects on fitness can be held at low
ation frequencies [20,28], The frequencies of new
ions are therefore strongly influenced by their
i on fitness, which may be substantial for mutations
significant effects on disease, because the size of
or indirect (pleiotropic) allelic effects on traits tends
:orrelated with their effects on fitness [27,29,30]. For
ticular disease susceptibility gene, the collective
mcy of new deleterious mutations is therefore
ted to be low, and close to that expected under
ton-selection balance (Box 2) [14-16].
The large size of the human genome results in a steady
and substantial input of new mutations - estimated to be
in the region of 175 per person per generation [31]. As a
result, each ofus carries a predicted 500-1200 deleterious
mutations, most of which are rare (<0.01), in addition to
those that are strongly deleterious and too rare to be
detected in small sequence surveys [14].
Many variants with small phenotypic effects occur
outside coding regions, so that genome-wide mutation
rates to deleterious alleles [32] and the number of
deleterious mutations each person carries could be con¬
siderably higher than estimates based only on coding
regions. Noncoding regions might contribute at least 60%
as much as coding regions to the genome-wide mutation
rate [15]. There are examples ofnoncoding mutationswith
large effects on disease [33], but those with small effects
should be even more common, because there are many
more ways for these to subtly alter expression or function.
Indeed, there is an increasing number of examples of
small-effect quantitative trait locus (QTL) alleles
located within noncoding regions, including ones relevant
to human disease [34,35]. Mutations with essentially no
effect on fitness can also influence late-onset traits, and
should be at higher frequency. At the other extreme, only a
small proportion of mutations show large phenotypic
effects, but these tend to be over-represented in indivi¬
duals with disease, as a result of selective ascertainment.
Summarizing the evidence
The possibility that a significant fraction of the genetic
variation in complex traits is owing to rare alleles
maintained by mutation-selection balance is supported
[.trends.com
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3. Estimating the number and effect size of genes influencing a complex trait
'inciple, it is possible to estimate the number of genetic loci
ancing a complex trait. In practice, estimates often have large
iling variances and require assumptions that are not always met.
:lassical method [a] is to cross inbred or natural populations that
/ a large difference in trait value and estimate the number of
valent effect' genes accounting for the difference on the basis of the
variances in the hybrid offspring (F1, F2 and backcross gener¬
is). This assumes that all 'high' alleles are fixed (homozygous) in
Darental line and 'low' alleles in the other. Zeng [b] has eliminated
in these estimates by accounting for recombination between loci
inequal gene effects. For tomato fruitweight, he found it difficult to
late the total number of genes, which varied from 17 to 1540
nding on the shape of the gene effect distribution, but a minimum
loci accounted for 95% of the genetic variance regardless of the
t distribution.
;econd method depends on the systematic genetic mapping of trait
distinguishing a pair of lines, yielding direct estimation of gene
bers [c]. This approach is constrained by lack of power to detect
nts with small effects without unrealistically large samples but has
useful in showing the leptokurtic or L-shaped distribution of gene
t size using livestock and bristle number data [c,d].
:ither of these methods provides a direct estimate of the number of
;egregating within a population; if the lines concerned have been
ed from a natural population, they at least provides lower bound to
umber of such loci.
A third method can be applied directly to population data, including
humans, and is useful for estimating the number of recessive or partially
recessive loci contributing to a trait that shows inbreeding depression
[e,f]. The effect of inbreeding, B, and the dominance variance, Vo, are
measured (Box 1). A lower bound to the number of genes, n, affecting
the trait is provided by:
n a B2/Vd
References
a Falconer, D.S. and Mackay, T.F.C. (1996) Introduction to Quantitat¬
ive Genetics, 4th edn, Longman
b Zeng, Z.-B. (1992) Correcting the bias of Wright's estimates of the
number of genes affecting a quantitative character: a further
improved method. Genetics 131, 987-1001
c Barton, N.H. and Keightley, P.D. (2002) Understanding quantitative
genetic variation. Nat. Rev. Genet. 3, 11-21
d Hayes, B. and Goddard, M.E. (2001) The distribution of the effects of
genes affecting quantitative traits in livestock. Genet. Sel. Evol. 33,
209-230
e Charlesworth, B. and Hughes, K.A. (1999) The maintenance of
genetic variation in life-history traits. Evolutionary Genetics: From
Molecules to Morphology (Vol. 1) (Singh, R.S., Krimbas, C.B. eds),
pp. 369-392, Cambridge University Press
f Rudan, I. et al. (2002) Inbreeding and the genetic complexity of
human hypertension. Genetics in press
years of research into the genetics of quantitative
(QTs) in Drosophila. A review of this extensive
ture [27] suggests that deleterious alleles generated
utation, and kept at low frequencies by selection,
bute between 33% and 67% of the genetic variation
epical trait with at least some effect on reproductive
s. These are likely to include many of the QTs that
ajor determinants oflate-onset disease, whose effects
isease begin well within reproductive life. The
nder of the genetic variance appears to involve
3 at higher frequencies, maintained by some form of
icing selection, such as heterozygote advantage or
>ral, spatial or frequency-dependent selection [1,27].
erall, allele frequencies might be higher for late-
for early-onset traits, but this is consistent with
is favouring both low (MA model) and intermediate
lodel) frequency alleles. We currently lack any firm
m the size of these effects in humans, and onwhether
cting alleles that are at higher frequencies are the
nost likely to be important in understanding disease,
e contrary, the low predicted frequency of function-
ieleterious alleles suggests that most clinically
icant disease susceptibility alleles will not be 'high'
sense implied by the CD/CV hypothesis. Strategies
mtifying susceptibility alleles that are not robust in
ce of a large and diverse group of rare alleles could
'ore fail.
umber and size of allelic effects
plicit assumption ofmost common disease mapping
gies, including the CD/CV hypothesis [11], is that
ex traits are oligogenic, so that susceptibility loci are
tially detectable and informative for disease predic-
r understanding. If, however, common diseases are
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truly polygenic, most individual effects will be too small to
be useful. A limited number of loci appear able to exert
strong monogenic effects on disease, suggesting that these
influence rate-determining steps in disease pathways. The
rarity of individual mutations under the CD/RV model,
together with the large number of loci atwhich mutations
can arise, means that the genetic basis of disease could
vary greatly among individuals with the same disease.
The locus complexity ofa trait depends on two factors. The
first is its physiological complexity. Hirschsprung disease, for
example, is a rare and highly specific lack ofenteric ganglia,
in which no more than eight loci account for most of the
variance [36]. By contrast, coronary artery disease is ahighly
complex multidimensional trait with an exponentially
increasing lifetime risk that is influenced by more than 280
risk factors [37,38] (Fig. 2a). The second factor is the
distribution ofgene effects. This is clearly important, because
if most of the trait variance is determined by a handful of
potentially detectable genes, the total number is irrelevant.
An L-shaped or exponential distribution ofmutation effect
sizes has wide support [1,39], with many genes of small
effect and fewer of large effect. However, even if a small
number of genes account for the most extreme effects, the
average patient with disease will not show large effects if
there are many other determinants (Box 3).
Genetic models commonly assume a polygenic basis for
complex traits, but the actual number of loci is hard to
estimate [1]. Many loci with small effects will not be
detectable using finite samples, and the effects ofindividual
alleles are commonly overestimated. One way to estimate
the number of loci is to combine estimates of dominance
variance (VD) and the inbreeding load CB) (Box 3). Because
inbreeding depression results from increased homozygosity
at loci influencing the trait, a regression of QT value (or
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etection of clinically useful genetic effects in 'typical' patients with late-
;ease is likely to be impossible, but it may be feasible in those at the
; of the disease or risk factor distribution, (a) Average patients have aver-
;tic effects. The relationship between risk factor distributions in the gen-
jlation and in a population with disease shows that most disease events
those within the normal range, because risk increases at all levels [41,42].
jhasizes the need for genetic analysis of those at the extremes of the dis-
. (b) Predicted L-shaped relationship between the number of quantitative
(QTL) genes and the percentage of the trait variance explained. QTL con-
to the left of the distribution will often be undetectable, and those contri-
3 the tail of the distribution on the right show larger effects and are
ly detectable. The number of QTL might be too large for specific loci to be
illy detectable in 'typical' patients, most of whom lie within the normal
r individual risk factors. However, gene identification could be both tract-
I heuristically useful in those at the extremes of the distribution (e.g.
10%) [40].
e prevalence) on the inbreeding coefficient can
e a lower limit for the number of segregating loci
). If the minimum number of loci required to explain
>f the trait variance is large, then individual QTL
might be too small to be detected with finite samples,
i et al. [40] came to exactly this conclusion in a study of
ding effects on blood pressure. Assuming an L-shaped
ution of allelic effect sizes and VD/VP of 0.33, the
25% of variation in systolic blood pressure could be
icd by aminimum of24-48 genes, and the upper 50%
east 90-165 genes [40] (Fig. 3b). The total number of
mtory loci must be even larger, because this estimate
es those with purely additive effects. These results
suggest that loci underlying a trait such as hypertension in a
'typical' patient are likely to be so numerous and of such
small effect that gene identificationwill be either impossible
or unhelpful. The problem is compounded by the fact that
most risk factors in common diseases operate at virtually all
levels, so that the 'average' patient typically has a traitvalue
within the normal range, and most individual effects
could be too small to detect [41,42] (Fig. 3a).
Global environmental change
To what extent does recent human environmental change
affect our increasingly elderly populations? The shift in
age structure is itself a major environmental change to
which our genomes are poorly adapted. However, a wide
range of common diseases have shown large changes even
in age-standardized prevalence within the past 50 years,
especially in western societies [43], Environmental changes
almost certainly account for this, raising questions about
the overall significance of heritable components (Box 4).
Gene-environment interactions can be seen with late-
onset diseases, such as type 2 diabetes [44], inwhich recent
dietary changes appear to be amajor contributor to disease
[45]. Ethnic variation in susceptibility to such diseases is
often taken as support for the role ofgenes, but it is equally
plausible that the most relevant genetic factors are
essentially invariant in such populations as a result of
strong selective advantages in the past [46] — the common
disease/fixed variant (cd/fv) hypothesis. Conventional
mapping studies would then fail to detect them. A striking
example of the power of selection is the relatively recent
fixation of the Duffy blood group FY*0 allele in sub-
Saharan Africans, probably because of increased resist¬
ance to Plasmodium vivax malaria [47].
Other genes appear to have been under strong selection
in certain populations without leading to fixation, result¬
ing in alleles at intermediate frequencies [48,49] (Fig. la).
Variants such as those found in certain MHC class I and II
haplotypes show functionally significant effects and are
therefore good candidates for the CD/CV approach. Traits
exposed to major environmental change, such as dietary
alteration at the time of urbanization, immunity to
disease, response to starvation and some cultural beha¬
viours are promising in this respect.
Gene identification under a polygenic hypothesis
The scenario of a major class of deleterious but individu¬
ally rare alleles of recent origin underlying the heritable
component of late-onset diseases has been largely ignored
until recently. It poses seemingly intractable statistical
problems for gene mapping and is therefore an unattrac¬
tive investment for grant-awarding agencies and biotech¬
nology companies. More attractive alternatives, such as
the CD/CV hypothesis, appear to be driving the research
strategy in spite of, rather than because of, the science.
An example is the proposal to use high-frequency SNP
haplotypes to identify common disease determinants by
population association studies [50,51]. A recent muta¬
tional origin for the variants underlying much of the
heritability in such diseases means that many will be
superimposed on ancient core haplotypes. The majority of
new variants are deleterious [26,27] and multiple variants
trends.com
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4. Establishing a genetic basis for late-onset disorders
rding to the website Online Mendelian Inheritance in Man (http://
r.ncbi.nlm.nih.gov/entrez/Omim/mimstats.html), fewer than 10%
uman transcribed sequences (including alternative transcripts)
j mutations capable of major (monogenic) effects that are relatively
aendent of context. By contrast, most common diseases are highly
indent on both genetic and environmental context, although they
irally show significant heritability (&0.1) (see Fig. 2b in main text),
iritability is assumed to be present if there is an increased trait
ilation in relatives compared with unrelated individuals. Relatives
scially twins) are, however, exposed to more similar environments
random controls; also, genetic and environmental effects fre-
itly interact and are correlated, so that in the absence of extensive
sib or adoptive twin data, basic assumptions may not be met,
ng to overestimation of heritability [aj.
e magnitude of genetic effects in complex traits is frequently
-fed by known environmental factors, leading some to question
turrent emphasis on genetics [b]. For example, diet, physical
ivity and tobacco have been proposed to account for 75% of new
s of cardiovascular disease [c]. In developed countries, tobacco
ting alone causes one-third of all cancer deaths [d], 80% of
nic bronchitis [e] and 13% of coronary artery disease [e]. In
tion, recent environmental change has resulted in a global
amic of type 2 diabetes, with uncertain consequences for
ability. In coronary artery disease, heritability declines with
af onset [f], implicating either increased environmental variance
reduced total genetic variance (V/G), or both, in later life (see
2b in main text).
e contribution of individual genetic factors to complex disease is, in
teases, seldom greater than a few percent of the trait variance and a
I percentage of cases. For example, currently known breast cancer
s account for <2% of population risk [g]. The collective contri-
>n of genetic variability, summarized by measures such as
ability or coefficients of genetic variation, is however both
tantial and almost universal in complex traits, for reasons that
liscussed in the text.
en with the standardized environments and reduced diversity of
-atory mice, mapping of QTL for obesity-related traits suggests
/ genes of small effect [h]. Some QTL influencing human disease
/ larger effects, such as APOE*E4, which accounts for up to 10% of
ariance in both plasma cholesterol and age of onset for Alzheimer
disease, although some of these effects might result from interactions
(e.g. with dietary fat [i]). Opportunities for disentangling interactions
between genes and environment are often limited [j].
The identification of genes accounting for rare monogenic forms of
common diseases (e.g. breast and colon cancer, Alzheimer disease) has
made a substantial contribution towards elucidating disease mechan¬
isms and has led to therapeutic progress (e.g. statins, secretase
inhibitors). It is less clear whether the identification of variants with
small effects on disease risk will have a similar impact. Predictions
based on experimental organisms suggest that the lack of control of
genotype or environment in human studies, together with context-
dependence of QTL effects, mean that individual QTL effects will
generally be very small [k].
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